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Abstract 
 The asymmetric alkylation of a glycine Schiff base in addition to the development of a 
[2,3]-Wittig rearrangement under phase transfer catalysis (PTC) reaction conditions was 
investigated. Supplementing these studies, a deeper understanding of the PTC mechanism was 
sought for the alkylation of phenol. 
 In regards to the asymmetric PTC (APTC) alkylation, a small library of catalysts derived 
from Cinchona alkaloids was examined for selectivity and activity. An array of substituent 
modifications were tested, examining the role of steric and electronics on catalyst activity. 
Catalysts that contained large substituents attached to the quinuclidinium core were found to be 
the most selective and those in which the hydroxyl group was protected generally afforded faster 
catalysts.  The removal or augmentation of the dipole of the hydroxyl group position 
significantly impacted catalyst activity. 
 For the development of an APTC [2,3]-Wittig rearrangement, substituted α-allyloxy-
phenylacetonitrile substrates were employed. Under liquid-liquid PTC reaction conditions, these 
substrates were found to rearrange and afford phenyl ketone products. Initial rearrangement 
products that contained enolizable hydrogens were found to isomerize under the reaction 
conditions. The use of terminally disubstituted allkyloxy substituents led to the formation of 
ketones containing adjacent carbon-centered quaternary stereocenters as stable rearrangement 
products. When a [5,5,5]-pyrolizidinium type of chiral, non-racemic catalyst was employed with 
a prochiral substrate, an enantioenriched rearrangement product was obtained, albeit in low 
selectivity (er 55:45). 
 The mechanistic analysis of the base-mediated PTC alkylation of phenol has revealed 
startling insights. A series of symmetrical, tetraalkylammonium salts were examined for their 
 iii 
catalytic and intrinsic reactivity.  Tetraalkylammonium phenolate salts were prepared from the 
corresponding ammonium bromides and their activity was evaluated for the n-butylation of 
phenol.  Small differences in intrinsic reactivity were observed with alkyl lengths greater than 
C2.  In contrast, under phase transfer catalysis conditions large differences in alkylation rate were 
observed among C2, C3 and C4 tetraalkylammonium catalysts.  Consequently, the intrinsic 
reaction rate plays only a minor role in the reactivity of tetraalkylammonium catalysts using a 
phase transfer process. Benzyl bromide titration of the organic under PTC reaction conditions 
revealed the presence of potassium phenoxide complexed with the tetraalkylammonium 
phenoxide. The relative amounts of complexed potassium phenoxide was found to have a 
negligible impact on the catalytic activity. 
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CHAPTER 1: Phase Transfer Catalysis Fundamentals 
1.1. Introduction 
1.1.1. What is Phase Transfer Catalysis? 
 Phase transfer catalysis (PTC) as a reaction protocol is defined by the separation of 
reactants and reagents between two or more different immiscible phases in which the transport of 
the reactants and reagents is facilitated by a phase-transfer agent.1 Often, this agent is referred to 
as the phase transfer catalyst, or simply catalyst. Generally, this process involves the transport of 
ions between phases facilitated by the formation of a catalyst-reagent ion pair. After the 
intermediate ion-pair has crossed the phase boundary, this reactive ion-pair can participate in a 
number of different chemical reactions. Finally, the catalyst must be regenerated after its 
transport of the reactant/reagent to complete the catalytic cycle. 
 PTC reactions are performed as a combination of phases; the most common are liquid-
liquid and liquid-solid phase reactions.  In the case of liquid-liquid PTC reactions, one phase is 
generally a non-polar organic solvent and the other phase is a polar solvent, typically an aqueous 
solution. Most often, a reagent is transferred from the aqueous phase into the organic phase. 
Solid-liquid PTC reactions are similar in most respects with the exception that one phase remains 
a solid. The majority of PTC processes involve reactions of interest taking place in the organic 
phase, although in certain cases this trend may be inverted and the desired reaction will proceed 
in the aqueous or solid phase.2 
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1.1.2. Advantages of a PTC Process 
 PTC reactions has enjoyed much commercial success in recent decades and as of the 
early 1990’s over 500 applications of PTC have been implemented within the chemical industry.3  
PTC represents an attractive alternative to traditional chemical reactions conducted in a 
homogeneous medium, primarily because of its generality with regard to reaction scope.  In 
addition to its generality, PTC processes offer the advantage of mild reactions conditions, readily 
available raw materials, solvent flexibility, and facile product isolation.  Often the main obstacles 
to the implementation of a successful PTC process are the choice of catalyst and the time 
required for process optimization at large scale.4  Advances in recent decades have demonstrated 
that PTC processes can be applied to asymmetric transformations as well (See Section 1.2).5 
 
1.1.3. Examples of PTC Reactions 
 The concept of PTC was first described by Starks in which various alkyl halides in an 
organic solvent underwent SN2 displacement reactions by cyanide ions in aqueous solution 
catalyzed by a quaternary ammonium or phosphonium salt.6  These catalysts allowed for the 
transport of anion, normally insoluble in an organic solvent, to react with a suitable electrophile 
in the organic phase. This catalyst-reagent ion pair is sufficiently reactive to displace an alkyl 
halide. Starks also investigated olefin oxidation, olefin cyclopropanation, hydrogen/deuterium 
exchange, ketone reduction, and hydrolysis reaction through similar PTC processes. 
 Some of the more widely applicable reaction classes that are susceptible to PTC include 
SN2 displacements, alkylations, oxidations, reductions, polymerizations, hydrogenation, and 
hydrogen/deuterium exchange.7 Some of the oxidizing agents that have been applied to PTC 
include, permaganate, hypochlorite, peroxide, oxygen, and periodate.8,9 Common PTC reducing 
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agents have included borohydride, aluminohydride, and formate anions. Examples of SN2 
displacements include the use of cyanide, halide, alkoxide, and carboxylate anions.  PTC 
alkylations have been employed for the formation of C-C, C-N, and C-S bond with a variety of 
organic substrates. 
 In addition to the wide scope of reagents employed in PTC processes, the catalyst used 
for a particular reaction has shown similar chemical diversity.  The catalyst used can be either 
soluble in one of the two phases or insoluble.  Soluble catalysts include quaternary ammonium 
and phosphonium salts, polyethylene glycol and its derivatives, crown ethers and cryptands, and 
polymeric analogs.  Insoluble catalysts include polymer-bound derivatives of soluble catalysts, 
or species which show negligible solubility in either phase and exist as a separate third phase.  
No one class of catalyst can be applied to all reactions amenable to PTC processes.  For this 
manuscript, only quaternary ammonium salt catalysts will be discussed. 
 
1.2. Mechanisms of Phase Transfer Catalysis 
1.2.1. Extraction Mechanism 
 Two competing mechanisms are thought to exist for PTC processes.10,11 The extraction 
mechanism, first proposed by Starks in the early 1970’s, postulates that the phase-transfer 
catalyst can transport counterions between the aqueous and organic phases.6 For example, in the 
PTC cyanide displacement of 1-bromooctane with a tetraalkylammnonium (R4N
+) and/or 
phosphonium salts (R4P
+), Q+ (Figure 1). First, the phase-transfer catalyst exchanges its native 
counterion for a cyanide anion in the aqueous phase. Second, the newly formed ion pair, Q+CN-, 
must then be extracted into the organic phase by crossing the interface where the equilibrium of 
this transfer is determined by the properties of the ion pair. The Q+CN- ion pair is then poised to 
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react with 1-bromooctane in the organic phase, and this step is referred to as the intrinsic 
reaction. In this case the intrinsic reaction regenerates the catalyst, but the original ion pair, 
Q+Br-, must be extracted back into the aqueous phase to complete the catalytic cycle. The 
sequences of steps that transport cyanide into the organic phase are referred to as transfer steps. 
 
Figure 1. Starks extraction mechanism. 
 Starks’ extraction mechanism can be reduced to a series of equilibrium constants in and 
between the phases of a PTC reaction, specifically a liquid-liquid process (Figure 2). First, there 
is the ion exchange of Q+X-, where X- is a generic anion, with the aqueous phase anion, Y- (K1 = 
k1/k-1). Second, the newly formed quaternary ammonium ion pair, Q
+Y-, must partition between 
the aqueous and organic phases (K2 = k2/k-2). Third, the intrinsic reaction occurs within the 
organic phase (k3) and this reaction is irreversible. Fourth, the quaternary ammonium ion pair 
product from the intrinsic reaction, Q+X-, must again partition between the aqueous and organic 
phases to complete the catalytic cycle (K4 = k4/k-4).  This last step is important and can be 
significant affected by the choice of the X- anion.  For instance, quaternary ammonium iodides 
are sufficiently lipophilic such that transport back to the aqueous phase is often the rate-
determining step of the catalytic cycle.  For this reason quaternary ammonium iodides are 
viewed as ineffective phase transfer catalysts.12,13  Each rate constant (k1 – k4) is a product of the 
intrinsic mass transfer rate constant, k0n, and the interfacial surface area. The intrinsic mass 
transfer rate constant is a function of the structure of Q+ with respect to the two solvents 
employed.  Often the rate-determining step of an extraction mechanism is the intrinsic reaction 
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because the transfer steps (K1, K2, and K4) are rapid. In most cases the organic phase 
concentration of Q+Y- remains constant for the course of the reaction, in which case steady-state 
kinetics can be applied. 
 
Figure 2. Extraction mechanism with mass transfer steps. 
 The extraction mechanism becomes more complicated for a base-mediated PTC reaction 
(Figure 3).  In theses reactions an organic substrate, such as phenol, is deprotonated in the 
aqueous phase or interfacial layer.  The resulting anion can then exchange with Q+X- to form 
Q+R-, where R- = PhO- in this instance. The intermediate, Q+R-, can then transverse into the 
organic phase where the intrinsic reaction takes place. A base-mediate PTC reaction adds two 
important equilibriums to the mechanism, the partition of substrate between the aqueous and 
organic phases (K5 = k5/k-5) and the acid-base equilibrium between substrate and base (K6 = k6/k-
6). Both equilibriums are highly dependent on the lipophilicity and acidity of the substrate. While 
substrate lipophilicity can sometimes be overcome by modification to the mechanism (see 
section 1.2.3.), changes in substrate acidity are often responsible for a change in PTC reaction 
mechanism.  An increase in substrate pKa can turn an extraction mechanism into an interfacial 
mechanism. 
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Figure 3. Base-mediated, extraction PTC mechanism. 
 
1.2.2. Interfacial Mechanism 
 The second mechanism is referred to as the Makosza interfacial mechanism.14 This 
mechanism is postulated from the observation that highly lipophilic tetraalkylammonium salts 
showed limited or no aqueous solubility yet still remained highly active catalysts.15 As an 
example, the PTC alkylation of phenylacetonitrile with benzyl bromide and aqueous hydroxide 
base illustrates the Makosza interfacial mechanism (Figure 4). Unlike the Starks extraction 
mechanism, Q+, does not enter the aqueous phase.  First, phenylacetonitrile migrates to the 
interfacial layer where it undergoes depro tonation by a hydroxide anion, which is also present in 
the interface.  The resulting nitrile anion is formed in the interface layer.  This intermediate is too 
polar to be extracted into the organic phase and too basic to persist in the aqueous phase.  
Concurrently, Q+Br- will exist in equilibrium between the organic phase and interfacial layer.  
Once at the interface, Q+Br- can undergo an ion exchange with the nitrile anion.  The resulting 
ion pair is now sufficiently lipophilic to be extracted into the organic phase and participate in the 
intrinsic reaction, in this case an alkylation with benzyl bromide. 
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Figure 4. Makosza interfacial mechanism for phenylacetonitrile alkylation. 
 
 Given the several phase equilibria which transverse the interfacial layer, the rate 
determining step of a particular interfacial PTC process often involves an intermediate at the 
interphase.  Therefore, an interfacial PTC mechanism is strongly dependent on the interfacial 
surface area between the bulk phases. For this reason, efficient agitation methods (e.g. stirring 
speed) are necessary for a PTC reaction operating under an interfacial mechanism. 
 
1.2.3. Mechanism Modifications 
 To summarize, in the extraction mechanism the catalyst can cross the interfacial layer and 
exist in both the aqueous an organic phase, whereas in the interfacial mechanism the catalyst 
cannot penetrate beyond the interfacial layer. In the modified interfacial mechanism the organic 
acid, hydroxide base, and the Q+X- can exist in the interfacial layer (Figure 5).  Both Q+X- and 
M+OH- base undergo ion exchange at the interface similar to the extraction mechanism, wherein 
this step occurs in the aqueous phase.  The organic acid in the interfacial layer is not 
deprotonated by a metal hydroxide but rather by Q+OH- present in the interfacial layer to 
generate the carbanion intermediate, Q+R-.  The Q+R- intermediate is extracted back into the 
organic phase where the intrinsic reaction takes place, similar to original interfacial mechanism.  
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Also, as was the case in the original interfacial mechanism, the Q+ species does not enter the 
aqueous phase. 
 
Figure 5. Modified interfacial mechanism. 
 
 A similar modification exists for the extraction mechanism, the Brandstrom-Montanari 
modification. Like the modified interfacial mechanism the catalyst species, Q+, does not enter the 
aqueous phase. Instead the reagent from the aqueous phase partitions into the interfacial layer 
where the catalyst will undergo ion exchange and transport the aqueous reagent to the organic 
phase. However, no experimental evidence exists to support this modified mechanism.16  
 These mechanisms illustrate the variables that may affect a PTC reaction.  Reaction 
variables such as the catalyst structure, reactant and reagent structure, solvent, temperature, 
agitation (e.g. stirring speed, reaction vessel, stirrer paddle shape), and the organic/aqueous 
volume ratio can all affect the multitude of kinetic steps in a PTC reaction. Because many of the 
transfer steps involve the catalyst, its structure is critical to developing an efficient PTC process. 
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1.3. Asymmetric Phase Transfer Catalysis 
 Phase transfer catalyzed processes that can afford enantioenriched products by the action 
of chiral, nonracemic catalyst are referred to as asymmetric phase-transfer catalysis (APTC) 
reactions. Given the immense range of reaction classes that are amenable to PTC, the 
development of general asymmetric variants would be desirable.  For the large-scale synthesis of 
enantioenriched therapeutic compounds, APTC can offer an alternative to classical chiral 
resolutions and transition metal-catalyzed reactions.  To date, investigations into APTC have 
been primarily focused on improving enantioselectivity and expanding reaction 
scope.17,18,19,20,21,22,23,24 
 
1.3.1. Early Examples 
 Because quaternary ammonium salts form the vast majority of catalysts, the first APTC 
reactions employed catalysts derived from chiral amines.  Hiyama et al. reported the first APTC 
for an enantioselective oxirane synthesis employing quaternary ammonium salts derived from 
enantiomerically pure ephedrine.25 Further examples of APTC nucleophilic displacements were 
developed over the next decade that employed chiral, nonracemic quaternary ammonium salts 
derived from ephedrine26, amino alcohols27, and Cinchona alkaloids.28  However, these early 
examples afforded products with low to moderate levels of enantioenrichment with limited 
catalyst optimization.  Amongst the chiral quaternary ammonium salts employed in the initial 
development of APTC, those derived from Cinchona alkaloids have seen the most development 
in recent years. 
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Figure 6. Cinchona alkaloids. 
 Cinchona alkaloids have a long history as therapeutic agents and as catalysts in 
asymmetric synthesis.29,3031 The diverse array of functional groups present in the Cinchona 
alkaloids, a tertiary amine (quinuclidine), a heteroaromatic nitrogen (quinoline), a 
monosubstituted alkene, and a secondary hydroxyl group permit an immense range chemical 
manipulations to the core structure (Figure 6).  Perhaps most importantly, these alkaloids are 
readily available and in the optically enriched form. The application of Cinchona alkaloids in 
chemical synthesis will often involve a manipulation at one or more of the functional groups 
previously mentioned. Examples of reactions catalyzed by Cinchona alkaloids include 
asymmetric reductions, oxidations, and carbon-carbon or carbon-heteroatom couplings in both 
transition metal catalyzed and organocatalytic variants. Outside the realm of APTC, Cinchona 
alkaloids have gained the most visibility and utility as ligands for transition metal catalyzed 
asymmetric dihydroxylations and as organocatalysts for the aldol and Michael reactions.32,33,34 
The scope of reactions employing Cinchona alkaloids has proven applicable to a wide variety of 
substrates, with high levels of selectivity, and low catalyst loadings. It is this versatility in 
substrate and reaction scope, combined with a diverse library of catalyst analogs that elevates the 
Cinchona alkaloid scaffold to the class of ‘privileged’ chiral catalysts.35 Some of the more 
widely employed catalysts derived from Cinchona alkaloids are shown below (Figure 7) but will 
be discussed in more detail later (See Chapter 2). 
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Figure 7. Generations of catalysts derived from Cinchona alkaloids. 
 
1.3.2. Other Chiral Catalyst Scaffolds 
 Highly selective APTC catalysts have utilized scaffolds other than the Cinchona alkaloid-
derived ones. C2-Symmetric chiral binaphthyl and spiro, two-center, and crown ethers motifs 
have all been applied to APTC reaction with high levels of selectivity. For brevity, only the most 
selective catalysts that have been applied to the APTC glycine Sciff base alkylation will be 
mentioned.  
 Maruoka et al. was first to incorporate the BINOL scaffold into a selective catalyst 
(Figure 8).36,37,38 Unfortunately, these catalysts are sluggish under normal reaction conditions due 
to their high lipophilicity. With the aid of crown ethers, catalyst activity improved, which the 
authors speculated arises from the ability of the crown ether to extract KOH into the organic 
phase.  By replacing two of the quaternary ammonium aromatic substituents with alkyl chains, 
catalytic activity is improved such that a cocatalyst is unnecessary, and high levels of selectivity 
are preserved.39 
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Figure 8. C2-Symmetric binaphthyl and biphenyl catalysts. 
 Employing a configurationally labile biphenyl backbone, a similar catalyst scaffold has 
been developed by Lygo et al. that derived its chirality from a chiral amine component.40 A 
number chiral, non-racemic, secondary amines were used in the final step of the catalyst 
synthesize to create a small library of catalysts that were then screened for the APTC alkylation 
of a glycine imine. Moderate to very high levels of enantioselectivity (er 35:65 to 95.5:4.5) were 
afforded with this class of catalyst (Scheme 1). 
Scheme 1 
 
 Additional C2-symmetric catalysts have been developed that do not incorporate the 
BINOL or biphenyl backbone and contain two quaternary ammonium centers (Figure 9). One 
such catalyst constructed by Shibasaki et al. was synthesized from enantioenriched diethyl-
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tartrate.41,42 Applied to the APTC alkylation of a glycine imine, these catalyst have afford 
products of only moderate to good levels of enantioselectivity.  A similar tartrate-derived catalyst 
has been examined by MacFarland et al. that also employed a dual quaternary ammonium center 
motif.43,44 Despite extensive modification, only low levels of enantioselectivity were obtained 
from these novel catalysts.  An unusual spirobenzopyrrolidine based catalyst was pioneered by 
Sasai, but suffered from the same lack of selectivity.45  
 
Figure 9. C2-Symmetric, Two-center Catalysts.
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CHAPTER 2: Catalyst Screening with Cinchona-Alkaloid Derived 
Catalysts for APTC Alkylation 
2.1. Introduction 
 Cinchona alkaloid-derived catalysts have enjoyed much success within the realm of 
APTC and other catalytic asymmetric reactions.46,47,48 Despite such applicability, the vast 
majority of studies dealing with development of the Cinchona alkaloid-derived catalysts has 
focused on expanding reaction scope and improving selectivity.  Little attention has been paid to 
study of catalyst activity, and catalyst design has proceeded on primarily an empirical basis. 
 The following section will discuss the four main generations of catalyst design with 
Cinchona alkaloids. The first generation of catalysts contain modifications to the quinuclidine 
nitrogen in the form of benzyl derivatives.  The second catalyst generation arises from 
modifications made to the hydroxyl group and use of a large π-surface area, such as anthracene, 
for the quinuclidine substituent.  Third generation catalysts employ a dimeric structure 
containing a linker substituent attached to the quinuclidine nitrogen.  The fourth generation of 
Cinchona alkaloid catalysts contains electronic substituents to the benzyl group appended to the 
quinuclidine nitrogen. 
 
2.1.1 First Generation Catalysts 
 The first major utilization of Cinchona alkaloids as a catalyst scaffold for APTC was 
carried out by the Merck process development group for the alkylation of a substituted indanone 
substrate (Scheme 2).49 Prior to this work, only moderate levels of enantioselectivity had been 
reported for APTC alkylations. A preliminary Hammett study of several N-benzyl substituents 
revealed that electron withdrawing groups afforded higher levels of enantioselectivity, with the –
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CF3 substituent yielding the best selectivity.  The authors hypothesize that a π-stacking 
interaction is the primary interaction for asymmetric induction in the catalyst-enolate ion pair. 
Detailed mechanistic studies were later conducted for this APTC alkylation revealed that the 
reaction was half-order in catalyst.50  Further experiments revealed the catalyst formed a 
lipophilic, catalyst dimer intermediate due to its unmodified hydroxyl group. 
Scheme 2 
 
 Later work by O’Donnell et al. demonstrated that the APTC alkylation of N-
(diphenylmethylene)glycine tert-butyl ester, 1, with 1st generation catalysts afforded good levels 
of enantioselectivity (Scheme 3).51 Among the Cinchona alkaloids examined, cinchonine and 
cinchonidine derived catalysts afforded the R and S configurations of the alkylation product as 
the major enantiomer, respectively.  It was also observed that the cinchonidine based catalyst 
were more selective than the corresponding quinine-derived catalyst (er 78:22 compared to er 
60:40, respectively). 
Scheme 3 
 
 The use of 1 as an APTC alkylation substrate was undertaken for several reasons.  First, 
the substrate is relatively acidic (pKa 18.7, DMSO, ethyl ester analogue) and therefore can be 
deprotonated under most base-mediated PTC reaction conditions.52  Second, 1 selectively forms 
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monoalkylated products. A dramatic decrease in acidity of 2 (pKa 23.2, DMSO, ethyl ester 
analogue) results from A1,3-strain in the enolate intermediate derived from 2 (Scheme 4). And 
third, alkylation products derived from 1 can be easily converted to novel, synthetically useful α-
amino acids.  These advantages have ensured the continued use of 1 as a model substrate for 
APTC alkylations. 
Scheme 4 
 
 A subsequent study by O’Donnell et al., investigated the fate of the phase-transfer 
catalyst during the reaction.53 Contrary to the previous assertion by Dolling et al. that invoked a 
dimer intermediate, O’Donnell reasoned that the hydroxyl group is alkylated in situ to form the 
O-alkylated, active catalyst. This notion was supported by the observation that the catalysts N-
benzylcinchonidinim bromide and O-benzyl-N-benzylcinchonidinium bromide afforded 2 with 
nearly identical levels of enantioselectivity. 
 To further elucidate the nature of the active catalyst in the reaction, enantiopure 2 was 
subjected to the reaction conditions in the absence of a catalyst, and in the presence of the 
following catalysts tetrabutylammonium bromide (TBAB), N-benzylcinchonidinium bromide, N-
benzylcinchonidinim bromide with benzyl bromide, and O-benzyl-N-benzylcinchonidinium 
bromide to test for racemization.  With no catalyst, TBAB, N-benzylcinchonidinium bromide 
with benzyl bromide, and O-benzyl-N-benzylcinchonidinium bromide no racemization was 
observed.  However with N-benzylcinchonidinium bromide alone, a 70% loss of enantiopurity 
was observed after ten hours.  The authors proposed that during the course of the reaction the 
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unprotected hydroxyl group becomes deprotonated to form a zwitterionic quaternary ammonium 
alkoxide.  In the presence of sufficient quantities of benzyl bromide, this species becomes 
alkylated in situ to form O-benzyl-N-benzylcinchonidinium.  If no benzyl bromide was present, 
then this zwitterion intermediate could deprotonate 2, leading to racemization under the reaction 
conditions.  The zwitterion can also slowly form the oxirane through a ring expansion process, 
leading to an inactive catalyst (Scheme 5). As a result of this study, the use of Cinchona catalysts 
for APTC containing an unmodified hydroxyl group has been rendered obsolete.  
Scheme 5 
 
 
2.1.2 Second Generation Catalysts 
 Investigations by Lygo and Wainwright first observed that augmenting the steric bulk of 
the quinuclidine arylmethylene substituent afforded a catalyst with remarkable selectivity 
(Scheme 6).54 The use of a 9-substituted anthracene as the aryl group afforded 2 in excellent 
enantioselectivity (er 95.5:4.5).  It was also observed that the background reaction was inhibited 
when aqueous potassium hydroxide was used in place of aqueous sodium hydroxide.  A variety 
of other electrophiles afforded good levels of enantioselectivity (er 86:14 to 94.5:5.5). 
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Scheme 6 
 
 The catalyst structure was further optimized by Corey et al. with the introduction of an 
O-allyl substituent at C(9).55,56 In contrast to previous APTC alkylations of 1 that employed a 
liquid-liquid PTC conditions, low temperature (-78 °C) solid-liquid PTC conditions were 
employed to afford 2 in excellent enantioselectivity (er 97:3, Scheme 7). The authors proposed a 
stereochemical model that reasoned that the 9-anthracenylmethyl substituent provides 
conformational rigidity in the catalyst-substrate ion-pair during the stereodetermining step of the 
reaction. In contrast to Dolling’s stereochemical rationalization that invoked a π-stacking 
interaction, the authors do not suggest such interaction occurs. 
Scheme 7 
 
 Lygo et al. undertook a preliminary structure selectivity study with the second generation 
of Cinchona catalysts.57 In this study the quinuclidine core was kept intact with the sites of 
modification restricted to the quinoline region, the C(9) hydroxyl, and the arylmethylene 
substituent appended to the quinuclidine nitrogen. Previous work had shown that modifications 
to the quinuclidine vinyl group had little effect on catalyst selectivity and so it was removed prior 
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to catalyst modification. 19 catalysts were screened for selectivity in the APTC alkylation of 1 
(Figure 10). 
 Results from this catalyst screen showed that the original quinoline group provided a 
more selective catalyst. Substitution of the quinoline nitrogen for a carbon atom afforded a less 
selective catalyst (er 78:22 versus 68:32).  At the quinuclidine region, R3, alkyl substituents 
showed minimal enantioselectivity.  Incorporation of 4-nitrobenzyl and 4-methoxybenzyl 
substituents led to catalysts that are less selective than a benzyl substituent.  The C(9) oxygen 
substituents, R1, showed the least influence on catalyst enantioselectivity. The configuration of 
the substituent at C(9) was left unexamined. 
 
Figure 10. Second generation cinchonidine based catalyst library. 
 
2.1.3 Third Generation Catalysts 
 Drawing inspiration from the dimeric Cinchona alkaloid ligands utilized successfully in 
the Sharpless asymmetric dihydroxylation,32,33 a third generation of Cinchona alkaloid based 
catalysts were developed that incorporate a dimeric catalyst structure.  Unlike the Sharpless 
ligands that require a tertiary amine for activity and are linked at the C(9) oxygen, the dimeric 
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phase transfer catalysts are linked at the quinuclidine nitrogen. Jew and Park demonstrated the 
α,α’-bis[O-allylcinchonidinium)-m-xylene dibromide catalyst afford high levels of 
enantioselectivity for the APTC alkylation of 1 (Scheme 8).58 The p-xylene dimer shows similar 
enantioselectivity to previously employed monomeric catalysts, whereas a reduction in 
selectivity is observed with the o-xylene dimer, presumably due to unfavorable steric 
interactions.  Trimeric catalysts were also tested under similar reaction conditions with substrate 
1 to afford alkylation products with similar levels of enantioenrichment (er 97:3).59 
Scheme 8 
 
 
2.1.4 Fourth Generation Catalysts 
 The first three generations of Cinchona alkaloid based catalysts deal primarily with steric 
modification to the quinuclidine substituent and secondarily with modification to the hydroxyl 
group.  The effect of varying the electronic properties of the substituent on the quinucldine 
nitrogen was briefly investigated by Dolling et al., who found that that increased π-acidity of the 
quinuclidine substituent afforded increased enantioselectivity in an APTC alkylation of an 
indanone derivative.49,50 Studies undertaken by Jew and Park had shown that incorporation of a 
fluorine atom in the ortho position of the quinuclidine benzyl substituent led to a significant 
increase in selectivity.60 Monofluoro analogs at the meta and para positions were no more 
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selective than the non-fluorinated catalyst and the incorporation of two additional fluorines at the 
meta and para positions led to a synergistic increase in selectivity (Scheme 9). 
Scheme 9 
 
 The arylfluorine substituent is proposed to provide for a more conformationally rigid 
catalyst by means of a hydrogen bonding interaction between the fluorine and hydroxyl group. 
On the basis of this hypothesis, additional analogs were synthesized with varying electronegative 
functional groups.  Both the 2-cyanobenzyl and N-(1-oxy-2-pyridinylmethyl) derivatives afford 
catalysts with high levels of enantioselectivity similar to those observed with the 2-fluorobenzyl 
analog (Figure 11).61  It is speculated that a water molecule from the reaction mixture remains 
hydrogen bound in a cavity between the O-allyl and fluoro/N-oxy/cyano benzyl substituent.  
However, there is some debate as to whether arylfluorines can even participate in hydrogen 
bonding.62 
 
Figure 11. Electronic modifications to fourth generation catalysts. 
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2.1.5 Objectives 
 Despite the numerous examples of modified Cinchona alkaloids in APTC, no systematic 
study has been conducted to examine to effect of substituents on catalyst selectivity and 
reactivity. Of the many modifications to the Cinchona alkaloid scaffold in APTC, few studies 
have probed the importance of the C(9) oxygen-bearing center.63 Variables such as the 
configuration, substituents on the oxygen, the replacement of the oxygen atom, or the removal of 
that heteroatom remain to be investigated.  
 The aim of this study was to examine the steric and electronic contributions of the 
arylmethylene substituent appended to the quinuclidinium nitrogen (substituent X). Specifically, 
the aromatic groups that would be surveyed are 9-anthracenyl, 2-naphthyl, 1-naphthyl, phenyl, 
and 3,5-bis(trifluoromethyl)phenyl. Eight different substituents were proposed for the C(9) 
position on cinchonidine to examine the effect of sterics, dipole strength, and configuration 
(substituent Y). To that end, hydroxy, epi-hydroxy, benzyloxy, allyloxy, methoxy, epi-methoxy, 
fluoro, and hydro group would be screened for substituent Y. The substitution of the native 
hydroxyl group with a fluoro substituent would determine what effect dipole strength and 
hydrogen bonding have on catalyst activity and selectivity. Additionally, removal of the dipole at 
C(9) would also provide similar answers. Altogether, 40 catalysts were to be screened for 
activity and selectivity for the APTC benzylation of 1 (Figure 12). 
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Figure 12. Proposed Cinchona catalyst library. 
 
2.2 Catalyst Synthesis 
2.2.1 Retrosynthesis 
 Cinchona alkaloid based catalysts for APTC have been synthesized by first generating 
the quaternary ammonium salt by alkylation of the quinuclidine nitrogen followed by 
modification to the C(9) hydroxyl group, often under PTC reaction conditions.  If the alkylating 
reagent for both the hydroxyl and tertiary amine groups is the same, then both alkylations could 
be performed in one pot. 
 Following the previously described catalyst syntheses of O’Donnell, Lygo, Wainwright, 
and Corey afford catalysts in low yields and complex product mixtures, which required difficult 
separations. Shortly thereafter, a new strategy was implemented wherein the hydroxyl group 
would be modified first followed by alkylation of the quinuclidine nitrogen (Scheme 10).  This 
strategy has an advantage over previous methods by introducing the C(9) functionality prior to 
N-alkylation, thus yielding a more stable catalyst precursor.  Additionally, this route is more 
amenable to a library synthesis. Generally, the quinuclidine alkylation is robust and performed 
under neutral conditions, thus rendering it ideal for the last step of the catalyst synthesis.  This 
strategy allowed for the efficient synthesis of 39 catalysts from only 8 precursors. 
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Scheme 10  
 
 
2.2.2 C(9) Epi-cinchonidine 
 Epi-cinchonidine was synthesized by means of a Mitsunobu reaction, following 
conditions reported by Lectka et al..64  On small scale, this procedure was found to be effective, 
but upon scale-up, a complex product mixture was obtained.  Subsequent optimization found that 
the addition of three equivalents of the carboxylic acid led to a formation of a single product in 
85% yield (Scheme 11). 
Scheme 11 
 
 Prior to the hydrolysis of the benzoyl ester, the cinchonidine reactant was not observed in 
the crude product by thin-layer chromatography (TLC).  Yet after hydrolysis with saturated 
aqueous potassium carbonate, significant amount of cinchonidine were observed in the reaction 
product by 1H-NMR spectroscopy. Mechanistically, the Mitsunobu reaction proceeds through an 
SN2 displacement of an oxyphosphonium ion to afford stereoinverted products.  To obtain a 
stereoretentive product, a double SN2 displacement must be operative through the intermediacy 
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of an azirdinium ion. In the presence of one equivalent of carboxylic acid, the quinuclidine 
nitrogen competes with the carboxylate anion for displacement of the oxyphosphonium ion. The 
aziridinium ion can then be opened by the carboxylate anion to afford the stereoretentive 
benzoate (Scheme 12). A stoichiometric excess of 4-nitrobenzoic acid (3 equivalents) ensures the 
quinuclidine nitrogen remains protonated, preventing aziridinium ion formation. 
Scheme 12 
 
 
2.2.3 Ether Analogs of Cinchonidine 
 The alkyloxy Cinchona catalyst analogues were synthesized by mean of a Williamson 
ether synthesis with the respective alkyl halide (Scheme 13).  All ether analogs were obtained in 
moderate to good yields (61-86% yield).  Despite employing only a minimal excess of alkyl 
halide and low reaction temperatures, trace amounts of the undesired quaternary ammonium salt 
were observed in all cases. 
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Scheme 13 
 
 
2.2.4 Deoxyfluorocinchonidine Synthesis 
 The initial efforts towards the synthesis of deoxyfluorocinchonidine followed the 
synthesis reported by Hoffmann et al., wherein O-mesyl-cinchonidine was displaced by fluoride 
with a TBAF/THF solution.65  Unfortunately, this method resulted in low yields and a complex 
product mixture. However, a later procedure reported by Gilmour demonstrated improved yields 
starting from cinchonidine and employed the fluorinating agent, diethylaminosulfur trifluoride 
(DAST).66 Application of this synthetic protocol proved successful, although at somewhat lower 
yields than reported (Scheme 14).   
Scheme 14 
 
 The synthesis of deoxyfluorocinchonidine was complicated by the formation of several 
side products.  The DAST mediated fluorination of cinchonidine afforded the stereoinversion 
product, 9b, the [3,2,2] ring-expanded product, 9c, decomposition products that showed no 
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incorporation of fluorine, in addition to the desired product, 9a. Interestingly, the product ratio 
was significantly dependent on the reaction temperature.  At lower reaction temperatures (-60 
°C), 9c was formed almost exclusively, while at higher temperatures (0 °C), product 
decomposition was observed.  These results, in addition to the reported mechanism of DAST 
fluorinations, supported the presence of an aziridinium ion intermediate (Scheme 15).67  The near 
exclusive formation of 9c at low temperatures suggests that ring expansion by fluorine 
displacement is the kinetically favored pathway.  Similar functionalized substrates have been 
shown to proceed through an aziridinium ion intermediate under DAST fluorination.68 Given the 
structural similarity of 9a and 9b, laborious chromatographic purification was required for the 
isolation of 9a. 
Scheme 15 
 
 
2.2.5 Deoxycinchonidine Synthesis 
 A synthesis of deoxycinchonidine was reported by Stenberg and Travecedo through an 
acid-catalyzed photochemical reduction.69 This method utilized ultraviolet irradiation and 
suffered from low yield (49%), and as a result a more general synthesis was sought.  
Accordingly, deoxycinchonidine was synthesized by means of a Barton-McCombie radical 
deoxygenation from the precursor thionocarbonate in excellent yield (Scheme 16).70,71 
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Scheme 16 
 
 
2.2.6 Alkylation of the Quinuclidine Nitrogen 
 Typically the SN2 alkylation of the quinuclidine nitrogen of Cinchona alkaloids and its 
derivatives is performed in either toluene or 2-propanol, either at reflux or room temperature.  
This approach was reproduced early during quaternization attempts of cinchonidine, but often 
resulted in impure product mixtures.  Given that SN2 reactions are typically accelerated in polar 
aprotic media, this alkylation reaction was tested in acetonitrile.72  The desired quaternary 
ammonium salts were obtained in good to excellent yields in nearly all cases (Scheme 17).  The 
catalysts were purified by means of recrystallization or silica gel chromatography. 
Scheme 17 
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Table 1. Catalyst Library Synthesis 
 
 
aCatalyst yield 
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In most cases the alkylation of the quinuclidine nitrogen with an arylmethylene bromide 
proceeded in good to excellent yields. The exception to this trend was observed with the 
alkylation of deoxycinchonidine (Table 1, row h). Several deoxycinchonidinium catalysts proved 
to be unstable to workup or purification conditions. Notably, catalyst 5h was unable to be 
isolated with sufficient purity and was therefore removed from the catalyst library.  
Chromatographic purification of several deoxycinchonidinium catalysts afforded a side product 
with an extra olefinic signal in the 1H-NMR spectrum, suggesting an elimination mechanism to 
the ring-expanded product.  In cases where chromatographic separation led to decomposition, the 
catalysts was precipitated with ether and washed repeatedly prior to use. 
 
2.3 Results 
2.3.1 APTC Reaction Conditions 
 For this catalyst survey, the asymmetric alkylation reaction of interest was the 
benzylation of 1 under liquid-liquid PTC conditions. To gain insight into catalyst activity, the 
formation of 2 was monitored with the aid of an internal standard, 1,1-diphenyl-1-heptene 
(Scheme 18).73 First, all the organic components were combined and then allowed to cool to 2-4 
°C. To start the reaction, pre-cooled aqueous base was then added. Catalyst activity and 
selectivity were determined by high-performance liquid chromatographic (HPLC) analysis from 
aliquots of the organic phase. 
Scheme 18 
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 The APTC alkylation rate of 1 was found to be significantly dependent on the stirring 
speed of the reaction due to the change in interfacial surface area. This finding suggests an 
interfacial mechanism is operative for the APTC alkylation of 1. To ensure reproducible 
interfacial surface area during the reaction, magnetic stir bars of a consistent size and shape (1.5 
cm length, egg-shapped) were employed. Additionally, the solvent volumes were adjusted such 
that the stir bar lay between the phase boundaries in order to provide satisfactory mixing between 
the aqueous and organic phases. All stir plates were set to the maximum stirring speed and after 
calibration were found to rotate at 1500 rpm or higher.74 
 
Figure 13. APTC reaction from beginning to completion. 
From left to right: reaction immediately after the addition of 
base; stirring with base; reaction after completion 
 The decision to perform the APTC reaction at 2-4 °C was done primarily to ensure 
reproducible alkylation rate data, rather than for the sake of enantioselectivity. A catalyst loading 
of 0.025 equivalents was employed because of the limited solubility of quaternary ammonium 
salts in organic solvents. The comparison of catalyst activity would be complicated if all 
catalysts were present in varying concentrations. Potassium hydroxide was used instead of 
sodium hydroxide because the later was found to promote a significant background reaction. 
 Each catalyst was run in duplicate for both activity and selectivity measurements. 
Catalyst activity was determined by the percent conversion to product. For each run these 
percent conversion values were fitted to either an exponential decay or logistic decay function 
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with the aid of OriginLab Pro™ software.  A reaction half-life was then calculated from each 
fitting function and reported in minutes. Generally, a logistic decay function was required for 
catalysts that displayed an induction period. Catalyst selectivity was determined as the mean 
enantiomeric ratio of 2 on a chiral stationary phase (CSP) HPLC from duplicate runs. The 
absolute configuration of the major enantiomer formed was established to be S by comparison of 
the optical rotation of 2 with known values.75 
 
2.3.2 Reaction Half-Life Results 
 The calculated half-life values shown below were calculated from percent conversion to 
alkylated product plots for each catalyst in duplicate and then fitted to an exponential decay 
functon (Figure 14).  Each column in the table represents a different N-quinuclidine substituent, 
X, and each row represents a different substituent at C(9), Y.  While most catalysts were soluble 
in the organic phase when dissolved at room temperature, a number of them showed a minor 
amount of precipitation after equilibration at the reaction temperature.  However, some catalysts 
(2a, 2b, 4c, 1g, 2g, 1h, 2h, 3h, 4h) were observed to be only partially soluble even at room 
temperature. 
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Figure 14. Reaction half life, t1/2 (min.). 
 A significant dependence of reaction rate on the π-acidity of substituent X was observed 
in this survey.  For nearly every Y substituent examined, catalysts bearing a (CF3)2C6H3 group 
showed significantly less activity compared to other catalysts.  With the exception of the 
deoxycinchonidinium catalysts (series h), the reaction half-life was ten-fold higher with X = 3,5-
(CF3)2C6H3.  
 An induction period was observed for some of the hydroxy catalysts (1a, 2a, 3a, 4a), yet 
surprisingly not observed with the respective epi-hydroxy catalysts (1b, 2b, 3b, 4b).  A clear 
difference in reaction rate was observed between the hydroxy (series a) and benzyloxy (series c) 
catalysts.  In several instances benzyloxy catalysts showed less activity than their hydroxyl 
catalyst analog (1c, 4c, 5c) while the other benzyloxy catalysts (2c, 3c) had significantly 
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enhanced activity.  Inversion of configuration at C(9) for both the hydroxyl substituent (series a 
and b) and the methoxy substituent (series e and f) showed little difference on reaction rate.   
 Substitution of hydroxy group at C(9) with a fluoro substituent generally afforded less 
active catalysts (1g, 3g, 4g, 5g).  In one instance, a deoxyfluorocinchonidinium catalyst (2g) was 
observed as a more active catalyst than its hydroxyl analog.  Both catalysts 2a and 2g displayed 
limited solubility in the organic phase, and one cannot compare their relative activities with 
certainty since their effective concentrations in the reaction mixture are unknown.  Moreover, it 
can be seen that removing the heteroatom entirely will result in a sluggish catalyst.  Reactions 
with the deoxycinchonidinium catalysts had half-lives two to three orders of magnitude larger 
than their hydroxyl or ether counterparts.  Additionally, these catalysts consistently failed to 
catalyze the APTC alkylation to full conversion. 
 
2.3.3 Catalyst Selectivity Results 
 In cases where the reaction did not reach full conversion (<70%), the alkylation product 
was isolated by chromatographic purification and then subsequently analyzed by CSP-HPLC.  
The results of this enantioselectivity survey are shown below and represent the average value 
over two or more reactions (Figure 15). 
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Figure 15. Catalyst selectivity screen. 
 The product enantiomeric ratio was most dependent on the X substituent.  The highest 
enantioselectivities were observed for series 1 (X = 9-anthracenyl) and decreasing in selectivity 
to series 3 (X = 1-naphthyl), series 4 (X = phenyl), series 5 (X = 3,5-(CF3)2C6H3), and with 
lowest enantioselectivities observed with series 2 (X = 2-naphthyl).  The increased selectivity of 
the 1-naphthyl substituent versus its isomeric 2-naphthyl analog reaffirms a similar finding by 
Lygo (er 76:24 versus 70:30, respectively).40  An important result of this study was the effect on 
catalyst selectivity by the substituent configuration at C(9).  Not only do both the C(9)-hydroxy 
(series a) and C(9)-epi-hydroxy (series b) afford the same major enantiomer, but both catalyst 
series have nearly identical enantiomeric ratios.  Similar results were obtained for the methoxy 
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(series e) and C(9)-epi-methoxy (series f) catalyst series.  Although, the C(9)-epi-methoxy 
catalysts were observed to be somewhat more selective.  No significant differences in selectivity 
were observed among the ether analogs although generally the O-alkylated catalysts were 
slightly more selective than their hydroxy analogs.   
 The deoxyfluoro catalysts (series g) afforded catalysts of similar selectivity compared to 
the parent hydroxy catalysts (series a).  Catalyst 1g remained an outlier to this trend, but given its 
low activity, its decomposition to a less selective species cannot be ruled out.  Removal of the 
dipole at C(9) with the deoxycinchonidium catalysts (series h) resulted in a near complete loss in 
product enantioselectivity. 
 
2.4 Discussion 
2.4.1 Catalyst Reactivity 
 Among the X substituents the primary trend observed is a pronounced reduction in 
catalyst activity for series 5 (X = 3,5-(CF3)2C6H3).  The steric bulk of the X substituent showed 
little effect on catalyst activity.  The increased π-acidity of the 3,5-bis(trifluoromethyl)benzyl 
substituent may explain the slower reaction rate due to a tighter enolate-catalyst ion pair. The 
incorporation of electron withdrawing substituents to the catalyst may increase the coulombic 
interaction between the ammonium-enolate ion-pair. A stronger coulombic interaction would 
raise the activation barrier to the ammonium-enolate alkylation transition state. This tight ion 
pair may shift the reaction to the intrinsic rate limited regime if the interaction energy between 
substrate and catalyst is sufficiently large. 
 Catalyst activity was most dependent on the Y substituent. One of the most surprising 
results of this survey was the significant difference in reaction rate between the hydroxy (series 
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a) and benzyloxy (series c) catalysts. Previous reports suggested that the C(9)-hydroxyl catalyst 
is transformed to its O-benzylated analog in situ based on similar enantioselectivity values.53 
This rate difference excludes the possibility that the C(9)-benzyloxy catalyst is solely responsibly 
for the observed rates within the hydroxy catalyst series.  Additionally, most of the C(9)-
hydroxyl catalysts showed an induction period.  This induction period may be the result of in situ 
O-alkylation by benzyl bromide, but it does not account for why some catalysts showed 
increased activity as the benzyloxy analog (2c, 3c) and other catalysts (1c, 4c, 5c) showed 
diminished activity as the benzyloxy appended structure.    
 A more likely explanation of this induction period can be found in Dolling’s study in the 
APTC alkylation of a substituted indanone substrate with Cinchona alkaloid based catalyst.50 
The authors observed that the hydroxy cinchoninium catalysts had poor solubility in the organic 
solvent, yet after the addition of aqueous base significant amounts of the catalyst could be 
detected in the organic phase.  Further tritration and elemental analysis studies led the authors to 
conclude that the catalyst forms a pseudo-dimer species (monobromide and monoalkoxide) in the 
presence of aqueous base. This induction period can be explained by the formation of a dimer 
species, which exhibits increased organic phase solubility. Interestingly, none of the epi-hydroxy 
catalysts showed any noticeable induction period.  This finding would suggest that the rate of 
dimer formation is dependent on the diastereomeric configuration of the hydroxyl group. 
 The reduction in catalytic activity for catalysts bearing electron deficient substituents, due 
to an increase in coulombic interaction, may be a likely explanation for the lack of activity 
within the deoxyfluoro catalyst analogues (series g).  Across most X substituents, the 
deoxyfluoro catalysts were less active than their hydroxy counterparts.  The exception, catalyst 
2a, was likely due to solubility factors. The absence of an induction period with the deoxyfluoro 
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catalysts provides further support of a functionalization of the hydroxy group during the course 
of the alkylation reaction.  The drastic drop in catalytic activity going from 1a to 1g (two orders 
of magnitude) is more indicative of catalyst decomposition rather than the reactivity of the 
ammonium-enolate ion-pair.  It is unknown why catalyst 1g would be more susceptible to 
decomposition than the rest of series g. 
 The near total loss of catalytic activity for the deoxycinchonidinium catalyst (series h) 
mainly stems from obstacles encountered during their synthesis.  Given their facile 
decomposition under the relatively mild conditions of reaction workup, the likelihood these 
catalysts would persist under a base-mediated PTC reaction conditions is marginal. The 
mechanism for catalyst decomposition within series h is a Hoffmann elimination (Scheme 19). 
According to the mechanism, the initial decomposition product may be alkylated at the tertiary 
amine.  The product of such an alkylation could function as a phase transfer catalyst. Without 
any knowledge on the rate of catalyst decomposition under the reaction conditions, it is difficult 
to determine what catalyst structure is responsible for the diminished reactivity of series h.  
Another possible explanation would be that the starting deoxycinchonidinium catalyst is 
immediately decomposed upon addition of base.  The inactivated catalyst could then undergo a 
slow alkylation under the PTC reaction conditions with benzyl bromide to afford an active 
catalyst. This alkylation would likely proceed at a diminished rate considering it would take 
place in a toluene solvent at 0 °C.  Therefore, the lack of catalytic activity would be the result of 
a very low loading of active catalyst. 
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Scheme 19 
 
 
2.4.2 Catalyst Selectivity 
 In contrast to reaction rate, which was dependent on the Y substituent, catalyst 
enantioselectivity was found to be dependent on the structure of the X substituent. Most of the 
catalyst enantioselectivity trends are consistent with the tetrahedron stereochemical model as 
proposed by Park and Jew (Figure 16).76 The highest enantioselectivities were observed with 
catalyst series 1 (X = 9-anthracenyl) whereas the lowest enantioselectivities were observed for 
catalyst series 2 (X = 2-naphthyl).  Catalyst series 4 (X = phenyl) was shown to be more 
selective than both series 2 and series 5 (X = 3,5-(CF3)2C6H3) despite having less steric bulk.  
This finding suggests that not only the size but also the relative orientation of the X substituent is 
critical to the enantiomeric ratio of the product. Contrary to previous studies by Dolling et. al. 
who proposed a π-π stacking interaction in the catalyst-substrate ion pair, increasing the π-acidity 
of position X did not result in a more enantioselective catalyst; the unmodified benzyl substituent 
was more selective in every case.49 
 
Figure 16. Jew and Park tetrahedron stereochemical model. 
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 Whereas the Y substituent did not provide significant influence on product selectivity, its 
structure and configuration has provided several insights into the mechanism of asymmetric 
induction.  Earlier work by Dehmlow had shown that inverting the C(9) hydroxyl group 
configuration led to a reversal in product configuration in the APTC epoxidation of 
naphthoquinones.63 The insignificant differences in enantioselectivites between the epimeric 
hydroxy and methoxy series demonstrated that the configuration of the substituent at C(9) does 
not significantly alter the geometry of the catalyst-enolate ion pair. The slight increase in 
selectivity of the ether catalysts (series c, d, e, and f) compared to the C(9)-hydroxy and the 
C(9)-deoxyfluoro (series g) catalyst would indicate that any additional steric bulk at that position 
is beneficial to selectivity.   
 The remarkably similar enantioselectivity values between the C(9)-hydroxy and C(9)-
deoxyfluoro catalyst series (excluding 1g) suggests that increasing the electronegativity or 
altering the hydrogen bonding aptitude of substituent Y has only a minor influence on the 
stereodetermining step. More importantly, a hydrogen bonding interaction originating from the 
C(9) hydroxyl group was not necessary for asymmetric induction. The lack of selectivity with 
the deoxycinchonidinium catalysts (series h) can be attributed to catalyst decomposition. The 
initial product formed from the elimination can be subsequently N-alkylated with the excess 
benzyl bromide present in the reaction mixture. Although this newly formed quaternary 
ammonium salt is still chiral, the stereocenters are far removed from the charged center and 
would provide less influence on the stereodeterming step. The use of a less reactive electrophile 
would inhibit the formation of the less desired N-alkylation product and could result in a more 
accurate enantioselectivity value of the initial catalyst. 
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2.5 Conclusion 
2.5.1 Summary 
 A library of 39 catalysts was examined for activity and selectivity for the APTC 
alkylation of 1. The catalysts were synthesized cinchonidine by formation of a quaternary 
ammonium ion at the quinuclidine nitrogen.  Catalyst modification was limited to two regions of 
the Cinchona alkaloid scaffold, the C(9) hydroxyl group (Y substituent) and the arylmethylene 
group appended to the quinuclidine nitrogen (X substituent).  Five different aromatic groups 
were screened at the X substituent, and eight different groups were tested at the Y substituent. 
 In regards to catalyst activity, the C(9) substituent was observed to contribute most 
significantly to reaction half-life.  Ether substituents were found to afford the most active 
catalysts with the configuration at C(9) having an insignificant effect on activity. Installation of a 
fluoro group or removal of the heteroatom at C(9) consistently afforded less active catalysts.  
However, it is unclear whether the increased reaction half-life is due to poor catalyst activity or 
stability to the reaction conditions.  Less active catalysts were also observed when electron-
withdrawing groups were incorporated at the X substituent. 
 Catalyst selectivity was found to be primarily influenced by the structure of the X 
substituent, with the 9-anthracenyl series affording the most selective catalysts. Inversion of the 
stereocenter at C(9) led to the same major enantiomer of 2 with negligible differences in 
enantioselectivity. In most cases substitution of a fluoro for a hydroxyl at C(9) resulted in 
catalysts of comparable selectivity.  The removal of the C(9)-heteroatom led to a substantial loss 
of selectivity. Combined with the low activity of the deoxycinchonidinium catalyst series, this 
loss of selectivity is likely related to rapid catalyst decomposition. 
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2.5.2 Future Directions 
 Future studies will focus on expanding the catalyst library by introducing modifications 
to the Cinchona alkaloid scaffold.  Synthetic targets include heteroatom analogs at the C(9) 
position on the Cinchona scaffold. The introduction of two heteroatoms at this position would 
significantly affect the catalyst’s dipole as well as remove a possible catalyst decomposition 
pathway (Figure 17). Additionally, other X substituents may be introduced similar to those 
employed for Jew and Park’s fourth generation catalyst series.60,61 Although the selectivity of the 
4th generation Cinchona alkaloid based catalyst are well known, no investigation into the relative 
activity of these catalysts has been conducted. 
 
Figure 17. Future catalyst structures. 
 The presence of two heteroatoms at C(9) can also provide significantly more dipole 
enhancements as well as steric bulk compared to a single heteroatom substituent. Without a 
hydrogen present a C(9) Hoffmann degradation would be less likely and could potentially result 
in more stable catalysts. Other degradation pathways can still exist, in which the position 
adjacent to the quaternary ammonium and C(9) is deprotonated under sufficiently basic 
conditions to afford configurationally labile scaffold or eliminate one of the  heteroatom 
substituents (Figure 18). 
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Figure 18. Other decompostion mechanisms. 
 Efforts are underway to develop a deeper understanding of the stereodetermining step. 
These studies will provide a more detailed stereochemical model, which can allow for the 
development of more selective catalysts. An experimental determination of the E/Z geometry of 
the intermediate enolate formed under the standard reaction conditions could provide a better 
stereochemical model. Previous studies only dealt with the enolate geometry computationally, 
which suggested a more favorable E configuration.77  A recent study by Porco et al. examined 
the conformation of an enolate/dimeric Cinchona catalyst ion pair through NOESY and ROESY 
NMR spectroscopy in conjunction with molecular docking software, for an asymmetric 
dearomatization/alkylation reaction.78 To date, no such spectroscopic study has been conducted 
for the APTC alkylation reaction with monomeric Cinchona alkaloid-derived catalysts. The 
incorporation of Porco’s methods into this study may provide useful insight into the 
stereodetermining step. 
 44 
CHAPTER 3: Asymmetric Phase Transfer Catalyzed [2,3]-Wittig 
Rearrangement 
3.1. Introduction 
3.1.1 Background 
 The [2,3]-Wittig rearrangement is a well-established reaction within the synthetic 
chemist’s toolbox.79,80,81,82 The [2,3]-Wittig rearrangement falls under a class of transformations 
referred to as sigmatropic reactions, which is defined as “the migration of a σ bond flanked by 
one or more π electron systems, … in an uncatalyzed intramolecular process.”83 Examples of the 
sigmatropic rearrangements include the [1,5]-hydride shift,84 the Claisen rearrangement,85,86,87 
and the Cope rearrangement.85,88,89 Specifically, the [2,3]-Wittig rearrangement can be classified 
as an anionic sigmatropic reaction (i.e. rearrangement starting material is anionic) which includes 
reactions such as the Sommelet-Hauser90,91 and sulfonium ylide92 rearrangements. 
 The general transformation of a [2,3] sigmatropic rearrangement is the migration of 
stabilized carbanion across a π-system, typically an allyl or a benzyl group (Figure 20). When X 
= O, the rearrangement is called a Wittig rearrangement and for X = N, an aza-Wittig 
rearrangement. Mechanistically, both [1,2] and [2,3] sigmatropic rearrangement products can be 
obtained. In nearly all cases, a carbanion stabilizing group, G, is required for the rearrangement 
to occur. The activation energy of the [2,3]-Wittig rearrangment is proportional to the HOMO-
LUMO energy gap between the carbanion and π-system, respectively. Less stable carbanions 
will react faster than their more stabilized counterparts due to an increase in the HOMO energy 
level. 
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Scheme 20 
 
 Wittig and Löhmann were first to report this class of pericyclic reaction for the [1,2]-
sigmatropic rearrangement of several benzylic ethers.93,94 Stevens et al. observed that the 
treatment of allyl flourenyl ethers in presence of organolithium bases or sodium alkoxide bases 
afforded a mixture of both [1,2] and [2,3] rearrangement products (Scheme 21).95 For the 
purposes of this report, only the [2,3]-Wittig rearrangement and its asymmetric variants will be 
discussed in this chapter 
Scheme 21 
 
 Both [1,2] and [2,3]-Wittig rearrangement pathways can be operative depending on the 
substrate structure and reaction temperature. Generally, it has been observed that the [1,2] 
pathway can be inhibited at lower reaction temperatures (Scheme 22).96 Another factor to 
consider are the various resonance structures of the intermediate carbanion. Rautenstrauch 
reported that for the lithiation of bis(prenyl) ether, [1,2], [2,3], [3,4], and [1,4]-rearrangement 
pathways are possible, but the [2,3]-rearrangement is the dominant pathway (Scheme 23).96 
Alternative rearrangement pathways become more of an issue when substrates contain similar π-
systems in close proximity.  A related issue to consider is the possibility of additional 
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sigmatropic rearrangements resulting from the initial rearrangement product. With a suitable 
substrate, the [2,3]-Wittig rearrangement can be followed by one or a series of sigmatropic 
rearrangements, such as a Claisen or a Cope rearrangement (Scheme 24).97,98  
Scheme 22 
 
Scheme 23 
 
Scheme 24 
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 The [2,3]-Wittig rearrangement proceeds by means of a six-electron, five-membered, 
cyclic transition state in a concerted mechanism. The transition state of the [2,3]-Wittig 
rearrangement is often represented as one of three different conformations, A-C (Figure 19).79,80 
Substituent G represents the various carbanion stabilizing functional groups and its structure can 
have a significant impact on the transition state.  Generally with monosubstituted alkenes, the 
[2,3]-Wittig rearrangement affords the (E)-olefin as the major isomer. The highest selectivities 
are observed when G is a phenyl or alkynyl group (Scheme 25).99 
 
Figure 19. [2,3]-Wittig rearrangement transition state conformations. 
Scheme 25 
 
 To selectively access the (Z)-olefin as the major, other reaction conditions are required.  
Experiments conducted by Still and Mitra showed that allyl stannylmethyl ethers serve as 
excellent carbanion precursors via a tin-lithium exchange to afford the (Z)-olefin [2,3]-Wittig 
product with good to excellent selectivity depending of the substrate substituents (Scheme 26).100 
The organolithium compound resulting from the tin-lithium exchange lacks a stabilizing group, 
and in its absence the HOMO energy level is raised for the carbanion intermediate. This increase 
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in the HOMO energy level of the carbanion decreases the HOMO-LUMO energy gap, and 
therefore significantly enhances its reactivity to afford (Z)-olefin rearrangement products. 
Scheme 26 
 
 This high level of stereoselectivity for [2,3]-Wittig rearrangements can be maintained 
when additional substituents are appended, such as with disubstituted alkene substrates.  This 
high degree of stereocontrol is illustrated in transitions state structures, T1-T4 (Scheme 27).  The 
formation of cis or trans products with respect to the hydroxy group, is primarily determined by 
the olefin geometry of the starting material, and the level of diastereoselectivity is greatly 
impacted by the structure of substituent G. 
Scheme 27 
 
 When the [2,3]-Wittig rearrangement substrate is an (E)-olefin, T1 becomes the favored 
conformation due to a 1,3-psuedo axial interaction between Hβ and G, thus affording the trans 
product. If a (Z)-olefin is employed as the substrate, T4 is favored due to a minimization of steric 
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repulsion between substituent R and G, thus affording the cis product. Generally, (Z)-olefin 
substrates afford more diastereoenriched rearrangement products than their (E)-olefin 
counterparts.  The basis for this observation for this observation can be found in T3 and T4. If 
another substituent were appended to the allylic position (to the right of Hβ) of the substrate, it 
would result in a A1,3 strain interaction with substituent R. The stereochemical preferences 
described previously have dealt primarily with benzylic, allylic, and propargylic substrates (G = 
phenyl, alkenyl, alkynyl).  A notable exception to this diastereomeric selectivity can occur with 
α-allyloxy appended esters, acids, and amides (G = CO2H, CO2R, and CONR2).
101,102 In these 
instances, the gauche interactions between G and R could have more influence and may 
overcome the pseudo-1,3-diaxial interaction between Hβ and G.  As a result (E)-α-allyloxy acids, 
esters, and amides can afford cis products as the major diastereomer.  
 The asymmetric [2,3]-Wittig rearrangement (AWR) has also been developed successfully 
and can be organized into four different classes, which include the transition, asymmetric 
induction, chiral base-induced, and the configurationally defined carbanion type of AWR.80 For 
the asymmetric transition class, asymmetry is introduced with the use of a chiral, non-racemic 
allylic alcohol. Generally this configurationally defined stereocenter is directly involved within 
the transition state. The second class is referred to as asymmetric induction, which is 
accomplished by means of a chiral auxillary and is not directly involved in the transition state.  
The third class of asymmetric variants involves a chiral base induction, typically through the use 
of chiral, non-racemic lithium amide bases.  The fourth class incorporates the use a 
configurationally defined carbanion, such as those generated via a tin-lithium exchange from a 
configurationally defined organostannane.  Focus will be given to the third class of AWR 
because the asymmetric induction is derived from reagent control. 
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 The first example of a reagent-controlled AWR was performed by Marshall and Lebreton 
for the ring contraction of a macrocyclic ether in the total synthesis of (+)-Aristolactone.103 In 
this instance, chiral, non-racemic lithium amide bases was employed to afford both enantiomers 
of the [2,3]-Wittig rearrangement product in good yield and enantioselectivity (er 85.5:14.5 to 
86.5:13.5). However, these chiral bases were unselective with acyclic substrates.104 Later work 
with this ligand by Marshall and Wang with α-propargyloxyacetic acids underwent the AWR to 
afford the allenyl alcohol product with low levels of enantioselectivity (er 67:33 to 74:26).105 
Further success with acyclic substrates for the AWR was realized by Kang et al. for allyl 
propargyl ethers with sec-butyllithium and an excess of (-)-α-isosparteine.106  Good 
diasteroselectives and low to moderate levels of enantioselectivity (er 64.5:35.5 to 85.5:14.5) 
were obtained when the reaction was performed at low temperature (-78 °C) in hexane. Manabe 
had also reported the use of a chiral lithium amide base complex for the AWR of dipropargyl 
ethers to generate enantioenriched allenyl proparyl alcohols with moderate levels of 
enantioselectivity (er 73:27 to 81:19).107 High levels of enantioselectivity were established with 
acyclic substrate by Jefferson et al. in the AWR with allyl benzylic ethers of 
tricarbonylchromium complexes.108 Employing a bidentate lithium amide complex, the selected 
substrates underwent the AWR in low to good yields with good to excellent levels of 
enantioselectivity (er 92:8 to 99.5:0.5). Work by Nakai et al. also observed good 
enantioselectivities (er ≤ 94.5:5.5) with acyclic substrate when using a chiral bis(oxazoline) 
ligand.109 
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Scheme 28 
 
 The first catalytic AWR was conducted by Kimachi and Kawaski.110 In this study, a 
benzyl allyl ether was treated with n-butyllithium in the presence of a substoichiometric amount 
of (-)-sparteine to afford product in modest yield (44%) and a moderate level of 
enantioselectivity (er 74:26). Nakai et al. explored the catalytic AWR utilizing benzyl allyl 
ethers, propargyl allyl ethers, tert-butylithium, and 0.2 equivalents of a chiral bis(oxazoline) 
ligand, but afford products with low enantioenrichment (er 65:35–67:33).111 Maezaki et al. 
obtained excellent asymmetric induction for a catalytic AWR of an allyl benzyl ether substrate, 
employing a bis(oxazoline) ligand (Scheme 29).112 The benzylic alcohol product derived from 
this rearrangement was obtained in low to moderate yields (23-52%) but with consistently high 
levels of enantioselectivity (er >97.5:2.5). While this most recent example may suggest the 
catalytic AWR is well-developed, it employs harsh conditions (alkyllithium bases) at cryogenic 
temperatures with relatively large quantities of a chiral ligand. 
Scheme 29 
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 To date only one example of a PTC [2,3]-Wittig rearrangement has been reported.  
Yamamoto et al. observed the rearrangement of several allyl fluorenyl ethers in presence of solid 
potassium hydroxide and either a quaternary ammonium/phosphonium salt or crown ether as a 
catalyst (Scheme 30).113 When more substituted ethers were employed a significant amount of 
the [1,2]-rearrangement product was obtained, but its formation could be suppressed at lower 
reaction temperatures. The authors note that aqueous potassium hydroxide, in addition to solid 
potassium carbonate, bicarbonate, and fluoride were unable to promote the rearrangement.  
Benzyl allyl ether was found to be completely resistant to rearrangement with all bases 
examined. 
Scheme 30 
 
 Base-mediated PTC reaction conditions have the potential to generate carbanions of 
relatively weak C-H acids that are typically associated with traditional [2,3]-Wittig 
rearrangement substrates and would normally require strong bases for rearrangement, such as 
organolithiums. For instance, deuterium exchange studies conducted by Rabinovitz et al. 
observed that allyl benzene (pKa = 34, DMSO) could incorporate a deuterium label and 
isomerized to β-methyl-styrene when treated with aqueous sodium hydroxide (18.3 M NaOD in 
D2O) and toluene in the presence of a catalyst.
114,115 Deuterium was exclusively incorporated at 
the allylic position of β-methyl-styrene.  This finding demonstrated that while carbanion 
formation from weak C-H acids may occur under PTC conditions, the resulting carbanion was 
sufficiently reactive such that isomerization was preferred kinetically, even in the presence of an 
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aqueous solvent. These reports were encouraging for the development of a general PTC [2,3]-
Wittig rearrangement. 
 
3.1.2 Objectives 
 All [2,3]-Wittig rearrangements involve the intermediacy of a carbanion that is typically 
generated from reactive bases such as alkyllithiums and lithium amides and at cryogenic 
temperatures.  It has been well established that base-mediated PTC is an attractive and efficient 
method for the generation of carbanions intermediates without the need for reactive bases and 
employing milder reagents and temperatures (See Chapter 1.1). In particular, the alkylation of 
PTC-generated carbanions has been applicable to a wide array of substrates, with large range of 
C-H acidities, and with highly stereoselective variants.116  It should be possible to develop a 
base-mediate PTC process for the [2,3]-Wittig rearrangement and potentially other sigmatropic 
rearrangements. If such carbanions could react with a suitable π-system, a new class of PTC 
reactions would be open to development. 
 The [2,3]-Wittig rearrangement was selected amongst other sigmatropic rearrangements 
because it has employed substrates amenable to other base-mediated PTC reactions (e.g. 
alkylation), and had the potential to form two contiguous stereocenters.  A variety of carbanion 
stabilizing groups, G, would be tested including substrates such as cyanides, carboxylic acids, 
esters, amides, phosphonates, and sulfonates (Scheme 31). The primary objective of this 
investigation will be to develop a base-mediated PTC [2,3]-Wittig rearrangement under liquid-
liquid reaction conditions.  Employing aqueous bases, this PTC rearrangement should have a 
general substrate scope and afford a minimal amount of side products. Should this PTC 
rearrangement be found to proceed effectively, a secondary objective will be to develop a first-
 54 
in-class APTC [2,3]-Wittig rearrangement with the aid of a chiral, non-racemic quaternary 
ammonium salt. 
Scheme 31 
 
 Previous studies have shown substrates such as phenylacetonitrile can be alkylated 
through the use of base-mediated PTC conditions.117,118 Additionally, the introduction of an 
terminally substituted allyloxy group on the methylene carbon position of phenylacetonitrile 
would afford a substrate capable of [2,3]-Wittig rearrangement.119,120,121 These reports 
demonstrate that under homogeneous reaction conditions, the initial [2,3]-Wittig rearrangement 
product, a cyanohydrin, collapses down to form a ketone under the basic reaction conditions 
(Scheme 32). A propargyloxy group could also be appended to the same position to afford 
aromatic allenyl ketones in a stereoselective fashion.120 Consequently, this class of substrates 
may only form one stereocenter that is adjacent to a ketone. Substitution of the cyano group with 
other carbanion-stabilizing groups (e.g. esters, amides, phosphonates) offers the possibility of 
forming two contiguous stereocenters in a diastereoselective and enantioselective fashion. 
Scheme 32 
 
 A tertiary objective of this study will be to test higher pKa C-H acid substrates such as 
allyl-propargyl, bis(allyl), allyl-benzyl, and benzyl-propargyl ethers. Classical [2,3]-Wittig 
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rearrangement reaction conditions require the use of lithium amide, aryllithium, or alkyllithium 
bases. These harsh reaction conditions limit the scope of applicable substrates, making a PTC 
process a viable alternative. 
 
3.2 Substrate Synthesis 
3.2.1 Synthetic Routes Based on Phenylacetonitrile Derivatives 
 Several obstacles were encountered en route to the desired α-allyloxy-phenylacetonitrile 
derivatives required to test the feasibility of this reaction.  Initially, it was proposed this material 
could be generated from an α-bromo-phenylacetronitrile and the appropriate alcohol by means of 
the Williamson ether synthesis.122,123,124 This route was unsuccessful because the stoichiometric 
formation of the alkali metal alkoxide led to deprotonation of α-bromo-phenylacetonitrile rather 
than a displacement of the bromide and afforded a complex mixture of products (Scheme 33). 
The α-tosyl-phenylacetonitrile was also prepared as a substrate precursor, but several O-
alkylation conditions tested were unable to afford the desired cyano ether product.  A minor 
amount of the α-crotyloxy-phenylacetonitrile was prepared by heating α-tosyl-phenylacetonitrile 
in neat crotyl alcohol.  However, this method required laborious chromatographic purification, 
and other alcohols that were tested afforded a complex mixture of products. 
Scheme 33 
 
 A two-step route for the preparation of α-allyloxy-phenylacetonitrile derivatives from 
phenylacetonitrile and an allylic alcohol was not viable.  Given the acidity of the methine 
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position of the brominated phenylacetonitrile-derived precursor, alternative synthetic routes were 
investigated.  One option was to perform an O-alkylation of a cyanohydrin intermediate, and 
another option was to perform a cyanide displacement of an acetal with Lewis acid catalysis 
(Scheme 34). 
Scheme 34 
 
 The preparation of α-allyloxy-phenylacetonitrile derivatives was attempted by means of a 
PTC method with benzaldehyde, aqueous potassium cyanide, allyl bromide, and a catalyst, 
triethylbenzylammonium chloride.125 When 3-bromo-2-methyl-2-propene was used as the 
alkylating agent, only a trace amount of the desired product was observed with the majority of 
the product determined to be the substituted allyl cyanide. Other conditions developed by Cazes 
and Julia for the synthesis of substituted cyanoethers have been reported, and these routes have 
yet to be fully investigated (Scheme 35).126,127 
Scheme 35 
 
 
3.2.2 Current Synthetic Route 
 A recent disclosure by Oriyama and Iwanami reported the preparation of α-allyloxy-
phenylacetonitrile from benzaldehyde, trimethylsilyl allyl ether, trimethylsilyl cyanide, and a 
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substoichiometric amount of ferric chloride in one-pot.128  Replication of this procedure with 
trimethylsilyl allyl ether afforded the desired product in good yield and purity (Scheme 36).  
Unfortunately, the use of more substituted TMS-protected allyl alcohols did not afford the 
desired product.  The use of crotyl, prenyl, and cinnamyl derivatives resulted in a complex 
product mixture in each case. 
Scheme 36 
 
 Because these substrates were required only for a proof of concept experiment, extensive 
experimentation to indentify the cause of this failure was not performed.  Instead of 
troubleshooting the one-pot method described previously, the synthesis was split into two 
separate reactions, acetalization followed by displacement with cyanide. 
 Crotyl (R1=H, R2=Me), prenyl (R1=Me, R2=Me), cinnamyl (R1=H, R2=Ph), and (E)-α-
methyl-cinnamyl alcohol (R1=Me, R2=Ph) were O-silylated by heating in neat 
hexamethyldisilazane to afford the desired products in good to excellent yields after distillation 
(Scheme 37).  The crotyl, prenyl, and cinnamyl alcohols were commercially available and used 
directly without further purification.   
Scheme 37 
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 To prepare α-methyl-cinnamyl alcohol, acetophenone was treated with 
triethylphosphonoacetate in the presence of n-BuLi in a Horner-Wadsworth-Emmons 
olefination.129 Chromatographic purification afforded a 5:1 ratio of E:Z olefin isomers of the α,β-
unsaturated ester product in 79% overall yield (Scheme 38). Each ester was subsequently 
reduced with diisobutylaluminum hydride (DIBAL-H) to afford both the E and Z allylic alcohols 
in 50% and 76% yield, respectively.129 Later experiments found this reduction could be 
performed with lithium aluminum hydride at 0 °C to selectively afford the 1,2-reduction product 
in 89% yield starting from the (E)-olefin (Scheme 39). 
Scheme 38 
 
Scheme 39 
 
 Only the prenyl and (E)-α-methyl-cinnamyl silyl ethers were carried forward to the target 
α-allyloxy-phenylacetonitrile substrate by means of the two step acetalization/cyanation route.  
Employing Noyori acetalization conditions, both TMS-ethers were combined with benzaldehyde 
and a substoichiometric amount of trimethylsilyl trifluoromethanesulfonate to afford the desired 
acetal in good and moderate yields (Scheme 40).130 Unfortunately, this procedure has thus far 
been irreproducible. The source of problem is unknown at this time, and other acetalization 
methods are currently under investigation. 
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Scheme 40 
 
 From here the acetal was treated with one equivalent of cyanide in the presence of a 
Lewis acid catalyst to afford a cyanoether product.131  Several Lewis acids were examined and 
stannous chloride was found to be the most effective catalyst.  Employing a slight excess of 
trimethylsilyl cyanide as the cyanide source, the target α-allyloxy-phenylacetonitrile analogues 
were prepared in moderate to low yields (Scheme 41). 
Scheme 41 
 
 Although this route was ultimately successful in providing adequate amounts of substrate 
for proof of concept experiments, a more general and efficient synthesis would be required for 
examining the substrate scope of the PTC [2,3]-Wittig arrangement.  Ideally, such a synthetic 
route would be based on the use of allylic alcohol precursors, given their potentially large 
structural diversity and ease of preparation. Transition metal-catalyzed diazo insertion into an O-
H bond was briefly investigated although ultimately unsuccessful, likely due to competeing 
reactivity of the alkene functional group.132,133 Unless the reproducibility issue of the 
acetalization reaction can be overcome, the most promising route for the preparation of the 
cyanoethers would be a base-mediated alkylation of a cyanohydrin. 
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3.3 Results and Discussion 
3.3.1 Achiral [2,3]-Wittig Rearrangement Substrates 
 Once sufficient amounts of the α-allyloxy-phenylacetonitriles were prepared, a proof of 
concept experiment was performed under base-mediated PTC reaction conditions utilizing 
tetrabutylammonium bromide (TBAB) as the phase transfer catalyst.  Employing an aqueous 
potassium hydroxide/toluene biphase, the starting material was consumed within 20 minutes at 
ambient temperature after the addition of base (Scheme 42). In the absence of TBAB, no reaction 
was observed after stirring overnight at ambient temperature. 
Scheme 42 
 
 Isolation and purification of the crude product led to an interesting observation. The 13C-
NMR spectroscopic data from the purified material indicated the presence of two ketone 
functional groups, and the 1H-NMR spectroscopic data contained far too many 1H absorbences to 
support a phenyl allyl ketone structure.  Both the thin-layer (TLC) and gas chromatography (GC) 
data supported the formation of a single compound, or at the least the formation of a mixture of 
inseparable isomers. The most interesting result came for the chemical ionization (CI+) mass 
spectrometry data, which supported the formation of a Michael addition product (293.1 m/z [M-
H+]).  This observation can be explained by the formation of an enolizable ketone as the initial 
product of the reaction.  The allyl ketone may form an enolate intermediate under the reaction 
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conditions, and any enolate that is subsequently isomerized to an α,β-unsaturated ketone could 
participate in a Michael addition with the enolate. Ultimately, this proof of concept experiment 
had demonstrated that the facile deprotonation of the initial [2,3]-Wittig rearrangement product 
led to rapid, undesired side reaction. 
 The use of a crotyloxy analogue (Scheme 32, R2=Me, R4=Ph) suffered the same pitfall as 
the rearrangement of α-allyloxy-phenylacetonitrile. The initial [2,3]-Wittig rearrangement 
product was observed to isomerize to an α,β-unsaturated ketone under the base-mediatied PTC 
reaction conditions (Scheme 43).  This product structure was supported by two methyl signals in 
the 1H-NMR spectrum, one doublet and one singlet. With this result in hand, it was deemed 
unnecessary to examine the cinnamyloxy derivative (Scheme 32, R2=Ph, R4=Ph) given the 
likelihood of isomerization.  
Scheme 43 
 
 While disappointing, the observation of a rapid isomerization under the reaction 
conditions is not surprising. Given the C-H acidity of the initial [2,3]-Wittig rearrangement 
product (pKa <25, DMSO), the thermodynamic stability provided by the formation of a 
trisubstituted alkene over a monosubstituted one, and the extension of the conjugated π-system, it 
would have been more surprising had the product not isomerized under the reaction conditions. 
This isomerization had unfortunate side effect of destroying the one stereocenter formed in the 
sigmatropic rearrangement, thus limiting the choice of substrate to terminally disubstituted 
allyloxy analogues for an APTC reaction. 
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 When two methyl groups were appended to alkene terminus of α-allyloxy-
phenylacetonitrile and then subjected to base-mediated PTC reaction conditions, the desired 
[2,3]-Wittig rearrangement product was afforded in 66% yield (Scheme 44). The 1H-NMR 
spectrum of the product after chromatographic purification contained 1H absorbencies suggestive 
of a trace amount of the [1,2]-Wittig rearrangement product.  Replication of this reaction with 
the same substrate on larger scale would be required in order to confirm this finding.  These 
proof of concept experiments demonstrated that under base-mediated PTC reaction conditions, 
carbanions derived from alpha-allyloxy-phenylacetonitrile and its analogues will successfully 
undergo a [2,3]-Wittig sigmatropic rearrangement. 
Scheme 44 
 
 
3.3.2 Preliminary APTC [2,3]-Wittig Rearrangement 
 With the feasibility of the PTC [2,3]-Wittig rearrangement established, the secondary 
objective of this study, the development of an APTC [2,3]-Wittig rearrangement was initiated. 
For this study, substrates would have to be limited to terminally disubstituted allyl groups to 
yield quaternary stereocenters adjacent to ketones. Using the dimethyl, terminally, disubstituted 
substrate as a starting point, a methyl group was replaced with a phenyl ring to generate the (E)-
olefin configuration and a prochiral substrate. Initially, TBAB was first used as a catalyst, both to 
generate racemate and to provide a rough estimate of reaction time at lower temperatures (0 °C). 
The first chiral, non-racemic quaternary ammonium salt catalyst tested was Corey’s catalyst (See 
Chapter 2, catalyst 1d). However, after two additions of 0.1 equivalents of catalyst and two days 
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of stirring at ambient temperature, no starting material was observed to undergo the 
rearrangement. When a [5,5,5]-pyrolizindium catalyst was employed for the rearrangement, the 
starting material was consumed in less than an hour at 0 °C to afford the desired product in 49% 
yield and an enantiomeric ratio of 55:45 (Scheme 45).73,134 This was the first example of 
asymmetric induction for a [2,3]-Wittig rearrangement under PTC reaction conditions! The 
absolute configuration of the product was not determined. 
Scheme 45 
 
 The absence of catalytic activity with a Cinchona alkaloid derived catalyst was 
surprising.  It is unclear at this time whether this result is due to the decomposition of the catalyst 
or it is simply unable to promote the rearrangement. One possibility, is that the formation of the 
ammoniumcarbanion ion pair leads to an unfavorable conformation of the reactant carbanion 
and therefore unable to participate in a [2,3]-Wittig rearrangement. If a quaternary ammonium 
hydroxide intermediate is indeed responsible for the generation of the reactive carbanion, then 
another possibility exists that the hydroxide ion-pair derived from Corey’s catalyst is simply 
unstable. Because only one chiral, non-racemic catalyst has been found to promote asymmetric 
induction, the degree to which enantioselectivity could be further improved is unknown. Given 
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the unimolecular nature of the [2,3]-Wittig rearrangement, it is possible that an entirely different 
catalyst scaffold would be required for a high level of enantioselectivity. 
 
3.4 Conclusion 
3.4.1 Summary 
 This preliminary investigation into the [2,3]-Wittig rearrangement has demonstrated that 
α-allyloxy-phenylacetonitrile and its more substituted analogues are capable of undergoing 
rearrangement under PTC reaction conditions. Further, the choice of substrate was critical to the 
structure of the product.  The initial rearrangement products that possessed enolizable hydrogens 
were found to isomerize under the base-mediated reactions conditions to an α-β-unsaturated 
ketone. Therefore, all potential APTC substrates could only afford quaternary stereocenters 
adjacent to ketones.  A proof of concept APTC [2,3]-Wittig rearrangement was conducted with a 
[5,5,5]-pyrolizindium catalyst but only afforded low levels of enantioselectivity. 
 
3.4.2 Future Directions 
 Preliminary investigations have begun to expand this new reactivity to other substrates. 
α-Allyloxy-t-butyl acetate has been tested under similar PTC reaction conditions, however no 
[2,3]-Wittig rearrangement product was detected (Scheme 46). While this was a disappointing 
result it was not entirely unexpected.  Earlier experiments by Nakai et al. had shown that the 
[2,3]-Wittig rearrangement pathway could not be obtained with α-allyloxy-esters in a LDA/THF 
system alone.135  It was found that only after the addition of hexamethylphosphoramide (HMPA, 
25% by vol.) could the [2,3]-Wittig rearrangement proceed to afford the desired hydroxy ester. 
That same study also observed that carboxylic acids and amides proceeded through a [2,3]-
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Wittig rearrangement without the addition of HMPA.  The authors propose that lithium 
coordination to the enolate minimizes the carbanion reactivity of ester substrate. Other methods 
exist for the preparation of [2,3]-Wittig rearrangement products from ester substrates, although 
with a limited substrate scope.136 
Scheme 46 
 
 If the base-mediated PTC method could be extended successfully to the ester substrate 
class, it would represent an attractive alternative to traditional reaction conditions.  It is likely 
that alternative PTC reaction conditions (e.g. solvent, catalyst, base) would be required for a 
successful rearrangement of the ester substrate class. 
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CHAPTER 4: Phase Transfer Catalyzed Phenol Alkylation 
4.1. Introduction 
 The past several decades have seen tremendous advances in the realm of phase transfer 
catalysis (PTC).1,5,12,14 One type of PTC reaction that has shown considerable importance is base-
mediated reactions. Since the initial developments of PTC processes, base-mediated PTC has 
become the most widely employed class of PTC reactions. Base-mediated PTC reactions are 
used for the deprotonation of acidic organic reactants to generate reactive anions, which can then 
undergo a multitude of nucleophilic displacements within the organic solvent. Roughly 60% of 
all commercial PTC processes incorporate the hydroxide ion as a reagent.137 
 A wide range of acidic substrate are accessible for a base-mediated PTC reaction, and 
may include functional groups such as O-H acids (e.g. carboxylic acids, alcohols, phenols), N-H 
acids (e.g. amines, amides), and C-H acids (e.g. ketones, esters, alkyl nitriles) to name a few. 
Among the most useful base-mediated PTC reactions are alkylations, through formation of C-O, 
C-N, and C-C covalent bonds. Although homogeneous reaction conditions have traditionally 
been used to access these reactive anion intermediates, in many cases strong bases (pKa >35, 
DMSO) are required. Perhaps the greatest advantage of a base-mediated PTC process is the use 
of inexpensive, relatively less reactive bases, such as alkali metal hydroxide and carbonate bases 
as aqueous solutions or solids. 
 Although the substrate and reaction scope of base-mediated PTC reactions is well-
developed, some more fundamental questions remain.  For instance, how does the intrinsic 
reactivity of a quaternary ammonium-carbanion intermediate under PTC reaction conditions 
compare to the reactivity of an alkali metal-carbanion under homogeneous reaction conditions.  
The latter has been extensively studied and has shown a large dependence on solvent polarity 
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and choice of cation.138 Are the same factors responsible for reactivity under homogeneous 
reaction conditions applicable to the catalytic activity in a PTC process? Given the large 
structural diversity of quaternary ammonium cations, the exact role of the catalyst structure on 
intrinsic reactivity of the ion-pair intermediate under PTC reaction conditions remains obscure. 
 
4.1.1 Mechanism 
 With respect to the kinetics of a PTC reaction, catalyst activity is controlled by three 
factors (1) the reaction rate in the organic phase, (2) the mass transfer steps between the organic 
and aqueous phases and (3) the distribution equilibrium of the tetraalkylammonium species 
between two phases.139 Base-mediated PTC reactions operate in a mechanistic continuum that is 
significantly dependent on the pKa of the organic substrate and the lipophilicity of the catalyst 
species.  More acidic substrates (pKa <18 (DMSO)) often react by means of an extractive 
mechanism, whereas more basic substrates proceed through an interfacial mechanism (See 
Chapter 1). Should a catalyst species be sufficiently lipophilic such that its aqueous phase 
concentration is negligible, interfacial transport steps must be invoked to account for any 
observed catalytic activity. It is important to note that just because mass transport through an 
interfacial layer is part of a kinetic rate expression in a PTC reaction, it does not imply that the 
reaction proceeds through an interfacial mechanism. For an interfacial mechanism to be 
operative, the rate-determining step must be one of the transport steps to or from the interfacial 
layer. 
 Regardless of which mechanism is dominant, because base-mediated PTC reactions 
involve an additional anionic species, generally hydroxide (OH-), the kinetics analysis becomes 
complicated due to additional transfer steps (Figure 20). In the context of Starks’ extraction 
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mechanism, hydroxide stays in the aqueous phase where it can deprotonate the organic substrate 
(R-H) to generate reactive anion intermediate (M+R-), and the catalyst (Q+X-) can partition 
between both phases. The intermediate M+R- can then undergo ion exchange with Q+X- to 
generate the catalystanion reactive intermediate (Q+R-) in the bulk aqueous phase. If Q+R- is 
sufficiently lipophilic, then it will partition into the organic phase where it can react with a 
suitable electrophile (R’-X). 
 
Figure 20. Base-mediated PTC extraction mechanism with hydroxide base. 
 A modification of this mechanism was proposed by Brändström and Montanari, in which 
Q+X- or R-H is unable to partition into the aqueous phase, but can exist in the interfacial layer of 
the organic/aqueous biphase.140,141 At the interphase, Q+X- can undergo ion exchange with the 
hydroxide base (M+OH-) also present to genera +OH-). The 
now more lipophlic base, Q+OH-, can deprotonate the R-H at the interphase (not shown) or 
migrate to the organic phase for the deprotonation. The product of either deprotonation, Q+R-, 
may then migrate into the organic phase and participate in the intrinsic reaction with R’-X to 
generate the final product (R’-R). 
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 An interfacial mechanism can arise in one of two ways for a base-mediated PTC reaction. 
For PTC process with a visible and distinct biphase, the reaction rate is typically limited by the 
transport of Q+R- out of the interfacial layer. The interfacial mechanism can also arise from the 
formation of a third liquid phase (TLP) depending on the reactants, catalyst, and conditions 
employed. The former scenario will not be discussed here because it has already been 
extensively studied for a range of reactions.142,143,144,145,146,147 The latter scenario is more 
interesting because it can manifest from PTC reactions normally operating under an extraction 
mechanism by a relatively minor change in reaction conditions (e.g. catalyst loading, 
temperature).148 
 
4.1.2 Background 
 Despite the complexity of transfer steps in a base-mediated PTC process, a more 
fundamental question persists. How does the intrinsic reactivity of Q+R- affect the overall 
catalytic activity of Q+X- in a PTC process? To investigate this question, a suitable model, base-
mediated PTC reaction would be developed, one that would also been amenable to homogeneous 
reaction conditions. In this regard, the alkylation of phenol was chosen for this study. This subset 
of PTC alkylation has been well studied in regards to reaction conditions, scope of electrophile, 
and the phenol substrate derivatives.137,149 Depending on the reaction conditions and catalyst 
employed, the PTC alkylation of phenol can proceed by means of an extraction or interfacial 
mechanism.148 
 The first examples of a PTC alkylation of phenol was reported by McKillop et al. that 
subjected many different phenols and several naphthols with several alkylating agents, mainly 
methylating agents, in the presence of a substoichiometric amount of tri(n-
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butyl)benzylammonium bromide (Scheme 47).150 Wang and Yang conducted more detailed PTC 
alkylation studies for the allylation of 2,4,6-tribromophenol for the purpose of optimizing the 
synthesis of a monomer in the development of poly-bromominated polymers (Scheme 48).151  
Scheme 47 
 
Scheme 48 
 
 This mechanistic study found that potassium hydroxide was a better aqueous base, more 
polar, organic solvents afforded higher reactivities, and above an impellor speed of 600 rpm, 
stirring rate did not affect the reaction rate.  The reaction was observed to be first order in 
catalyst, tetra(n-butyl)ammonium bromide (TBAB), and allyl bromide.  Similar alkylation rates 
were observed for tri(n-butyl)benzylammonium bromide as well. A later kinetic modeling study 
by the same authors, determined the intrinsic alkylation rate of the quaternary 
-pair.152 With this information in hand, it was possible to 
computationally model this particular PTC alkylation based on the mass transfer and distribution 
coefficients of the ammonium species present in the reaction. There was excellent agreement 
between the model and experimental data. 
 The reactivity of phenoxides has been extensively investigated under homogeneous 
reaction conditions, both in the context of total synthesis and the initial development of a linear 
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free energy relationship (LFER).153,154,155,156,157 One of the earliest studies that examined the 
reactivity of ammonium phenoxides was undertaken by Ugelstad et al. for the alkylation of butyl 
halides under homogeneous reaction conditions (Scheme 49).158  The substitution of a potassium 
cation by a tetra(n-butyl)ammonium cation was found to increase the rate of alkylation by 
several orders of magnitude more, and the reaction rate of the ammonium phenoxide was 
significantly less sensitive to the polarity of the solvent compared to the potassium salt. 
Scheme 49 
 
 The augmented reactivity of the quaternary ammonium phenoxide is rationalized by the 
greater ionic radius of the tetra(n-butyl)ammonium cation (~4.37 Å)159 compared to the 
potassium ion (1.33 Å).160 This increase in charge separation allows for greater localization of 
charge density on the phenoxide oxygen, thus leading to enhanced nucleophilicity.161 
Computational studies have determined that the interaction energy for tetrabutylammonium 
phenoxides (2.5 kcal/mol) is significantly lower than for sodium phenoxide (4.5 kcal/mol), 
further supporting the observation that ammonium ion-pairs are more reactive than their alkali 
metal counterparts.162 
 Although the PTC alkylation of phenol was chosen as the model reaction, the first 
detailed investigation that aimed to elucidate the role of catalyst structure on a PTC nucleophilic 
displacement was undertaken by Landini et al. with inorganic anions.163 The authors examined 
the rates of displacement of six anions (e.g. halides, cyanides, azides) with n-octyl 
methanesulfonate in the presence of eleven different quaternary ammonium salts and two 
phosphonium salts in a chlorobenzene/water biphase (Scheme 50). Stirring speeds above 300 
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rpm were found to have no influence on the reaction rate and suggested that an extraction 
mechanism was operative. 
Scheme 50 
 
 In addition to studying the reaction under PTC conditions, intrinsic reaction rates for 
eight different quaternary ammoniumanions were determined under homogeneous conditions. 
Furthermore, when these homogeneous reaction rate studies were conducted with wet solvent, 
the specific water content of which was determined from Karl-Fisher titration under the 
respective PTC reaction conditions, the intrinsic reactivities were found to closely resemble that 
of the PTC reaction rates.  This finding led the authors to conclude that the level hydration of the 
ion-pair intermediate significantly influences the intrinsic reaction rate of a PTC process. A later 
study by the same authors sought to answer what effect the level of hydration of the anionic 
nucleophile would have on the intrinsic reactivity of the quaternary ammonium ion-pair.164 Their 
investigation revealed that decreasing the level of hydration led to reaction rates approaching that 
of the rates under anhydrous homogeneous reaction conditions.  Specifically in the displacement 
of n-octyl methanesulphonate with tetra(n-hexyl)ammonium phenoxidenH2O, a factor of 75 rate 
enhancement was observed upon increasing the aqueous sodium hydroxide base concentration 
from 15% to 50% and a reduction in the hydration state from n = 4.0 to n = 1.5. Additional 
experiments on the rate of the Hoffman elimination for quaternary ammonium ions have 
demonstrated that the effect on intrinsic reactivity by the level of hydration is significantly 
enhanced for anionic nucleophiles with high charge density, such as hydroxide and fluoride.165 
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 A more thorough study emphasizing the effect of catalyst structure on the alkylation of 
thiophenol with 1-bromooctane was undertaken by Herriott and Picker (Scheme 51).166 In their 
investigation, the activities of nearly two dozen phase transfer catalysts were determined. The 
authors observed that catalysts with longer alkyl groups led to increased reactivity. 
Scheme 51 
 
 With the catalysts examined in this study, no alkylation rate ceiling (i.e. activity plateau) 
was observed. Attempts were made to determine the intrinsic reactivity of the ion pair 
intermediate with the homogeneous alkylation rate of tetra(n-butyl)ammonium thiophenoxide. 
Unfortunately, the authors were unable to obtain reproducible alkylation rates and could not 
conclude to what degree the reactivity of the catalystthiophenoxide ion-pair played in the 
catalytic reactivity. 
 Landini and Maia reported the most comprehensive comparison between the intrinsic 
reactivity of a quaternary ammonium ion-pair and its activity as a catalyst under PTC reaction 
conditions.167 In the displacement of n-octylmethane sulphonate with chloride anion or the 
displacement of n-butyl bromide with 4-nitro-phenoxide anion under PTC reaction conditions, 
the authors observed significant rate constant differences between the organic solvents 
(chlorobenzene and 4-methyl-2-pentanone) and the quaternary ammonium cation employed 
(Me(n-Bu)3N
+, (n-Bu)4N
+, (n-Hex)4N
+) (Scheme 52). 
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Scheme 52 
 
 In the chlorobenzene/water biphase, the rate constant increased by a factor of a 100 with 
the chloride anion and nearly a factor of 14 for the 4-nitro-phenoxide anion going from Me(n-
Bu)3N
+ to (n-hexyl)4N
+. For the 4-methyl-2-pentanone/water biphase, a 20-fold rate constant 
enhancement was observed with the chloride anion and virtually no enhancement was observed 
with the 4-nitro-phenoxide anion with the same quaternary ammonium catalysts. The authors 
rationalized this observation based on the partition coefficient of the quaternary ammonium 
nitrophenoxide in 4-methyl-2-pentanone, which was found to be very soluble in the more polar 
ketone solvent, in contrast to chlorobenzene. The intrinsic reactivity of the ion-pair was 
examined under homogeneous reaction conditions for the displacement of n-butyl bromide with 
the respective quaternary ammonium halide (I-, Br-, and Cl-) in a chlorobenzene, methyl-tert-
amyl ether, and 4-methyl-2-pentanone solvents. A 1.7 to 30-fold rate constant enhancement was 
observed in comparison to the analogous reaction conducted in the biphase. In general, a much 
wider range in rates was observed under anhydrous, homogeneous reaction conditions, in which 
chloride anions were found to be the most reactive. 
 
4.1.3 Characterization of the Quaternary Ammonium Phenoxide 
 To perform an accurate kinetic analysis between homogeneous and PTC reaction 
conditions so that a comparison between intrinsic reactivity and catalytic activity could be made, 
a suitable procedure for the preparation of quaternary ammonium phenoxides would be required. 
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Nielsen and Hammerich found that treatment of tetra(n-butyl)ammonium hydroxide with two 
equivalents of phenol, followed by azeotropic removal of water with cyclohexane, afforded the 
homo-hydrogen bonded quaternary ammonium phenoxide dimer, (n-Bu)4N
+[(PhOH)OPh]- 
(Scheme 53, left).168 Reetz et al. reported the X-Ray crystal structure of (n-Bu)4N
+[(PhOH)OPh]- 
and prepared the complex by a similar protocol, wherein water was removed under high-vacuum 
over phosphorus pentoxide (Scheme 53, right).169 The ion-pair distance between the phenoxide 
oxygen and the α-carbon adjacent to the ammonium center was measured as 3.340 Å (Figure 
21).170  
 These higher order aggregates are less prone to decomposition when paired with 
quaternary ammonium salt due to the decreased basicity (i.e. nucleophilicity) of phenoxide anion 
in the homo-hydrogen bonded complex.154 Landini et al. have demonstrated that quaternary 
ammonium hydroxide ion-pairs are capable of undergoing a Hoffman elimination pathway (i.e. 
deprotonation of the β-hydrogen with respect to the ammonium center).171 In the absence of 
hydrogen bond donors (e.g. H2O), the phenoxide anion may react with its quaternary ammonium 
counterion.  
Scheme 53 
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Figure 21. X-Ray crystal structure for (n-Bu)4N
+[(PhOH)OPh]-. 
 Limited solution phase characterization studies on quaternary ammonium borohydride 
ion-pairs have been conducted by Pochapsky et al.172,173 Employing nuclear Overhauser effects 
(NOE) on tetra(n-butyl)ammonium borohydride in a CDCl3 solvent, the authors observed a 
significant enhancement at the α-CH (18.0%) and β-CH (8.1%). No concentration dependence 
was observed over a 0.02 to 0.60 M range, indicating that aggregate formation (if any) had an 
insignificant effect on the proximity of the borohydride anion to the ammonium center. 
Combined with CPK modeling (i.e. space-filling) calculations, the authors estimated the 
nitrogen-boron distance at ~3 Å. 
 
4.1.4 Objectives 
 The objective of this study was to develop a quantitative structure activity relationship 
(QSAR) for the PTC alkylation of phenol with linear, symmetric quaternary ammonium salts. 
Six ammonium cations would be examined, Me4N
+, Et4N
+, (n-Pr)4N
+, (n-Bu)4N
+, (n-Hex)4N
+, 
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and (n-Oct)4N
+. These particular ammonium cations were chosen for this study because they 
were readily available as their bromide salts and spanned a large range of relative lipophilicity. 
For each ammonium cation, the relative contribution of anion activation and anion transport to 
PTC reaction rate would be determined. To do so, the reactivity of the ammonium phenoxide 
under homogeneous reaction conditions and the activity of the same ammonium salts under PTC 
reaction conditions would be determined. This investigation would serve to answer a 
fundamental question, namely, what role does charge separation (i.e. nucleophile activation) play 
in PTC reaction rate. 
 
4.2 Results 
 The synthesis and alkylation kinetic studies of the quaternary ammonium, homo-
hydrogen bonded phenoxides were performed by a Nathan D. Gould.174 
 
4.2.1 Synthesis of the Quaternary Ammonium Phenoxides 
 The requisite quaternary ammonium hydroxides were prepared from the commercially 
available bromide salts by ion exchange, closely following the protocol of Harlow, Noble, and 
Wild, with the exception that anhydrous methanol was used as the solvent rather than 
isopropanol.175 Multiple passes (3 to 6) through an AmberlystTM A-26 resin were required to 
fully exchange the halide for hydroxide.176 The resulting quaternary ammonium hydroxide 
solutions in methanol were titrated for total base to a phenolphthalein endpoint (3-6 
determinations) and titrated for residual halide with an ion selective electrode (2-3 
determinations).177 The extent of exchange was greater than 97% in all cases, and the methanolic 
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salt solutions could be stored at -20 °C for an extended period (~1 month) with no change in 
effective base concentration. 
 The quaternary ammonium hydroxide solutions were then combined with a solution of 
phenol in dioxane to afford a quaternary ammonium phenoxides. Removal of water from these 
solutions was accomplished by three azeotropic concentrations with additional dioxane which 
then afforded finely powdered solids that could be handled in a glove box (Scheme 54). The 
stoichiometry of the phenoxide complexes was confirmed by treating the salts with a 
stoichiometric excess of benzyl bromide in acetonitrile. The ratio of benzyl phenyl ether to 
phenol was found to be 1:1 (± 0.04) by GC analysis in all cases. Thus, the salts corresponded to 
the homo-hydrogen bonded complexes of the ammonium phenoxides, R4N
+[(PhOH)OPh]-. 
Scheme 54 
 
 
4.2.2 Kinetic Analysis of Phenoxide Alkylation under Homogeneous Reaction Conditions 
 The intrinsic reactivity of the R4N
+[(PhOH)OPh]- ion-pair was determined by employing 
conditions directly analogous to the most comprehensive set of data available, namely, reaction 
with a slight excess of 1-bromobutane in acetonitrile at 0.016 M.158 The least polar, water 
immiscible, aprotic solvent that was tested and could completely dissolve the ammonium 
phenoxides was diisopropyl ketone (DIPK).178 Initial-rate kinetic data was collected for each 
ammonium phenoxide as well as the corresponding sodium and potassium homo-hydrogen 
bonded dimers in each solvent (Scheme 55).179  
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Scheme 55 
 
 The reactions were monitored to typically 5-10% conversion and reaction rate was 
expressed as the mean of triplicate reactions in terms of the change in n-butyl phenyl ether 
concentration (mol/L) with respect to time (s).180 The error bars in the summary plot represent 
one standard deviation in reaction rate (Figure 22). The alkylation rate for Na+[(PhOH)OPh]- was 
5.09 x 10-8 (mol*L-1*s-1) and was not shown on the plot. 
 
Figure 22. Stoichiometric ammonium phenoxide reactivity. 
 Reactions performed in acetonitrile were between a factor of 1.5 to 5 faster than those in 
DIPK in every case, with the quaternary ammonium cations examined. Overall, the reaction rates 
were more reproducible in DIPK than acetonitrile, potentially as a consequence of the difficulty 
of removing all adventitious water from the acetonitrile. The homogeneous, phenoxide alkylation 
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survey showed a strong solvent dependence on the rate of the reaction when the cation employed 
was an alkali metal (Na+ and K+) or Me4N
+. For acetonitrile, the alkylation rate increased by a 
factor of 9 going from sodium phenoxide (Na+[(PhOH)OPh]-) to a potassium phenoxide 
(K+[(PhOH)OPh]-). Whereas with DIPK, the rate increase going from sodium to potassium was 
slightly greater than a factor of two. The alkylation rate of K+[(PhOH)OPh]- was 18% higher 
than that of Me4N
+[(PhOH)OPh]- in acetonitrile. In contrast, the rate for Me4N
+[(PhOH)OPh]- 
was higher than potassium by more than a factor of 4 in DIPK. 
 In comparison of both solvents, DIPK showed a wider range in rate (a factor of 67), 
whereas acetonitrile displayed a narrower range in reactivity (a factor of 18.6). The highest 
reaction rate in acetonitrile was observed for the (n-Pr)4N
+ and was faster than the most active 
cation in DIPK, (n-Bu)4N
+, by nearly a factor of two. For quaternary ammonium cations larger 
than Me4N
+, the range in rate for acetonitrile varied by a factor of 1.8, and for DIPK the 
reactivity range varied by a factor of 1.7. This finding was surprising given the difference in 
ionic radius between the Et4N
+ and (n-Oct)4N
+ cation. Furthermore, the alkylation rates for Et4N
+ 
and (n-Oct)4N
+ in DIPK were remarkably similar at 2.02 x 10-6 versus 2.08 x 10-6 (mol*L-1*s-1), 
respectively. 
 
4.2.3 Kinetic Analysis of Phenoxide Alkylation under PTC Reaction Conditions 
 The PTC alkylation of phenol with n-butyl bromide was then conducted as a comparison 
to the stoichiometric, homogeneous ammonium phenoxide alkylation rates (Scheme 56). The 
same series of quaternary ammonium cations that were employed for the homogeneous reaction 
study were surveyed under PTC reaction conditions starting from the quaternary ammonium 
bromide. Both phases appeared homogeneous prior to and after the addition of n-butyl bromide 
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at ambient (~20 °C) and elevated temperature (40 °C). This eliminated the possibility of any 
solid to liquid transfer steps. Biphenyl was employed as an internal standard to monitor the initial 
rate for the formation of n-butyl phenyl ether by GC analysis. 
Scheme 56 
 
 Employing these reactions conditions, the background reaction was very slow; only 5% 
conversion to product was observed after five days.181 Several aqueous base concentrations were 
tested (10 M and 50% (w/w) aq. NaOH and KOH), and it was observed that 5 M aq. KOH 
afforded the most reproducible results. Higher aqueous base concentrations led to the formation 
of a white precipitate and alkylation rates that were too rapid to reliably monitor. All of the 
catalysts were screened at 0.05 equivalent loading and at 0.10 equivalent loading for tetra(n-
propy)ammonium bromide (TPAB), tetra(n-butyl)ammonium bromide (TBAB), tetra(n-
hexyl)ammonium bromide (THAB), and tetra(n-octyl)ammonium bromide (TOAB). 
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Figure 23. Catalyst survey for PTC phenol alkylation. 
 Tetramethylammonium bromide (TMAB) was found to be an inactive catalyst at 0.05 
equivalent loading and afforded an alkylation rate no greater than the background rate. At the 
same catalyst loading, tetraethylammonium bromide (TEAB) was able to catalyze the reaction 
4.6 times faster than background and TPAB catalyzed the reaction 167 times faster than 
background. Another significant jump in catalytic activity was observed with TBAB, which 
afforded a 660 fold rate increase over background and the represented the maximum rate for the 
catalyst series. For catalysts more lipophilic than TBAB, only a small change in catalytic activity 
was seen at 0.05 equivalents and virtually no difference was seen at 0.10 equivalents of catalyst. 
 Carrying out the alkylation with 0.10 equivalents insteads of 0.05 equivalents of TPAB 
afforded a two fold increase in alkylation rate, consistent with intrinsic-rate limited PTC reaction 
that is first order in catalyst.  However, for TBAB, THAB, and TOAB a 2.6, 3.0, and 2.9 factor 
increase, respectively, in alkylation rate was observed upon doubling the catalyst loading. These 
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increases in alkylation rates suggest the presence of higher order ammonium and potassium 
phenoxide aggregates in the organic phase. The emergence of an interfacial mechanism may also 
be responsible for the alkylation rate augmentation. 
 The range in catalytic activity (a factor of 660) was approximately an order of magnitude 
greater than the range in reactivity observed for R4N
+[(PhOH)OPh]- observed under 
homogeneous reaction conditions (a factor of 67). A relatively large difference in catalytic 
activity was observed with TEAB and TPAB under PTC reaction conditions, in contrast to the 
homogeneous reaction conditions that displayed similar reactivities with the same ammonium 
cations. As was the case in the reactions of the ammonium phenoxides under homogeneous 
reaction conditions in DIPK, a maximum rate was observed with the (n-Bu)4N
+ cation. However, 
in DIPK under homogeneous reaction conditions the reactivity went down after (n-Bu)4N
+, 
whereas under PTC reactions conditions the activity stayed nearly constant after TBAB. The 
catalyst survey under PTC reaction conditions clearly demonstrates that the intrinsic reactivity of 
R4N
+[(PhOH)OPh]- has little effect on the catalytic activity. 
 
4.2.4 Order in Electrophile for the PTC Phenol Alkylation 
 It was first hypothesized that the leveling off in catalytic activity after TBAB under PTC 
reaction conditions was the result of a change in reaction mechanism. Specifically, it was 
proposed that the PTC reaction deviated from an intrinsic-rate limited process, either with small 
or large alkyl chains on the quaternary ammonium cation. To test for the possibility of a change 
in reaction mechanism, the order in electrophile was determined.  The PTC reactions with TPAB 
and TOAB were repeated using a range of n-butyl bromide equivalents spanning an order of 
magnitude (0.5, 1.0, 2.0, and 5.0 equivalents with respect to phenol) (Figure 24). If a change in 
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reaction mechanism were operative (i.e. a change from intrinsic rate to transport rate limiting), 
then a different order in electrophile would be observed for the two catalysts. If one of the 
catalysts led to a transport rate-limited PTC reaction, then a zero order in n-butyl bromide would 
be expected. 
 
Figure 24. Variable n-butyl bromide equivalents. 
 A direct, linear relationship of n-butyl bromide concentration on alkylation rate was 
observed for both catalysts. With TPAB, the alkylation rate increased a factor of 8 over the range 
of n-butyl bromide concentrations, and with TOAB over the same range; the alkylation rate 
increased a factor of 14. For a reaction that is first order in electrophile, the initial alkylation rate 
should only increase by a factor of 10. It is possible that increasing the quantity of n-butyl 
bromide in the reaction may change the polarity of the bulk organic solvent, thereby affecting the 
intrinsic reactivity of the tetraalkylammonium phenoxide ion-pair. Neither catalyst demonstrated 
a zero order in n-butyl bromide, and this finding supported an intrinsic reaction rate-limiting 
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PTC reaction. In essence, the rate-determining step of this PTC reaction is the alkylation of the 
ammonium phenoxide in the organic phase. 
 
4.2.5 Effect of Variable Stirring Speed on PTC Alkylation Rate 
 To determine whether an extraction mechanism or interfacial mechanism was operative, a 
variable stirring speed experiment was conducted with TBAB as the catalyst (Scheme 57). The 
PTC reaction had to be run at ambient temperature because of the design of the electric motor. 
The stirring speed was varied from 500 rpm to 2000 rpm, and no stirring speed dependence on 
the reaction rate was observed above 500 rpm (Figure 25).  Therefore, this result supports an 
extraction mechanism and an intrinsic reaction rate-limited PTC reaction. 
Scheme 57 
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Figure 25. Variable stirring speed under PTC reaction conditions. 
4.2.6 UV-vis Spectroscopy of the Aqueous Phase 
 The results of the previous studies had supported that an extraction mechanism was 
operative in this PTC reaction, with the rate-determining step being the intrinsic reaction in the 
organic phase. It was postulated that the concentration of the quaternary ammonium phenoxide 
intermediate, [R4N
+PhO-], approaches its theoretical maximum with TBAB, THAB, and TOAB. 
To test this hypothesis several experiments were conducted to quantify the amount of this 
reactive species in the organic phase.  Given that the reaction of interest was the alkylation of 
phenol, it was reasoned that the partition of phenol could be analyzed by UV-vis spectroscopy.  
Unfortunately, DIPK is a UV-active solvent and masked the UV absorption of phenoxide anion. 
Instead, the change in phenoxide concentration of the aqueous phase would be used to calculate 
the amount of phenoxide transferred to the organic phase by difference (Scheme 58). 
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Scheme 58 
 
 The same tetraalkyl ammonium bromide catalysts were surveyed for the amount of 
phenoxide transferred to the organic phase at 0.2 and 1.0 equivalents (Figure 26).  With 1.0 
equivalent of catalyst the organic phase volume was reduced to 0.7 mL, the same as the aqueous 
phase volume. No measurement was made with 0.2 equivalents of TMAB, a hydrophilic 
ammonium salt, due to the likelihood of an insignificant change in aqueous phase concentration.  
  
Figure 26. UV-vis data for the transfer of aqueous phase phenoxide. 
 The results from the UV-vis absorbtion survey show that at 1.0 equivalent loading the 
more lipophilic salts, TPAB, TBAB, THAB, and TOAB, transferred a large amount of 
phenoxide out of the aqueous phase. The less lipophilic salts, TMAB and TEAB, would transfer 
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a much smaller amount (c.a. 5-10%). At 1.0 equivalent of TPAB, an amber colored third liquid 
phase (TLP) was observed that formed between the aqueous and organic phases (Figure 27). An 
analysis of the TLP by UV-vis spectroscopy found that the phenoxide concentration was a little 
more than twice the starting aqueous phase concentration.182  
 
Figure 27. Third liquid phase visible with 1.0 equivalent of TPAB. 
 At 0.2 equivalent catalyst loading, a large difference in phenoxide transport was observed 
between TEAB and TBAB (a factor of 16.5). The largest change was found going from TPAB to 
TBAB, which afforded nearly a 7-fold increase in the transport of phenoxide out of the aqueous 
phase. At 0.2 equivalents of TPAB, the amount of transferred phenoxide was drastically reduced 
and no TLP was observed. Taking into account the relatively large alkylation rate observed for 
TPAB (a factor of 120 over background), this finding suggests that the observed TLP is rich in 
both ammonium and phenoxide ions.  The critical catalyst concentration required for the 
formation of TLP with TPAB was not determined. 
 The second important finding from the catalyst survey with UV-vis spectroscopy was that 
the amount of phenol transferred to the organic phase with TBAB, THAB, and TOAB, was 
27.2%, 27.6%, and 29.3% when only 0.2 equivalents of the ammonium salts were employed, 
Third Liquid Phase 
Organic Phase 
Aqueous Phase 
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respectively.  This corresponds to a greater than 100% transfer of phenoxide per molecule of 
tetraalkylammonium salt. This striking and unexpected finding stimulated a more direct and 
refined analysis of the composition of the phenoxide species in the organic phase. 
 
4.2.7 Benzyl Bromide Titrations of the Organic Phase 
 The first stage in this study was to quantitatively determine the composition of the 
organic phase.  Direct analysis of the organic phase was accomplished by quenching reaction 
aliquots with an excess of benzyl bromide so that the active phenoxide concentration could be 
determined by measuring the amount of benzyl phenyl ether formed.  The quenched reaction 
aliquots were analyzed by gas chromatography with the aid of a biphenyl internal standard.  The 
same set of tetraalkylammonium salts were surveyed at 0.1 equivalents with respect to phenol 
(Figure 28). 
 
Figure 28. Benzyl bromide titration of organic phase using 0.1 equiv of R4N
+Br-. 
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 At 0.10 equivalent catalyst loading, both TMAB and TEAB had no active phenoxide 
present in the organic phase and only a minimal amount of phenol had transferred. This finding 
was expected given their respectively sluggish alkylation rates. With TPAB a small amount of 
active phenoxide was present in the organic phase, but with substantial greater proportion of 
phenol. The active phenoxide content with TPAB was lower than expected given its relatively 
large PTC initial alkylation rate. A significant amount of active phenoxide was present in the 
organic phase for TBAB, THAB, and TOAB with a 9.35, 14.13, and 16.77%, respectively. The 
amount of active phenoxide was found to increase with increasing the alkyl chain length of the 
catalyst, and the greater than 10% transfer of active phenoxide to the organic phase suggests the 
presence of potassium phenoxide complexed with the ammonium phenoxide. 
 A notable feature of this catalyst survey was the presence of phenol in the organic phase. 
This was unusual because hydroxide base was chosen as the aqueous phase, and the acid/base 
equilibrium should heavily favor (by several pKa units) the formation of potassium phenoxide 
over phenol. Even more interesting was that the concentration of organic phase phenol was 
unique to each ammonium salt examined, and therefore not simply a consequence of the 
employed base and organic solvent. For TBAB, THAB, and TOAB the amount of transferred 
phenol was found to be 6.78, 4.92, and 2.30%, respectively. The less lipophilic ammonium salts 
showed a lesser amount of phenol in the organic phase. What was unexpected was the difference 
in phenol and active phenoxide content between the lipophilic catalysts, given their similar 
alkylation rates. The amount of transferred phenol was found to decrease with increasing alkyl 
chain length of the catalyst. 
 Attempts to quantify the amount of potassium phenoxide associated with [R4N
+PhO-] in 
the organic phase have been limited.  An experiment that employed 0.10 equivalents of TOAB, 
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provided a sample for direct analysis of the organic phase. After quenching the organic phase 
phenoxide with an excess of benzyl bromide, analysis by inductively coupled plasma-optical 
emission spectroscopy (ICP-OES) found that the concentration of potassium in the organic phase 
was 590 ppm (590 mg/L). This value corresponds to a 6.82% transfer of potassium phenoxide to 
the organic phase based on the initial amount of phenol.  Given that there was a 16.77% transport 
of active phenoxide to the organic phase with TOAB, this leads to a 9.95% transport of 
[R4N
+PhO-] to the organic phase, and that 99.5% of the quaternary ammonium cation forms an 
ion pair with phenoxide. 
 
4.3 Discussion 
4.3.1 Homogeneous vs. PTC 
 Comparison of both the stoichiometric and catalytic series, the quaternary ammonium 
cations reveals significant differences in reactivity and activity. Under homogeneous reaction 
conditions, the quaternary ammonium cations, Et4N
+, (n-Pr)4N
+, (n-Bu)4N
+, (n-Hex)4N
+, and (n-
Oct)4N
+, displayed a narrow reactivity range, with a 1.6 to 1.7 factor difference in rate for 
acetonitrile and DIPK, respectively. This outcome was in stark contrast to the PTC reaction 
conditions that displayed an activity range of just over two orders of magnitude for the same 
ammonium cations. It was clear that the intrinsic reactivity of the ammonium phenoxide ion pair 
does not correlate well with its activity as a catalyst under PTC reaction conditions.  
 The finding that Me4N
+ had a significant reactivity under homogeneous reaction 
conditions, but no catalytic activity, is consistent with an extraction mechanism, wherein reaction 
rate is reflected by the concentration of [R4N
+PhO-] in the organic phase. This finding was 
further supported by the extraction constants for several linear, tetraalkylammonium picrate 
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(ArO-) salts in a dichloromethane/water biphase (Eq 1).183 The extraction constant (K) for 
[Me4N
+ArO-] was measured at 1.5 and was found to increase by approximately two orders of 
magnitude for each extension of the alkyl chain, Et4N
+ (K = 220) through (n-Pent)4N
+ (K = 
2.45*108). 
Equation 1 
Extraction Constant, K = [R4N
+ArO-]org. / [R4N
+ArO-]aq. 
 
4.3.2 Determination of the PTC Rate Constant  
 A PTC rate constant can be calculated from the initial alkylation rate (Eq 2). Because 
only the initial alkylation rates were collected, the concentration of n-butyl bromide can be 
treated as a constant and will not be factored into any calculations. These PTC rates constants 
were then compared to the rate constants collected under homogeneous reaction conditions. The 
effective concentration of the ammonium phenoxide was expressed one of two ways, (1) that all 
of the ammonium salt partitions into the organic phase and the ammonium phenoxide 
concentration reflects the concentration of the catalyst loading, or (2) the ammonium phenoxide 
concentration was calculated based on the amount of active phenoxide as was determined by the 
benzyl bromide titrations. While the 100% transfer of the tetraalkylammonium species for every 
catalyst is unlikely, it will be presented as a comparison to the homogeneous rate constants. 
Notably, the benzyl bromide titration data is an expression of the active phenoxide 
(tetraalkylammonium phenoxide and potassium phenoxide) in the organic phase. The red and 
green data points are representative of a 100% transfer of the tetraalkylammonium salt, and the 
blue squares factor in the organic phase active phenoxide content as determined by benzyl 
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bromide titration (Figure 29). The homogeneous rate constants are expressed as purple data 
points. 
Equation 2 
Alkylation Rate (mol*L-1*s-1) = Rate constant, k (s-1)*[R4N
+PhO-](mol/L)*[n-BuBr](mol/L) 
 
Figure 29. Rate constant comparison between homogeneous and PTC conditions. 
 For ammonium cations larger than (n-Pr)4N
+ at both 0.05 and 0.10 equivalents loading, 
the calculated rate constants under PTC reaction conditions were approximately an order of 
magnitude larger than the homogeneous ones for the same ammonium cations. Only the TMAB 
and TEAB displayed rate constants lower than that of the homogeneous rate constants. Under 
PTC reaction conditions, a wide range in rate constant values was calculated for TPAB.  At 0.05 
and 0.10 equiv loading, its rate constant was similar to the homogeneous series. However, when 
the effective active phenoxide concentration was taken into account, the rate constant increases 
35-fold to 9.39*10-3 (s-1) for TPAB at 0.10 equivalents loading (not shown in Figure 29). This 
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large jump in rate constant is likely due to the formation of a TLP (See section 4.3.4.). When the 
benzyl bromide titration data was incorporated into the calculation of the ammonium phenoxide 
present in the organic phase, a different trend emerges for TBAB, THAB, and TOAB. The rates 
constants are still an order of magnitude larger than their homogeneous counterparts, but the rate 
constant for TBAB is roughly double than that of the TOAB rate constant. 
 While the rate constants between homogeneous and PTC reaction conditions have been 
compared, the tetraalkylammonium phenoxides employed under homogeneous conditions were 
actually a homo-hydrogen bonded dimer with phenol. In this regard, the observed alkylation 
rates cannot accurately reflect the intrinsic reactivity of an unstabilized, tetraalkylammonium 
phenoxide. It has been previously demonstrated by experiment that hydration of the anionic 
nucleophile, which is ion-paired with a quaternary ammonium cation, inhibits catalytic activity 
under PTC reaction conditions.163,164,165 These experimental observations are supported by 
computational studies conducted by Benjamin et al.184 Using ab initio calculations in a 
polarizable continuum solvent model, the activation energy was found to depend significantly on 
the level of hydration of the anionic nucleophile. The source of this difference in rate constants 
between homogeneous and PTC system is currently under investigation. 
 
4.3.3 Composition of the Organic Phase 
 Although the UV-vis spectroscopy data was not able to quantitatively determine the 
composition of reactive species in the organic phase, it did bring to light the superstoichiometric 
transfer of phenoxide out of the aqueous phase with respect to the amount of catalyst employed.  
For TBAB, THAB, and TOAB, ~50% more phenoxide was transferred to the organic phase than 
the theoretical maximum. It is tempting to attribute this observation to the formation of an 
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aggregated species. However, no spectroscopic evidence exists that would suggest this 
association of phenolic species and quaternary ammonium cations has any sort of geometric 
order. 
 The benzyl bromide titration survey sought to quantify the amount of phenolic 
compounds present in the organic phase as a function of the quaternary ammonium cation 
lipophilicity.  Surprisingly, the organic phase contained a significant quantity of phenol, 
particularly with the more lipophilic catalysts, and that the ratio of active phenoxide to phenol 
was unique to a particular ammonium salt.  These findings are striking for two reasons.  First, in 
a strongly basic aqueous medium the equilibrium between phenol and phenoxide strongly favors 
phenoxide given the difference in pKa between water and phenol (15.7 and 9.95, (H2O, 
respectively)). The observation that any phenol was left protonated was surprising. Second, 
despite the unique phenol/phenoxide ratios with TBAB, THAB, and TOAB, their PTC alkylation 
rates are remarkably similar.  This observation implies that under PTC reaction conditions the 
composition of the organic phase phenolic species was inconsequential to the activity of the 
ammonium phenoxide present. The most important factor was the effective concentration of the 
[R4N
+PhO-] ion-pair intermediate in the organic phase for the determination of catalytic activity. 
 To account for this transport of phenol in such a strongly basic medium, a hydrogen 
bonding interaction must be invoked. Dehmlow et al. and Sasson et al. had observed that 
quaternary tetraalkylammonium alkoxides derived from diols exhibited a greater organic phase 
concentration in contrast to alcohols containing a single hydroxyl group.185,186 These partition 
studies were conducted in excess base and it was thought that a dianion formed from the diol 
would be too polar for transport into the organic phase. This observation was rationalized by the 
formation of an intramolecular hydrogen bond between the tetraalkylammonium alkoxide and 
 96 
the other alcohol functional group contained within the diol. Such a hydrogen bonding 
interaction between phenol and phenoxide is likely responsible for the organic phase phenol. 
 Interestingly, the amount of phenol present in the organic phase was found to be 
inversely proportional to the lipophilicity of the tetraalkylammonium salt, whereas the amount of 
active phenoxide in the organic phase was found to be directly proportional to the lipophilicity of 
the tetraalkylammonium salt. This observation would appear counterintuitive to our 
understanding of intermolecular forces.  According to these results, the most lipophilic 
ammonium salt is able to transport the most potassium phenoxide, a highly polar ion pair.  This 
is in contrast to a slightly less lipophilic ammonium salt, TBAB, that has 55% the active 
phenoxide content of TOAB but nearly three fold the amount of organic phase phenol compared 
to TOAB. 
 To understand the role of the organic phase phenoxide in the rate of alkylation, a closer 
examination of the mechanism of tetraalkylammonium phenoxide transport is required. As a 
tetraalkylammonium cation approaches the interphase boundary separating the bulk aqueous and 
organic phase, its alkyl chains may orient toward the bulk organic phase due to hydrophobic 
interactions with the aqueous phase. This conformation change allows for an increase in polar 
surface area of the ammonium center.  At the interfacial boundary the tetraalkylammonium 
phenoxide forms first, and with this increased accessibility, an additional potassium phenoxide 
may complex with the ammonium phenoxide to form a quadrapolar complex/dimeric ion pair 
(Figure 30). This dimer is highly charged, and without sufficient lipophilicity provided by the 
tetraalkylammonium alkyl chains it is unable to partition into the bulk organic phase. On the 
basis of the benzyl bromide titration data, the (n-Bu)4N
+ cation is not sufficiently lipophilic to 
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transport the dimer to the organic phase compared to the (n-Oct)4N
+ cation that can complex a 
significant amount potassium phenoxide. 
 
Figure 30. Proposed tetrameric ion-pair complex. 
 These same interactions may also explain the inverse relationship between organic phase 
phenol content and ammonium lipophilicity. Since the dimeric complex with (n-Bu)4N
+ is 
insufficiently lipophilic for transport, phenol may displace a potassium phenoxide from the 
complex at the interfacial boundary. The newly formed homo-hydrogen bonded complex is less 
polar than the former quadrapole complex and sufficiently lipophilic for partition into the 
organic phase. In the case of (n-Oct)4N
+ the dimeric ion-pair readily moves into the organic 
phase before phenol can displace a potassium phenoxide.  With the increased alkyl chain length 
of (n-Oct)4N
+ this complex may also be sterically inaccessible for formation of a homo-hydrogen 
bonded complex. 
 The formation of dimeric, tetraalkylammonium ion-pair complexes has been previously 
observed in organic solvents. Sawada et al. examined the distribution between monomeric and 
dimeric tetraalkylammonium-anion ion-pairs in a wide range of solvent polarities in addition to 
anion structure.187,188 The authors observed that symmetrical tetraalkylammonium salts had a 
greater tendency to form dimers in solution. The latter study found that the dimerization constant 
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for tetraalkylammonium salts was inversely proportionally to the polarity of the medium and was 
also significantly affected by the choice of anion.  For instance, picrate anions displayed less 
solvent dependency on complex formation compared to other inorganic anions (e.g. halides, 
perchlorate). A similar study by Odashima et al. looked at the complex formation between 
tetraalkylammonium salts and neutral phenols.189 The authors found that complex stability was 
greatly dependent on the hydrogen bonding interaction between the phenolic O-H and the native 
anion of the ammonium salt, X-. The alkyl length of the tetraalkylammonium salt showed a 
minimal effect on the complex stability. The intrinsic reactivity of these tetraalkylammonium 
anion complexes remains to be elucidated. 
 
4.3.4 The Third Liquid Phase 
 The (n-Pr)4N
+ cation did not conform to the trends observed with the other cations. In 
view of its intrinsic reactivity and catalytic activity compared to its partition of phenolic 
intermediates between both phases.  The low concentration of organic phase reactive 
intermediates would suggest that this tetraalkylammonium cation is hydrophilic and should 
display poor catalyst activity.  Despite this finding, the catalytic activity of TPAB was more in 
common with activity of the lipophilic catalysts, TBAB, THAB, and TOAB. The intrinsic 
reactivity of (n-Pr)4N
+ excludes the possibility that the [(n-Pr)4N
+PhO-] intermediate is simply 
more reactive under PTC reaction conditions. 
 The UV-vis survey of catalysts provided a possible explanation for the augmented 
catalytic activity of TPAB, namely the formation of a TLP.  Earlier studies have concluded that 
the TLP in a PTC process is a catalyst rich phase, and therefore the presence of a TLP would 
explain the enhanced alkylation rate for an intrinsic reaction that was first order in 
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catalyst.148,190,191,192,193 A TLP was observed when a full equivalent of TPAB with respect to 
phenol was introduced.  However, no TLP was visually evident when substoichiometric amounts 
of TPAB were implemented.  This lack of an observable TLP does not exclude the possibility of 
its existence however.  Sasson et al. were able to observe the formation of a TLP in the 
elimination of phenethyl bromide to styrene under PTC reaction conditions.191 A closer 
examination of their TLP revealed its physical characteristics as a membrane surrounding an 
aqueous droplet.  If such a TLP were formed in reaction with a low ammonium salt content, it 
would be reasonable to assume that the total volume of the TLP is so low as to prevent 
coalescence of TLP droplets into a visible layer. 
 
4.4 Conclusion 
4.4.1 Summary 
 This survey of linear, symmetrical, tetraalkylammonium salts has shown that the intrinsic 
reactivity of the tetraalkylammonium phenoxide ion pair is greatly overshadowed by its effective 
concentration in the organic phase, the medium in which the intrinsic reaction takes place.  
Under PTC reaction conditions, the highest initial alkylation rate was observed for 
tetraalkylammonium salts with alkyl chains n-butyl and longer. Further kinetic studies concluded 
that the leveling off in catalytic activity was not the result of a change in reaction mechanism, but 
rather a change in the rate-determining step of the catalytic cycle. Subsequent experiments 
confirmed that the tetraalkylammonium phenoxide ion pair exists as a complex of phenolic 
species within the organic phase, and it was shown that ratio of complex components had no 
effect on catalytic activity.  Preliminary measurements of the amount of potassium phenoxide in 
the organic phase indicate that the near theoretical maximum of tetraalkylammonium phenoxide 
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was transported into the organic phase with the remaining active phenoxide complexed to the 
tetraalkylammonium phenoxide. 
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CHAPTER 5: Experimental and Supporting Information 
5.1 General Experimental 
All reactions were performed in oven-dried (145 °C) or flame-dried glassware under an 
inert atmosphere of dry argon. Reaction solvents THF (Fisher, HPLC grade), Et2O (Fisher, BHT 
stabilized ACS grade) and methylene chloride (Fisher, unstabilized HPLC grade) were dried by 
percolation through two columns packed with neutral alumina under a positive pressure of argon. 
Reaction solvents hexane (Fisher, OPTIMA grade) and toluene (Fisher, ACS grade) were dried 
by percolation through a column packed with neutral alumina and a column packed with Q5 
reactant, a supported copper catalyst for scavenging oxygen, under a positive pressure of argon. 
Reactions were carried out at the temperature indicated (external temperature) as measured by a 
thermocouple device unless otherwise indicated.  
Column chromatography was performed using Merck grade 9385, 60 Å silica gel and 
column diameter () was expressed in mm. Visualization was accomplished by UV light, 
permanganate (KMnO4), or iodine (I2) as indicated. Analytical and preparative thin-layer 
chromatography was performed on Merck silica gel plates with F-254 indicator. 
Chromatography solvents EtOAc (Honeywell, HPLC grade), CH2Cl2 (Sigma-Aldrich, ACS 
grade), TBME (Sigma-Aldrich, ACS grade), and MeOH (Fisher, Optima grade) were used as 
supplied. 
1H NMR, 13C NMR, 19F NMR spectra were acquired at 500 MHz, 126 MHz, and 376 
MHz, respectively, and referenced to residual solvent [CHCl3 at 7.26 (
1H) and 77.00 (13C) or 
MeOH 3.31 (1H), 49.00 (13C) or DMSO at 2.50 (1H) and 39.5 (13C) ppm]. Chemical shifts are 
reported in ppm; multiplicities are indicated by s (singlet), d (doublet), t (triplet), q (quartet), p, 
(pentet), m (multiplet) and br (broad). Coupling constants, J, are reported in Hertz. Mass 
Spectrometry was performed by the University of Illinois Mass Spectrometer Center. ESI mass 
spectra were performed on a Waters Q-Tof Ultima or a Waters ZMD Quadrupole instrument. 
Data are reported in the form of m/z (intensity relative to base peak = 100). Melting points were 
obtained in vacuum-sealed glass tubes using a Thomas-Hoover Uni-Melt™ melting point 
apparatus and are corrected. 
Analytical high performance liquid chromatography (HPLC) was performed using a 
Hewlett Packard 1090L Chromatograph equipped with a variable wavelength diode array 
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detector and an autosampler. The chromatograph was equipped with a reverse phase Agilent 
Zorbax 300SB-C8 column (5 µm, 4. 6x 200mm, lamp current = 1).  
HPLC Method 1: Linear Gradient; flow rate = 1.0 mL/min, l = 254 nm, solvent = 
CH3CN/H2O (30:70) to CH3CN/H2O (90:10) over 10 min, then isocratic for 7 min. A 3 min re-
equilibration time was utilized between runs. The water eluent contained 0.1% v/v acetic acid.  
Chiral stationary phase HPLC (CSP-HPLC) Method 2: R,R-Welk-O, 1.0 mL/min, 
IPA/hexanes 5:95.  
 Analytical capillary gas chromatography (GC) was performed using a gas chromatograph 
fitted with a flame ionization detector (H2 carrier gas, 1 mL/min). Retention times (tR) and 
integrated ratios were obtained using Agilent Chemstation Software. Sample injections were 
made using a PH 6890 Series Autosample Injector.  
 GC Method 1: Injections were made onto a Hewlett-Packard HP-1, 30-m x 0.320 mm 
column. The detector temperature was 300 °C. The column temperatures was maintained at 100 
°C isotherm over 3 minutes then ramped to 200 °C over 5 minutes (20 °C/min.). 
GC Method 2: Injections were made onto a Hewlett-Packard HP-1, 30-m x 0.320 mm 
column. The detector temperature was 300 °C. The column temperatures was maintained at 100 
°C isotherm over 3 minutes, ramped to 200 °C over 5 min (20 °C/min.), and then held at 200 °C 
for 2 minutes. 
 Analytical supercritical fluid chromatography (SFC) was performed on an Agilent 1100 
HPLC equipped with an Aurora Systems A-5 supercritical CO2 adapter for supercritical fluid 
chromatography and a UV detector (220 nm) using Daicel Chiralcel OJ column. 
 SFC Method 1: 15μL injection, 2.5 mL/min gradient elution 1% to 10% MeOH over 10 
min, hold 10% MeOH for 5 min, and then to 5% MeOH over 1 min and hold for 4 min.  Max 
pressure 350 bar. 
Fitting of kinetic data was done with OriginPro 8 SR4 version 8.0951 (B951). 
Interpolation of kinetic plots was done with Microsoft Excel 2008. 
 The variable stirring speed motor was constructed with the help of University of Illinois 
at Urbana-Champaign, School of Chemical Sciences electronics shop (special thanks to Ben 
Fisher).  The speeds were calibrated with the aid of a phototachometer measured at the rotating 
magnetic with no coupled magnetic stir-bar. 
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 Cinchonidine and diisopropyl ketone (DIPK) were purchased from Acros Organics. 3,5-
bis(trifluoromethyl)benzyl bromide was purchased from Alfa-Aesar. Benzyl bromide, allyl 
bromide, methyl iodide, diethylaminosulfur trifluoride (DAST), thiophosgene, 
Tributyltinhydride, benzaldehyde, trimethylsilyl allyl ether, and trimethylsilyl cyanide were 
purchased from Aldrich. 9-bromomethylanthracene194, 2-bromomethylnaphthalene195, 1-
bromomethylnaphthalene2, N-(diphenylmethylene)glycinetert-butyl ester,196,197 
phenylchlorothionoformate,198 and α-tosyl-phenylacetonitrile199 were prepared as described in the 
literature. DIPK was distilled over P2O5 under argon (b.p. 124-125 °C) prior to use. 
Tetramethylammonium bromide was purchased from Aldrich, recrystallized from refluxing 
ethanol, dried under high vacuum, and then stored in an argon glove box. Tetraethylammonium 
bromide (98%) was purchased from Aldrich, recrystallized from refluxing methanol, drieded 
under high vacuum, and then strored in an argon glove box. Tetra(n-propyl)ammonium bromide 
(98%) and tetra(n-butyl)ammonium bromide (>99%) were purchased from Aldrich, ground to a 
powder with a mortar and pestle, dried overnight a 100 °C under high vacuum, and then stored in 
an argon glove box. Tetra(n-hexyl)ammonium bromide (99%) and tetra(n-octyl)ammonium 
bromide (98%) were purchased from Aldrich and were used as supplied. 
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5.2 Chapter 2 
5.2.1. Catalyst Synthesis 
General Procedure I. N-Quaternization of Cinchona Alkaloids 
 
 The cinchona alkaloid was placed in a single-neck, round-bottomed flask containing a 
magnetic stir bar and the arylmethylene bromide was then added (1.1 equiv).  The flask was then 
purged with dry argon and the contents were dissolved in MeCN (0.1 M). The reaction mixture 
was allowed to stir until the starting material was consumed.  Reactions were typically monitored 
by 1H NMR spectroscopy of reaction aliquots (~100 μL).  Solvent was removed on a rotavap (20 
mm Hg, 25 °C) and the residue was purified either by washing, chromatography or 
recrystallization. 
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Preparation of epi-Cinchonidine (4) 
 
 Cinchonidine (3) (2.94 g, 10.0 mmol), triphenylphosphine (2.89 g, 11.0 mmol, 1.1 equiv), 
and 4-nitrobenzoic acid (5.18 g, 31.0 mmol, 3.1 equiv) were dissolved in THF (125 mL, 0.08 M) 
in a 250-mL, three-neck round-bottomed flask fitted with an argon inlet, septum, and 
thermocouple. The suspension was cooled to 0 °C (internal) in an ice-bath over 1 h, whereupon 
diisopropyl azodicarboxylate (2.17 mL, 11.0 mmol, 1.1 equiv) was then added slowly over the 
course of several minutes. The reaction mixture was stirred for an additional hour at 0 °C then 
was allowed to warm to 22 °C over 1 h. The reaction mixture was diluted with Et2O (50 mL), 
then was transferred to a 250-mL separatory funnel and was extracted with 1 N HCl aq. (3 x 50 
mL). The combined aqueous extracts were basified with solid K2CO3 to pH 9-11. This aqueous 
phase was extracted with Et2O (3 x 50 mL) then CH2Cl2 (50 mL). The combined organic extracts 
were dried over Na2SO4 and then the solvent was removed on a rotavap (20 mm Hg, 25 °C) to 
afford 2.50 g (85%) of 4 as a light-yellow solid. The entire product was further purified by 
recrystallization from boiling i-PrOH (~150 mL) to afford 4 as a white, crystalline solid. 
 
Data for 4: 
 mp: 203-205 °C 
 1H-NMR: (500 MHz, CDCl3) 
8.82 (d, J = 4.6 Hz, 1H, HC(2)), 8.24 (d, J = 8.2 Hz, 1H, HC(8)), 8.06 (dd, J = 
8.5, 0.6 Hz, 1H, HC(5)), 7.77 (ddd, J = 8.4, 6.9, 1.3 Hz, 1H, HC(6)), 7.72 (d, J = 
4.6 Hz, 1H, HC(3)), 7.66 (ddd, J = 8.3, 6.9, 1.3 Hz, 1H, HC(7)), 5.75 (ddd, J = 
17.7, 10.4, 7.6 Hz, 1H, HC(17)), 5.64 (d, J = 3.9 Hz, 1H, HC(9)), 5.01 - 4.82 (m, 
3H, HC(18)), 3.61 (dddd, J = 13.2, 10.6, 5.0, 2.5 Hz, 1H, HC(14)), 3.18- 3.01 (m, 
2H, HC(10), HC(15)), 2.73 - 2.57 (m, 2H, HC(14), HC(15)), 2.33 (d, J = 1.3 Hz, 
1H, HC(16)), 1.94 - 1.72 (m, 3H, HC(11), HC(12), HC(13)), 1.63 - 1.40 (m, 2H, 
HC(11), HC(13)). 
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13C-NMR:  (126 MHz, CDCl3) 
149.99, 149.61, 148.06, 141.77, 130.10, 128.95, 126.52, 125.61, 122.94, 118.19, 
114.27, 71.76, 60.34, 56.95, 43.16, 39.90, 27.88, 27.58, 21.45. 
 Analysis: C19H22N2O (294.39) 
  Calcd:  C, 77.52; H, 7.53; N, 9.52 
  Found:  C, 77.38; H, 7.67; N, 9.47 
 LRMS: (ESI+, Q-tof) 
  295.2 (100, M-Br+) 
 HRMS: C19H23N2O
+ (ESI+, Q-tof) 
  Calcd:  295.1810 
  Found:  295.1814 
 TLC: Rf 0.11 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
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Preparation of O-Benzylcinchonidine (5) 
 
 Potassium hydride (164 mg, 4.08 mmol, 1.2 equiv) was placed in a 100-mL, single-neck,, 
round-bottomed flask fitted with an argon inlet adapter and septum in a glove box. This flask 
was then removed from the glove box and a solution of 3 (1.00 g, 3.40 mmol) in THF (43 mL, 
0.08 M) was then added via syringe under argon. The reaction mixture was stirred for 15 min at 
22 °C until it became a light orange solution and no further gas evolution was observed. The 
reaction mixture was cooled to 0 °C (external) on an ice bath over 2 h. Benzyl bromide (420 μL, 
3.57 mmol, 1.05 equiv) was then added via syringe and the mixture was stirred for 4 h at 0 °C.  
The reaction mixture was quenched with sat. aq. NH4Cl solution (~2 mL), and then was 
diluted with Et2O (30 mL). The quenched reaction mixture was transferred to a 125-mL 
separatory funnel and then was extracted with 1 N aq. HCl solution (3 x 30 mL). The combined 
aqueous extracts were washed with Et2O (3 x 30 mL) then were basified with solid K2CO3 until a 
white suspension persisted with a pH of 9-11. The aqueous suspension was diluted with H2O (20 
mL) and then was extracted with CH2Cl2 (3 x 30 mL). The combined organic extracts were 
washed with brine (30 mL), dried over MgSO4, and then concentrated on a rotavap (20 mm Hg, 
25 °C) to afford 1.41 g of crude 5 as a light-amber oil.  
 The product was purified by silica gel flash chromatography (50 g SiO2,  = 30, 20:1 to 
5:1, EtOAc/MeOH gradient elution) to afford 1.03 g (79%) of 5 as an off-white amorphous solid. 
 
Data for 5: 
 1H-NMR: (500 MHz, CDCl3) 
8.96 (d, J = 4.6 Hz, 1H, HC(2)), 8.87 (dd, J = 9.7, 3.7 Hz, 1H, HC(8)), 8.30 (d, J 
= 7.7 Hz, 1H, HC(5)), 7.89 - 7.79 (m, 2H, HC(6), HC(7)), 7.67 (d, J = 4.5 Hz, 1H, 
HC(3)), 7.42 - 7.28 (m, 5H, HC(21), HC(22), HC(23)), 6.69 (d, J = 5.7 Hz, 1H, 
HC(9)), 5.57 (ddd, J = 17.1, 10.7, 6.6 Hz, 1H, HC(17)), 5.09 - 5.00 (m, 2H, 
HC(18)), 4.74 (d, J = 11.0 Hz, 1H, HC(19)), 4.53 (d, J = 11.0 Hz, 1H, HC(19)), 
4.08 (ddd, J = 10.8, 7.1, 2.5 Hz, 1H, HC(14)), 3.57 - 3.47 (m, 1H, HC(15)), 3.42 
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(t, J = 9.0 Hz, 1H, HC(10)), 3.26 - 3.12 (m, 2H, HC(14), HC(15)), 2.73 (d, J = 1.7 
Hz, 1H, HC(16)), 2.30 - 2.19 (m, 1H, HC(11)), 2.14 - 2.02 (m, 2H, HC(12), 
HC(13)), 1.93 - 1.80 (m, 1H, HC(13)), 1.53 (t, J = 12.0 Hz, 1H, HC(11)). 
 13C-NMR: (126 MHz, CDCl3) 
150.17, 148.60, 146.38, 141.84, 137.81, 130.52, 129.09, 128.42, 127.73, 127.64, 
126.69, 126.52, 123.21, 118.59, 114.25, 71.31, 60.80, 57.03, 43.15, 39.99, 27.92, 
27.73. 
 Analysis: C26H28N2O (384.51) 
  Calc:  C, 81.21; H, 7.34; N, 7.29 
  Found:  C, 81.24; H, 7.57; N, 7.30 
 LRMS: (ESI+, Q-tof) 
  385.2 (100, M+H+) 
 HRMS: C26H29N2O
+ (ESI+, Q-tof) 
  Calcd:  385.2280 
  Found:  385.2278 
 TLC: Rf 0.38 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
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Preparation of O-Allylcinchonidine (6) 
 
Potassium hydride (164 mg, 4.08 mmol, 1.2 equiv) was placed in a 100-mL, single-neck,, 
round-bottomed flask fitted with an argon inlet adapter and septum in a glove box. This flask 
was then removed from the glove box and a solution of 3 (1.00 g, 3.40 mmol) in THF (43 mL, 
0.08 M) was then added via syringe under argon. The reaction mixture was stirred for 15 min at 
22 °C until it became a light orange solution and no further gas evolution was observed. The 
reaction mixture was cooled to 0 °C (external) on an ice bath over 2 h. Allyl bromide (310 μL, 
3.57 mmol, 1.05 equiv) was then added via syringe and the mixture was stirred for 4 h at 0 °C.  
The reaction mixture was quenched with sat. aq. NH4Cl solution (~2 mL), and then was 
diluted with Et2O (30 mL). The quenched reaction mixture was transferred to a 125-mL 
separatory funnel and then was extracted with 1 N aq. HCl solution (3 x 30 mL). The combined 
aqueous extracts were washed with Et2O (3 x 30 mL) then were basified with solid K2CO3 until a 
white suspension persisted with a pH of 9-11. The aqueous suspension was diluted with H2O (20 
mL) and then was extracted with CH2Cl2 (3 x 30 mL). The combined organic extracts were 
washed with brine (30 mL), dried over MgSO4, and then concentrated on a rotavap (20 mm Hg, 
25 °C) to afford 1.13 g (99+%) of crude 6 as a light-brown oil.  
 The product was purified by silica gel flash chromatography (40 g SiO2,  = 30, 20:1 to 
10:1, EtOAc/MeOH) to afford 1.03 g (79%) of 6 as a light-amber oil.  
 
Data for 6: 
 1H-NMR: (500 MHz, CDCl3) 
8.90 (d, J = 4.4 Hz, 1 H, HC(2)), 8.13 (dd, J = 13.3, 8.5 Hz, 2 H, HC(5), HC(8)), 
7.72 (ddd, J = 8.3, 6.9, 1.3 Hz, 1 H, HC(7)), 7.57 (ddd, J = 8.2, 6.9, 1.2 Hz, 1 H, 
HC(6)), 7.49 (d, J = 4.4 Hz, 1 H, HC(3)), 5.93 (ddt, J = 17.1, 10.6, 5.4 Hz, 1 H, 
HC(20)), 5.77 - 5.65 (m, 1 H, HC(17)), 5.36 - 5.21 (m, 2 H, HC(9), HC(21)), 5.21 
- 5.13 (m, 1 H, HC(21)), 4.99 - 4.84 (m, 2 H, HC(18)), 3.95 (ddt, J = 12.8, 5.1, 1.4 
Hz, 1 H, HC(19)), 3.87 (dd, J = 12.8, 5.7 Hz, 1 H, HC(19)), 3.44 (s, 1 H, HC(14)), 
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3.10 (dd, J = 13.5, 10.1 Hz, 2 H, HC(10), HC(15)), 2.71 (dd, J = 17.0, 7.3 Hz, 1 
H, HC(14)), 2.63 (d, J = 13.4 Hz, 1 H, HC(15)), 2.27 (s, 1 H, HC(16)), 1.88 - 1.74 
(m, 3 H, HC(11), HC(12), HC(13)), 1.53 (ddd, J = 15.4, 12.7, 8.7 Hz, 2 H, 
HC(11), HC(13)). 
 13C-NMR: (126 MHz, CDCl3) 
150.14, 148.54, 146.31, 141.73, 134.31, 130.49, 129.05, 126.68, 126.41, 123.12, 
118.39, 116.95, 114.27, 70.14, 60.65, 57.09, 43.27, 39.98, 27.93, 27.69, 22.04. 
 Analysis: C22H26N2O (334.45) 
  Calc: C, 79.00; H, 7.84; N, 8.38 
  Found:  C, 78.76; H, 8.21; N, 8.11 
 LRMS: (ESI+, Q-tof) 
  335.2 (100, M+H+) 
 HRMS: C22H27N2O
+ (ESI+, Q-tof) 
  Calcd:  335.2123 
  Found:  335.2117 
 TLC: Rf 0.34 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
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Preparation of O-Methylcinchonidine (7) 
 
Potassium hydride (164 mg, 4.08 mmol, 1.2 equiv) was placed in a 100-mL, single-neck,, 
round-bottomed flask fitted with an argon inlet adapter and septum in a glove box. This flask 
was then removed from the glove box and a solution of 3 (1.00 g, 3.40 mmol) in THF (43 mL, 
0.08 M) was then added via syringe under argon. The reaction mixture was stirred for 15 min at 
22 °C until it became a light orange solution and no further gas evolution was observed. The 
reaction mixture was cooled to 0 °C (external) on an ice bath over 2 h. Methyl iodide (220 μL, 
3.57 mmol, 1.05 equiv) was then added via syringe and the mixture was stirred for 4 h at 0 °C.  
The reaction mixture was quenched with sat. aq. NH4Cl solution (~2 mL), and then was 
diluted with Et2O (30 mL). The quenched reaction mixture was transferred to a 125-mL 
separatory funnel and then was extracted with 1 N aq. HCl solution (3 x 30 mL). The combined 
aqueous extracts were washed with Et2O (3 x 30 mL) then were basified with solid K2CO3 until a 
white suspension persisted with a pH of 9-11. The aqueous suspension was diluted with H2O (20 
mL) and then was extracted with CH2Cl2 (3 x 30 mL). The combined organic extracts were 
washed with brine (30 mL), dried over MgSO4, and then concentrated on a rotavap (20 mm Hg, 
25 °C) to afford 1.17 g of crude 7 as a light-yellow, crystalline solid.  
 The product was purified by silica gel flash chromatography (40 g SiO2,  = 30, 20:1 to 
10:1, CH2Cl2/MeOH ) to afford 781 mg (75%) of 7 as a white, crystalline solid.  The entire 
product was further purified by recrystallization from boiling hexane. 
 
Data for 7: 
 m.p.: 125-126 °C 
 1H-NMR: (500 MHz, CDCl3) 
8.90 (d, J = 4.4 Hz, 1 H, HC(2)), 8.12 (dd, J = 21.0, 8.4 Hz, 2 H, HC(5), HC(8)), 
7.72 (ddd, J = 8.3, 6.9, 1.3 Hz, 1 H, HC(7)), 7.57 (ddd, J = 8.3, 6.9, 1.2 Hz, 1 H, 
HC(6)), 7.46 (d, J = 4.4 Hz, 1 H, HC(3)), 5.71 (ddd, J = 17.7, 10.3, 7.7 Hz, 1 H, 
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HC(17)), 5.07 (s, 1 H, HC(9)), 4.91 (ddt, J = 20.2, 10.3, 1.4 Hz, 2 H, HC(18)), 
3.39 (t, J = 9.0 Hz, 1 H, HC(14)), 3.30 (s, 3 H, HC(19)), 3.09 (dd, J = 13.5, 10.2 
Hz, 2 H, HC(10), HC(15)), 2.75 - 2.65 (m, 1 H, HC(14)), 2.65 - 2.55 (m, 1 H, 
HC(15)), 2.25 (s, 1 H, HC(16)), 1.84 - 1.69 (m, 3 H, HC(11), HC(12), HC(13)), 
1.51 (ddd, J = 16.8, 12.5, 7.7 Hz, 2 H, HC(11), HC(13)). 
 13C-NMR: (126 MHz, CDCl3) 
150.14, 148.56, 146.07, 141.67, 130.49, 129.04, 126.69, 126.52, 123.16, 118.34, 
114.34, 82.83, 60.57, 57.18, 56.96, 43.21, 39.92, 27.88, 27.59, 21.90. 
 Analysis: C20H24N2O (308.42) 
  Calcd:  C, 77.89; H, 7.84; N, 9.08 
  Found:  C, 77.96; H, 7.95; N, 9.17 
 LRMS: (ESI+, Q-tof) 
  309.2 (100, M+H+) 
 HRMS: C20H25N2O
+ (ESI+, Q-tof) 
  Calcd:  309.1967 
  Found:  309.1960 
 TLC: Rf 0.29 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
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Preparation of O-Methyl-epi-cinchonidine (8) 
 
Potassium hydride (120 mg, 3.00 mmol, 1.2 equiv) was placed in a 50-mL, single-neck, 
round-bottomed flask fitted with an argon inlet adapter and septum in a glove box. This flask 
was then removed from the glove box and a solution of 4 (736 mg, 2.50 mmol) in THF (31.0 
mL, 0.08 M) was then added via syringe under argon. The reaction mixture was stirred for 15 
min at 22 °C until it became a light orange solution and no further gas evolution was observed. 
The reaction mixture was cooled to 0 °C (external) on an ice bath over 2 h. Methyl iodide (164 
μL, 2.63 mmol, 1.05 equiv) was then added via syringe and the mixture was stirred for 4 h at 0 
°C.  
The reaction mixture was quenched with sat. aq. NH4Cl solution (~2 mL), and then was 
diluted with Et2O (30 mL). The quenched reaction mixture was transferred to a 125-mL 
separatory funnel and then was extracted with 1 N aq. HCl solution (3 x 30 mL). The combined 
aqueous extracts were washed with Et2O (3 x 30 mL) then were basified with solid K2CO3 until a 
white suspension persisted with a pH of 9-11. The aqueous suspension was diluted with H2O (20 
mL) and then was extracted with CH2Cl2 (3 x 30 mL). The combined organic extracts were 
washed with brine (30 mL), dried over MgSO4, and then concentrated on a rotavap (20 mm Hg, 
25 °C) to afford 1.04 g of crude 8 as a light-yellow, crystalline solid.  
 The product was purified by silica gel flash chromatography (50 g SiO2,  = 30, 20:1 to 
5:1, CH2Cl2/MeOH, gradient elution) to afford 665 mg (86%) of 8 as a white, crystalline solid. 
The entire product was further purified by recrystallization from boiling hexane. 
 
Data for 8: 
 m.p.: 125-126 °C 
 1H-NMR: (500 MHz, CDCl3) 
8.90 (d, J = 4.4 Hz, 1 H, HC(2)), 8.18 - 8.06 (m, 2 H, HC(5), HC(8)), 7.72 (ddd, J 
= 8.3, 6.9, 1.3 Hz, 1 H, HC(7)), 7.57 (ddd, J = 8.3, 6.9, 1.2 Hz, 1 H, HC(6)), 7.46 
(d, J = 4.4 Hz, 1 H, HC(3)), 5.76 - 5.66 (m, 1 H, HC(17)), 5.07 (s, 1 H, HC(9)), 
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4.91 (ddt, J = 20.2, 10.3, 1.4 Hz, 2 H, HC(18)), 3.43 - 3.33 (m, 1 H, HC(14)), 3.30 
(s, 3 H, HC(19)), 3.08 (dt, J = 18.9, 9.6 Hz, 2 H, HC(10), HC(15)), 2.75 - 2.64 (m, 
1 H, HC(14)), 2.64 - 2.57 (m, 1 H, HC(15)), 2.26 (s, 1 H, HC(16)), 1.83 - 1.69 (m, 
3 H, HC(11), HC(12), HC(13)), 1.51 (ddd, J = 16.4, 12.1, 7.7 Hz, 2 H, HC(11), 
HC(13)3). 
 13C-NMR: (126 MHz, CDCl3) 
150.14, 148.51, 146.25, 141.85, 130.46, 129.00, 126.61, 126.51, 123.10, 118.33, 
114.20, 83.09, 60.55, 57.17, 57.03, 43.16, 40.03, 27.87, 27.67, 21.98. 
 analysis: C20H24N2O (308.42) 
  Calcd:  C, 77.89; H, 7.84; N, 9.08 
  Found:  C, 77.90; H, 7.95; N, 9.14 
 LRMS: (ESI+, Q-tof) 
  309.2 (100, M+H+) 
 HRMS: C20H25N2O
+ (ESI+, Q-tof) 
  Calcd:  309.1967 
  Found:  309.1965 
 TLC: Rf 0.30 (CH2Cl2/MeOH, 10:1) [silica gel, I2]
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Preparation of Deoxyfluorocinchondine (9) 
 
 Cinchonidine (3) (2.36 g, 8.00 mmol) was placed in a 50-mL, single-neck,, PTFE round-
bottomed flask fitted with a septum and was then suspended in THF (16.0 mL, 0.50 M). The 
suspension was cooled to -20 °C (external) with a refrigerator unit in an i-PrOH bath over 2-3 h. 
Diethylaminosulfur trifluoride (1.58 mL, 12.0 mmol, 1.50 equiv) was then added slowly over 
several minutes via a polypropylene syringe under an argon atmosphere, and the mixture was 
then stirred for 14 h at -20 °C. The reaction was quenched by transferring the brown solution to a 
250-mL separatory funnel containing a sat. aq. NaHCO3 solution (60 mL) which was then 
extracted with CH2Cl2 (3 x 60 mL). The combined organic extracts were washed with brine (60 
mL), dried over MgSO4, and then were concentrated on a rotavap (20 mm Hg, 25 °C) to afford 
2.75 g (116%) of 9 as an orange-amber, viscous oil. 
 The crude product was purified by three successive chromatographic separations on silica 
gel. The first column (100 g SiO2,  = 40, 20:1 to 5:1, CH2Cl2/MeOH gradient elution) afforded 
1.42 g (60%) of crude 9 as a brown-amber oil. The second column (40 g SiO2,  = 30, 20:1 to 
5:1, EtOAc/MeOH gradient elution) afforded 521 mg (22%) of crude 9 as a yellow oil. The third 
column (50 g SiO2,  = 30, 10:1 to 8:1, TBME/MeOH) afforded 253 mg (11%) of 9 as a white, 
crystalline solid.  The entire product was further purified by recrystallization from boiling 
pentane. 
 
Data for 9: 
 m.p.: 78-81 °C 
 1H-NMR: (500 MHz, CD3OD) 
8.89 (d, J = 4.6 Hz, 1H, HC(2)), 8.11 (d, J = 8.3 Hz, 1H, HC(8)), 8.06 (d, J = 8.4 
Hz, 1H, HC(5)), 7.83 (ddd, J = 8.4, 6.9, 1.3 Hz, 1H, HC(7)), 7.71 (ddd, J = 8.3, 
6.9, 1.2 Hz, 1H, HC(6)), 7.66 (d, J = 4.6 Hz, 1H, HC(3)), 6.48 (dd, J = 48.5, 2.2 
Hz, 1H, HC(9)), 5.78 (ddd, J = 17.6, 10.4, 7.5 Hz, 1H, HC(17)), 4.96 (ddt, J = 
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31.6, 10.4, 1.4 Hz, 2H, HC(18)), 3.49 - 3.37 (m, 1H, HC(14)), 3.18 (dd, J = 13.7, 
10.2 Hz, 2H, HC(10), HC(15)), 2.89 - 2.78 (m, 1H, HC(14)), 2.73 (ddd, J = 13.7, 
5.1, 2.5 Hz, 1H, HC(15)), 2.40 (s, 1H, HC(16)), 1.89 - 1.77 (m, 3H, HC(11), 
HC(12), HC(13)), 1.66 (ddd, J = 14.6, 9.1, 3.2 Hz, 1H, HC(13)), 1.54 (td, J = 
10.4, 5.1 Hz, 1H, HC(11)). 
 13C-NMR: (126 MHz, CD3OD) 
150.89, 148.81, 145.79 (d, J = 20.5 Hz), 142.31, 131.13, 130.33, 128.78, 125.91 
(d, J = 5.3 Hz), 124.09, 118.93 (d, J = 11.6 Hz), 115.15, 93.76 (d, J = 178.9 Hz), 
60.81 (d, J = 21.9 Hz), 57.27, 44.22 (d, J = 5.4 Hz), 40.66, 29.03, 27.99, 21.27 (d, 
J = 5.8 Hz). 
 19F-NMR: (376 MHz, CD3OD) 
-199.29 (dd, JH-F = 48.4, 27.4 Hz). 
 analysis: C19H21FN2 (296.38) 
  Calcd:  C, 77.00; H, 7.14; N, 9.45 
  Found:  C, 77.04; H, 7.33; N, 9.47 
 LRMS: (ESI+, Q-tof) 
  297.2 (100, M+H+) 
 HRMS: C19H22FN2
+ (ESI+, Q-tof) 
  Calcd:  297.1767 
  Found:  297.1776 
 TLC: Rf 0.42 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
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Preparation of Cinchonan-9-ol, 9-(phenol thiocarbonate) (10) 
 
 Cinchonidine (3) (1.77 g, 6.00 mmol) and 4-dimethylaminopyridine (367 mg, 3.00 mmol, 
0.50 equiv) were added to a 100-mL, single-neck, round-bottomed flask fitted with an argon inlet 
adapater and septum and followed by THF (67.0 mL, 0.09 M). Triethylamine (1.92 mL, 13.8 
mmol, 2.30 equiv) was then added and the mixture was stirred until it became homogeneous. 
Phenyl chlorothionoformate (1.67 mL, 12.0 mmol, 2.0 equiv) was then added via syringe to 
afford a suspension with a yellow precipitate and the reaction mixture was stirred at room 
temperature for 3 h. The reaction mixture was transferred to 125-mL separatory funnel followed 
by the addition of a sat. aq. NaHCO3 solution (70 mL) and the suspension was extracted with 
EtOAc (3 x 70 mL). The combined organic extracts were washed with brine (70 mL), dried over 
Na2SO4, and concentrated on a rotavap (20 mm Hg, 30 - 35 °C) to afford 6.07 g of crude 10 as a 
dark-brown liquid.  
The product was purified by silica gel flash chromatography (100 g SiO2,  = 40, 20:1 to 
10:1, EtOAc/MeOH) to afford 2.18 g (85%) of 10 as a brown, amorphous solid. 
 
Data for 10: 
 1H-NMR: (500 MHz, CDCl3) 
8.94 (d, J = 4.5 Hz, 1 H, HC(2)), 8.20 (d, J = 8.2 Hz, 1 H, HC(8)), 8.16 (dd, J = 
8.5, 0.8 Hz, 1 H, HC(5)), 7.74 (ddd, J = 8.3, 6.9, 1.3 Hz, 1 H, HC(6)), 7.61 (ddd, J 
= 8.3, 6.9, 1.3 Hz, 1 H, HC(7)), 7.48 (d, J = 4.5 Hz, 1 H, HC(3)), 7.42 - 7.35 (m, 2 
H, HC(22)), 7.31 - 7.23 (m, 1 H, HC(23)), 7.09 - 7.00 (m, 3 H, HC(9), HC(21)), 
5.81 (ddd, J = 17.6, 10.4, 7.5 Hz, 1 H, HC(17)), 4.99 (ddt, J = 10.3, 6.4, 1.4 Hz, 2 
H, HC(18)), 3.43 (dd, J = 16.9, 7.8 Hz, 1 H, HC(10)), 3.28 - 3.16 (m, 1 H, 
HC(14)), 3.07 (dd, J = 13.9, 10.1 Hz, 1 H, HC(15)), 2.78 - 2.67 (m, 1 H, HC(14)), 
2.60 (ddd, J = 13.7, 4.5, 2.4 Hz, 1 H, HC(15)), 2.30 (s, 1 H, HC(16)), 1.96 - 1.85 
(m, 2 H, HC(11), HC(12)), 1.85 - 1.76 (m, 1 H, HC(13)), 1.76 - 1.68 (m, 1 H, 
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HC(11)), 1.64 - 1.52 (m, 1 H, HC(13)). 
 13C-NMR: (126 MHz, CDCl3) 
193.94, 153.33, 149.95, 148.59, 143.98, 141.51, 130.51, 129.53, 129.28, 126.99, 
126.67, 125.81, 123.41, 121.76, 118.67, 114.56, 84.01, 60.24, 56.80, 42.80, 39.66, 
27.58, 23.79 
 LRMS: (ESI+, ZMD) 
  277.2 (47), 431.1 (100, M+H+) 
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Preparation of Deoxycinchonidine (11) 
 
 Azodiisobutyrodinitrile (333 mg, 2.00 mmol, 0.40 equiv) and a solution of 10 (2.15 g, 
5.00 mmol) in toluene (50 mL, 0.10 M) were combined in a 100-mL, single-neck, round-
bottomed flask fitted with a condenser and argon inlet.  Tributyltinhydride (2.73 mL, 10.0 mmol, 
2.00 equiv) was then added via syringe and the reaction mixture was stirred at reflux for 1 h. The 
reaction mixture was allowed to cool to 22 °C and was then concentrated on a rotavap (20 mm 
Hg, 35-40 °C) to afford a yellow liquid. 
The product was purified by silica gel flash chromatography [50 g SiO2,  = 30, 10:1, 
EOAc : (10% aq. NH4OH in MeOH)] to afford 1.38 g (97%) of 11 as a light-brown, crystalline 
solid. The product was further purified by recrystallization from concentrated pentane solution 
and cooling overnight in a freezer to afford an off-white, crystalline solid. 
 
Data for 11: 
 m.p.: 58 – 59 °C 
 1H-NMR: (500 MHz, CDCl3) 
8.81 (d, J = 4.4 Hz, 1 H, HC(2)), 8.09 (dd, J = 19.7, 8.4 Hz, 2 H, HC(5), HC(8)), 
7.74 - 7.66 (m, 1 H, HC(7)), 7.61 - 7.52 (m, 1 H, HC(6)), 7.28 (d, J = 4.4 Hz, 1 H, 
HC(3)), 5.79 (ddd, J = 17.8, 10.3, 7.6 Hz, 1 H, HC(17)), 4.97 (ddd, J = 13.7, 11.3, 
1.2 Hz, 2 H, HC(18)), 3.41 (dd, J = 13.8, 5.8 Hz, 1 H, HC(9)), 3.28 - 3.15 (m, 3 
H, HC(10), HC(14), HC(15)), 3.08 (dd, J = 13.8, 8.5 Hz, 1 H, HC(9)), 2.85 - 2.74 
(m, 1 H, HC(14)), 2.70 (ddd, J = 13.8, 4.9, 2.4 Hz, 1 H, HC(15)), 2.33 - 2.22 (m, 
1 H, HC(16)), 1.87 - 1.72 (m, 2 H, HC(11), HC(13)), 1.71 - 1.62 (m, 1 H, 
HC(12)), 1.62 - 1.51 (m, 1 H, HC(11)), 1.17 (dd, J = 13.2, 6.6 Hz, 1 H, HC(13)). 
 13C-NMR: (126 MHz, CDCl3) 
150.04, 148.37, 145.40, 141.77, 130.31, 128.95, 127.76, 126.38, 123.44, 121.52, 
114.29, 56.25, 56.05, 41.06, 39.54, 38.18, 28.87, 27.96, 27.90. 
 analysis: C19H22N2O (278.39) 
  120 
 Calcd:  C, 81.97; H, 7.97; N, 10.06 
 Found:  C, 82.13; H, 8.11; N, 10.13 
 LRMS: (ESI+, Q-tof) 
  279.2 (100, M+H+) 
 HRMS: C19H23N2O
+ (ESI+, Q-tof) 
  Calcd:  279.1861 
  Found:  279.1864 
 TLC: Rf 0.28 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
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Preparation of Cinchonidinium Salts in Series A  
Preparation of N-9-Anthracenylmethylcinchonidinium Bromide (1a)  
 
Following General Procedure I, cinchonidine (1.31 g, 4.4 mmol), MeCN (25 mL), and 9-
bromomethylanthracene (1.32 g, 4.84 mmol, 1.1 equiv) were combined in a 50-mL, single-neck, 
round-bottomed flask fitted with an argon inlet, wrapped in aluminum foil and the mixture was 
stirred overnight. Care was taken to avoid light exposure. The solvent was removed on a rotavap 
(20 mm Hg, 25 °C) and yellow solid residue was triturated with Et2O (25-mL) and filtered to 
afford 2.16 g (86%) of 1a as a light-yellow, crystalline solid. The entire product was further 
purified by recrystallization from a concentrated CH2Cl2 solution by slow diffusion of Et2O in a 
chamber. 
 
Data for 1a: 
 m.p.: 154 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
9.01 (d, J = 4.6 Hz, 1 H), 8.86 - 8.77 (m, 2 H), 8.66 - 8.56 (m, 2 H), 8.22 (d, J = 
8.5 Hz, 2 H), 8.20 - 8.14 (m, 1 H), 8.08 (d, J = 4.5 Hz, 1 H), 7.96 - 7.88 (m, 2 H), 
7.83 - 7.75 (m, 2 H), 7.63 (ddd, J = 8.4, 6.6, 4.1 Hz, 2 H), 7.11 (d, J = 1.8 Hz, 1 
H), 6.50 (d, J = 14.0 Hz, 1 H), 5.93 (d, J = 14.0 Hz, 1 H), 5.71 (ddd, J = 17.4, 
10.4, 7.2 Hz, 1 H), 5.01 (dd, J = 26.2, 13.8 Hz, 2 H), 4.74 - 4.63 (m, 1 H), 4.48 (t, 
J = 9.0 Hz, 1 H), 3.86 (ddd, J = 12.5, 4.9, 3.2 Hz, 1 H), 3.24 (dd, J = 12.4, 10.9 
Hz, 1 H), 2.80 (td, J = 11.7, 4.6 Hz, 1 H), 2.45 (s, 1 H), 2.30 (dd, J = 13.4, 8.2 Hz, 
1 H), 2.18 - 2.07 (m, 1 H), 1.93 (d, J = 2.7 Hz, 1 H), 1.62 - 1.50 (m, 1 H), 1.50 - 
1.39 (m, 1 H). 
 13C-NMR: (126 MHz, CD3OD) 
151.03, 148.72, 147.83, 138.79, 134.80, 134.71, 133.72, 133.04, 133.00, 131.35, 
131.16, 131.08, 130.29, 129.29, 126.59, 126.32, 125.60, 125.12, 124.51, 121.55, 
121.52, 119.25, 117.63, 69.95, 67.24, 63.74, 56.84, 53.37, 39.66, 27.29, 26.26, 
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23.04. 
 LRMS: (ESI+, Q-tof) 
  191.1 (35), 295.2 (25), 485.3 m/z (100, M-Br+) 
 HRMS: C34H33N2O
+ (ESI+, Q-tof) 
  Calcd:  485.2593 
  Found:  485.2598 
 TLC: Rf 0.31 (CH2Cl2/MeOH, 5:1) [silica gel, I2] 
 
Preparation of N-(2-Naphthylmethyl)cinchonidinium Bromide (2a) 
 
Following General Procedure I, cinchonidine (1.47 g, 5 mmol), MeCN (50 mL), and 2-
bromomethylnaphthalene (2.35 g, 10.5 mmol, 2.1 equiv) were combined in a 100-mL, single-
neck, round-bottomed flask and the mixture was stirred overnight. The solvent was removed on a 
rotavap (20 mm Hg, 25 °C) and the remaining off-white solid was triturated in Et2O (3 x 25 mL) 
then was filtered three times separately to afford 2.27 g (88%) of 2a as a white, crystalline solid. 
 
Data for 2a: 
 m.p.: 236 °C (decomp.) 
 1H-NMR: (500 MHz, d6-DMSO) 
9.00 (d, J = 4.4 Hz, 1 H), 8.37 - 8.28 (m, 2 H), 8.12 (dd, J = 7.9, 6.0 Hz, 2 H), 
8.08 - 8.01 (m, 2 H), 7.89 - 7.80 (m, 3 H), 7.79 - 7.72 (m, 1 H), 7.69 - 7.61 (m, 2 
H), 6.78 (d, J = 4.3 Hz, 1 H), 6.62 (s, 1 H), 5.69 (ddd, J = 17.2, 10.5, 6.5 Hz, 1 H), 
5.31 (d, J = 12.4 Hz, 1 H), 5.17 (dd, J = 14.5, 13.3 Hz, 2 H), 4.96 (d, J = 10.5 Hz, 
1 H), 4.35 (t, J = 10.6 Hz, 1 H), 3.98 (t, J = 8.9 Hz, 1 H), 3.81 (dd, J = 8.9, 3.7 Hz, 
1 H), 3.46 - 3.34 (m, 2 H), 2.64 (s, 1 H), 2.11 (dt, J = 22.9, 10.9 Hz, 2 H), 1.99 (d, 
J = 2.3 Hz, 1 H), 1.79 (t, J = 10.4 Hz, 1 H), 1.31 (dd, J = 12.9, 10.3 Hz, 1 H). 
 13C-NMR: (126 MHz, d6-DMSO) 
150.17, 147.62, 145.26, 138.13, 133.91, 133.27, 132.55, 130.15, 129.88, 129.45, 
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128.38, 128.33, 127.65, 127.54, 127.17, 126.83, 125.41, 124.30, 123.64, 120.06, 
116.36, 67.57, 64.20, 62.92, 59.29, 50.67, 36.93, 25.87, 24.25, 20.92. 
 LRMS: (ESI+, Q-tof) 
  295.2 (10), 435.2 (100, M-Br+) 
 HRMS: C30H31N2O
+ (ESI+, Q-tof) 
  Calcd:  435.2436 
  Found:  435.2439 
 TLC: Rf 0.25 (CH2Cl2/MeOH, 5:1) [silica gel, I2] 
 
Preparation of N-(1-Naphthylmethyl)cinchonidinium Bromide (3a) 
 
Following General Procedure I, cinchonidine (1.47 g, 5.00 mmol), MeCN (50.0 mL), and 
1-bromomethylnaphthalene (1.22 g, 5.50 mmol, 1.1 equiv) were combined in a 100-mL, single-
neck, round-bottomed flask fitted with an argon inlet and the reaction mixture was stirred 
overnight. The solvent was removed on a rotavap (20 mm Hg, 25 °C) and remaining solid was 
triturated with Et2O (50 mL) then was filtered to afford 2.33 g (90%) of 3a as a white, crystalline 
solid. The entire crude product was further purified by recrystallization from a concentrated 
CH2Cl2 solution by slow diffusion of Et2O in a chamber. 
 
Data for 3a: 
 m.p.: 200 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
8.98 (d, J = 4.6 Hz, 1 H), 8.40 (d, J = 8.2 Hz, 2 H), 8.20 - 8.11 (m, 2 H), 8.09 - 
7.99 (m, 3 H), 7.87 (dtd, J = 16.5, 6.9, 1.2 Hz, 2 H), 7.79 - 7.73 (m, 1 H), 7.73 - 
7.67 (m, 1 H), 7.65 (t, J = 7.5 Hz, 1 H), 6.87 (s, 1 H), 5.91 (d, J = 13.1 Hz, 1 H), 
5.70 (ddd, J = 17.3, 10.5, 6.8 Hz, 1 H), 5.37 (d, J = 13.1 Hz, 1 H), 5.14 (d, J = 
17.2 Hz, 1 H), 5.00 (d, J = 10.5 Hz, 1 H), 4.68 - 4.57 (m, 1 H), 4.22 (t, J = 9.1 Hz, 
1 H), 3.88 - 3.78 (m, 1 H), 3.56 (dd, J = 12.5, 10.8 Hz, 1 H), 3.16 (td, J = 11.4, 3.7 
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Hz, 1 H), 2.65 (s, 1 H), 2.35 - 2.25 (m, 1 H), 2.24 - 2.14 (m, 1 H), 2.04 (s, 1 H), 
1.80 - 1.69 (m, 1 H), 1.42 (td, J = 10.2, 3.2 Hz, 1 H). 
 13C-NMR: (126 MHz, CDCl3) 
 149.28, 146.89, 144.85, 135.77, 134.29, 133.01, 132.77, 130.27, 129.31, 128.64, 
128.06, 127.41, 126.88, 125.70, 124.74, 124.11, 123.45, 123.25, 122.09, 119.48, 
117.78, 65.92, 65.80, 59.49, 57.22, 50.99, 37.89, 25.93, 25.31, 22.81 
 LRMS: (ESI+, Q-tof) 
  435.2 (100, M-Br+) 
 HRMS: C30H31N2O
+ (ESI+, Q-tof) 
  Calcd:  435.2436 
  Found:  435.2436 
 TLC: Rf 0.31 (CH2Cl2/MeOH, 5:1) [silica gel, I2] 
 
Preparation of N-(Benzyl)cinchonidinium Bromide (4a) 
 
 Following General Procedure I, cinchonidine (1.47 g, 5.00 mmol), MeCN (50.0 mL), and 
benzyl bromide (650 μL, 5.50 mmol, 1.1 equiv) were combined in a 100-mL, single-neck, round-
bottomed flask fitted with an argon inlet and the mixture was stirred overnight. The reaction 
mixture was filtered and the filter cake washed several times with MeCN (50 mL). The filtrate 
was concentrated on a rotavap (20 mm Hg, 25 °C) and the solid residue triturated with Et2O (50 
mL) then filtered. Both filter cakes were combined to afford 2.25 g (97%) of 4a as a white, 
crystalline solid. The entire crude product was further purified by recrystallization from a 
concentrated CH2Cl2 solution by slow diffusion of Et2O in a chamber. 
 
Data for 4a: 
 m.p.: 164 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
8.95 (d, J = 4.6 Hz, 1 H), 8.28 (d, J = 8.2 Hz, 1 H), 8.13 (d, J = 8.2 Hz, 1 H), 7.97 
(d, J = 4.6 Hz, 1 H), 7.90 - 7.84 (m, 1 H), 7.84 - 7.77 (m, 1 H), 7.74 (dd, J = 6.5, 
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2.9 Hz, 2 H), 7.62 - 7.55 (m, 3 H), 6.66 (s, 1 H), 5.69 (ddd, J = 17.3, 10.5, 6.8 Hz, 
1 H), 5.17 (dd, J = 21.7, 14.8 Hz, 2 H), 5.00 (d, J = 11.9 Hz, 2 H), 4.50 - 4.40 (m, 
1 H), 4.00 (t, J = 9.1 Hz, 1 H), 3.66 (ddd, J = 12.7, 4.7, 3.3 Hz, 1 H), 3.48 (dd, J = 
12.7, 10.8 Hz, 1 H), 3.41 (td, J = 11.3, 3.8 Hz, 1 H), 2.72 (s, 1 H), 2.33 - 2.19 (m, 
2 H), 2.08 (d, J = 2.8 Hz, 1 H), 1.88 (ddd, J = 15.1, 5.2, 2.6 Hz, 1 H), 1.42 (ddd, J 
= 13.4, 6.5, 3.4 Hz, 1 H). 
 13C-NMR: (126 MHz, CDCl3) 
149.42, 147.14, 144.42, 135.97, 134.02, 129.92, 129.58, 128.62, 128.34, 127.28, 
126.90, 123.57, 122.88, 119.76, 117.77, 66.96, 65.06, 62.16, 60.04, 50.28, 37.79, 
26.44, 25.08, 22.36 
 LRMS: (ESI+, Q-tof) 
  385.2 (100, M-Br+) 
 HRMS: C26H29N2O
+ (ESI+, Q-tof) 
  Calcd:  385.2280 
  Found:  385.2282 
 TLC: Rf 0.27 (CH2Cl2/MeOH, 5:1) [silica gel, I2] 
 
Preparation of N-(3,5-Bis-trifluoromethylbenzyl)cinchonidinium Bromide (5a) 
 
 Following General Procedure I, cinchonidine 589 mg (2.00 mmol), MeCN (20.0 mL), 
and bis-(3,5-trifluoromethyl)benzyl bromide (404 μL, 2.20 mmol, 1.1 equiv) were combined in a 
50-mL, single-neck, round-bottomed flask fitted with an argon inlet and the mixture was stirred 
for 72 hours. The solvent was removed on a rotavap (20 mm Hg, 25 °C) and the solid residue 
was triturated with Et2O (30 mL) then filtered to afford 1.04 g (87%) of 5a as a white, crystalline 
solid. The product was further purified by recrystallization from a concentrated CH2Cl2 solution 
by slow diffusion of Et2O in a hamber.  
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Data for 5a: 
 m.p.: 173 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
8.95 (d, J = 4.6 Hz, 1 H), 8.45 (s, 2 H), 8.33 (d, J = 8.1 Hz, 1 H), 8.24 (s, 1 H), 
8.13 (dd, J = 8.4, 1.0 Hz, 1 H), 7.96 (d, J = 4.5 Hz, 1 H), 7.85 (dddd, J = 16.5, 8.2, 
6.9, 1.3 Hz, 2 H), 6.66 (s, 1 H), 5.69 (ddd, J = 17.3, 10.5, 6.8 Hz, 1 H), 5.34 (dd, J 
= 63.7, 12.6 Hz, 2 H), 5.17 (d, J = 17.2 Hz, 1 H), 5.01 (d, J = 10.5 Hz, 1 H), 4.64 - 
4.52 (m, 1 H), 4.05 (t, J = 8.4 Hz, 1 H), 3.83 - 3.70 (m, 1 H), 3.47 (dd, J = 12.3, 
10.8 Hz, 1 H), 3.39 (td, J = 11.3, 3.8 Hz, 1 H), 2.74 (s, 1 H), 2.38 - 2.20 (m, 2 H), 
2.10 (d, J = 2.4 Hz, 1 H), 1.96 - 1.84 (m, 1 H), 1.50 - 1.38 (m, 1 H). 
 13C-NMR: (126 MHz, CD3OD) 
151.06, 148.76, 147.28, 138.52, 135.45, 133.68 (q, JC-F = 33.8 Hz), 132.03, 
131.22, 130.41, 129.25, 126.06, 125.50 (m), 124.10, 123.43, 121.31, 117.69, 
70.34, 66.32, 63.43, 61.93, 53.02, 39.13, 27.92, 25.86, 22.51. 
  LRMS: (ESI+, Q-tof) 
  521.2 (100, M-Br+) 
 HRMS: C28H27N2OF6
+ (ESI+, Q-tof) 
  Calcd:  521.2028 
  Found:  521.2029 
 TLC: Rf 0.28 (CH2Cl2/MeOH, 5:1) [silica gel, I2] 
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Preparation of Cinchonidinium Salts in Series B 
Preparation of N-(9-Anthracenylmethyl)-epi-cinchonidinium Bromide (1b)  
 
Following General Procedure I, epi-cinchonidine (100 mg, 0.340 mmol), MeCN (3.4 
mL), and 9-bromomethylanthracene (101 mg, 0.374 mmol, 1.10 equiv) were combined in a 10-
mL, single-neck, round-bottomed flask fitted with an argon inlet, wrapped in aluminum foil and 
the mixture was stirred overnight. Care was taken to avoid light exposure. The reaction mixture 
was diluted with CH2Cl2 (~5 mL) then was loaded directly on a silica gel column (15 g SiO2,  
= 20, 100:0 to 10:1, CH2Cl2/MeOH gradient elution) to afford 169 mg (88%) of 1b as a light-
yellow, crystalline solid. The entire product was further purified by recrystallization from a 
concentrated CH2Cl2 solution by slow diffusion of Et2O in a chamber. 
 
Data for 1b: 
 mp: 154-162 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
9.01 (d, J = 4.6 Hz, 1 H), 8.85 (s, 1 H), 8.80 (d, J = 9.0 Hz, 1 H), 8.63 (d, J = 9.0 
Hz, 1 H), 8.61 - 8.56 (m, 1 H), 8.23 (d, J = 8.5 Hz, 2 H), 8.20 - 8.15 (m, 1 H), 
8.08 (d, J = 4.5 Hz, 1 H), 7.95 - 7.88 (m, 2 H), 7.80 (dtd, J = 7.7, 6.2, 1.1 Hz, 2 
H), 7.67 - 7.59 (m, 2 H), 7.11 (d, J = 1.9 Hz, 1 H), 6.51 (d, J = 14.0 Hz, 1 H), 5.93 
(d, J = 14.0 Hz, 1 H), 5.70 (ddd, J = 17.4, 10.4, 7.2 Hz, 1 H), 5.01 (dd, J = 23.7, 
13.8 Hz, 2 H), 4.74 - 4.64 (m, 1 H), 4.46 (t, J = 9.0 Hz, 1 H), 3.85 (ddd, J = 12.5, 
4.9, 3.2 Hz, 1 H), 3.24 (dd, J = 12.4, 10.9 Hz, 1 H), 2.81 (td, J = 11.3, 4.2 Hz, 1 
H), 2.45 (s, 1 H), 2.30 (dd, J = 13.6, 8.1 Hz, 1 H), 2.19 - 2.08 (m, 1 H), 1.93 (d, J 
= 2.7 Hz, 1 H), 1.62 - 1.52 (m, 1 H), 1.47 (ddd, J = 13.3, 8.3, 3.3 Hz, 1 H). 
 13C-NMR: (126 MHz, CD3OD) 
151.10, 148.88, 147.65, 138.76, 134.82, 134.73, 133.74, 133.07, 133.03, 131.28, 
131.17, 131.09, 130.44, 129.30, 129.25, 129.22, 126.60, 126.56, 126.32, 125.50, 
125.07, 124.38, 121.50, 119.23, 117.61, 70.06, 67.24, 63.80, 56.89, 53.42, 39.66, 
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27.29, 26.27, 23.04 
 LRMS: (ESI+, Q-tof) 
  485.2 (100, M-Br+) 
 HRMS: C34H33N2O
+ (ESI+, Q-tof) 
  Calcd:  485.2593 
  Found:  485.2594 
 TLC: Rf 0.58 (CH2Cl2/MeOH, 5:1) [silica gel, I2] 
 
Preparation of N-(2-Naphthylmethyl)-epi-cinchonidinium Bromide (2b) 
 
 Following General Procedure I, epi-cinchonidine (100 mg, 0.340 mmol), MeCN (3.4 
mL), and 2-bromomethylnaphthalene (83.0 mg, 0.374 mmol, 1.1 equiv) were combined in a 10-
mL, single-neck, round-bottomed flask fitted with an argon inlet and the mixture was stirred 
overnight. Reaction was diluted with CH2Cl2 (~5 mL) and MeOH (several drops) then was 
loaded directly on a silica gel column (15 g SiO2,  = 20, 100:0 to 10:1, CH2Cl2/MeOH gradient 
eleution) to afford 125 mg (71%) of 2b as a pale-yellow, crystalline solid.  
 
Data for 2b 
 m.p.: 198-210 °C (decomp.) 
 1H-NMR: (500 MHz, d6-DMSO) 
9.00 (d, J = 4.5 Hz, 1 H), 8.37 - 8.29 (m, 2 H), 8.15 - 8.08 (m, 2 H), 8.08 - 8.00 
(m, 2 H), 7.85 (ddd, J = 11.4, 8.3, 2.5 Hz, 3 H), 7.76 (ddd, J = 8.2, 6.9, 1.2 Hz, 1 
H), 7.69 - 7.60 (m, 2 H), 6.82 (d, J = 4.3 Hz, 1 H), 6.62 (d, J = 2.9 Hz, 1 H), 5.69 
(ddd, J = 17.2, 10.6, 6.5 Hz, 1 H), 5.33 (d, J = 12.4 Hz, 1 H), 5.17 (t, J = 14.5 Hz, 
2 H), 4.96 (d, J = 10.5 Hz, 1 H), 4.36 (t, J = 10.6 Hz, 1 H), 3.98 (t, J = 8.9 Hz, 1 
H), 3.86 - 3.76 (m, 1 H), 3.39 (ddd, J = 18.8, 12.1, 7.8 Hz, 2 H), 2.65 (d, J = 3.7 
Hz, 1 H), 2.19 - 2.02 (m, 2 H), 1.99 (d, J = 2.5 Hz, 1 H), 1.79 (t, J = 9.3 Hz, 1 H), 
1.31 (dd, J = 12.9, 10.2 Hz, 1 H). 
  129 
 13C-NMR: (126 MHz, d6-DMSO) 
150.11, 147.60, 145.21, 138.08, 133.86, 133.24, 132.51, 130.10, 129.84, 129.38, 
128.33, 128.28, 127.60, 127.49, 127.12, 126.77, 125.38, 124.28, 123.59, 120.03, 
116.31, 67.58, 64.14, 62.88, 59.33, 50.64, 36.90, 25.85, 24.22, 20.90, 19.27. 
 LRMS: (ESI+, Q-tof) 
  435.2 (100, M-Br+) 
 HRMS: C30H31N2O
+ (ESI+, Q-tof) 
  Calcd:  435.2436 
  Found:  435.2432 
 TLC: Rf 0.51 (CH2Cl2/MeOH, 5:1) [silica gel, I2] 
 
Preparation of N-(1-Naphthylmethyl)-epi-cinchonidinium Bromide (3b) 
 
Following General Procedure I, epi-cinchonidine (100 mg, 0.340 mmol), MeCN (3.4 
mL), and 1-bromomethylnaphthalene (83.0 mg, 0.374 mmol, 1.1 equiv) were combined in a 10-
mL, single-neck, round-bottomed flask fitted with an argon inlet and the mixture was stirred 
overnight. The reaction mixture was diluted with CH2Cl2 (~5 mL) and then was loaded directly 
on a silica gel column (15 g SiO2, d = 20, 100:0 to 10:1, CH2Cl2/MeOH gradient eleution) to 
afford 141 mg (81%) of 3b as a white, crystalline solid. 
 
Data for 3b: 
 m.p.: 189-197 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
8.98 (d, J = 4.5 Hz, 1 H), 8.41 (dd, J = 8.0, 4.6 Hz, 2 H), 8.21 - 8.10 (m, 2 H), 
8.10 - 7.99 (m, 3 H), 7.93 - 7.80 (m, 2 H), 7.76 (t, J = 7.6 Hz, 1 H), 7.72 - 7.67 
(m, 1 H), 7.64 (t, J = 7.5 Hz, 1 H), 6.87 (s, 1 H), 5.91 (d, J = 13.1 Hz, 1 H), 5.70 
(ddd, J = 17.2, 10.5, 6.8 Hz, 1 H), 5.39 (d, J = 13.1 Hz, 1 H), 5.14 (d, J = 17.2 Hz, 
1 H), 5.00 (d, J = 10.5 Hz, 1 H), 4.63 (t, J = 10.2 Hz, 1 H), 4.22 (t, J = 8.9 Hz, 1 
  130 
H), 3.89 - 3.79 (m, 1 H), 3.61 - 3.51 (m, 1 H), 3.16 (td, J = 11.3, 3.8 Hz, 1 H), 
2.65 (s, 1 H), 2.35 - 2.24 (m, 1 H), 2.24 - 2.13 (m, 1 H), 2.04 (s, 1 H), 1.81 - 1.68 
(m, 1 H), 1.42 (td, J = 10.0, 2.8 Hz, 1 H). 
 13C-NMR: (126 MHz, CD3OD) 
151.07, 148.81, 147.54, 138.73, 135.81, 135.65, 134.80, 133.10, 131.20, 130.64, 
130.42, 129.18, 128.96, 127.60, 126.41, 126.16, 124.53, 124.14, 121.35, 117.52, 
69.68, 66.74, 62.70, 61.28, 53.30, 39.36, 27.64, 26.08, 22.74. 
 LRMS: (ESI+, Q-tof) 
  435.2 (100, M-Br+)  
 HRMS: C30H31N2O
+ (ESI+, Q-tof) 
  Calcd:  435.2436 
  Found:  435.2444 
 TLC: Rf 0.55 (CH2Cl2/MeOH, 5:1) [silica gel, I2] 
 
Preparation of N-(Benzyl)-epi-cinchonidinium Bromide (4b) 
 
Following General Procedure I, epi-cinchonidine (100 mg, 0.340 mmol), MeCN (3.4 
mL), and benzyl bromide (44.0 μL, 0.374 mmol, 1.10 equiv) were combined in a 10-mL, single-
neck, round-bottomed flask fitted with an argon inlet and the mixture was stirred overnight. The 
reaction mixture was diluted with CH2Cl2 (~5 mL) and then was loaded directly on a silica gel 
column (15 g SiO2,  = 20, 100:0 to 10:1, CH2Cl2/MeOH gradient eleution) to afford 137 mg 
(87%) of 4b as a white, crystalline solid. 
 
Data for 4b: 
 m.p.: 165-169 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
8.95 (d, J = 4.6 Hz, 1 H), 8.29 (d, J = 7.9 Hz, 1 H), 8.13 (dd, J = 8.4, 0.9 Hz, 1 H), 
7.97 (d, J = 4.4 Hz, 1 H), 7.84 (dtd, J = 16.5, 7.0, 1.2 Hz, 2 H), 7.75 (dd, J = 6.4, 
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2.9 Hz, 2 H), 7.59 (dd, J = 4.7, 1.8 Hz, 3 H), 6.66 (s, 1 H), 5.69 (ddd, J = 17.2, 
10.5, 6.8 Hz, 1 H), 5.17 (dd, J = 22.4, 14.8 Hz, 2 H), 5.01 (t, J = 11.5 Hz, 2 H), 
4.46 (t, J = 10.5 Hz, 1 H), 4.01 (t, J = 9.1 Hz, 1 H), 3.68 (ddd, J = 12.7, 4.5, 3.1 
Hz, 1 H), 3.48 (dd, J = 12.6, 10.9 Hz, 1 H), 3.41 (td, J = 11.2, 3.5 Hz, 1 H), 2.72 
(s, 1 H), 2.26 (ddd, J = 25.9, 14.7, 6.5 Hz, 2 H), 2.07 (s, 1 H), 1.94 - 1.81 (m, 1 
H), 1.42 (td, J = 10.1, 2.8 Hz, 1 H). 
 13C-NMR: (126 MHz, CD3OD) 
151.04, 148.78, 147.52, 138.73, 134.90, 131.76, 131.15, 130.40, 129.15, 128.72, 
126.11, 124.08, 121.32, 117.50, 69.70, 66.32, 65.26, 62.10, 52.75, 39.13, 28.04, 
25.95, 22.51. 
 LRMS: (ESI+, Q-tof) 
  295.2 (40), 385.2 m/z (100, M-Br+) 
 HRMS: C26H29N2O
+ (ESI+, Q-tof) 
  Calcd:  385.2280 
  Found:  385.2285 
 TLC: Rf 0.51 (CH2Cl2/MeOH, 5:1) [silica gel, I2] 
 
Preparation of N-(3,5-Bis-trifluoromethylbenzyl)-epi-cinchonidinium Bromide (5b) 
 
 Following General Procedure I, epi-cinchonidine (100 mg, 0.340 mmol), MeCN (3.4 
mL), and bis-(3,5-trifluormethyl)-benzyl bromide (69.0 μL, 0.374 mmol, 1.10 equiv) were 
combined in a 10-mL, single-neck, round-bottomed flask fitted with an argon inlet and the 
mixture was stirred overnight. The reaction mixture was diluted with CH2Cl2 (~5 mL) and then 
was loaded directly on a silica gel column (15 g SiO2,  = 20, 100:0 to 10:1, CH2Cl2/MeOH 
gradient eleution) to afford 200 mg (98%) of 5b as a white, crystalline solid. 
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Data for 5b: 
 m.p.: 200-212 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
8.96 (d, J = 4.6 Hz, 1 H), 8.45 (s, 2H), 8.32 (d, J = 8.5 Hz, 1 H), 8.25 (s, 1 H), 
8.14 (dd, J = 8.4, 1.0 Hz, 1 H), 7.96 (d, J = 4.4 Hz, 1 H), 7.85 (dddd, J = 24.2, 8.2, 
6.9, 1.3 Hz, 2H), 6.66 (s, 1 H), 5.69 (ddd, J = 17.3, 10.5, 6.8 Hz, 1 H), 5.40 (d, J = 
12.6 Hz, 1 H), 5.27 (d, J = 12.6 Hz, 1 H), 5.17 (d, J = 17.2 Hz, 1 H), 5.01 (d, J = 
10.5 Hz, 1 H), 4.63 - 4.52 (m, 1 H), 4.05 (t, J = 9.1 Hz, 1 H), 3.81 - 3.69 (m, 1 H), 
3.48 (dd, J = 12.3, 10.8 Hz, 1 H), 3.39 (td, J = 11.3, 4.2 Hz, 1 H), 2.74 (s, 1 H), 
2.37 - 2.21 (m, 2H), 2.10 (d, J = 2.3 Hz, 1 H), 1.97 - 1.85 (m, 1 H), 1.45 (td, J = 
10.3, 3.3 Hz, 1 H). 
 13C-NMR: (126 MHz, CD3OD) 
151.07, 148.80, 147.24, 138.51, 135.43, 133.71 (q, JC-F = 33.7 Hz), 132.02, 
131.21, 130.45, 129.23, 126.07, 125.59, 124.05, 123.42, 121.30, 117.70, 70.39, 
66.34, 63.48, 62.00, 53.04, 39.14, 27.92, 25.87, 22.51. 
 LRMS: (ESI+, Q-tof) 
  261.1 (15), 521.2 (100, M-Br+) 
 HRMS: C28H27N2OF6
+ (ESI+, Q-tof) 
  Calcd:  521.2028 
  Found:  521.2023 
 TLC: Rf 0.55 (CH2Cl2/MeOH, 5:1) [silica gel, I2] 
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Preparation of Cinchonidinium Salts in Series C 
Preparation of O-Benzyl-N-(9-Anthracenylmethyl)cinchonidinium Bromide (1c) 
 
 Following General Procedure I, a solution O-benzyl-cinchonidine (100 mg, 0.260 mmol) 
in MeCN (2.60 mL, 0.1 M) was combined with 9-bromomethylanthracene (82.0 mg, 0.286 
mmol, 1.1 equiv) in a 5-mL, single-neck, round-bottomed flask fitted with an argon inlet, 
wrapped in aluminum foil and the mixture was stirred overnight. Care was taken to avoid light 
exposure. The reaction mixture was diluted with CH2Cl2 (~5 mL) and then was loaded directly 
on a silica gel column (15 g SiO2,  = 20, 100:0 to 2.5:1, TBME/MeOH, gradient elution) to 
afford 140 mg (82%) of 1c as a light-yellow, crystalline solid. The entire product was further 
purified by recrystallization from a concentrated CH2Cl2 solution via Et2O slow diffusion in a 
chamber. 
 
Data for 1c: 
 m.p.: 185-188 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
9.08 (d, J = 4.5 Hz, 1 H), 8.87 (s, 1 H), 8.69 (d, J = 9.0 Hz, 1 H), 8.59 (s, 1 H), 
8.28 - 8.16 (m, 3 H), 8.09 (dd, J = 10.3, 6.8 Hz, 2 H), 8.01 - 7.90 (m, 2 H), 7.79 
(ddd, J = 8.9, 6.6, 1.2 Hz, 1 H), 7.72 (d, J = 7.3 Hz, 2 H), 7.66 - 7.47 (m, 5 H), 
7.41 - 7.32 (m, 1 H), 7.06 (s, 1 H), 6.27 (d, J = 13.7 Hz, 1 H), 5.87 (d, J = 13.9 
Hz, 1 H), 5.67 (ddd, J = 17.4, 10.2, 7.4 Hz, 1 H), 4.99 (ddd, J = 17.6, 14.9, 8.0 
Hz, 4 H), 4.47 (t, J = 8.8 Hz, 1 H), 4.43 - 4.34 (m, 1 H), 3.69 (ddd, J = 12.6, 5.6, 
3.0 Hz, 1 H), 3.21 - 3.09 (m, 1 H), 2.85 (td, J = 11.4, 5.6 Hz, 1 H), 2.61 - 2.50 (m, 
1 H), 2.40 (s, 1 H), 2.19 - 2.07 (m, 1 H), 1.97 (d, J = 2.8 Hz, 1 H), 1.71 - 1.50 (m, 
2H ). 
 13C-NMR: (126 MHz, CD3OD) 
150.46, 148.26, 144.28, 138.46, 138.11, 134.78, 134.43, 133.91, 133.02, 132.96, 
132.15, 131.21, 131.15, 130.29, 129.86, 129.77, 129.45, 129.31, 129.17, 126.63, 
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126.44, 125.33, 124.75, 118.74, 117.82, 79.47, 72.73, 70.28, 63.31, 57.62, 53.82, 
39.48, 27.33, 26.17, 23.31. 
 LRMS: (ESI+, Q-tof) 
  575.3 (100, M-Br+) 
 HRMS: C41H39N2O
+ (ESI+, Q-tof) 
  Calcd:  575.3062 
  Found:  575.3059 
 TLC: Rf 0.24 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
 
Preparation of O-Benzyl-N-(2-Naphthylmethyl)cinchonidinium Bromide (2c) 
 
Following General Procedure I, a solution of O-benzyl-cinchonidine (100 mg, 0.260 
mmol) in MeCN (2.60 mL, 0.1 M) was combined with 2-bromomethylnaphthalene (63.0 mg, 
0.286 mmol, 1.10 equiv) in a 5-mL, single-neck, round-bottomed flask fitted with an argon inlet 
and the mixture was stirred overnight. The reaction mixture was diluted with CH2Cl2 (~5 mL) 
and then was loaded directly on a silica gel column (15 g SiO2,  = 20, 100:0 to 10:1, 
CH2Cl2/MeOH, gradient elution) to afford 146 mg (93%) of 2c as a pale-yellow, crystalline 
solid. The entire product was further purified by recrystallization from a CH2Cl2 solution via 
Et2O slow diffusion in a chamber. 
 
Data for 2c: 
 m.p.: 167-175 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
9.03 (d, J = 4.4 Hz, 1 H), 8.26 (d, J = 7.6 Hz, 1 H), 8.20 (d, J = 8.4 Hz, 1 H), 8.08 
- 7.95 (m, 5 H), 7.95 - 7.87 (t, J = 7.5 Hz, 1 H), 7.83 (t, J = 7.4 Hz, 1 H), 7.63 
(ddd, J = 21.1, 11.3, 6.2 Hz, 4 H), 7.58 - 7.49 (m, 3 H), 7.45 (t, J = 7.3 Hz, 1 H), 
6.51 (s, 1 H), 5.68 (ddd, J = 17.3, 10.4, 6.9 Hz, 1 H), 5.11 (d, J = 17.2 Hz, 1 H), 
5.00 (d, J = 10.5 Hz, 1 H), 4.93 (dd, J = 13.9, 12.1 Hz, 2 H), 4.80 (d, J = 12.3 Hz, 
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1 H), 4.67 (d, J = 11.5 Hz, 1 H), 4.20 (dd, J = 14.5, 7.2 Hz, 1 H), 4.01 (t, J = 9.0 
Hz, 1 H), 3.63 (ddd, J = 12.6, 5.0, 3.0 Hz, 1 H), 3.57 - 3.46 (m, 1 H), 3.40 (td, J = 
11.3, 4.8 Hz, 1 H), 2.65 (s, 1 H), 2.47 (dd, J = 13.1, 7.9 Hz, 1 H), 2.20 (dd, J = 
18.9, 8.0 Hz, 1 H), 2.07 (d, J = 2.6 Hz, 1 H), 1.83 (t, J = 9.6 Hz, 1 H), 1.59 (dd, J 
= 13.2, 10.7 Hz, 1 H). 
 13C-NMR: (126 MHz, CD3OD) 
151.11, 149.29, 142.99, 138.50, 137.75, 135.37, 135.35, 134.44, 131.45, 130.72, 
130.55, 130.49, 130.32, 130.12, 130.10, 129.47, 129.45, 129.02, 128.85, 128.26, 
126.95, 125.47, 123.85, 121.75, 117.67, 79.46, 72.48, 69.59, 65.56, 62.24, 52.88, 
38.95, 27.97, 25.84, 22.82. 
 LRMS: (ESI+, Q-tof) 
  525.3 (100, M-Br+) 
 HRMS: C37H37N2O
+ (ESI+, Q-tof) 
  Calcd:  525.2906 
  Found:  525.2910 
 TLC: Rf 0.28 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
 
Preparation of O-Benzyl-l-N-(1-Naphthylmethyl)cinchonidinium Bromide (3c) 
 
Following General Procedure I, a solution of O-benzyl-cinchonidine (100 mg, 0.260 
mmol) in MeCN (2.6 mL, 0.1 M) was combined with 1-bromomethylnaphthalene (63.0 mg, 
0.286 mmol, 1.10 equiv) in a 5-mL, single-neck, round-bottomed flask fitted with an argon inlet 
and the mixture was stirred overnight. The reaction mixture was diluted with CH2Cl2 (~5 mL) 
and then was loaded directly on a silica gel column (15 g SiO2,  = 20, 100:0 to 10:1, 
CH2Cl2/MeOH, gradient elution) to afford 144 mg (92%) of 3c as a pale-yellow, crystalline 
solid. The entire product was further purified by recrystallization from a concentrated CH2Cl2 
solution via Et2O slow diffusion in a chamber. 
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Data for 3c: 
 m.p.: 164-173 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
9.05 (d, J = 4.5 Hz, 1 H), 8.43 (d, J = 5.2 Hz, 1 H), 8.21 (d, J = 7.8 Hz, 1 H), 8.14 
(d, J = 8.2 Hz, 1 H), 8.03 (dd, J = 11.0, 5.8 Hz, 3 H), 7.98 - 7.80 (m, 3 H), 7.67 
(dd, J = 13.4, 7.5 Hz, 3 H), 7.60 (t, J = 7.5 Hz, 1 H), 7.51 (ddd, J = 23.2, 14.8, 7.3 
Hz, 4 H), 6.75 (s, 1 H), 5.68 (ddd, J = 17.3, 10.4, 7.0 Hz, 1 H), 5.49 (d, J = 12.9 
Hz, 1 H), 5.30 (d, J = 13.0 Hz, 1 H), 5.09 (d, J = 17.1 Hz, 1 H), 4.97 (dd, J = 22.8, 
10.9 Hz, 2 H), 4.81 (d, J = 11.3 Hz, 1 H), 4.33 - 4.16 (m, 2 H), 3.79 - 3.67 (m, 1 
H), 3.44 (t, J = 11.7 Hz, 1 H), 3.15 (td, J = 11.2, 4.8 Hz, 1 H), 2.59 (s, 1 H), 2.55 - 
2.42 (m, 1 H), 2.16 (dd, J = 19.2, 7.9 Hz, 1 H), 2.05 (d, J = 2.5 Hz, 1 H), 1.73 (t, J 
= 9.4 Hz, 1 H), 1.59 (dd, J = 13.0, 10.6 Hz, 1 H). 
 13C-NMR: (126 MHz, CD3OD) 
151.10, 149.35, 142.89, 138.47, 137.98, 135.76, 134.53, 133.23, 131.50, 130.70, 
130.65, 130.26, 129.94, 129.84, 129.50, 128.91, 127.57, 127.00, 126.36, 124.38, 
124.16, 124.08, 121.78, 117.72, 79.46, 72.62, 69.90, 62.63, 61.89, 53.44, 39.17, 
27.65, 25.96, 23.07. 
 LRMS: (ESI+, Q-tof) 
  525.3 (100, M-Br+) 
 HRMS: C37H37N2O
+ (ESI+, Q-tof) 
  Calcd:  525.2906 
  Found:  525.2914 
 TLC: Rf 0.31 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
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Prepartion of O-Benzyl-N-(Benzyl)cinchonidinium Bromide (4c) 
 
Following General Procedure I, a solution of O-benzyl-cinchonidine (100 mg, 0.260 
mmol) in MeCN (2.6 mL, 0.1 M) was combined with beznyl bromide (34 μL, 0.286 mmol, 1.1 
equiv) in a 5-mL, single-neck, round-bottomed flask fitted with an argon inlet and the mixture 
was stirred overnight. The reaction mixture was diluted with CH2Cl2 (~5 mL) and then was 
loaded directly on a silica gel column (15 g SiO2,  = 20, 100:0 to 10:1, CH2Cl2/MeOH, 
gradient elution) to afford 134 mg (93%) of 4c as a white, crystalline solid. The entire product 
was further purified by recrystallization from a concentrated CH2Cl2 solution via Et2O slow 
diffusion in a chamber. 
 
Data for 4c: 
 m.p.: 201 - 205 °C(decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
9.02 (d, J = 4.5 Hz, 1 H), 8.25 (d, J = 7.6 Hz, 1 H), 8.19 (dd, J = 8.4, 0.9 Hz, 1 H), 
7.95 (d, J = 4.5 Hz, 1 H), 7.91 (ddd, J = 8.3, 6.9, 1.2 Hz, 1 H), 7.85 (ddd, J = 8.2, 
7.0, 1.2 Hz, 1 H), 7.61 - 7.45 (m, 9 H), 7.44 - 7.38 (m, 1 H), 6.46 (s, 1 H), 5.67 
(ddd, J = 17.3, 10.5, 6.9 Hz, 1 H), 5.11 (d, J = 17.2 Hz, 1 H), 4.99 (d, J = 10.5 Hz, 
1 H), 4.90 - 4.76 (m, 2 H), 4.65 (dd, J = 11.8, 7.1 Hz, 2 H), 4.17 - 4.06 (m, 1 H), 
3.97 (dd, J = 9.8, 8.4 Hz, 1 H), 3.57 (ddd, J = 12.8, 5.3, 3.1 Hz, 1 H), 3.43 (dd, J = 
12.8, 10.7 Hz, 1 H), 3.32 (dd, J = 16.6, 10.6 Hz, 1 H), 2.72 - 2.61 (m, 1 H), 2.49 - 
2.38 (m, 1 H), 2.24 - 2.12 (m, 1 H), 2.07 (dd, J = 6.0, 2.9 Hz, 1 H), 1.84 (ddd, J = 
14.4, 4.7, 2.3 Hz, 1 H), 1.61 - 1.49 (m, 1 H). 
 13C-NMR: (126 MHz, CD3OD) 
151.09, 149.26, 142.99, 138.51, 137.69, 134.83, 131.83, 131.46, 130.65, 130.41, 
130.37, 130.24, 130.04, 129.50, 128.25, 126.93, 123.95, 121.75, 117.66, 73.17, 
72.41, 69.59, 65.33, 61.98, 52.70, 38.91, 27.99, 25.79, 22.80. 
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 LRMS: (ESI+, Q-tof) 
  475.3 (100, M-Br+) 
 HRMS: C33H35N2O
+ (ESI+, Q-tof) 
  Calcd:  475.2749 
  Found:  475.2756 
 TLC: Rf 0.26 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
 
Preparation of O-Benzyl-N-(3,5-Bis-trifluoromethylbenzyl)cinchonidinium Bromide (5c) 
 
Following General Procedure I, a solution of O-benzyl-cinchonidine (100 mg, 0.260 
mmol) in MeCN (2.60 mL, 0.1 M) was combined with beznyl bromide (34.0 μL, 0.286 mmol, 
1.10 equiv) in a 5-mL, single-neck, round-bottomed flask fitted with an argon inlet and the 
mixture was stirred overnight. The reaction mixture was diluted with CH2Cl2 (~5 mL) and then 
was loaded directly on a silica gel column (15 g SiO2,  = 20, 100:0 to 10:1, CH2Cl2/MeOH, 
gradient elution) to afford 166 mg (92%) of 5c as a white, crystalline solid. The entire product 
was further purified by trituration in hexane then filtered. 
 
Data for 5c: 
 m.p.: 164-170 °C (decomp.)  
 1H-NMR: (500 MHz, CD3OD) 
9.02 (d, J = 4.5 Hz, 1 H), 8.31 (d, J = 7.8 Hz, 1 H), 8.24 (s, 1 H), 8.21 - 8.12 (m, 3 
H), 7.96 (d, J = 4.5 Hz, 1 H), 7.92 (t, J = 7.2 Hz, 1 H), 7.87 (dd, J = 11.2, 3.9 Hz, 
1 H), 7.60 (d, J = 7.2 Hz, 2 H), 7.48 (t, J = 7.5 Hz, 2 H), 7.41 (t, J = 7.4 Hz, 1 H), 
6.46 (s, 1 H), 5.67 (ddd, J = 17.3, 10.5, 6.9 Hz, 1 H), 5.12 (t, J = 14.8 Hz, 2 H), 
5.00 (d, J = 10.5 Hz, 1 H), 4.88 (d, J = 11.5 Hz, 1 H), 4.75 (d, J = 12.5 Hz, 1 H), 
4.68 (d, J = 11.4 Hz, 1 H), 4.19 (dd, J = 12.4, 8.7 Hz, 1 H), 4.02 (t, J = 9.0 Hz, 1 
H), 3.68 (ddd, J = 12.3, 4.7, 3.2 Hz, 1 H), 3.47 - 3.37 (m, 1 H), 3.36 - 3.21 (m, 1 
H), 2.70 (s, 1 H), 2.53 - 2.41 (m, 1 H), 2.28 - 2.15 (m, 1 H), 2.10 (d, J = 2.6 Hz, 1 
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H), 1.87 (t, J = 9.5 Hz, 1 H), 1.58 (dd, J = 13.2, 10.6 Hz, 1 H). 
 13C-NMR: (126 MHz, CD3OD) 
151.11, 149.27, 142.81, 138.25, 137.86, 135.29, 133.68 (q, JC-F = 33.8 Hz), 
131.46 (d, JC-F = 4.3 Hz), 130.71, 130.41, 130.23, 130.09, 129.59, 126.87, 125.76 
(d, JC-F = 3.7 Hz), 125.52, 123.95, 123.35, 121.68, 117.86, 73.37 (d, JC-F = 11.2 
Hz), 72.52, 70.28, 63.61, 61.91, 52.97, 38.90, 27.85, 25.74, 22.79. 
 LRMS: (ESI+, Q-tof) 
  611.2 (100, M-Br+) 
 HRMS: C35H33N2OF6
+ (ESI+, Q-tof) 
  Calcd:  611.2497 
  Found:  611.2499 
 TLC: Rf 0.29 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
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Preparation of Cinchonidinium Salts in Series D 
Preparation of O-Allyl-N-(9-Anthracenylmethyl)cinchonidinium Bromide (1d) 
 
 Following General Procedure I, a solution of O-allyl-cinchonidine (103 mg, 0.308 mmol) 
in MeCN (3.20 mL, 0.1 M) was combined with 9-bromomethylanthracene (92.0 mg, 0.339 
mmol, 1.10 equiv) in a 10-mL, single-neck, round-bottomed flask fitted with an argon inlet, 
wrapped in aluminum foil and the mixture was stirred overnight. Care was taken to avoid light 
exposure.  The reaction mixture was diluted with CH2Cl2 (~5 mL) and then was loaded directly 
on a silica gel column (30 g SiO2, =30, 100:0 to 5:1, CH2Cl2/MeOH, gradient elution) to afford 
135 mg (72%) of 1d as a yellow, crystalline solid. 
 
Data for 1d: 
 m.p.: 102 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
9.04 (d, J = 4.5 Hz, 1 H), 8.89 (s, 1 H), 8.77 (d, J = 9.0 Hz, 1 H), 8.59 (d, J = 5.8 
Hz, 1 H), 8.45 (d, J = 9.0 Hz, 1 H), 8.30 - 8.17 (m, 3 H), 7.94 (dt, J = 12.5, 5.7 
Hz, 3 H), 7.85 - 7.71 (m, 2 H), 7.69 - 7.59 (m, 2 H), 6.95 (s, 1 H), 6.41 (ddd, J = 
15.4, 10.7, 5.3 Hz, 2 H), 5.91 (d, J = 14.0 Hz, 1 H), 5.75 - 5.62 (m, 2 H), 5.55 (d, 
J = 10.5 Hz, 1 H), 4.99 (t, J = 13.3 Hz, 2 H), 4.60 - 4.36 (m, 4 H), 3.80 (dd, J = 
7.5, 3.2 Hz, 1 H), 3.24 (t, J = 11.6 Hz, 1 H), 2.90 (td, J = 11.2, 4.9 Hz, 1 H), 2.54 - 
2.35 (m, 2 H), 2.18 (t, J = 11.2 Hz, 1 H), 1.97 (d, J = 2.5 Hz, 1 H), 1.61 (dd, J = 
24.9, 12.3 Hz, 2 H). 
 13C NMR: (126 MHz, CD3OD) 
151.05, 149.35, 142.99, 138.54, 134.81, 134.71, 134.62, 133.92, 133.10, 133.03, 
131.53, 131.30, 131.15, 130.60, 129.45, 129.43, 129.25, 127.09, 126.66, 126.56, 
125.42, 124.94, 124.45, 121.68, 119.05, 118.91, 117.80, 71.42, 70.04, 63.50, 
57.41, 53.65, 39.50, 27.32, 26.26, 23.34. 
 LRMS: (ESI+, Q-tof) 
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  191.1 (10), 335.2 (5), 525.3 (100, M-Br+) 
 HRMS: C37H37N2O
+ (ESI+, Q-tof) 
  Calcd:  525.2906 
  Found:  525.2906  
 TLC: Rf 0.32 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
 
Preparation of O-Allyl-N-(2-Naphthylmethyl)cinchonidinium Bromide (2d) 
 
 Following General Procedure I, a solution of O-allyl-cinchonidine (201 mg, 0.598 mmol) 
in MeCN (6.00 mL, 0.1 M) was combined with 2-bromomethylnaphthalene (146 mg, 0.660 
mmol, 1.10 equiv) in a 10-mL, single-neck, round-bottomed flask fitted with an argon inlet and 
the mixture was stirred overnight. The solvent was removed on a rotavap (20 mm Hg, 25 °C) and 
the solid residue was triturated with Et2O (10 mL) and then filtered. The filter cake was purified 
by silica gel flash chromatography (20 g SiO2,  = 20, 100:0 to 10:1, CH2Cl2/MeOH, gradient 
elution) to afford 215 mg (64%) of 2d as an off-white, crystalline solid. 
 
Data for 2d: 
 m.p.: 133 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
8.99 (d, J = 4.4 Hz, 1 H), 8.31 (d, J = 6.4 Hz, 2 H), 8.17 (d, J = 8.4 Hz, 1 H), 8.07 
(dd, J = 18.2, 8.2 Hz, 2 H), 7.99 (d, J = 7.6 Hz, 1 H), 7.94 - 7.80 (m, 3 H), 7.77 (d, 
J = 8.4 Hz, 1 H), 7.68 - 7.59 (m, 2 H), 6.53 (s, 1 H), 6.28 (dq, J = 10.5, 5.8 Hz, 1 
H), 5.71 (ddd, J = 17.3, 10.4, 7.0 Hz, 1 H), 5.52 (d, J = 17.2 Hz, 1 H), 5.41 (d, J = 
10.4 Hz, 1 H), 5.28 (d, J = 12.4 Hz, 1 H), 5.14 (d, J = 14.7 Hz, 2 H), 5.01 (d, J = 
10.5 Hz, 1 H), 4.41 - 4.19 (m, 3 H), 4.06 (t, J = 8.6 Hz, 1 H), 3.77 - 3.65 (m, 1 H), 
3.63 - 3.45 (m, 2 H), 2.69 (s, 1 H), 2.51 - 2.37 (m, 1 H), 2.28 (t, J = 11.6 Hz, 1 H), 
2.10 (d, J = 2.1 Hz, 1 H), 1.90 (t, J = 10.1 Hz, 1 H), 1.58 (dd, J = 13.1, 10.9 Hz, 1 
H). 
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 13C-NMR: (126 MHz, CD3OD) 
151.04, 149.22, 143.33, 138.54, 135.49, 135.42, 134.76, 134.56, 131.43, 130.75, 
130.58, 130.17, 129.54, 129.41, 129.00, 128.86, 128.22, 126.87, 125.79, 124.10, 
121.39, 119.40, 117.69, 73.98, 71.34, 69.77, 66.05, 62.13, 53.10, 39.02, 28.08, 
25.95, 22.80. 
 LRMS: (ESI+, Q-tof) 
  475.3 (100, M-Br+) 
 HRMS: C33H35N2O
+ (ESI+, Q-tof) 
  Calcd:  475.2749 
  Found:  475.2758 
 TLC: Rf 0.33 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
 
Preparation of O-Allyl-N-(1-Naphthylmethyl)cinchonidinium Bromide (3d) 
 
 Following General Procedure I, a solution of O-allyl-cinchonidine (201 mg, 0.598 mmol) 
in MeCN (6.00 mL, 0.1 M) was combined with 1-bromomethylnaphthalene (146 mg, 0.660 
mmol, 1.10 equiv) in a 10-mL, single-neck, round-bottomed flask fitted with an argon inlet and 
the mixture was stirred overnight. The solvent was removed on a rotavap (20 mm Hg, 25 °C) and 
the solid residue was triturated with Et2O (10 mL) then filtered. The filter cake was purified by 
silica gel flash chromatography (20 g SiO2,  = 20, 100:0 to 10:1, CH2Cl2/MeOH, gradient 
elution) to afford 280 mg (84%) of 3d as a white, crystalline solid. 
 
Data for 3d: 
 m.p.: 119 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
9.01 (d, J = 4.5 Hz, 1 H), 8.42 (d, J = 8.1 Hz, 1 H), 8.30 (d, J = 8.5 Hz, 1 H), 8.18 
(t, J = 7.3 Hz, 2 H), 8.06 (dd, J = 15.2, 7.6 Hz, 2 H), 7.95 - 7.83 (m, 3 H), 7.72 
(dd, J = 15.4, 8.0 Hz, 2 H), 7.65 (t, J = 7.5 Hz, 1 H), 6.69 (s, 1 H), 6.35 (ddd, J = 
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22.2, 10.9, 5.6 Hz, 1 H), 5.71 (ddd, J = 17.3, 15.9, 10.1 Hz, 2 H), 5.60 (dd, J = 
17.2, 1.2 Hz, 1 H), 5.49 (d, J = 10.5 Hz, 1 H), 5.38 (d, J = 13.0 Hz, 1 H), 5.12 (d, 
J = 17.2 Hz, 1 H), 4.99 (d, J = 10.5 Hz, 1 H), 4.38 (ddd, J = 17.4, 12.3, 5.6 Hz, 3 
H), 4.23 (t, J = 9.1 Hz, 1 H), 3.90 - 3.75 (m, 1 H), 3.55 (t, J = 11.7 Hz, 1 H), 3.24 
(td, J = 11.4, 4.5 Hz, 1 H), 2.65 (s, 1 H), 2.44 (dd, J = 13.2, 8.3 Hz, 1 H), 2.23 
(dd, J = 19.5, 7.7 Hz, 1 H), 2.07 (d, J = 2.4 Hz, 1 H), 1.79 (t, J = 9.3 Hz, 1 H), 
1.55 (dd, J = 13.1, 10.6 Hz, 1 H). 
 13C-NMR: (126 MHz, CD3OD) 
151.04, 149.27, 143.04, 138.51, 135.76, 134.72, 134.67, 133.21, 131.45, 130.71, 
130.60, 129.42, 128.92, 127.64, 126.91, 126.47, 124.45, 124.32, 124.17, 121.43, 
119.28, 117.69, 71.40, 69.73, 62.60, 61.86, 53.49, 39.19, 27.67, 26.04, 23.07. 
 LRMS: (ESI+, Q-tof) 
  335.2 (5), 475.3 (100, M-Br+) 
 HRMS: C33H35N2O
+ (ESI+, Q-tof) 
  Calcd:  475.2749 
  Found:  475.2758 
 TLC: Rf 0.28 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
 
Preparation of O-Allyl-N-(Benzyl)cinchonidinium Bromide (4d) 
 
 Following General Procedure I, a solution of O-allyl-cinchonidine (201 mg, 0.598 mmol) 
in MeCN (6.00 mL, 0.1 M) was combined with benzyl bromide (78.5 μL, 0.660 mmol, 1.10 
equiv) in a 10-mL, single-neck, round bottom flask fitted with an argon inlet and the mixture was 
stirred overnight. The solvent was removed on a rotavap (20 mm Hg, 25 °C) and the solid 
residue was triturated with hexane then filtered. The filter cake was purified by silica gel flash 
chromatography (20 g SiO2,  = 20, 100:0 to 10:1, CH2Cl2/MeOH, gradient elution) to afford 
222 mg (73%) of of 4d as a white, crystalline solid. 
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Data for 4d: 
 m.p.: 123 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
8.98 (d, J = 4.5 Hz, 1 H), 8.28 (d, J = 8.3 Hz, 1 H), 8.16 (d, J = 8.4 Hz, 1 H), 7.94 
- 7.80 (m, 3 H), 7.73 (dd, J = 6.3, 2.7 Hz, 2 H), 7.65 - 7.55 (m, 3 H), 6.47 (s, 1 H), 
6.24 (ddd, J = 22.9, 11.0, 5.8 Hz, 1 H), 5.69 (ddd, J = 17.3, 10.5, 6.9 Hz, 1 H), 
5.49 (dd, J = 17.2, 1.3 Hz, 1 H), 5.38 (d, J = 10.4 Hz, 1 H), 5.12 (t, J = 14.9 Hz, 2 
H), 4.99 (dd, J = 18.8, 11.4 Hz, 2 H), 4.26 (ddd, J = 17.5, 12.3, 5.7 Hz, 3 H), 4.01 
(t, J = 9.0 Hz, 1 H), 3.63 (ddd, J = 12.6, 5.1, 3.1 Hz, 1 H), 3.56 - 3.38 (m, 2 H), 
2.72 (s, 1 H), 2.42 (dd, J = 13.1, 7.9 Hz, 1 H), 2.32 - 2.19 (m, 1 H), 2.10 (d, J = 
2.8 Hz, 1 H), 1.92 (t, J = 9.5 Hz, 1 H), 1.61 - 1.48 (m, 1 H). 
 13C-NMR: (126 MHz, CD3OD) 
151.02, 149.22, 143.25, 138.52, 134.91, 134.69, 131.87, 131.40, 130.59, 130.47, 
129.39, 128.51, 126.84, 124.07, 121.37, 119.43, 117.68, 73.99, 71.33, 69.76, 
65.86, 62.02, 52.94, 38.98, 28.08, 25.92, 22.80. 
 LRMS: (ESI+, Q-tof) 
  425.3 (100, M-Br+) 
 HRMS: C29H33N2O
+ (ESI+, Q-tof) 
  Calcd:  425.2593 
  Found:  425.2603 
 TLC: Rf 0.28 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
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Preparation of O-Allyl-N-(3,5-Bistrifluoromethylbenzyl)cinchonidinium Bromide (5d) 
 
 Following General Procedure I, a solution of O-allyl-cinchonidine (201 mg, 0.598 mmol) 
in MeCN (6.00 mL, 0.1 M) was combined with bis-(3,5-trifluoromethyl)benzyl bromide (121 
μL, 0.660 mmol, 1.10 equiv) in a 10-mL, single-neck, round-bottomed flask fitted with an argon 
inlet and the mixture was stirred overnight. The solvent was removed on a rotavap (20 mm Hg, 
25 °C) and the solid residue was triturated with hexane then filtered. The filter cake was purified 
by silica gel flash chromatography (20 g SiO2,  = 20, 100:0 to 10:1, CH2Cl2/MeOH, gradient 
elution) to afford 307 mg (85%) of 5d as a white, crystalline solid. 
 
Data for 5d: 
 m.p.: 140 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
8.98 (d, J = 4.6 Hz, 1 H), 8.46 (s, 2 H), 8.31 (d, J = 8.2 Hz, 1 H), 8.26 (s, 1 H), 
8.20 - 8.13 (m, 1 H), 7.94 - 7.81 (m, 3 H), 6.45 (s, 1 H), 6.24 (ddd, J = 22.9, 10.9, 
5.7 Hz, 1 H), 5.70 (ddd, J = 17.3, 10.5, 7.0 Hz, 1 H), 5.49 (dd, J = 17.2, 1.5 Hz, 1 
H), 5.36 (dd, J = 10.5, 1.2 Hz, 1 H), 5.27 (dd, J = 36.6, 12.6 Hz, 2 H), 5.15 (d, J = 
17.2 Hz, 1 H), 5.02 (d, J = 10.5 Hz, 1 H), 4.37 (td, J = 11.8, 4.7 Hz, 2 H), 4.19 
(dd, J = 12.2, 5.5 Hz, 1 H), 4.10 - 3.98 (m, 1 H), 3.71 (ddd, J = 12.3, 5.0, 3.1 Hz, 
1 H), 3.54 - 3.40 (m, 2 H), 2.74 (s, 1 H), 2.48 (dd, J = 13.1, 7.8 Hz, 1 H), 2.35 - 
2.23 (m, 1 H), 2.13 (d, J = 2.9 Hz, 1 H), 1.95 (t, J = 9.5 Hz, 1 H), 1.59 (td, J = 
10.5, 3.1 Hz, 1 H). 
 13C-NMR: (126 MHz, CD3OD) 
151.02, 149.25, 143.04, 138.29, 135.50, 134.81, 133.74 (q, JC-F = 33.9 Hz), 
131.81, 131.43, 130.62, 129.48, 126.79, 125.77, 125.58, 124.08, 123.41, 121.35, 
119.05, 117.89, 73.95, 71.30, 70.58, 64.18, 61.95, 53.27, 39.00, 27.97, 25.87, 
22.76. 
 LRMS: (ESI+, Q-tof) 
  561.2 (100, M-Br+) 
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 HRMS: C31H31N2OF6
+ (ESI+, Q-tof) 
  Calcd:  561.2341 
  Found:  561.2344 
 TLC: Rf 0.32 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
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Preparation of Cinchonidinium Salts in Series E 
Preparation of O-Methyl-N-(9-Anthracenylmethyl)cinchonidinium Bromide (1e) 
 
 Following General Procedure I, O-methyl-cinchonidine (100 mg, 0.324 mmol), MeCN 
(3.2 mL, 0.1 M), and 9-bromomethylanthracene (97.0 mg, 0.360 mmol, 1.10 equiv) were 
combined in a 10-mL, single-neck, round-bottomed flask fitted with an argon inlet, wrapped in 
aluminum foil and the mixture was stirred overnight. Care was taken to avoid light exposure. 
The solvent was removed on a rotavap (20 mm Hg, 25 °C) and the yellow solid residue was then 
purified by silica gel flash chromatography (15 g SiO2,  = 20, 100:0 to 10:1, CH2Cl2/MeOH, 
gradient elution) to afford 141 mg (75%) of 1e as a light-yellow, crystalline solid. 
 
Data for 1e: 
 m.p.: 120 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
9.05 (d, J = 4.5 Hz, 1 H), 8.89 (s, 1 H), 8.75 (d, J = 9.0 Hz, 1 H), 8.57 (d, J = 8.7 
Hz, 1 H), 8.52 (d, J = 9.0 Hz, 1 H), 8.23 (ddd, J = 9.2, 7.7, 4.6 Hz, 3 H), 7.98 - 
7.89 (m, 3 H), 7.85 (ddd, J = 8.9, 6.6, 1.2 Hz, 1 H), 7.80 (ddd, J = 8.9, 6.5, 1.2 Hz, 
1 H), 7.65 (ddd, J = 11.6, 8.3, 6.8 Hz, 2 H), 6.82 (s, 1 H), 6.42 (d, J = 14.0 Hz, 1 
H), 5.90 (d, J = 14.0 Hz, 1 H), 5.69 (ddd, J = 17.4, 10.4, 7.3 Hz, 1 H), 5.04 - 4.93 
(m, 2 H), 4.55 - 4.40 (m, 2 H), 3.85 (s, 3 H), 3.78 (ddd, J = 12.5, 5.4, 3.1 Hz, 1 
H), 3.24 (dd, J = 12.4, 10.9 Hz, 1 H), 2.95 - 2.85 (m, 1 H), 2.42 (dd, J = 15.6, 5.0 
Hz, 2 H), 2.20 - 2.08 (m, 1 H), 1.95 (d, J = 2.8 Hz, 1 H), 1.58 (ddd, J = 13.8, 13.4, 
8.4 Hz, 2 H). 
 13C-NMR: (126 MHz, CD3OD) 
151.06, 149.35, 142.98, 138.54, 134.79, 134.66, 133.90, 133.09, 133.05, 131.50, 
131.28, 131.17, 130.59, 129.43, 129.41, 129.36, 127.23, 126.65, 126.61, 125.37, 
124.81, 124.44, 121.67, 119.00, 117.77, 70.22, 63.45, 57.51, 57.48, 53.77, 39.53, 
27.31, 26.22, 23.13. 
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 LRMS: (ESI+, Q-tof) 
  191.1 (15), 499.3 (100, M-Br+) 
 HRMS: C35H35N2O
+ (ESI+, Q-tof) 
  Calcd:  499.2749 
  Found:  499.2739 
 TLC: Rf 0.34 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
 
Preparation of O-Methyl-N-(2-Naphthylmethyl)cinchonidinium Bromide (2e) 
 
 Following General Procedure I, O-methyl-cinchonidine (185 mg, 0.600 mmol), MeCN 
(6.0 mL, 0.1 M), and 2-bromomethylnaphthalene (146 mg, 0.660 mmol, 1.10 equiv) were 
combined in a 10-mL, single-neck, round-bottomed flask fitted with an argon inlet and the 
mixture was stirred overnight. The solvent was removed on a rotavap (20 mm Hg, 25 °C) and the 
solid residue was then purified by silica gel flash chromatography (15 g SiO2,  = 20, 100:0 to 
10:1, CH2Cl2/MeOH, gradient elution) to afford 265 mg (83%) of 2e as an off-white, crystalline 
solid. 
 
Data for 2e: 
 m.p.: 144 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
9.00 (d, J = 4.5 Hz, 1 H), 8.39 - 8.28 (m, 2 H), 8.17 (d, J = 8.4 Hz, 1 H), 8.07 (dd, 
J = 16.9, 7.8 Hz, 2 H), 8.00 (d, J = 8.3 Hz, 1 H), 7.93 - 7.87 (m, 1 H), 7.87 - 7.77 
(m, 3 H), 7.68 - 7.59 (m, 2 H), 6.39 (s, 1 H), 5.70 (ddd, J = 17.3, 10.4, 6.9 Hz, 1 
H), 5.27 (d, J = 12.4 Hz, 1 H), 5.14 (dd, J = 15.1, 4.8 Hz, 2 H), 5.01 (d, J = 10.5 
Hz, 1 H), 4.33 (t, J = 10.8 Hz, 1 H), 4.04 (t, J = 9.0 Hz, 1 H), 3.78 - 3.69 (m, 1 H), 
3.65 (s, 3 H), 3.54 (dd, J = 22.1, 9.9 Hz, 2 H), 2.69 (s, 1 H), 2.39 (dd, J = 13.1, 8.1 
Hz, 1 H), 2.25 (t, J = 11.6 Hz, 1 H), 2.08 (d, J = 2.5 Hz, 1 H), 1.88 (t, J = 9.4 Hz, 
1 H), 1.54 (dd, J = 13.3, 10.6 Hz, 1 H). 
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 13C-NMR: (126 MHz, CD3OD) 
151.04, 149.23, 143.10, 138.58, 135.54, 135.42, 134.57, 131.39, 130.81, 130.55, 
130.10, 129.53, 129.36, 128.97, 128.86, 128.19, 127.01, 125.88, 124.15, 121.34, 
117.65, 76.06, 69.81, 66.04, 62.04, 57.42, 53.03, 39.03, 28.05, 25.90, 22.74. 
 LRMS: (ESI+, Q-tof) 
449.2 (100, M-Br+) 
 HRMS: C31H33N2O
+ (ESI+, Q-tof) 
  Calcd:  449.2593 
  Found:  449.2594 
 TLC: Rf 0.38 (CH2Cl2:MeOH, 10:1) [silica gel, I2] 
 
Preparation of O-Methyl-N-(1-Naphthylmethyl)cinchonidinium Bromide (3e) 
 
 Following General Procedure I, O-methyl-cinchonidine (185 mg, 0.600 mmol), MeCN 
(6.0 mL, 0.1 M), and 1-bromomethylnaphthalene (146 mg, 0.660 mmol, 1.10 equiv) were 
combined in a 10-mL, single-neck, round-bottomed flask fitted with an argon inlet and the 
mixture was stirred overnight. The solvent was removed on a rotavap (20 mm Hg, 25 °C) and the 
solid residue was triturated with Et2O then filtered. The filter cake was purified by silica gel flash 
chromatography (15 g SiO2,  = 20, 100:0 to 10:1, CH2Cl2/MeOH, gradient elution) to afford 
287 mg (90%) of 3e as a white, crystalline solid. 
 
Data for 3e: 
 m.p.: 132 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
9.02 (d, J = 4.5 Hz, 1 H), 8.40 (d, J = 8.2 Hz, 1 H), 8.34 (d, J = 8.6 Hz, 1 H), 8.21 
- 8.14 (m, 2 H), 8.06 (dd, J = 11.3, 7.7 Hz, 2 H), 7.94 - 7.83 (m, 3 H), 7.79 (dd, J 
= 11.3, 4.1 Hz, 1 H), 7.75 - 7.69 (m, 1 H), 7.66 (t, J = 7.5 Hz, 1 H), 6.55 (s, 1 H), 
5.70 (ddd, J = 17.3, 16.5, 10.0 Hz, 2 H), 5.37 (d, J = 13.1 Hz, 1 H), 5.10 (d, J = 
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17.2 Hz, 1 H), 4.99 (d, J = 10.5 Hz, 1 H), 4.39 (ddd, J = 11.7, 8.0, 4.6 Hz, 1 H), 
4.21 (t, J = 9.0 Hz, 1 H), 3.78 (ddd, J = 12.7, 5.0, 3.2 Hz, 1 H), 3.74 (s, 3 H), 3.56 
- 3.45 (m, 1 H), 3.30 - 3.21 (m, 1 H), 2.63 (s, 1 H), 2.40 (dd, J = 13.3, 8.0 Hz, 1 
H), 2.21 (dd, J = 19.5, 8.4 Hz, 1 H), 2.05 (d, J = 2.9 Hz, 1 H), 1.86 - 1.71 (m, 1 
H), 1.54 (td, J = 10.5, 3.1 Hz, 1 H). 
 13C-NMR: (126 MHz, CD3OD) 
151.05, 149.30, 143.00, 138.51, 135.82, 135.77, 134.71, 133.22, 131.42, 130.71, 
130.60, 129.37, 129.07, 127.65, 127.07, 126.45, 124.39, 124.37, 124.18, 121.42, 
117.69, 76.30, 69.98, 62.55, 62.03, 57.43, 53.53, 39.24, 27.70, 26.03, 22.87. 
 LRMS: (ESI+, Q-tof) 
  449.2 (100, M-Br+) 
 HRMS: C31H33N2O
+ (ESI+, Q-tof) 
  Calcd:  449.2593 
  Found:  449.2574 
 TLC: Rf 0.38 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
 
Preparation of O-Methyl-N-(Benzyl)cinchonidinium Bromide (4e) 
 
 Following General Procedure I, O-methyl-cinchonidine (185 mg, 0.60 mmol), MeCN 
(6.0 mL, 0.1 M), and benzyl bromide (78.0 μL, 0.660 mmol, 1.10 equiv) were combined in a 10-
mL, single-neck, round-bottomed flask fitted with an argon inlet and the mixture was stirred for 
41 h. The solvent was removed on a rotavap (20 mm Hg, 25 °C) and the solid residue was 
triturated with hexanes then filtered. The filter cake was purified by silica gel flash 
chromatography (15 g SiO2,  = 20, 100:0 to 10:1, CH2Cl2/MeOH, gradient elution) to afford 
211 mg (73%) of 4e as a white, crystalline solid. 
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Data 4e: 
 m.p.: 140 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
8.98 (d, J = 4.5 Hz, 1 H), 8.28 (d, J = 8.3 Hz, 1 H), 8.19 - 8.12 (m, 1 H), 7.93 - 
7.86 (m, 1 H), 7.84 (dd, J = 11.4, 3.1 Hz, 2 H), 7.76 (dd, J = 6.6, 2.9 Hz, 2 H), 
7.60 (dd, J = 4.0, 1.8 Hz, 3 H), 6.33 (s, 1 H), 5.68 (ddd, J = 17.3, 10.5, 6.9 Hz, 1 
H), 5.18 - 5.06 (m, 2 H), 4.98 (dd, J = 16.9, 11.4 Hz, 2 H), 4.28 - 4.16 (m, 1 H), 
3.98 (t, J = 9.1 Hz, 1 H), 3.69 - 3.56 (m, 4 H), 3.53 - 3.38 (m, 2 H), 2.71 (s, 1 H), 
2.42 - 2.31 (m, 1 H), 2.23 (tdd, J = 10.9, 6.9, 4.3 Hz, 1 H), 2.08 (d, J = 2.9 Hz, 1 
H), 1.96 - 1.83 (m, 1 H), 1.58 - 1.45 (m, 1 H). 
 13C-NMR: (126 MHz, CD3OD) 
151.02, 149.24, 143.03, 138.56, 134.95, 131.83, 131.36, 130.56, 130.43, 129.33, 
128.59, 126.98, 124.10, 121.32, 117.64, 76.03, 69.85, 65.90, 61.95, 57.36, 52.90, 
39.00, 28.05, 25.88, 22.72. 
 LRMS: (ESI+, Q-tof) 
  399.2 (100, M-Br+) 
 HRMS: C27H31N2O
+ (ESI+, Q-tof) 
  Calcd:  399.2436 
  Found:  399.2420 
 TLC: Rf 0.38 (CH2Cl2:MeOH, 10:1) [silica gel, I2] 
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Preparation of O-Methyl-N-(3,5-Bistrifluoromethylbenzyl)cinchonidinium Bromide (5e) 
 
 Following General Procedure I, O-methyl-cinchonidine (185 mg, 0.600 mmol), MeCN 
(6.0 mL, 0.1 M), and bis-(3,5-trifluoromethyl)benzyl bromide (121 μL, 0.660 mmol, 1.10 equiv) 
were combined in a 10-mL, single-neck, round-bottomed flask fitted with an argon inlet and the 
mixture was stirred for 41 h. The solvent was removed on a rotavap (20 mm Hg, 25 °C) and the 
solid residue was triturated with hexane then filtered. The filter cake was purified by silica gel 
flash chromatography (15 g SiO2,  = 20, 100:0 to 10:1, CH2Cl2/MeOH, gradient elution) to 
afford 249 mg (67%) of 5e as a white, crystalline solid. 
 
Data for 5e: 
 m.p.: 154 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
8.99 (d, J = 4.5 Hz, 1 H), 8.51 (s, 2 H), 8.32 (d, J = 8.3 Hz, 1 H), 8.26 (s, 1 H), 
8.16 (d, J = 8.4 Hz, 1 H), 7.94 - 7.78 (m, 3 H), 6.30 (s, 1 H), 5.68 (ddd, J = 17.3, 
10.5, 6.9 Hz, 1 H), 5.25 (q, J = 12.6 Hz, 2 H), 5.15 (d, J = 17.2 Hz, 1 H), 5.01 (d, 
J = 10.5 Hz, 1 H), 4.39 (t, J = 11.2 Hz, 1 H), 4.01 (t, J = 9.1 Hz, 1 H), 3.76 - 3.68 
(m, 1 H), 3.62 (s, 3 H), 3.45 (t, J = 11.5 Hz, 2 H), 2.73 (s, 1 H), 2.40 (dd, J = 12.3, 
9.1 Hz, 1 H), 2.24 (dd, J = 19.5, 8.4 Hz, 1 H), 2.11 (s, 1 H), 1.93 (t, J = 11.7 Hz, 1 
H), 1.54 (t, J = 11.8 Hz, 1 H). 
 13C NMR: (126 MHz, CD3OD) 
151.03, 149.27, 142.72, 138.36, 135.55, 133.72 (q, JC-F = 33.9 Hz). 131.90, 
131.40, 130.62, 129.43, 126.94, 125.69, 125.61, 124.08, 123.44, 121.35, 117.83, 
76.01, 70.52, 64.05, 61.90, 57.49, 53.21, 39.01, 27.92, 25.81, 22.79 
 LRMS: (ESI+, Q-tof) 
  535.2 (100, M-Br+) 
 HRMS: C29H29N2OF6
+ (ESI+, Q-tof) 
  Calcd:  535.2184 
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  Found:  535.2187 
 TLC: Rf 0.34 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
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Preparation of Cinchonidinium Salts in Series F 
Preparation of O-Methyl-N-(9-Anthracenylmethyl)-epi-cinchonidinium Bromide (1f) 
 
Following General Procedure I, O-methyl-epi-cinchonidine (81 mg, 0.26 mmol), MeCN 
(2.6 mL, 0.1 M), and 9-bromomethylanthracene (78 mg, 0.29 mmol, 1.1 equiv) were combined 
in a 10-mL, single-neck, round-bottomed flask fitted with an argon inlet, wrapped in aluminum 
foil and the mixture was stirred overnight. Care was taken to avoid light exposure. The reaction 
mixture was diluted with CH2Cl2 (~5 mL) and then was loaded directly on a silica gel column 
(15 g SiO2,  = 20, 100:0 to 2.5:1, TBME/MeOH, gradient elution) to afford 136 mg (90%) of 
1f as a light-yellow, crystalline solid.  
 
Data for 1f: 
 m.p.: 143 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
9.04 (d, J = 4.5 Hz, 1 H), 8.89 (s, 1 H), 8.76 (d, J = 9.0 Hz, 1 H), 8.58 (d, J = 7.4 
Hz, 1 H), 8.51 (d, J = 9.0 Hz, 1 H), 8.22 (ddd, J = 9.5, 7.5, 4.6 Hz, 3 H), 7.98 - 
7.89 (m, 3 H), 7.88 - 7.76 (m, 2 H), 7.65 (ddd, J = 11.8, 8.3, 6.7 Hz, 2 H), 6.82 (s, 
1 H), 6.42 (d, J = 14.0 Hz, 1 H), 5.91 (d, J = 14.0 Hz, 1 H), 5.69 (ddd, J = 17.4, 
10.4, 7.3 Hz, 1 H), 4.99 (m, 2 H), 4.53 - 4.40 (m, 2 H), 3.85 (s, 3 H), 3.79 (ddd, J 
= 12.5, 5.4, 3.0 Hz, 1 H), 3.23 (dd, J = 12.4, 10.9 Hz, 1 H), 2.90 (td, J = 11.0, 4.7 
Hz, 1 H), 2.41 (dd, J = 15.4, 4.6 Hz, 2 H), 2.20 - 2.08 (m, 1 H), 1.95 (d, J = 3.0 
Hz, 1 H), 1.66 - 1.49 (m, 2 H) 
 13C-NMR: (126 MHz, CD3OD) 
151.05, 149.37, 142.95, 138.54, 134.79, 134.66, 133.89, 133.09, 133.05, 131.48, 
131.27, 131.16, 130.61, 129.43, 129.41, 129.36, 127.23, 126.64, 126.60, 125.39, 
124.80, 124.45, 121.67, 118.99, 117.76, 76.83, 70.24, 63.48, 61.55, 57.53, 53.79, 
39.52, 27.31, 26.23, 23.15 
 LRMS: (ESI+, Q-tof) 
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  191.1 (10), 499.3 (100, M-Br+) 
 HRMS: C35H35N2O
+ (ESI+, Q-tof) 
  Calcd:  499.2749 
  Found:  499.2741 
 TLC: Rf 0.36 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
 
Preparation of O-Methyl-N-(2-Naphthylmethyl)-epi-cinchonidinium Bromide (2f) 
 
Following General Procedure I, O-methyl-epi-cinchonidine (90 mg, 0.29 mmol), MeCN 
(2.9 mL, 0.1 M), and 2-bromomethylnaphthalene (71 mg, 0.32 mmol, 1.1 equiv) were combined 
in a 10-mL, single-neck, round-bottomed flask fitted with an argon inlet and the mixture was 
stirred overnight. The reaction mixture was diluted with CH2Cl2 (~5 mL) and then was loaded 
directly on a silica gel column (15 g SiO2,  = 20, 100:0 to 10:1, CH2Cl2/MeOH, gradient 
elution) to afford 170 mg of 2f as an off-white, crystalline solid. The entire product was further 
purified by trituration in Et2O (~10 mL) then filtered to afford 115 mg (74%) of 2f as an off-
white crystalline solid. 
 
Data for 2f: 
 m.p.: 163 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
9.00 (d, J = 4.4 Hz, 1 H), 8.38 - 8.26 (m, 2 H), 8.17 (d, J = 8.3 Hz, 1 H), 8.12 - 
8.02 (m, 2 H), 7.99 (d, J = 6.9 Hz, 1 H), 7.93 - 7.76 (m, 4 H), 7.70 - 7.58 (m, 2 H), 
6.38 (s, 1 H), 5.70 (ddd, J = 17.3, 10.5, 6.9 Hz, 1 H), 5.27 (d, J = 12.4 Hz, 1 H), 
5.19 - 5.08 (m, 2 H), 5.01 (d, J = 10.4 Hz, 1 H), 4.33 (t, J = 10.4 Hz, 1 H), 4.04 (t, 
J = 8.7 Hz, 1 H), 3.77 - 3.68 (m, 1 H), 3.65 (s, 3 H), 3.61 - 3.45 (m, 3 H), 2.68 (s, 
1 H), 2.46 - 2.33 (m, 1 H), 2.24 (dd, J = 18.6, 8.0 Hz, 1 H), 2.08 (s, 1 H), 1.88 (t, J 
= 11.6 Hz, 1 H), 1.54 (t, J = 10.5 Hz, 1 H). 
 13C-NMR: (126 MHz, CD3OD) 
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151.04, 149.25, 143.07, 138.57, 135.52, 135.42, 134.57, 131.37, 130.79, 130.58, 
130.11, 129.53, 129.35, 128.97, 128.85, 128.19, 127.01, 125.86, 124.12, 121.34, 
117.65, 76.08, 69.84, 66.07, 62.10, 57.42, 53.05, 39.03, 28.05, 25.91, 22.75. 
 LRMS: (ESI+, Q-tof) 
  142.0 (10), 449.2 (100, M-Br+) 
 HRMS: C31H33N2O
+ (ESI+, Q-tof) 
  Calcd:  449.2593 
  Found:  449.2576 
 TLC: Rf 0.36 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
 
Preparation of O-Methyl-N-(1-Naphthylmethyl)-epi-cinchonidinium bromide (3f) 
 
Following General Procedure I, O-methyl-epi-cinchonidine (90 mg, 0.29 mmol), MeCN 
(2.9 mL, 0.1 M), and 1-bromomethylnaphthalene (71 mg, 0.32 mmol, 1.1 equiv) were combined 
in a 10-mL, single-neck, round-bottomed flask fitted with an argon inlet and the mixture was 
stirred overnight. The reaction mixture was diluted with CH2Cl2 (~5 mL) then loaded directly on 
a silica gel column (15 g SiO2,  = 20, 100:0 to 10:1, CH2Cl2/MeOH, gradient elution) to afford 
176 mg of 3f as an off-white, crystalline solid. The entire product was further purified by 
trituration in Et2O (~10 mL) the filtered to afford 111 mg (72%) of 3f as an off-white, crystalline 
solid. 
 
Data for 3f: 
 m.p.: 158 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
9.01 (d, J = 4.5 Hz, 1 H), 8.40 (d, J = 8.2 Hz, 1 H), 8.34 (d, J = 8.5 Hz, 1 H), 8.22 
- 8.14 (m, 2 H), 8.06 (t, J = 8.4 Hz, 2 H), 7.95 - 7.83 (m, 3 H), 7.78 (ddd, J = 8.4, 
6.9, 1.2 Hz, 1 H), 7.72 (dd, J = 8.1, 7.3 Hz, 1 H), 7.66 (t, J = 7.2 Hz, 1 H), 6.55 (s, 
1 H), 5.80 - 5.62 (m, 2 H), 5.38 (d, J = 13.1 Hz, 1 H), 5.10 (d, J = 17.2 Hz, 1 H), 
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4.99 (d, J = 10.5 Hz, 1 H), 4.45 - 4.34 (m, 1 H), 4.21 (t, J = 9.0 Hz, 1 H), 3.83 - 
3.69 (m, 4 H), 3.56 - 3.47 (m, 1 H), 3.29 - 3.21 (m, 1 H), 2.63 (s, 1 H), 2.46 - 2.34 
(m, 1 H), 2.21 (ddd, J = 10.8, 8.7, 4.8 Hz, 1 H), 2.05 (d, J = 2.9 Hz, 1 H), 1.85 - 
1.73 (m, 1 H), 1.54 (td, J = 10.3, 3.0 Hz, 1 H). 
 13C-NMR: (126 MHz, CD3OD) 
151.05, 149.26, 143.03, 138.52, 135.79, 134.71, 133.20, 131.43, 130.70, 130.56, 
129.38, 129.07, 127.64, 127.07, 126.45, 124.40, 124.39, 124.22, 121.42, 117.69, 
76.26, 69.93, 62.48, 61.99, 57.42, 53.51, 39.25, 27.70, 26.02, 22.86. 
 LRMS: (ESI+, Q-tof) 
  449.2 m/z (100, M-Br+) 
 HRMS: C31H33N2O
+ (ESI+, Q-tof) 
  Calcd:  449.2593 
  Found:  449.2580 
 TLC: Rf 0.33 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
 
Preparation of O-Methyl-N-(Benzyl)-epi-cinchonidinium Bromide (4f) 
 
Following General Procedure I, O-methyl-epi-cinchonidine (90 mg, 0.29 mmol), MeCN 
(2.9 mL, 0.1 M), and beznyl bromide (38 μL, 0.32 mmol, 1.1 equiv) were combined in a 10-mL, 
single-neck, round-bottomed flask fitted with an argon inlet and the mixture was stirred 
overnight. The reaction mixture was diluted with CH2Cl2 (~5 mL) and then was loaded directly 
on a silica gel column (15 g SiO2,  = 20, 100:0 to 10:1, CH2Cl2/MeOH, gradient elution) to 
afford 156 mg of 4f as a light-yellow, crystalline solid. The entire product was further purified by 
trituration in Et2O (~10 mL) and then filtered to afford 136 mg (97%) of 4f as an off-white, 
crystalline solid. 
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Data for 4f: 
 m.p.: 176 – 180 °C (decomp.) 
 1H-NMR: (500 MHz, CDCl3) 
8.98 (d, J = 4.5 Hz, 1 H), 8.93 (d, J = 8.6 Hz, 1H), 8.15 (d, J = 8.4 Hz, 1H), 8.02 - 
7.93 (m, 3 H), 7.82 (t, J = 7.2 Hz, 1 H), 7.54 - 7.50 (m, 3 H), 6.74 (d, J = 11.8 Hz, 
1 H), 6.06 (d, J = 3.2 Hz, 1 H), 5.74 (ddd, J = 17.0, 10.5, 6.3 Hz, 1 H), 5.41 (dd, J 
= 17.2, 1.3 Hz, 1 H), 5.05 (dd, J = 10.6, 1.3 Hz, 2 H), 4.79 (s, 1 H), 4.51 (d, J = 
11.8 Hz, 1 H), 4.33 - 4.23 (m, 1 H), 3.54 (s, 3 H), 3.51 - 3.39 (m, 1 H), 3.19 (dd, J 
= 12.9, 10.8 Hz, 1 H), 2.59 (s, 1 H), 2.10 (ddd, J = 31.5, 20.0, 9.3 Hz, 3 H), 1.78 
(dd, J = 19.3, 11.5 Hz, 1 H), 1.40 (t, J = 14.3 Hz, 1 H). 
 13C-NMR: (126 MHz, CD3OD) 
 LRMS: (ESI+, Q-tof) 
142.0 (20), 178.9 (10), 309.2 (5), 329.9 (10), 399.2 (100, M-Br+), 449.3 (5) 
 HRMS: C27H31N2O
+ (ESI+, Q-tof) 
  Calcd:  399.2436 
  Found:  399.2421 
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Preparation of O-Methyl-N-(3,5-Bistrifluoromethylbenzyl)-epi-cinchonidinium Bromide 
(5f) 
 
Following General Procedure I, O-methyl-epi-cinchonidine (90 mg, 0.29 mmol), MeCN 
(2.9 mL, 0.1 M), and bis-(3,5-trifluoromethyl)benzyl bromide (59 μL, 0.32 mmol, 1.1 equiv) 
were combined in a 10-mL, single-neck, round-bottomed flask fitted with an argon inlet and the 
mixture was stirred overnight. The reaction mixture was diluted with CH2Cl2 (~5 mL) and then 
was loaded directly on a silica gel column (15 g SiO2,  = 20, 100:0 to 10:1, CH2Cl2/MeOH, 
gradient elution) to afford 168 mg (93%) of 5f as a white, crystalline solid. 
 
Data for 5f: 
 m.p.: 165 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
8.99 (d, J = 4.5 Hz, 1 H), 8.51 (s, 2 H), 8.32 (d, J = 8.1 Hz, 1 H), 8.25 (s, 1 H), 
8.16 (dd, J = 8.4, 1.0 Hz, 1 H), 7.92 - 7.80 (m, 3 H), 6.30 (s, 1 H), 5.68 (ddd, J = 
17.3, 10.5, 6.9 Hz, 1 H), 5.30 - 5.20 (m, 2 H), 5.15 (d, J = 17.2 Hz, 1 H), 5.00 (d, 
J = 10.5 Hz, 1 H), 4.44 - 4.33 (m, 1 H), 4.01 (dd, J = 9.8, 8.5 Hz, 1 H), 3.73 (ddd, 
J = 12.4, 4.8, 3.2 Hz, 1 H), 3.63 (s, 3 H), 3.45 (dd, J = 14.9, 8.2 Hz, 2 H), 2.73 (d, 
J = 1.5 Hz, 1 H), 2.46 - 2.34 (m, 1 H), 2.31 - 2.19 (m, 1 H), 2.11 (d, J = 2.8 Hz, 1 
H), 1.93 (ddd, J = 15.2, 5.0, 2.4 Hz, 1 H), 1.59 - 1.47 (m, 1 H). 
 13C NMR: (126 MHz, CD3OD) 
151.03, 149.27, 142.73, 138.36, 135.56, 133.72 (q, JC-F = 33.8 Hz), 131.91, 
131.40, 130.61, 129.43, 126.94, 125.61, 124.10, 123.44, 121.35, 117.83, 76.02, 
70.51, 64.05, 61.90, 57.49, 53.21, 39.01, 27.92, 25.81, 22.80. 
 LRMS: (ESI+, Q-tof) 
535.2 (100, M-Br+) 
 HRMS: C29H29N2OF6
+ (ESI+, Q-tof) 
  Calcd:  535.2184 
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  Found:  535.2179 
 TLC: Rf 0.34 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
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Preparation of Cinchonidinium Salts in Series G 
Preparation of N-(9-Anthracenylmethyl)deoxyfluorocinchonidinium Bromide (1g) 
 
Following General Procedure I, deoxyfluorocinchonidine (50 mg, 0.17 mmol), MeCN 
(1.7 mL, 0.1 M), and 9-bromomethylanthracene (48 mg, 0.18 mmol, 1.05 equiv) were combined 
in a 5-mL, single-neck, round-bottomed flask fitted with an argon inlet, wrapped in aluminum 
and the mixture was stirred for 2 days. Care was taken to avoid light exposure. The reaction 
mixture was cooled to 0 °C (external) in an ice bath and the product was then precipitated with 
ice-cold Et2O (3-4 mL). The reaction mixture was filtered and the filter cake was washed several 
times with cold Et2O (5-10 mL) to afford 84 mg (88%) of 1g as a yellow, crystalline solid. The 
entire product was further purified by recrystallization from a concentrated CH2Cl2 solution (2-4 
mL), layering Et2O (6-12 mL), and then cooling overnight at -20 °C. 
 
Data for 1g: 
 m.p.: 183 – 186 °C (decomp.) 
 1H-NMR: (500 MHz, CDCl3) 
9.68 (d, J = 9.0 Hz, 1 H), 9.03 (d, J = 4.4 Hz, 1 H), 8.93 (d, J = 8.4 Hz, 1 H), 8.67 
(s, 1 H), 8.35 (d, J = 9.0 Hz, 1 H), 8.18 (dd, J = 8.4, 0.9 Hz, 1 H), 8.12 (d, J = 8.3 
Hz, 1 H), 8.07 (d, J = 8.4 Hz, 1 H), 7.96 - 7.90 (m, 2 H), 7.88 (ddd, J = 8.9, 6.5, 
1.2 Hz, 1 H), 7.83 (ddd, J = 8.2, 6.9, 1.1 Hz, 1 H), 7.73 (dd, J = 49.6, 1.9 Hz, 1 
H), 7.72 (ddd, J = 8.9, 6.5, 1.2 Hz, 1 H), 7.57 (ddd, J = 13.3, 8.2, 6.6 Hz, 2 H), 
7.25 (d, J = 13.5 Hz, 1 H), 6.26 - 6.09 (m, 2 H), 5.99 (ddd, J = 17.3, 10.5, 7.1 Hz, 
1 H), 5.33 - 5.20 (m, 2 H), 5.14 (d, J = 9.9 Hz, 1 H), 4.14 (t, J = 11.7 Hz, 1 H), 
3.23 (dd, J = 12.8, 10.7 Hz, 1 H), 2.67 (td, J = 12.4, 4.9 Hz, 1 H), 2.39 (s, 1 H), 
2.08 - 1.90 (m, 3 H), 1.84 (td, J = 10.6, 3.2 Hz, 1 H), 1.54 (s, 3H), 1.25 (s, 1 H). 
 13C-NMR: (126 MHz, CD3OD) 
151.06, 149.06, 141.87 (d, 2JC-F = 20.0 Hz), 137.94, 134.86, 134.62, 134.12, 
133.13, 133.05, 131.68, 131.22 (d, 3JC-F = 6.3 Hz), 130.75, 129.59, 129.51, 126.66 
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(d, J = 3.4 Hz), 125.15, 124.95, 124.32, 120.43 (d, 3JC-F = 12.5 Hz), 118.68, 
118.10, 87.83 (d, 1JC-F = 182.0 Hz), 70.41 (d, 
2
JC-F = 20.3 Hz), 62.68, 58.47, 54.15 
(d, 3JC-F = 7.4 Hz), 39.49, 27.30, 25.95, 22.17. 
 19F-NMR: (376 MHz, CDCl3) 
198.65 (dd, J = 48.8, 33.7 Hz). 
 LRMS: (ESI+, Q-tof) 
  150 (20), 191.1 (70), 487.2 (100, M-Br+)  
 HRMS: C34H32N2F
+ (ESI+, Q-tof) 
  Calcd:  487.2550 
  Found:  487.2551 
 TLC: Rf 0.60 (CH2Cl2/MeOH, 5:1) [silica gel, I2] 
 
Preparation of N-(2-Naphthylmethyl)deoxyfluorocinchonidinium Bromide (2g) 
 
Following General Procedure I, deoxyfluorocinchonidine (100 mg, 0.337 mmol), MeCN 
(3.4 mL, 0.1 M), and 1-bromomethylnaphthalene (82.0 mg, 0.371 mmol, 1.10 equiv) were 
combined in a 10-mL, single-neck, round-bottomed flask fitted with an argon inlet and the 
mixture was stirred for 2 days. The reaction mixture was diluted with CH2Cl2 (~5 mL) and 
MeOH (<1 mL) and then was loaded directly on a silica gel column (20 g SiO2,  = 20, 100:0 to 
5:1, CH2Cl2/MeOH, gradient elution) to afford 126 mg (72%) of 2g as a light-orange, crystalline 
solid.  
The entire product was further purified by recrystallization from a CH2Cl2 solution (2-4 
mL), layered with Et2O (6-12 mL), and then was allowed to cool overnight in a freezer to afford 
2g as an off-white, crystalline solid. 
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Data for 2g: 
 m.p.: 210-213 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
9.01 (d, J = 4.6 Hz, 1 H), 8.27 (s, 1 H), 8.18 (dd, J = 12.9, 8.3 Hz, 2 H), 8.08 (d, J 
= 8.5 Hz, 1 H), 8.00 (d, J = 8.1 Hz, 2 H), 7.95 - 7.89 (m, 1 H), 7.87 - 7.79 (m, 2 
H), 7.73 (d, JH-F = 48.0 Hz, 1 H), 7.76 (m, 1 H), 7.64 (pd, J = 7.0, 1.4 Hz, 2 H), 
5.79 (ddd, J = 17.4, 10.4, 7.2 Hz, 1 H), 5.54 (d, J = 12.5 Hz, 1 H), 5.22 - 5.05 (m, 
3 H), 4.35 (ddd, J = 30.6, 10.9, 6.3 Hz, 1 H), 4.17 - 4.07 (m, 1 H), 3.78 - 3.54 (m, 
3 H), 2.75 (dd, J = 15.9, 7.6 Hz, 1 H), 2.42 - 2.21 (m, 2 H), 2.15 (d, J = 2.7 Hz, 1 
H), 1.99 (t, J = 11.4 Hz, 1 H), 1.86 (dd, J = 13.7, 11.1 Hz, 1 H) 
 13C-NMR: (126 MHz, CD3OD) 
151.05, 148.97, 141.69 (d, 2JC-F = 19.7 Hz), 138.09, 135.47, 134.56, 131.63, 
130.73, 130.56, 130.29, 129.56, 129.50, 129.09, 128.89, 128.29, 125.55, 125.24 
(d, 3JC-F = 5.2 Hz), 124.04, 121.34, 120.24 (d, 
3
JC-F = 12.5 Hz), 118.08, 87.26 (d, 
1
JC-F = 182.3 Hz), 69.28 (d, 
2
JC-F = 20.4 Hz), 66.22, 61.84, 53.18, 39.15, 28.10, 
25.68, 21.87 
 19F-NMR: (376 MHz, CD3OD) 
-199.46 (dd, J = 48.0, 30.8 Hz) 
 LRMS: (ESI+, Q-tof) 
  150 (8), 437.2 (100, M-Br+) 
 HRMS: C30H30N2F
+ (ESI+, Q-tof) 
  Calcd:  437.2393 
  Found:  437.2400 
 TLC: Rf 0.60 (CH2Cl2/MeOH, 5:1) [silica gel, I2] 
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Preparation of N-(1-Naphthylmethyl)deoxyfluorocinchonidinium Bromide (3g) 
 
Following General Procedure I, deoxyfluorocinchonidine (100 mg, 0.337 mmol), MeCN 
(3.4 mL, 0.1 M), and 1-bromomethylnaphthalene (82.0 mg, 0.371 mmol, 1.10 equiv) were 
combined in a 10-mL, single-neck, round-bottomed flask fitted with an argon inlet and the 
mixture was stirred for 2 days. The reaction mixture was diluted with CH2Cl2 (~5 mL) and then 
was loaded directly on a silica gel column (15 g SiO2,  = 20, 100:0 to 10:1, CH2Cl2/MeOH, 
gradient elution) to afford 90 mg (52%) of 3g as a light-orange, crystalline solid.  
The entire product was further purified by recrystallization from a CH2Cl2 solution (2-4 
mL), layered with Et2O (6-12 mL), and then was allowed to cool overnight in a freezer to afford 
3g as an light-amber, crystalline solid. 
 
Data for 3g: 
 m.p.: 150 – 155 °C (decomp.) 
 1H-NMR: (500 MHz, CD3OD) 
9.03 (d, J = 4.5 Hz, 1 H), 8.40 (d, J = 8.6 Hz, 1 H), 8.27 - 8.16 (m, 3 H), 8.07 (d, J 
= 8.2 Hz, 1 H), 7.99 (d, J = 6.8 Hz, 1 H), 7.96 - 7.79 (m, 4 H), 7.77 - 7.68 (m, 2 
H), 7.65 (t, J = 7.3 Hz, 1 H), 5.94 (d, J = 13.1 Hz, 1 H), 5.77 (ddd, J = 17.4, 10.4, 
7.2 Hz, 1 H), 5.38 (d, J = 13.0 Hz, 1 H), 5.08 (dd, J = 18.8, 13.8 Hz, 2 H), 4.57 
(ddd, J = 30.7, 10.6, 6.0 Hz, 1 H), 4.17 (dd, J = 16.0, 7.5 Hz, 1 H), 3.71 (ddd, J = 
12.5, 6.7, 3.0 Hz, 1 H), 3.60 - 3.41 (m, 2 H), 2.65 (d, J = 8.3 Hz, 1 H), 2.38 (d, J = 
13.7 Hz, 1 H), 2.32 - 2.20 (m, 1 H), 2.11 (d, J = 2.6 Hz, 1 H), 1.90 (dd, J = 27.2, 
13.6 Hz, 2 H) 
 13C-NMR: (126 MHz, CD3OD) 
151.05, 148.99, 141.79 (d, 2JC-F = 19.8 Hz), 137.97, 135.85, 135.73, 134.67, 
133.40, 131.65, 130.71 (d, 3JC-F = 4.1 Hz), 129.59, 129.10, 127.72, 126.44, 
125.30, 125.26, 124.52, 124.19, 124.10, 120.32 (d, 3JC-F = 12.4 Hz), 118.10, 87.40 
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(d, 1JC-F = 182.2 Hz), 69.95 (d, 
2
JC-F = 20.1 Hz), 62.62, 62.12, 53.50, 39.29, 27.75, 
25.78, 21.94 
 19F-NMR: (376 MHz, CD3OD) 
-199.38 (dd, J = 48.0, 31.0 Hz) 
 LRMS: (ESI+, Q-tof) 
  437.2 (100, M-Br+) 
 HRMS: C30H30N2F
+ (ESI+, Q-tof) 
  Calcd:  437.2393 
  Found:  437.2400 
 TLC: Rf 0.60 (CH2Cl2/MeOH, 5:1) [silica gel, I2] 
 
Preparation of N-(Benzyl)deoxyfluorocinchonidinium Bromide (4g) 
 
Following General Procedure I, deoxyfluorocinchonidine (50.0 mg, 0.170 mmol), MeCN 
(1.70 mL, 0.10 M), and benzyl bromide (21.0 μL, 0.180 mmol, 1.05 equiv) were combined in a 
5-mL, single-neck, round-bottomed flask fitted with an argon inlet and the mixture was stirred 
for 2 days. The reaction mixture was cooled to 0 °C (external) in an ice bath and then the product 
was precipitated with ice-cold Et2O (3-4 mL). The suspension was filtered and then washed 
several times with cold Et2O (~5 mL) to afford 65 mg (82%) of 4g as a light-yellow, crystalline 
solid. The entire product was further purified by recrystallization from a concentrated CH2Cl2 
solution (2-4 mL), layered with Et2O (6-12 mL), and was then allowed to cool in a freezer 
overnight. 
 
Data for 4g: 
 m.p.: 150-155 °C (decomp.) 
 1H-NMR: (500 MHz, CDCl3) 
8.98 (d, J = 4.5 Hz, 1 H), 8.77 (d, J = 8.4 Hz, 1 H), 8.15 (d, J = 8.4 Hz, 1 H), 7.94 
(dt, J = 5.4, 3.2 Hz, 3 H), 7.82 (t, J = 7.2 Hz, 1 H), 7.64 (d, J = 4.4 Hz, 1 H), 7.56 
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- 7.46 (m, 4 H), 7.32 (d, J = 49.8 Hz, 2 H), 6.73 (d, J = 11.8 Hz, 1 H), 5.82 (ddd, J 
= 17.1, 10.6, 6.5 Hz, 1 H), 5.43 (dd, J = 17.2, 1.2 Hz, 1 H), 5.28 (dt, J = 20.2, 9.8 
Hz, 1 H), 5.21 - 5.15 (m, 1 H), 5.13 (dd, J = 10.6, 1.2 Hz, 1 H), 4.78 (d, J = 11.8 
Hz, 1 H), 3.97 (t, J = 11.4 Hz, 1 H), 3.54 - 3.47 (m, 1 H), 3.32 (dd, J = 13.0, 10.7 
Hz, 1 H), 2.65 (s, 1H), 2.22 - 2.13 (m, 1 H), 2.11 (d, J = 2.3 Hz, 1 H), 1.99 (dd, J 
= 13.6, 8.8 Hz, 1 H), 1.88 (t, J = 14.2 Hz, 1 H), 1.68 (td, J = 10.3, 3.1 Hz, 1 H) 
 13C-NMR: (126 MHz, CD3OD) 
151.04, 148.98, 141.63 (d, 2JC-F = 20.3 Hz), 138.08, 134.82, 132.02, 131.61, 
130.74, 130.56, 129.54, 128.29, 125.21 (d, 3JC-F = 5.3 Hz), 123.99, 120.21 (d, 
3
JC-
F = 12.5 Hz), 118.06, 87.20 (d, 
1
JC-F = 182.3 Hz), 69.37 (d, 
2
JC-F = 20.3 Hz), 
66.04, 61.68, 52.99 (d, 3JC-F = 7.2 Hz), 39.10, 28.10, 25.64, 21.84 (d, 
4
JC-F = 3.9 
Hz) 
 19F-NMR: (376 MHz, CDCl3) 
  -201.07 (dd, J = 48.9, 32.7 Hz) 
 LRMS: (ESI+, Q-tof) 
  367.2 (5), 387.2 (100, M-Br+) 
 HRMS: C26H28N2F
+ (ESI+, Q-tof) 
  Calcd:  387.2237 
  Found:  387.2246 
 TLC: Rf 0.49 (CH2Cl2/MeOH, 5:1) [silica gel, I2] 
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Preparation of N-(9-Anthracenylmethyl)deoxyfluorocinchonidinium Bromide (5g) 
 
Following General Procedure I, deoxyfluorocinchonidine (44 mg, 0.15 mmol), MeCN 
(1.5 mL), and bis-(3,5-trifluoromethyl)benzyl bromide (28 μL, 0.16 mmol, 1.05 equiv) were 
combined in a 5-mL, single-neck, round-bottomed flask fitted with an argon inlet and the 
mixture was stirred for 4 days. The reaction mixture was cooled to 0 °C (external) in an ice bath 
and then the product was precipitated with ice-cold Et2O (3-4 mL) then filtered. The filter cake 
was washed several times with ice-cold Et2O (~5 mL) to afford 68 mg (76%) of 5g as a light-
orange, crystalline solid.  
The entire product was further purified by recrystallization from a CH2Cl2 solution (2-4 
mL), layered with Et2O (6-12 mL), and then was allowed to cool overnight in a freezer. 
 
Data for 5g: 
 m.p.: 150-155 °C (decomp.) 
 1H-NMR: (500 MHz, CDCl3) 
8.98 (d, J = 4.5 Hz, 1 H), 8.80 (d, J = 8.4 Hz, 1 H), 8.56 (s, 2 H), 8.14 (d, J = 8.3 
Hz, 1 H), 8.06 (s, 1 H), 7.92 (t, J = 7.7 Hz, 1 H), 7.81 (t, J = 7.6 Hz, 1 H), 7.63 (d, 
J = 4.4 Hz, 1 H), 7.33 (dd, J = 30.5, 23.3 Hz, 2 H), 5.81 (ddd, J = 17.1, 10.6, 6.4 
Hz, 1 H), 5.54 - 5.30 (m, 4 H), 5.16 (d, J = 10.5 Hz, 1 H), 4.92 (d, J = 12.1 Hz, 1 
H), 4.10 (s, 1 H), 3.36 (td, J = 11.8, 4.3 Hz, 1 H), 3.14 (dd, J = 12.5, 10.8 Hz, 1 
H), 2.71 (s, 1 H), 2.23 (dd, J = 19.2, 8.6 Hz, 1 H), 2.17 (s, 1 H), 2.08 - 1.99 (m, 1 
H), 1.94 (t, J = 15.2 Hz, 1 H), 1.69 (dd, J = 13.1, 10.1 Hz, 1 H) 
 13C-NMR: (126 MHz, CD3OD) 
151.06, 149.00, 141.32 (d, 2JC-F = 20.7 Hz), 137.87, 135.35, 133.72 (dd, JC-F = 
36.5, 31.1 Hz), 131.66, 131.53, 130.80, 129.65, 125.92, 125.54, 125.14 (d, 3JC-F = 
5.3 Hz), 123.91, 120.21 (d, 3JC-F = 12.5 Hz), 118.27, 87.10 (d, 
1
JC-F = 182.9 Hz), 
70.00 (d, 2JC-F = 20.4 Hz), 64.14, 61.75, 53.16, 39.11, 27.95, 25.56, 21.87 
 19F-NMR: (376 MHz, CDCl3) 
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-63.03 (s, 6 F), -200.89 (dd, J = 48.1, 32.3 Hz, 1 F) 
 LRMS: (ESI+, Q-tof) 
  503.2 (5), 523.2 (100, M-Br+) 
 HRMS: C28H26N2F7
+ (ESI+, Q-tof) 
  Calcd:  523.1984 
  Found:  523.1984 
 TLC: Rf 0.49 (CH2Cl2/MeOH, 5:1) [silica gel, I2] 
 
  169 
Preparation of Cinchonidinium Salts in Series H 
Preparation of N-(9-Anthracenylmethyl)deoxycinchonidinium Bromide (1h) 
 
Following General Procedure I, deoxycinchonidine (100 mg, 0.359 mmol), MeCN (3.6 
mL), and 9-bromomethylanthracene (107 mg, 0.390 mmol, 1.10 equiv) were combined in a 10-
mL, single-neck, round-bottomed flask fitted with an argon inlet, wrapped in aluminum foil and 
the mixture was stirred for 4 h. Care was taken to avoid light exposure. The solvent was removed 
on a rotavap (20 mm Hg, 25 °C) and the yellow, solid residue was sonicated in Et2O (10 mL) in 
an ultrasonic bath then filtered.  
The entire product was purified by recrystallization from a concentrated CH2Cl2 solution 
by a slow diffusion of Et2O in a chamber stored in a freezer. The first crop of recrystallized 
product afforded 29.0 mg (15%) of 1h as a light-yellow, crystalline solid. 
 
Data for 1h: 
 m.p.: 132 °C (decomp.) 
 1H-NMR: (500 MHz, CDCl3) 
9.16 (d, J = 9.0 Hz, 1 H), 8.80 (d, J = 8.9 Hz, 1 H), 8.45 (d, J = 8.2 Hz, 1 H), 8.40 
(s, 1 H), 8.04 (s, 2 H), 7.98 (d, J = 8.2 Hz, 1 H), 7.81 (d, J = 8.2 Hz, 1 H), 7.77 - 
7.68 (m, 2 H), 7.55 - 7.38 (m, 4 H), 7.33 - 7.27 (m, 1 H), 6.74 (d, J = 14.2 Hz, 1 
H), 6.04 (d, J = 14.2 Hz, 1 H), 5.60 (ddd, J = 17.2, 10.5, 6.8 Hz, 1 H), 5.45 - 5.32 
(m, 1 H), 4.98 (dd, J = 32.1, 13.8 Hz, 2 H), 4.75 (dd, J = 13.4, 4.7 Hz, 1 H), 4.55 
(t, J = 11.5 Hz, 1 H), 4.43 (t, J = 12.5 Hz, 1 H), 3.75 (dd, J = 11.7, 5.0 Hz, 1 H), 
2.94 (td, J = 11.9, 6.1 Hz, 1 H), 2.84 (dd, J = 13.0, 10.7 Hz, 1 H), 2.13 (d, J = 7.3 
Hz, 1 H), 1.99 - 1.87 (m, 1 H), 1.81 (dd, J = 13.6, 10.7 Hz, 1 H), 1.66 (d, J = 2.5 
Hz, 1 H), 1.52 (t, J = 10.0 Hz, 1 H), 1.21 (dd, J = 18.2, 11.2 Hz, 1 H). 
 LRMS: (ESI+, Q-tof) 
  191.1 (80), 279.2 (35), 469.3 (100, M-Br+) 
 HRMS: C34H33N2
+ (ESI+, Q-tof) 
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  Calcd:  469.2644 
  Found:  469.2639 
 
Preparation of N-(2-Naphthylmethyl)deoxycinchonidinium Bromide (2h) 
 
 Following General Procedure I, deoxycinchonidine (100 mg, 0.359 mmol), MeCN (3.60 
mL, 0.1 M), and 2-bromomethylnaphthalene (87.0 mg, 0.390 mmol, 1.10 equiv) were combined 
in a 10-mL, single-neck, round-bottomed flask fitted with an argon inlet and the mixture was 
stirred for 3 h. The solvent was removed on a rotavap (20 mm Hg, 25 °C) and the solid residue 
was triturated with Et2O (10 mL) then filtered. The filter cake was then sonicated in TBME (10 
mL) in an ultrasonic bath and then filtered to afford 156 mg (87%) of 2h as an off-white, 
crystalline solid. 
 
Data for 2h: 
 m.p.: 165 °C (decomp.) 
 1H-NMR: (500 MHz, CDCl3) 
8.61 (d, J = 4.4 Hz, 1 H), 8.44 - 8.37 (m, 1 H), 8.09 (s, 1 H), 8.02 - 7.95 (m, 1 H), 
7.72 - 7.57 (m, 5 H), 7.52 (d, J = 8.4 Hz, 1 H), 7.48 - 7.43 (m, 1 H), 7.43 - 7.36 
(m, 2 H), 5.88 (d, J = 12.8 Hz, 1 H), 5.65 (ddd, J = 17.2, 14.4, 9.9 Hz, 2 H), 5.12 
(dd, J = 13.7, 9.2 Hz, 2 H), 4.52 (dt, J = 13.9, 8.4 Hz, 2 H), 4.37 (dd, J = 14.5, 3.7 
Hz, 1 H), 3.97 - 3.79 (m, 3 H), 3.50 - 3.39 (m, 1 H), 2.65 (dd, J = 16.6, 7.5 Hz, 1 
H), 2.08 (dd, J = 18.4, 11.5 Hz, 1 H), 1.96 - 1.77 (m, 3 H), 1.61 (s (br), 1 H), 1.36 
(d, J = 13.2 Hz, 1 H). 
 13C-NMR: (126 MHz, CD3OD) 
150.90, 148.95, 143.86, 137.88, 135.41, 134.96, 134.54, 131.36, 130.26, 130.24, 
129.42, 129.07, 128.95, 128.93, 128.85, 128.22, 125.91, 125.05, 123.30, 118.11, 
66.03, 65.89, 61.41, 50.93, 39.22, 33.22, 28.38, 27.62, 25.54. 
 LRMS: (ESI+, Q-tof) 
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  419.2 (100, M-Br+) 
 HRMS: C30H31N2
+ (ESI+, Q-tof) 
  Calcd:  419.2487 
  Found:  419.2491 
 TLC: Rf 0.55 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
 
Preparation of N-(1-Naphthylmethyl)deoxycinchonidinium Bromide (3h) 
 
Following General Procedure I, deoxycinchonidine (100 mg, 0.359 mmol), MeCN (3.60 
mL, 0.1 M), and 2-bromomethylnaphthalene (87.0 mg, 0.390 mmol, 1.10 equiv) were combined 
in a 10-mL, single-neck, round-bottomed flask fitted with an argon inlet and the mixture was 
stirred for 2 days. The solvent was removed on a rotavap (20 mm Hg, 25 °C) and the solid 
residue was triturated with Et2O (10 mL) then filtered. The filter cake was then sonicated in 
TBME (10 mL) in an ultrasonic bath and then filtered to afford 156 mg (87%) of 2h as an off-
white, crystalline solid. 
 
Data for 3h 
 m.p.: 165 °C (decomp.) 
 1H-NMR: (500 MHz, CDCl3) 
8.64 (d, J = 8.6 Hz, 1 H), 8.30 (dd, J = 10.2, 6.4 Hz, 2 H), 8.02 (d, J = 7.0 Hz, 1 
H), 7.90 (dd, J = 8.3, 1.1 Hz, 1 H), 7.69 - 7.53 (m, 5 H), 7.48 - 7.38 (m, 2 H), 6.96 
- 6.88 (m, 1 H), 6.42 (d, J = 13.1 Hz, 1 H), 5.86 (d, J = 13.2 Hz, 1 H), 5.59 (ddd, J 
= 17.3, 10.5, 7.0 Hz, 1 H), 5.01 (dd, J = 27.1, 13.8 Hz, 2 H), 4.92 (dt, J = 15.7, 5.3 
Hz, 1 H), 4.64 (t, J = 12.0 Hz, 1 H), 4.42 (dd, J = 13.8, 4.8 Hz, 1 H), 4.09 - 4.00 
(m, 1 H), 3.53 - 3.35 (m, 2 H), 3.10 (dd, J = 13.0, 10.6 Hz, 1 H), 2.33 (d, J = 9.2 
Hz, 1 H), 1.99 (dd, J = 17.1, 10.8 Hz, 1 H), 1.80 - 1.62 (m, 3 H), 1.19 (d, J = 10.3 
Hz, 1 H) 
 13C-NMR: (126 MHz, CDCl3) 
153.60, 141.23, 136.86, 136.67, 135.52, 134.41, 133.33, 132.72, 131.70, 130.65, 
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129.51, 128.25, 128.10, 126.94, 125.67, 124.88, 124.44, 122.84, 122.35, 121.78, 
118.61, 66.25, 60.83, 59.68, 48.67, 37.76, 33.26, 27.16, 25.98, 24.94 
 LRMS: (ESI+, Q-tof) 
  110.1 (20), 141.1 (80), 170.1 (8), 279.2 (100), 419.2 (50, M-Br+) 
 HRMS: C30H31N2
+ (ESI+, Q-tof) 
  Calcd:  419.2487 
  Found:  419.2490 
 
Preparation of N-(Benzyl)deoxycinchonidinium Bromide (4h) 
 
 Following General Procedure I, deoxycinchonidine (101 mg, 0.362 mmol), MeCN (3.60 
mL, 0.1 M), and benzyl bromide (47.0 μL, 0.400 mmol, 1.10 equiv) were combined in a 10-mL, 
single-neck, round-bottomed flask fitted with an argon inlet and the mixture was stirred for 3 h. 
The solvent removed was removed on a rotavap (20 mm Hg, 25 °C) and the solid residue was 
then triturated with hexane and filtered. The filter cake sonicated twice with Et2O (2 x 10 mL) in 
an ultrasonic bath and then filtered to afford 136 mg (84%) of 4h as a pale-green, crystalline 
solid. 
 
Data for 4h: 
 m.p.: 113 °C (decomp) 
 1H-NMR: (500 MHz, CDCl3) 
8.73 (d, J = 4.5 Hz, 1 H), 8.50 - 8.44 (m, 1 H), 8.06 (dd, J = 8.2, 1.2 Hz, 1 H), 
7.75 - 7.62 (m, 4 H), 7.44 (d, J = 4.5 Hz, 1 H), 7.31 - 7.25 (m, 1 H), 7.22 (t, J = 
7.3 Hz, 2 H), 5.75 - 5.59 (m, 2 H), 5.45 (d, J = 12.7 Hz, 1 H), 5.16 (dd, J = 17.8, 
14.0 Hz, 2 H), 4.62 - 4.46 (m, 2 H), 4.27 (dd, J = 14.5, 3.6 Hz, 1 H), 3.86 (dd, J = 
25.2, 12.8 Hz, 2 H), 3.79 - 3.69 (m, 1 H), 3.54 - 3.44 (m, 1 H), 2.69 (dd, J = 16.0, 
7.6 Hz, 1 H), 2.15 - 2.03 (m, 1 H), 1.97 - 1.83 (m, 3 H), 1.44 - 1.34 (m, 1 H). 
 LRMS: (ESI+, Q-tof) 
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  91.1 (10), 110.1 (10), 279.2 (40), 369.2 (100, M-Br+) 
 HRMS: C26H29N2
+ (ESI+, Q-tof) 
  Calcd:  369.2331 
  Found:  369.2337 
 TLC: Rf 0.54 (CH2Cl2/MeOH, 10:1) [silica gel, I2] 
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5.2.2. PTC Alkylation Kinetics 
General Procedure II. PTC Alkylation of N-(Diphenylmethylene)glycine tert-Butyl Ester (1) 
 
 A 2 mL scintillation vial was fitted with a Teflon lined rubber septum and tert-butyl 2-
(diphenylmethyleneamino)acetate (100 mg, 0.34 mmol), and the phase transfer catalyst (8.48 
μmol, 0.025 equiv) were added.  The liquid reagents, benzyl bromide (800 μL, 0.51 M in 
toluene, 1.2 equiv), internal standard (790 μL, 0.32 M in tolune, 0.75 equiv), and toluene (410 
μL) were added via syringe.  Then, a 1.5 cm egg-shaped magnetic stir bar was placed in the vial 
and the contents were briefly agitated in an ultrasonic bath (10-20 s). Reaction vials were then 
transferred to a cold room maintained at 2-4 oC and were allowed to equilibrate for at least 1 h 
with stirring while immersed in a water bath to control temperature fluctuations. Lastly, 50% aq. 
(w/w) KOH solution (670 μL, 11.9 mmol, 17.8 M, 35.0 equiv) was added to the rapidly stirred 
(1600 rpm) organic phase.  Aliquots were taken at the indicated times and analyzed as follows.  
 The internal standard employed in these reactions was 1,1-diphenyl-1-heptene. 
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General Procedure III. Performing Kinetics and Enantioselectivity Measurements on PTC 
Alkylations 
Three seconds prior to the indicated time interval, the stirrer was turned off. At the 
indicated time interval a 10-µL aliquot of the organic layer was removed and then was injected 
into MeCN (2.0 mL) containing glacial acetic acid (several drops).  This clear solution was 
filtered through a small plug of silica gel (0.5 x 1 cm) and the filtrate was analyzed by Reverse 
Phase-HPLC Method 1.  
For the PTC alkylations that reached near to full completion (70-85% conversion to 
product), a 10-μL aliquot was taken from the organic phase and injected into i-PrOH (2 mL). 
This aliquot was filtered through a small plug of silica gel (0.5 x 1 cm) and the filtrate was 
analyzed by CSP-HPLC Method 2 
 For the PTC alkylations that did not reach full completion (<70% conversion to product), 
the organic phase was first separated from the aqueous base via pipette.  The alkylation product 
was obtained by preparative thin-layer chromatography (8 x 10 cm plate) using 0.5 - 1.0 mL of 
the organic phase directly.  The product was eluted with 5:95 TBME/hexane.  The product band 
was removed, suspended in i-PrOH (4 mL), and the silica gel was removed by filtration. The 
solvent was removed on a rotavap (20 mm Hg, 35-40 °C).  The product was then dissolved in an 
appropriate amount of i-PrOH (1 mg/mL) and then analyzed by CSP-HPLC Method 2. 
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Kinetic Analyzses of Catalysts in Series A 
Catalyst 1a: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.00 0.0 
4 254.0 6315.24 68.36 3.27 1.0 
8 254.0 6655.10 462.93 21.03 6.2 
12 254.0 6107.59 1115.00 55.20 16.3 
16 254.0 5897.88 2466.57 126.45 37.3 
20 254.0 6424.48 3549.97 167.08 49.3 
24 254.0 7382.42 4765.74 195.19 57.6 
28 254.0 6173.24 4297.34 210.48 62.1 
32 254.0 6503.01 4885.58 227.16 67.0 
36 254.0 7039.97 5559.75 238.79 70.4 
40 254.0 6655.06 5052.67 229.56 67.7 
 
 
 
Half-Life = 20 min 
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Catalyst 1a: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
4 254.0 6525.65 70.70 3.3 1.0 
8 254.0 6077.37 336.71 16.8 4.9 
12 254.0 6667.15 879.72 39.9 11.8 
16 254.0 6060.03 1905.65 95.1 28.0 
20 254.0 6189.47 3102.61 151.6 44.7 
24 254.0 6697.23 4101.86 185.2 54.6 
28 254.0 7045.90 4652.70 199.7 58.9 
32 254.0 6297.25 4608.70 221.3 65.3 
36 254.0 8091.08 6307.97 235.7 69.5 
40 254.0 7020.25 5777.23 248.8 73.4 
 
 
 
 
Half-Life = 22 min 
Average Half-Life = 21 min
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Catalyst 2a: Run 1 
Time (min) Standard (umol) Standard Area Product Area Product (umol) % Product 
0 254.4 1.00 0.00 0.0 0.0 
30 254.4 6090.60 113.01 5.6 1.7 
61 254.4 6386.44 362.39 17.2 5.1 
120 254.4 7553.15 1097.38 44.0 13.0 
180 254.4 7437.62 1885.13 76.8 22.6 
244 254.4 7170.76 2708.80 114.4 33.7 
300 254.4 7017.54 3317.81 143.2 42.2 
360 254.4 7163.19 3952.86 167.1 49.3 
420 254.4 7223.67 4427.49 185.6 54.8 
480 254.4 7401.25 4928.23 201.6 59.5 
540 254.4 7653.35 5427.32 214.8 63.3 
600 254.4 7117.47 5262.02 223.9 66.0 
1320 254.4 7197.75 5979.38 251.6 74.2 
1860 254.4 7042.44 5868.89 252.4 74.4 
2760 254.4 7217.98 6162.11 258.5 76.3 
 
 
 
Half-Life = 363 min
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Catalyst 2a: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.4 1.00 0.00 0.0 0.0 
60 254.4 7764.86 557.63 21.7 6.4 
120 254.4 7135.54 1641.45 69.7 20.5 
180 254.4 7211.92 2565.60 107.7 31.8 
240 254.4 7838.86 3141.89 121.4 35.8 
300 254.4 7704.01 4191.80 164.8 48.6 
360 254.4 7821.57 4611.86 178.6 52.7 
420 254.4 7893.62 5272.90 202.3 59.7 
1103 254.4 6816.47 5738.17 254.9 75.2 
1468 254.4 7103.48 5878.89 250.6 73.9 
2550 254.4 7509.56 6426.51 259.2 76.4 
 
 
 
 
Half-Life = 340 min 
Average Half-Life = 351 min
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Catalyst 3a: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
3 254.0 5724.09 20.61 1.1 0.3 
9 254.0 5899.33 112.17 5.7 1.7 
18 254.0 6511.32 404.84 18.8 5.5 
30 254.0 6584.82 961.62 44.2 13.0 
45 254.0 7436.89 2004.76 81.5 24.0 
63 254.0 6987.36 2794.91 120.9 35.7 
84 254.0 7502.23 4116.53 165.9 48.9 
108 254.0 6968.71 4740.95 205.7 60.7 
135 254.0 7027.91 5503.32 236.8 69.8 
165 254.0 7938.40 6373.96 242.8 71.6 
 
 
 
 
 
Half-Life = 85 min
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Catalyst 3a: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
5 254.0 7109.33 115.26 4.9 1.4 
10 254.0 8054.54 347.28 13.0 3.8 
20 254.0 7641.84 831.24 32.9 9.7 
30 254.0 7735.89 1426.57 55.8 16.4 
45 254.0 7214.04 2169.73 90.9 26.8 
60 254.0 7402.72 3129.77 127.8 37.7 
90 254.0 7277.34 4554.41 189.2 55.8 
120 254.0 7206.75 5415.82 227.2 67.0 
180 254.0 7633.05 6456.10 255.7 75.4 
240 254.0 7413.94 6464.79 263.7 77.8 
300 254.0 7155.78 6019.47 254.3 75.0 
1020 254.0 8491.11 7208.87 256.7 75.7 
 
 
 
Half-Life = 78 min 
Average Half-Life = 82 min
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Catalyst 4a: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
7 254.0 8099.77 491.92 18.4 5.4 
14 254.0 6473.20 988.06 46.2 13.6 
21 254.0 6481.47 1618.83 75.5 22.3 
28 254.0 6848.23 2427.94 107.2 31.6 
30 254.0 7449.53 3034.09 123.1 36.3 
35 254.0 6195.73 2686.33 131.1 38.7 
42 254.0 6774.26 3486.69 155.6 45.9 
49 254.0 6132.76 3660.82 180.5 53.2 
56 254.0 6327.44 4259.80 203.6 60.0 
60 254.0 6343.97 4323.58 206.1 60.8 
63 254.0 7591.06 5350.65 213.1 62.9 
70 254.0 6811.49 5282.45 234.5 69.2 
90 254.0 6360.96 5518.83 262.3 77.4 
120 254.0 4711.11 4270.64 274.1 80.9 
150 254.0 7115.57 6684.37 284.0 83.8 
182 254.0 5451.71 5158.49 286.1 84.4 
 
 
 
Half-Life = 44 min 
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Catalyst 4a: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
5 254.0 6956.27 246.78 10.7 3.2 
10 254.0 6983.71 671.26 29.1 8.6 
20 254.0 7170.84 1646.42 69.4 20.5 
30 254.0 7011.34 2755.72 118.8 35.1 
45 254.0 6993.50 3834.21 165.8 48.9 
60 254.0 6879.12 4722.85 207.6 61.2 
90 254.0 6727.30 5568.84 250.3 73.8 
120 254.0 7350.99 6770.02 278.5 82.1 
180 254.0 7308.84 6618.29 273.8 80.8 
240 254.0 7265.55 6626.65 275.8 81.3 
 
 
Half-Life = 44 min  
Average Half-Life = 44 min
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Catalyst 5a: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.00 0.00 
60 254.0 6551.96 646.15 29.82 8.80 
120 254.0 6880.21 1634.19 71.82 21.19 
180 254.0 6970.26 2422.03 105.06 30.99 
240 254.0 6266.68 2842.73 137.16 40.46 
300 254.0 6886.98 3625.36 159.17 46.95 
360 254.0 7310.40 4273.93 176.77 52.15 
420 254.0 7259.71 4668.02 194.42 57.35 
480 254.0 7312.95 4913.18 203.14 59.92 
540 254.0 7515.24 5182.03 208.49 61.50 
600 254.0 6708.92 4674.66 210.68 62.15 
1440.00 254.00 6427.62 4976.42 234.10 69.05 
 
 
 
 
 
Half-Life = 343 min
  185 
Catalyst 5a: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.4 1.00 0.00 0.0 0.0 
30 254.4 6588.01 481.52 22.1 6.5 
60 254.4 6964.99 963.41 41.9 12.4 
90 254.4 6707.41 1436.32 64.8 19.1 
120 254.4 6766.07 1799.51 80.5 23.8 
180 254.4 6944.72 2876.93 125.5 37.0 
240 254.4 6749.27 3543.57 159.0 46.9 
300 254.4 7027.41 4341.94 187.1 55.2 
360 254.4 6643.04 4358.22 198.7 58.6 
420 254.4 6885.22 4763.41 209.5 61.8 
1153 254.4 6768.02 6137.83 274.6 81.0 
1478 254.4 6887.19 6364.26 279.8 82.5 
 
 
 
Half-Life = 277 min 
Average Half-Life = 310 min
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Kinetic Analyzses of Catalysts in Series B 
Catalyst 1b: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
6 254.0 7748.79 985.04 38.4 11.3 
12 254.0 6567.97 1942.93 89.4 26.4 
20 254.0 6318.09 3202.96 153.3 45.2 
30 254.0 6684.17 4851.38 219.5 64.7 
42 254.0 7460.54 6563.10 266.0 78.5 
56 254.0 7489.41 7423.38 299.7 88.4 
72 254.0 6878.57 6611.26 290.6 85.7 
90 254.0 7598.74 7197.71 286.4 84.5 
110 254.0 7548.24 7130.15 285.6 84.3 
300 254.0 6857.69 6376.37 281.1 82.9 
 
 
Half-Life = 21 min 
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Catalyst 1b: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.00 0.0 
2 254.0 6518.76 184.72 8.57 2.5 
6 254.0 7542.25 970.35 38.90 11.5 
12 254.0 6598.10 2082.50 95.43 28.2 
20 254.0 6865.16 3758.28 165.53 48.8 
30 254.0 6773.70 4987.07 222.61 65.7 
42 254.0 7644.02 6455.82 255.36 75.3 
56 254.0 6410.66 5388.35 254.14 75.0 
72 254.0 7777.18 6948.31 270.14 79.7 
90 254.0 7805.40 7196.24 278.76 82.2 
110 254.0 6747.65 5967.86 267.42 78.9 
300 254.0 6757.47 6230.80 278.80 82.2 
 
 
 
Half-Life = 21 min 
Average Half-Life = 21 min
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Catalyst 2b: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
5 254.0 7879.88 0.00 0.0 0.0 
30 254.0 7671.50 40.44 1.6 0.5 
60 254.0 7635.95 456.30 18.1 5.3 
120 254.0 7556.02 2331.50 93.3 27.5 
180 254.0 7112.89 3454.01 146.8 43.3 
240 254.0 7590.22 4029.87 160.5 47.4 
300 254.0 7260.17 4909.52 204.5 60.3 
1341 254.0 7782.06 6790.97 263.9 77.8 
1837 254.0 8306.82 7412.94 269.8 79.6 
 
 
 
 
 
 
 
 
 
Half-Life = 247 min 
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Catalyst 2b: Run 2 
Time (min) Standard (umol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
5 254.0 7841.88 0.00 0.0 0.0 
30 254.0 6461.39 107.85 5.0 1.5 
60 254.0 6917.40 978.41 42.8 12.6 
120 254.0 7423.29 2971.22 121.0 35.7 
180 254.0 6886.53 3387.69 148.7 43.9 
240 254.0 7504.17 3946.61 159.0 46.9 
300 254.0 7686.25 4676.79 184.0 54.3 
1341 254.0 7581.39 6448.81 257.2 75.9 
1837 254.0 7969.25 6801.76 258.1 76.1 
 
 
 
 
 
Half-Life = 244 min 
Average Half-Life = 246 min
  190 
Catalyst 3b: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
5 254.0 7116.94 0.00 0.0 0.0 
15 254.0 7529.49 78.86 3.2 0.9 
30 254.0 6689.77 486.96 22.0 6.5 
45 254.0 8134.10 1481.62 55.1 16.2 
60 254.0 6632.84 1941.55 88.5 26.1 
90 254.0 7293.13 3324.44 137.8 40.7 
120 254.0 7563.81 4471.39 178.7 52.7 
180 254.0 6919.37 5506.73 240.6 71.0 
240 254.0 6872.94 5607.03 246.7 72.8 
300 254.0 7407.61 6136.27 250.5 73.9 
1042 254.0 6839.24 5655.01 250.0 73.7 
 
 
 
 
 
Half-Life = 106 min 
  191 
Catalyst 3b: Run 2 
Time (min) Standard (μmol) Product Area Standard Area Product (μmol) % Product 
0 254.0 0.00 1.00 0.0 0.0 
5 254.0 0.00 7250.08 0.0 0.0 
15 254.0 90.06 7390.36 3.7 1.1 
30 254.0 579.70 7280.64 24.1 7.1 
45 254.0 1385.53 6780.43 61.8 18.2 
60 254.0 2690.50 7804.84 104.2 30.7 
90 254.0 4150.43 7281.74 172.3 50.8 
120 254.0 5310.07 7363.24 218.1 64.3 
180 254.0 6169.84 6990.93 266.8 78.7 
240 254.0 5813.56 6602.04 266.3 78.5 
300 254.0 6631.58 7357.89 272.5 80.4 
1042 254.0 6154.85 7266.25 256.1 75.5 
 
 
 
 
Half-Life = 85 min 
Average Half-Life = 95 min
  192 
Catalyst 4b: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
5 254.0 6915.34 783.53 34.3 10.1 
15 254.0 6980.95 2308.70 100.0 29.5 
30 254.0 6784.76 3985.27 177.6 52.4 
45 254.0 7278.12 5281.28 219.4 64.7 
60 254.0 7019.90 6137.38 264.3 78.0 
90 254.0 7091.19 5962.76 254.2 75.0 
120 254.0 6239.32 5139.75 249.1 73.5 
180 254.0 7578.16 6326.69 252.4 74.5 
240 254.0 6972.50 5818.39 252.3 74.4 
300 254.0 7026.35 5921.27 254.8 75.2 
1039 254.0 6420.38 5643.17 265.8 78.4 
 
 
 
 
 
 
Half-Life = 27 min
  193 
Catalyst 4b: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
5 254.0 8268.86 752.64 27.5 8.1 
15 254.0 7168.00 2337.65 98.6 29.1 
30 254.0 6913.03 3949.39 172.7 51.0 
45 254.0 8533.48 6104.96 216.3 63.8 
60 254.0 7106.51 5246.87 223.2 65.9 
90 254.0 6864.22 5574.94 245.6 72.4 
120 254.0 6501.38 5222.00 242.9 71.6 
180 254.0 7052.11 5870.49 251.7 74.2 
240 254.0 7260.77 5750.17 239.5 70.6 
300 254.0 7612.69 6545.06 260.0 76.7 
1039 254.0 6977.30 6410.19 277.8 81.9 
 
 
 
 
Half-Life = 30 min 
Average Half-Life = 29 min
  194 
Catalyst 5b: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Prodcut 
0 254.0 1.00 0.00 0 0.0 
60 254.0 7515.93 648.02 26.06956273 7.7 
120 254.0 7213.64 1646.44 69.01101463 20.4 
180 254.0 7913.31 2972.46 113.5755569 33.5 
240 254.0 6753.74 3360.49 150.4474812 44.4 
300 254.0 8002.67 4513.40 170.5276886 50.3 
360 254.0 7199.20 4499.93 188.9939234 55.8 
420 254.0 7478.48 4977.12 201.229079 59.4 
480 254.0 7621.79 5265.14 208.8716046 61.6 
1260 254.0 7331.66 6477.10 267.1191093 78.8 
4320 254.0 5576.05 4908.26 266.1507443 78.5 
 
 
 
 
 
Half-Life = 311 min
  195 
Catalyst 5b: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
60 254.0 7351.52 670.73 27.6 8.1 
120 254.0 7540.39 1830.13 73.4 21.6 
180 254.0 7364.30 2762.87 113.4 33.5 
240 254.0 8103.71 3953.71 147.5 43.5 
300 254.0 7115.94 4055.55 172.3 50.8 
360 254.0 7554.33 4646.77 186.0 54.9 
420 254.0 8041.56 5237.67 196.9 58.1 
480 254.0 7699.79 5380.62 211.3 62.3 
1260 254.0 8157.51 6690.44 248.0 73.2 
4320 254.0 7505.50 6188.76 249.3 73.5 
 
 
 
 
Half-Life = 313 min 
Average Half-Life = 312 min
  196 
Kinetic Analyzses of Catalysts in Series C 
Catalyst 1c: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
5 254.0 7229.86 157.52 6.6 1.9 
15 254.0 7227.43 715.20 29.9 8.8 
30 254.0 6995.94 1360.21 58.8 17.3 
45 254.0 6953.89 1844.50 80.2 23.7 
60 254.0 5980.81 2065.91 104.4 30.8 
90 254.0 6568.27 2955.29 136.0 40.1 
120 254.0 7866.16 4215.99 162.1 47.8 
180 254.0 6561.58 4296.26 198.0 58.4 
240 254.0 5995.08 4624.01 233.2 68.8 
300 254.0 6436.51 5480.08 257.4 75.9 
1044 254.0 6175.21 5432.38 266.0 78.5 
 
 
 
 
Half-Life = 125 min
  197 
Catalyst 1c: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.4 1.00 0.00 0.0 0.0 
5 254.4 7566.30 462.68 18.5 5.5 
10 254.4 6850.47 952.01 42.1 12.4 
20 254.4 7288.12 2061.08 85.6 25.3 
30 254.4 6502.60 2648.20 123.3 36.4 
45 254.4 6975.58 3500.42 152.0 44.8 
60 254.4 7321.79 4625.62 191.3 56.4 
90 254.4 6842.20 5492.58 243.1 71.7 
120 254.4 7374.77 5984.07 245.7 72.5 
180 254.4 7073.91 5517.55 236.2 69.7 
240 254.4 6882.90 6210.53 273.3 80.6 
300 254.4 7013.31 5829.00 251.7 74.2 
1020 254.4 7014.34 6614.44 285.6 84.2 
 
 
Half-Life = 49 min 
Average Half = 87 min 
  198 
Catalyst 2c: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
5 254.0 6948.18 1947.79 84.8 25.0 
10 254.0 6930.96 2691.80 117.4 34.6 
15 254.0 6307.47 3143.71 150.7 44.5 
30 254.0 7164.98 4270.94 180.2 53.2 
45 254.0 7140.67 5408.34 229.0 67.6 
60 254.0 6757.77 5358.52 239.8 70.7 
90 254.0 7322.81 5914.76 244.2 72.0 
120 254.0 8230.17 6404.85 235.3 69.4 
240 254.0 5617.81 4482.36 241.2 71.2 
390 254.0 6697.65 5419.45 244.7 72.2 
 
 
 
 
 
Half-Life = 20 min
  199 
Catalyst 2c: Run 2 
Time (min) Standard (μmol) Standard Area Prodcut Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
5 254.0 6953.20 1845.14 80.2 23.7 
10 254.0 6970.82 2801.66 121.5 35.8 
15 254.0 6513.41 3364.79 156.2 46.1 
30 254.0 5798.28 3899.58 203.4 60.0 
45 254.0 6796.95 5018.23 223.2 65.9 
60 254.0 7426.89 5575.46 227.0 67.0 
90 254.0 6143.65 5050.34 248.6 73.3 
120 254.0 7148.17 5951.79 251.8 74.3 
180 254.0 7203.04 5868.43 246.3 72.7 
240 254.0 6860.76 5555.94 244.9 72.2 
390 254.0 6819.18 5583.45 247.6 73.0 
 
 
 
Half-Life = 18 min 
Average Half-Life = 19 min
  200 
Catalyst 3c: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
5 254.0 6366.78 1987.10 94.4 27.8 
10 254.0 7271.42 3898.83 162.1 47.8 
15 254.0 6256.49 4213.33 203.6 60.1 
30 254.0 7361.20 6309.61 259.2 76.5 
45 254.0 6798.22 5649.22 251.3 74.1 
60 254.0 6758.95 5936.93 265.6 78.3 
90 254.0 6501.51 5679.15 264.1 77.9 
120 254.0 7536.02 6606.41 265.1 78.2 
180 254.0 6462.61 5706.41 267.0 78.8 
240 254.0 7300.15 6235.80 258.3 76.2 
390 254.0 6181.25 5085.59 248.8 73.4 
 
 
 
 
 
Half-Life = 11 min
  201 
Catalyst 3c: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
5 254.0 6497.60 2556.45 119.0 35.1 
10 254.0 6409.23 3971.14 187.3 55.3 
15 254.0 6714.73 5077.76 228.6 67.4 
30 254.0 6316.60 5565.02 266.4 78.6 
45 254.0 7164.22 6347.19 267.9 79.0 
60 254.0 7023.72 6111.76 263.1 77.6 
90 254.0 6812.49 6027.83 267.5 78.9 
120 254.0 6956.38 6147.80 267.2 78.8 
180 254.0 7296.56 6422.69 266.1 78.5 
240 254.0 6965.82 6136.37 266.4 78.6 
390 254.0 6369.80 5385.45 255.6 75.4 
 
 
 
 
Half-Life = 8 min 
Average Half-Life = 9 min
  202 
Catalyst 4c: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.4 1.00 0.00 0.0 0.0 
30 254.4 7863.59 474.71 18.3 5.4 
60 254.4 7367.71 840.71 34.6 10.2 
120 254.4 7404.97 1189.20 48.6 14.3 
180 254.4 7649.45 1421.59 56.3 16.6 
240 254.4 6730.51 1595.53 71.8 21.2 
300 254.4 7201.13 1955.34 82.2 24.3 
360 254.4 8112.84 2425.10 90.5 26.7 
420 254.4 7489.21 2506.72 101.4 29.9 
1096 254.4 7413.32 4588.50 187.4 55.3 
1463 254.4 6053.13 4300.86 215.2 63.5 
2546 254.4 6367.19 5077.05 241.5 71.2 
 
 
 
 
 
Half-Life = 893 min
  203 
Catalyst 4c: Run 2 
Time (min) Standard (umol) Standard Area Product Area Product (umol)  % Product 
0 254.4 1.00 0.00 0.0 0.0 
30 254.4 10788.78 814.29 22.9 6.7 
61 254.4 7527.68 843.86 33.9 10.0 
120 254.4 7031.33 1206.67 52.0 15.3 
180 254.4 8256.95 1782.66 65.4 19.3 
240 254.4 7013.87 1877.42 81.1 23.9 
300 254.4 8866.15 2744.85 93.8 27.7 
360 254.4 7546.60 2610.97 104.8 30.9 
420 254.4 7389.24 2834.78 116.2 34.3 
480 254.4 7238.21 2989.89 125.1 36.9 
540 254.4 7519.02 3385.00 136.3 40.2 
600 254.4 8010.17 3787.29 143.2 42.2 
1320 254.4 7710.55 5073.11 199.3 58.8 
1860 254.4 7707.93 5663.60 222.5 65.6 
2760 254.4 7732.30 6165.50 241.5 71.2 
 
 
Half-Life = 809 min 
Average Half-Life = 851 min 
  204 
Catalyst 5c: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
60 254.0 6368.39 629.97 29.9 8.8 
120 254.0 8045.95 1132.05 42.5 12.5 
180 254.0 8135.70 1627.98 60.5 17.8 
240 254.0 7363.66 2208.14 90.7 26.7 
300 254.0 8024.54 3125.56 117.8 34.7 
360 254.0 7958.76 3637.38 138.2 40.8 
420 254.0 7431.97 3903.86 158.8 46.9 
480 254.0 7875.20 4543.85 174.5 51.5 
1260 254.0 8115.78 5868.77 218.6 64.5 
4320 254.0 7319.30 4992.20 206.2 60.8 
 
 
 
 
 
Half-Life = 552 min 
  205 
Catalyst 5c: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.4 1.00 0.00 0.0 0.0 
30 254.4 7941.61 824.43 31.4 9.3 
60 254.4 7515.06 1058.79 42.7 12.6 
90 254.4 7593.52 1051.55 41.9 12.4 
120 254.4 7550.88 1271.89 51.0 15.0 
180 254.4 7588.20 1711.40 68.3 20.1 
240 254.4 7637.43 2287.61 90.7 26.8 
300 254.4 7619.27 2586.18 102.8 30.3 
360 254.4 8407.72 3149.90 113.5 33.5 
420 254.4 7873.94 3838.21 147.6 43.5 
480 254.4 8463.36 4825.66 172.7 50.9 
1153 254.4 8061.29 5340.12 200.6 59.2 
1478 254.4 7598.65 5239.92 208.8 61.6 
 
 
 
Half-Life = 636 min 
Average Half-Life = 594 min
  206 
Kinetic Analyzses of Catalysts in Series D 
Catalyst 1d: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
30 254.0 5406.24 1359.20 76.0 22.4 
60 254.0 5597.67 2322.44 125.4 37.0 
90 254.0 6022.80 3061.08 153.7 45.3 
120 254.0 5849.00 3388.52 175.2 51.7 
150 254.0 6356.35 4236.60 201.5 59.4 
180 254.0 6318.85 4449.16 212.9 62.8 
210 254.0 7329.06 5406.82 223.1 65.8 
240 254.0 7373.65 5588.14 229.1 67.6 
270 254.0 6735.73 5379.98 241.5 71.2 
300 254.0 7544.71 6096.67 244.3 72.1 
 
 
 
 
Half-Life = 151 min 
  207 
Catalyst 1d: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
3 254.0 7510.25 152.92 6.2 1.8 
9 254.0 7171.84 633.84 26.7 7.9 
18 254.0 6894.65 1217.50 53.4 15.8 
30 254.0 7108.05 1922.28 81.8 24.1 
45 254.0 6914.86 2451.89 107.2 31.6 
63 254.0 6219.46 2806.25 136.4 40.2 
84 254.0 7238.37 3738.36 156.2 46.1 
108 254.0 7818.04 4546.39 175.8 51.9 
135 254.0 7537.11 4559.36 182.9 54.0 
165 254.0 6789.20 4447.95 198.1 58.4 
 
 
 
 
Half-Life = 101 min 
Average Half-Life = 126 min
  208 
Catalyst 2d: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.00 0.00 
3 254.0 7452.19 1874.83 76.07 22.44 
6 254.0 6532.27 2598.15 120.26 35.48 
9 254.0 7411.18 3663.17 149.45 44.09 
12 254.0 6859.63 4003.37 176.46 52.05 
15 254.0 7120.64 4338.85 184.24 54.35 
18 254.0 7146.26 4860.47 205.65 60.66 
21 254.0 6564.03 4590.67 211.46 62.38 
24 254.0 6910.47 5137.96 224.81 66.31 
27 254.0 6548.18 5147.46 237.68 70.11 
30 254.0 6246.98 5100.82 246.89 72.83 
60 254.0 6088.17 5485.47 272.43 80.36 
90 254.0 6532.30 5906.09 273.38 80.64 
 
 
 
 
Half-Life = 12 min
  209 
Catalyst 2d: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
2 254.0 6657.24 1299.59 59.0 14.8 
4 254.0 6625.67 1886.22 86.1 21.6 
6 254.0 6654.65 2261.85 102.8 25.8 
8 254.0 5937.63 2420.91 123.3 30.9 
10 254.0 5945.19 2667.42 135.7 34.0 
15 254.0 7215.81 4097.74 171.7 43.0 
30 254.0 6335.24 4894.49 233.6 58.5 
45 254.0 6563.80 5590.47 257.5 64.5 
60 254.0 6914.90 6391.83 279.5 70.0 
90 254.0 6598.44 6016.79 275.7 69.1 
 
 
 
 
Half-Life = 19 min 
Average Half-Life = 15 min
  210 
Catalyst 3d: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
6 254.0 6734.66 2362.89 106.1 31.3 
12 254.0 6056.31 2956.87 147.6 43.5 
18 254.0 6426.49 4178.60 196.6 58.0 
24 254.0 6750.96 4853.43 217.4 64.1 
30 254.0 6287.08 5133.21 246.9 72.8 
36 254.0 6644.98 5394.88 245.5 72.4 
42 254.0 7858.06 6203.65 238.7 70.4 
48 254.0 6605.05 5815.88 266.2 78.5 
54 254.0 6342.74 5657.64 269.7 79.6 
60 254.0 6043.27 5389.82 269.7 79.5 
 
 
 
 
 
Half-Life = 14 min
  211 
Catalyst 3d: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
3 254.0 6489.00 1653.27 77.0 22.7 
9 254.0 5305.57 3070.89 175.0 51.6 
18 254.0 6664.46 5076.20 230.3 67.9 
30 254.0 6245.48 4917.91 238.1 70.2 
45 254.0 6719.35 5513.31 248.1 73.2 
63 254.0 6735.43 5660.49 254.1 75.0 
84 254.0 7491.39 5979.50 241.3 71.2 
108 254.0 6943.75 5782.35 251.8 74.3 
135 254.0 7099.50 5840.60 248.7 73.4 
165 254.0 7991.96 6587.32 249.2 73.5 
 
 
 
 
Half-Life = 9 min 
Average Half-Life = 11 min
  212 
Catalyst 4d: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
60 254.0 6546.90 774.40 35.8 10.6 
120 254.0 7212.06 1150.39 48.2 14.2 
180 254.0 7857.01 1744.91 67.1 19.8 
240 254.0 7190.91 2047.66 86.1 25.4 
300 254.0 8232.91 2921.40 107.3 31.6 
360 254.0 7411.91 3252.86 132.7 39.1 
420 254.0 7772.49 3857.10 150.0 44.3 
480 254.0 7283.47 4225.35 175.4 51.7 
540 254.0 7539.71 4745.14 190.3 56.1 
600 254.0 7667.28 5138.08 202.6 59.8 
1440 254.0 6692.90 5291.19 239.0 70.5 
 
 
 
 
 
Half-Life = 12 min
  213 
Catalyst 4d: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.4 1.00 0.00 0.0 0.0 
30 254.4 7838.54 638.49 24.7 7.3 
60 254.4 7546.78 975.79 39.2 11.6 
90 254.4 7084.29 1143.68 48.9 14.4 
120 254.4 7580.74 1380.32 55.1 16.3 
180 254.4 7560.03 1557.28 62.4 18.4 
240 254.4 8045.52 2350.86 88.5 26.1 
300 254.4 7200.37 2371.19 99.7 29.4 
480 254.4 8617.36 4650.85 163.4 48.2 
1153 254.4 5196.10 4010.78 233.8 69.0 
1478 254.4 7756.88 6064.77 236.8 69.8 
 
 
 
 
Half-Life = 11 min 
Average Half-Life = 11 min
  214 
Catalyst 5d: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
60 254.0 6546.90 774.40 35.8 10.6 
120 254.0 7212.06 1150.39 48.2 14.2 
180 254.0 7857.01 1744.91 67.1 19.8 
240 254.0 7190.91 2047.66 86.1 25.4 
300 254.0 8232.91 2921.40 107.3 31.6 
360 254.0 7411.91 3252.86 132.7 39.1 
420 254.0 7772.49 3857.10 150.0 44.3 
480 254.0 7283.47 4225.35 175.4 51.7 
540 254.0 7539.71 4745.14 190.3 56.1 
600 254.0 7667.28 5138.08 202.6 59.8 
1440 254.0 6692.90 5291.19 239.0 70.5 
 
 
 
 
Half-Life = 503 min 
  215 
Catalyst 5d: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.4 1.00 0.00 0.0 0.0 
30 254.4 7838.54 638.49 24.7 7.3 
60 254.4 7546.78 975.79 39.2 11.6 
90 254.4 7084.29 1143.68 48.9 14.4 
120 254.4 7580.74 1380.32 55.1 16.3 
180 254.4 7560.03 1557.28 62.4 18.4 
240 254.4 8045.52 2350.86 88.5 26.1 
300 254.4 7200.37 2371.19 99.7 29.4 
480 254.4 8617.36 4650.85 163.4 48.2 
1153 254.4 5196.10 4010.78 233.8 69.0 
1478 254.4 7756.88 6064.77 236.8 69.8 
 
 
 
 
Half-Life = 588 min 
Average Half-Life = 546 min
  216 
Kinetic Analyzses of Catalysts in Series E 
Catalyst 1e: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
3 254.0 6882.99 828.49 36.4 10.7 
9 254.0 8570.29 2953.49 104.2 30.7 
18 254.0 5777.19 2847.38 149.0 44.0 
30 254.0 7714.14 4008.40 157.1 46.3 
45 254.0 6368.22 4712.73 223.8 66.0 
63 254.0 6953.42 5236.57 227.7 67.2 
84 254.0 7315.55 6023.74 249.0 73.4 
108 254.0 6751.74 5595.77 250.6 73.9 
135 254.0 6672.18 5583.20 253.0 74.6 
165 254.0 6291.08 5132.58 246.7 72.8 
 
 
 
 
Half-Life = 25 min
  217 
Catalyst 1e: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
3 254.0 7234.79 1084.52 45.3 13.4 
9 254.0 6823.99 3065.34 135.8 40.1 
18 254.0 6804.85 4217.07 187.4 55.3 
30 254.0 6794.97 5397.66 240.2 70.9 
45 254.0 7175.81 5900.93 248.6 73.3 
63 254.0 7830.53 6754.11 260.8 76.9 
84 254.0 7106.46 5837.28 248.4 73.3 
108 254.0 7390.44 6250.08 255.7 75.4 
135 254.0 7153.57 5922.00 250.3 73.8 
165 254.0 7339.00 6055.46 249.5 73.6 
 
 
 
 
Half-Life = 14 min 
Average Half-Life = 19 min
  218 
Catalyst 2e: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
3 254.0 6239.34 1004.37 48.7 14.4 
9 254.0 5956.21 1963.61 99.7 29.4 
18 254.0 6389.58 3242.29 153.4 45.3 
30 254.0 6714.18 4574.33 206.0 60.8 
45 254.0 6706.44 5554.85 250.4 73.9 
63 254.0 7280.79 6275.59 260.6 76.9 
84 254.0 6529.20 5428.99 251.4 74.2 
108 254.0 7678.27 6514.85 256.5 75.7 
135 254.0 7619.53 6361.20 252.4 74.5 
165 254.0 7499.82 6115.74 246.6 72.7 
 
 
 
 
 
Half-Life = 19 min
  219 
Catalyst 2e: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
3 254.0 7412.62 1650.78 67.3 19.9 
9 254.0 6779.88 2923.76 130.4 38.5 
18 254.0 7300.21 4759.80 197.1 58.2 
30 254.0 7593.24 5761.56 229.4 67.7 
45 254.0 7793.95 6227.00 241.6 71.3 
63 254.0 8408.63 6764.48 243.2 71.8 
84 254.0 8153.02 6578.51 244.0 72.0 
108 254.0 7526.92 6135.04 246.4 72.7 
135 254.0 7776.50 6397.54 248.7 73.4 
165 254.0 8493.77 6966.35 248.0 73.2 
 
 
 
 
Half-Life = 13 min 
Average Half-Life = 16 min
  220 
Catalyst 3e: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
3 254.0 6120.53 404.98 20.0 5.9 
9 254.0 6216.99 1002.48 48.8 14.4 
18 254.0 6722.38 1963.40 88.3 26.1 
30 254.0 6362.14 2626.00 124.8 36.8 
45 254.0 6585.24 3349.33 153.8 45.4 
63 254.0 6746.52 4015.37 180.0 53.1 
84 254.0 6693.50 4643.27 209.7 61.9 
108 254.0 6446.70 4914.72 230.5 68.0 
135 254.0 6889.46 5521.58 242.3 71.5 
165 254.0 7153.94 5798.73 245.1 72.3 
 
 
 
 
 
Half-Life = 52 min 
  221 
Catalyst 3e: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
3 254.0 6604.29 547.47 25.1 7.4 
9 254.0 6912.08 1403.08 61.4 18.1 
18 254.0 6703.31 2373.20 107.0 31.6 
30 254.0 7172.43 3515.76 148.2 43.7 
45 254.0 6816.97 4103.24 182.0 53.7 
63 254.0 6987.07 4896.22 211.9 62.5 
84 254.0 7132.50 5304.48 224.9 66.3 
108 254.0 7104.38 5790.27 246.4 72.7 
135 254.0 7345.73 5933.77 244.2 72.0 
165 254.0 8554.62 6688.04 236.4 69.7 
 
 
 
 
Half-Life = 38 min 
Average Half-Life = 45 min
  222 
Catalyst 4e: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
3 254.0 6034.20 1681.63 84.3 24.9 
9 254.0 5815.10 3265.33 169.8 50.1 
18 254.0 7693.56 5776.40 227.0 67.0 
30 254.0 7152.44 5979.27 252.8 74.6 
45 254.0 7464.03 6305.21 255.4 75.3 
63 254.0 6860.98 5798.58 255.5 75.4 
84 254.0 6520.74 5640.82 261.6 77.2 
108 254.0 6816.84 5923.90 262.8 77.5 
135 254.0 7308.24 6179.92 255.7 75.4 
165 254.0 6008.21 5063.76 254.8 75.2 
 
 
 
 
 
Half-Life = 9 min
  223 
Catalyst 4e: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
6 254.0 7408.90 3181.06 129.8 38.3 
12 254.0 6486.04 4100.11 191.1 56.4 
18 254.0 9219.50 6773.80 222.2 65.5 
24 254.0 6842.62 5428.10 239.9 70.8 
36 254.0 14846.30 13414.10 273.2 80.6 
42 254.0 6787.48 5690.50 253.5 74.8 
48 254.0 6829.84 5728.66 253.6 74.8 
54 254.0 6693.96 5558.16 251.1 74.1 
60 254.0 6649.07 5620.00 255.6 75.4 
 
 
 
 
 
Half-Life = 9 min 
Average Half-Life = 9 min
  224 
Catalyst 5e: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
60 254.0 7802.71 1114.30 43.2 12.7 
120 254.0 8225.37 1433.34 52.7 15.5 
180 254.0 6856.91 1591.42 70.2 20.7 
240 254.0 7626.93 2416.44 95.8 28.3 
300 254.0 8083.26 3058.24 114.4 33.7 
360 254.0 7515.24 3412.32 137.3 40.5 
420 254.0 4895.07 2307.47 142.5 42.0 
480 254.0 8446.94 4589.99 164.3 48.5 
1440 254.0 8084.39 6235.59 233.2 68.8 
 
 
 
 
 
 
Half-Life = 550 min
  225 
Catalyst 5e: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
60 254.0 5736.16 776.53 40.9 12.1 
120 254.0 2850.93 449.61 47.7 14.1 
180 254.0 4661.94 1013.96 65.8 19.4 
240 254.0 6389.07 1775.61 84.0 24.8 
300 254.0 9501.85 3374.84 107.4 31.7 
360 254.0 5738.45 2442.08 128.7 38.0 
420 254.0 5254.53 2615.95 150.5 44.4 
480 254.0 3907.70 2226.49 172.3 50.8 
540 254.0 5259.69 3173.95 182.5 53.8 
600 254.0 4111.57 2688.67 197.7 58.3 
1440 254.0 6744.83 5156.23 231.1 68.2 
 
 
 
 
Half-Life = 525 min 
Average Half-Life = 537 min
  226 
Kinetic Analyzses of Catalysts in Series F 
Catalyst 1f: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
2 254.0 6746.20 689.73 30.9 9.1 
6 254.0 6197.64 1415.62 69.1 20.4 
12 254.0 6219.61 2211.64 107.5 31.7 
20 254.0 6887.98 3290.58 144.4 42.6 
30 254.0 6410.00 3887.26 183.4 54.1 
42 254.0 6988.92 5046.74 218.3 64.4 
56 254.0 7510.71 6032.30 242.8 71.6 
72 254.0 7749.14 6671.50 260.3 76.8 
90 254.0 6479.14 5612.92 261.9 77.3 
110 254.0 7366.58 6070.10 249.1 73.5 
300 254.0 7157.27 6408.50 270.7 79.9 
 
 
 
Half-Life = 25 min
  227 
Catalyst 1f: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
2 254.0 5080.48 644.75 38.4 11.3 
6 254.0 5237.71 1632.97 94.3 27.8 
12 254.0 6424.64 3309.58 155.8 45.9 
20 254.0 6994.52 4578.36 197.9 58.4 
30 254.0 7068.22 5386.00 230.4 68.0 
42 254.0 6840.88 5606.84 247.8 73.1 
56 254.0 6560.04 5537.58 255.2 75.3 
72 254.0 6075.60 5238.96 260.7 76.9 
90 254.0 7615.96 6618.52 262.8 77.5 
110 254.0 6549.97 5671.33 261.8 77.2 
300 254.0 7417.62 6411.60 261.4 77.1 
 
 
 
 
 
Half-Life = 14 min 
Average Half-Life = 19 min 
  228 
Catalyst 2f: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
12 254.0 6324.66 1567.39 74.9 22.1 
24 254.0 5366.03 2291.07 129.1 38.1 
36 254.0 6418.06 3533.47 166.5 49.1 
48 254.0 6675.58 4220.13 191.1 56.4 
60 254.0 6671.54 4712.91 213.6 63.0 
120 254.0 7093.22 6534.59 278.5 82.2 
180 254.0 6775.49 6791.46 303.1 89.4 
240 254.0 6865.26 7235.56 318.7 94.0 
300 254.0 6482.36 6879.45 320.9 94.7 
360 254.0 7270.22 7736.72 321.8 94.9 
 
 
 
 
 
 
Half-Life = 39 min
  229 
Catalyst 2f: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
12 254.0 6927.88 1612.46 70.4 20.8 
24 254.0 7272.62 2798.99 116.4 34.3 
36 254.0 6758.99 3329.83 149.0 43.9 
48 254.0 6662.96 3724.54 169.0 49.9 
60 254.0 7018.41 4168.07 179.6 53.0 
120 254.0 7401.03 5717.94 233.6 68.9 
180 254.0 7034.90 6083.71 261.5 77.1 
240 254.0 6652.70 5988.91 272.2 80.3 
300 254.0 7370.92 6729.16 276.0 81.4 
360 254.0 7207.37 6541.66 274.4 81.0 
 
 
 
 
Half-Life = 49 min 
Average Half-Life = 44 min
  230 
Catalyst 3f: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
12 254.0 6696.54 1815.67 82.0 24.2 
24 254.0 5904.32 2640.73 135.2 39.9 
36 254.0 6676.11 3768.43 170.7 50.3 
48 254.0 6494.00 4199.48 195.5 57.7 
60 254.0 6996.87 4941.47 213.5 63.0 
120 254.0 6669.55 6049.20 274.2 80.9 
180 254.0 6278.46 6013.98 289.6 85.4 
240 254.0 6974.64 6792.46 294.5 86.9 
300 254.0 6438.08 6240.71 293.1 86.5 
360 254.0 7661.69 7422.68 292.9 86.4 
 
 
 
 
 
Half-Life = 36 min
  231 
Catalyst 3f: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
12 254.0 7204.22 2552.93 107.1 31.6 
24 254.0 5943.56 3083.08 156.8 46.3 
36 254.0 6007.45 3816.28 192.1 56.7 
48 254.0 6786.74 4810.62 214.3 63.2 
60 254.0 7396.10 5661.89 231.5 68.3 
120 254.0 6214.94 5820.62 283.2 83.5 
180 254.0 6575.49 6480.29 298.0 87.9 
240 254.0 6611.76 6435.94 294.3 86.8 
300 254.0 6406.46 6114.86 288.6 85.1 
360 254.0 6888.95 6344.32 278.5 82.1 
 
 
 
 
Half-Life = 29 min  
Average Half-Life = 32 min
  232 
Catalyst 4f: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
2 254.0 8302.52 505.63 18.4 5.4 
6 254.0 8506.73 1537.43 54.6 16.1 
12 254.0 7923.75 2583.53 98.6 29.1 
20 254.0 7614.71 3222.40 128.0 37.7 
30 254.0 8226.42 4489.79 165.0 48.7 
42 254.0 8094.67 5048.39 188.6 55.6 
56 254.0 8570.60 6196.11 218.6 64.5 
72 254.0 8062.57 6122.82 229.6 67.7 
90 254.0 8202.17 6581.54 242.6 71.6 
110 254.0 9014.30 7392.26 248.0 73.1 
450 254.0 8553.64 7156.44 253.0 74.6 
 
 
 
 
 
Half-Life = 31 min
  233 
Catalyst 4f: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
2 254.0 8189.52 514.56 19.0 5.6 
6 254.0 6596.58 1266.05 58.0 17.1 
12 254.0 6805.55 2231.29 99.1 29.2 
20 254.0 8318.14 3846.29 139.8 41.2 
30 254.0 6211.89 3626.47 176.5 52.1 
42 254.0 7508.75 4711.72 189.7 56.0 
56 254.0 6662.03 4899.97 222.4 65.6 
72 254.0 6309.02 4707.80 225.6 66.6 
90 254.0 6673.20 5217.23 236.4 69.7 
110 254.0 7273.48 5498.61 228.6 67.4 
450 254.0 6265.72 4932.82 238.0 70.2 
 
 
 
Half-Life = 28 min 
Average Half-Life = 30 min
  234 
Catalyst 5f: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
60 254.0 6608.52 893.80 40.9 12.1 
120 254.0 6852.95 1218.56 53.8 15.9 
180 254.0 7020.18 1806.02 77.8 22.9 
240 254.0 6545.57 2252.42 104.0 30.7 
300 254.0 6793.92 2850.32 126.9 37.4 
360 254.0 6628.84 3477.13 158.6 46.8 
1011 254.0 7481.96 6413.33 259.2 76.5 
1440 254.0 7024.42 6051.69 260.5 76.8 
 
 
 
 
 
 
 
Half-Life = 444 min
  235 
Catalyst 5f: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
60 254.0 6451.04 808.15 37.9 11.2 
120 254.0 6972.20 1199.07 52.0 15.3 
180 254.0 6673.80 1702.65 77.1 22.8 
240 254.0 7158.30 2469.27 104.3 30.8 
300 254.0 6765.32 2842.87 127.1 37.5 
360 254.0 6806.36 3370.52 149.7 44.2 
1011 254.0 7313.61 6734.09 278.4 82.1 
1440 254.0 6722.68 6236.44 280.5 82.7 
 
 
 
 
 
 
Half-Life = 439 min 
Average Half-Life = 442 min
  236 
Kinetic Analyzses of Catalysts in Series G 
Catalyst 1g: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
5 254.0 4785.40 0.00 0.0 0.0 
10 254.0 6481.61 0.00 0.0 0.0 
15 254.0 6278.11 0.00 0.0 0.0 
30 254.0 6196.21 0.00 0.0 0.0 
45 254.0 7055.98 29.33 1.3 0.4 
60 254.0 7036.21 43.22 1.9 0.5 
90 254.0 7040.81 70.43 3.0 0.9 
120 254.0 6788.59 99.73 4.4 1.3 
180 254.0 6166.88 155.59 7.6 2.3 
240 254.0 7618.04 281.53 11.2 3.3 
1407 254.0 3124.85 977.35 94.6 27.9 
1705 254.0 7065.51 2760.89 118.1 34.9 
2544 254.0 5809.74 3190.58 166.1 49.0 
3993 254.0 6635.87 4481.06 204.2 60.2 
5460 254.0 8019.76 5833.45 219.9 64.9 
 
 
 
Half-Life = 2894 min
  237 
Catalyst 1g: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
60 254.0 6226.14 44.30 2.2 0.6 
120 254.0 6555.16 96.03 4.4 1.3 
180 254.0 6917.37 158.11 6.9 2.0 
240 254.0 6946.54 225.34 9.8 2.9 
300 254.0 7093.78 286.27 12.2 3.6 
360 254.0 7195.26 351.78 14.8 4.4 
1224 254.0 6945.15 1515.48 66.0 19.5 
1620 254.0 7602.57 2194.78 87.3 25.7 
2640 254.0 6005.86 2518.23 126.8 37.4 
4026 254.0 7049.26 3888.84 166.8 49.2 
5673 254.0 7061.82 4263.06 182.5 53.8 
 
 
 
 
Half-Life = 4489 min 
Average Half-Life = 3692 min 
  238 
Catalyst 2g: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.4 1.00 0.00 0.0 0.0 
30 254.4 6787.93 609.88 27.2 8.0 
60 254.4 7257.10 1481.89 61.8 18.2 
120 254.4 7551.69 3204.37 128.5 37.9 
187 254.4 7887.53 4220.36 162.0 47.8 
240 254.4 7380.23 4514.83 185.3 54.6 
300 254.4 8035.92 5323.30 200.6 59.2 
360 254.4 8171.71 5955.57 220.7 65.1 
420 254.4 7824.91 5666.78 219.3 64.7 
1147 254.4 8168.60 7071.88 262.2 77.3 
1560 254.4 7224.20 6097.69 255.6 75.4 
 
 
 
 
 
Half-Life = 206 min 
  239 
Catalyst 2g: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.4 1.00 0.00 0.0 0.0 
30 254.4 7879.70 974.28 37.4 11.0 
60 254.4 7632.34 2021.67 80.2 23.7 
120 254.4 7338.45 3373.79 139.2 41.1 
187 254.4 7725.06 4531.65 177.6 52.4 
240 254.4 7509.69 4875.33 196.6 58.0 
300 254.4 7493.59 5189.88 209.7 61.9 
360 254.4 8120.01 5647.67 210.6 62.1 
420 254.4 7942.36 5629.66 214.7 63.3 
1147 254.4 8318.25 7305.35 266.0 78.5 
1560 254.4 7807.39 6619.81 256.8 75.7 
 
 
 
 
Half-Life = 185 min 
Average Half-Life = 196 min
  240 
Catalyst 3g: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.4 1.00 0.00 0.0 0.0 
5 254.4 7555.78 137.60 5.5 1.6 
15 254.4 7675.03 269.49 10.6 3.1 
30 254.4 7437.46 467.38 19.0 5.6 
60 254.4 8236.57 1348.06 49.6 14.6 
90 254.4 7395.39 2152.72 88.2 26.0 
120 254.4 7192.46 2890.21 121.7 35.9 
180 254.4 8134.50 4423.51 164.7 48.6 
240 254.4 7371.72 4797.26 197.1 58.1 
300 254.4 7601.25 5521.92 220.0 64.9 
360 254.4 8066.03 6149.84 230.9 68.1 
1145 254.4 7824.90 7006.29 271.2 80.0 
1560 254.4 7618.68 6837.57 271.8 80.2 
 
 
 
 
Half-Life = 195 min 
  241 
Catalyst 3g: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.4 1.00 0.00 0.0 0.0 
5 254.4 7015.07 161.58 7.0 2.1 
15 254.4 8256.07 306.73 11.3 3.3 
30 254.4 7499.40 535.31 21.6 6.4 
60 254.4 7462.14 1404.07 57.0 16.8 
90 254.4 7326.29 2214.59 91.5 27.0 
120 254.4 7777.68 3203.36 124.7 36.8 
180 254.4 8064.22 4403.38 165.4 48.8 
240 254.4 7774.00 4752.02 185.1 54.6 
300 254.4 7759.49 5227.26 204.0 60.2 
1145 254.4 8132.78 6851.19 255.1 75.3 
1560 254.4 7680.57 6628.07 261.3 77.1 
 
 
 
Half-Life = 204 min 
Average Half-Life = 200 min
  242 
Catalyst 4g: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
5 254.0 6852.17 110.72 4.9 1.4 
10 254.0 6817.03 158.95 7.0 2.1 
15 254.0 7699.92 215.54 8.5 2.5 
30 254.0 6630.67 281.05 12.8 3.8 
45 254.0 7347.50 441.68 18.2 5.4 
60 254.0 7795.26 662.70 25.7 7.6 
90 254.0 6685.08 986.00 44.6 13.2 
120 254.0 3378.30 604.63 54.1 16.0 
180 254.0 7588.50 2102.34 83.8 24.7 
240 254.0 7529.30 2813.65 113.0 33.3 
420 254.0 8020.55 3789.02 142.8 42.1 
1402 254.0 7165.58 4748.75 200.4 59.1 
1700 254.0 7360.62 4932.70 202.6 59.8 
2540 254.0 7336.59 5072.65 209.1 61.7 
3988 254.0 7775.68 5465.47 212.5 62.7 
5455 254.0 7686.08 5322.10 209.4 61.8 
 
 
Half-Life = 591 min
  243 
Catalyst 4g: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
60 254.0 6065.59 515.52 25.7 7.6 
120 254.0 6510.57 1245.10 57.8 17.1 
180 254.0 6607.95 1771.45 81.1 23.9 
240 254.0 6189.82 2115.38 103.3 30.5 
300 254.0 6698.55 2625.93 118.5 35.0 
360 254.0 7265.78 3099.91 129.0 38.1 
420 254.0 7283.71 3425.02 142.2 41.9 
595 254.0 8157.31 4603.36 170.6 50.3 
1224 254.0 7028.87 5247.63 225.7 66.6 
1620 254.0 7270.08 5561.25 231.3 68.2 
2640 254.0 5815.63 4528.96 235.5 69.5 
4026 254.0 6589.75 5139.52 235.8 69.6 
5673 254.0 7112.28 5681.54 241.5 71.2 
 
 
Half-Life = 558 min 
Average Half-Life = 575 min
  244 
Catalyst 5g: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
20 254.0 6704.03 24.82 1.1 0.3 
40 254.0 7061.44 29.39 1.3 0.4 
60 254.0 6941.09 29.71 1.3 0.4 
120 254.0 6517.55 37.89 1.8 0.5 
180 254.0 7593.26 58.47 2.3 0.7 
240 254.0 7134.07 73.46 3.1 0.9 
1397 254.0 7796.78 1482.19 57.5 17.0 
1695 254.0 7398.42 1949.06 79.7 23.5 
2535 254.0 7565.42 3368.12 134.6 39.7 
3983 254.0 7863.07 5236.10 201.3 59.4 
5450 254.0 7261.97 5102.63 212.5 62.7 
5982 254.0 6722.67 4899.27 220.4 65.0 
 
 
 
 
Half-Life = 3160 min
  245 
Catalyst 5g: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
20 254.0 6810.74 22.83 1.0 0.3 
40 254.0 7555.66 31.60 1.3 0.4 
60 254.0 7428.10 26.43 1.1 0.3 
120 254.0 6894.61 34.74 1.5 0.4 
180 254.0 7584.21 47.24 1.9 0.6 
240 254.0 6978.06 54.40 2.4 0.7 
420 254.0 7301.12 127.65 5.3 1.6 
1397 254.0 7504.53 1322.42 53.3 15.7 
1695 254.0 7643.58 1916.64 75.8 22.4 
2535 254.0 7144.83 3052.49 129.2 38.1 
3983 254.0 7119.85 4665.06 198.1 58.4 
5450 254.0 7699.37 5449.40 214.0 63.1 
5982 254.0 6928.39 5159.28 225.2 66.4 
 
 
Half-Life = 3273 min 
Average Half-Life = 3216 min
  246 
Kinetic Analyzses of Catalysts in Series H 
Catalyst 1h: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
1276 254.0 5044.18 1520.27 91.1 26.9 
2888 254.0 6706.97 3865.74 174.3 51.4 
3852 254.0 5659.38 3583.60 191.5 56.5 
4543 254.0 7840.04 5115.84 197.3 58.2 
5702 254.0 6757.42 4455.41 199.4 58.8 
 
 
 
 
 
 
 
 
Half-Life = 3021 min
  247 
Catalyst 1h: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
1276 254.0 5857.86 2095.20 108.1 31.9 
2888 254.0 6751.11 3896.04 174.5 51.5 
3852 254.0 7596.78 5098.87 202.9 59.9 
4543 254.0 7845.55 5377.01 207.2 61.1 
5702 254.0 7161.18 5379.07 227.1 67.0 
 
 
 
 
 
 
 
Half-Life = 2657 min 
Average Half-Life = 2839 min
  248 
Catalyst 2h: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
1276 254.0 6692.21 2912.20 131.6 38.8 
2888 254.0 6891.21 4552.77 199.8 58.9 
3852 254.0 6510.76 4440.45 206.2 60.8 
4543 254.0 6905.02 4875.40 213.5 63.0 
5702 254.0 6350.41 4321.55 205.8 60.7 
 
 
 
 
 
 
 
 
 
 
 
 
 
Half-Life = 1969 min
  249 
Catalyst 2h: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.4 1.00 0.00 0.0 0.0 
60 254.4 7952.52 47.53 1.8 0.5 
423 254.4 7724.03 510.09 20.0 5.9 
1102 254.4 7640.90 2267.59 89.9 26.5 
1468 254.4 7368.77 2733.70 112.3 33.1 
2550 254.4 7712.36 3827.83 150.3 44.3 
4042 254.4 9474.91 5588.37 178.6 52.7 
5620 254.4 7859.00 4951.41 190.8 56.3 
 
 
 
 
 
 
Half-Life = 3434 min 
Average Half-Life = 2702 min
  250 
Catalyst 3h: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
60 254.0 5737.46 26.01 1.4 0.4 
414 254.0 6992.29 711.57 30.8 9.1 
1187 254.0 6390.86 2281.63 107.9 32.1 
1649 254.0 7496.73 3125.42 126.1 37.5 
3188 254.0 5325.90 2687.77 152.6 45.4 
4516 254.0 7979.26 4269.13 161.8 48.1 
5912 254.0 7060.27 3903.97 167.2 49.7 
 
 
 
 
 
 
 
 
Half-Life = 5912 min
  251 
Catalyst 3h: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
60 254.0 6080.03 35.79 1.8 0.5 
414 254.0 6877.12 590.05 25.9 7.7 
1187 254.0 6898.09 2455.45 107.6 32.0 
1649 254.0 6284.74 2781.60 133.8 39.8 
3188 254.0 6769.44 3985.13 178.0 52.9 
4516 254.0 6445.00 4194.09 196.8 58.5 
5912 254.0 6846.86 4804.95 212.2 63.1 
 
 
 
 
 
 
Half-Life = 2691 min 
Average Half-Life = 4301
  252 
Catalyst 4h: Run 1 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.0 1.00 0.00 0.0 0.0 
60 254.0 6670.25 59.28 2.7 0.8 
414 254.0 7258.66 790.51 32.9 9.7 
1187 254.0 7639.41 2535.21 100.3 29.6 
1649 254.0 6456.36 2853.02 133.6 39.4 
3188 254.0 7128.59 4175.76 177.1 52.2 
4516 254.0 6641.67 4380.18 199.4 58.8 
5912 254.0 6893.22 4624.21 202.8 59.8 
 
 
 
 
 
 
 
Half-Life = 2823 min
  253 
Catalyst 4h: Run 2 
Time (min) Standard (μmol) Standard Area Product Area Product (μmol) % Product 
0 254.4 1.00 0.00 0.0 0.0 
60 254.4 7350.67 32.88 1.4 0.4 
423 254.4 7464.41 725.62 29.4 8.7 
1102 254.4 7208.55 2300.29 96.6 28.5 
1468 254.4 7326.11 2862.31 118.3 34.9 
2550 254.4 7321.29 3977.12 164.5 48.5 
4042 254.4 9678.18 6186.04 193.6 57.1 
5620 254.4 7968.50 5485.01 208.5 61.5 
 
 
 
 
 
 
Half-Life = 2803 min 
Average Half-Life = 2813 min
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Tabular Summary of Kinetics Data 
C
a
ta
ly
st
 
R
u
n
 #
 
Exponential Fit 
Equation 
y0 A1 t1   R
2
 
Half-
Life, t1/2 
(min.) 
mean half 
life, t1/2 
(min.) 
Std. Dev. 
Half Life, 
t1/2 (min.) 
% Std. 
Dev./Mean 
2a 1 See Logistic Fit Table 363 
351 15.9 4.5 
2a 2 y = A1*exp(-x/t1) + y0 75.24479 -79.422 296.747   0.9862 340 
5a 1 y = A1*exp(-x/t1) + y0 71.18727 -74.391 272.916   0.9920 343 
310 46.6 15.0 
5a 2 y = A1*exp(-x/t1) + y0 83.14673 -85.271 292.987   0.9964 277 
1b 1 y = A1*exp(-x/t1) + y0 88.03818 -94.221 22.814   0.9711 21 
21 0.2 0.9 
1b 2 y = A1*exp(-x/t1) + y0 82.6915 -87.724 21.243   0.9868 21 
2b 1 y = A1*exp(-x/t1) + y0 79.59908 -86.498 230.774   0.9748 247 
246 2.5 1.0 
2b 2 y = A1*exp(-x/t1) + y0 75.8665 -79.473 217.282   0.9808 244 
4b 1 y = A1*exp(-x/t1) + y0 76.50725 -79.456 24.419   0.9835 27 
29 2.4 8.5 
4b 2 y = A1*exp(-x/t1) + y0 75.42997 -77.794 27.032   0.9850 30 
5b 1 y = A1*exp(-x/t1) + y0 79.5476 -83.213 300.471   0.9911 311 
312 1.2 0.4 
5b 2 y = A1*exp(-x/t1) + y0 74.4181 -78.133 268.977   0.9910 313 
1c 1 y = A1*exp(-x/t1) + y0 80.07375 -80.413 126.654   0.9968 125 
87 53.3 61.4 
1c 2 y = A1*exp(-x/t1) + y0 78.68537 -80.469 47.630   0.9838 49 
2c 1 y = A1*exp(-x/t1) + y0 71.04348 -67.956 16.652   0.9823 20 
19 1.0 5.5 
2c 2 y = A1*exp(-x/t1) + y0 72.02988 -69.997 15.622   0.9921 18 
3c 1 y = A1*exp(-x/t1) + y0 77.25537 -78.110 10.146   0.9928 11 
9 1.8 18.7 
3c 2 y = A1*exp(-x/t1) + y0 78.46948 -78.940 8.026   0.9967 8 
4c 1 y = A1*exp(-x/t1) + y0 75.31615 -72.481 849.155   0.9954 893 
851 59.4 7.0 
4c 2 y = A1*exp(-x/t1) + y0 70.65912 -67.409 684.260   0.9958 809 
5c 1 y = A1*exp(-x/t1) + y0 64.56136 -67.939 358.377   0.9685 552 
594 59.2 10.0 
5c 2 y = A1*exp(-x/t1) + y0 64.49535 -62.989 432.714   0.9697 636 
1d 1 y = A1*exp(-x/t1) + y0 59.83595 -60.380 83.405   0.9984 151 
126 35.9 28.5 
1d 2 y = A1*exp(-x/t1) + y0 61.87681 -62.416 60.653   0.9991 101 
2d 1 y = A1*exp(-x/t1) + y0 79.38606 -75.780 12.491   0.9898 12 
15 5.0 32.7 
2d 2 y = A1*exp(-x/t1) + y0 69.29378 -65.166 15.559   0.9903 19 
3d 1 y = A1*exp(-x/t1) + y0 79.71041 -78.566 14.264   0.9882 14 
11 3.7 33.1 
3d 2 y = A1*exp(-x/t1) + y0 73.33839 -73.891 7.475   0.9971 9 
4d 1 y = A1*exp(-x/t1) + y0 78.9461 -77.168 11.855   0.9910 12 
11 0.5 4.2 
4d 2 y = A1*exp(-x/t1) + y0 72.45223 -72.272 9.375   0.9968 11 
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Tabular Summary of Kinetics Data, cont. 
5d 1 y = A1*exp(-x/t1) + y0 77.29513 -79.438 471.051   0.9728 503 
546 59.9 11.0 
5d 2 y = A1*exp(-x/t1) + y0 77.74945 -75.886 584.374   0.9872 588 
1e 1 y = A1*exp(-x/t1) + y0 73.75451 -71.259 23.046   0.9792 25 
19 8.3 42.5 
1e 2 y = A1*exp(-x/t1) + y0 74.9476 -76.094 12.218   0.9949 14 
2e 1 y = A1*exp(-x/t1) + y0 75.72533 -75.076 18.011   0.9910 19 
16 4.3 26.8 
2e 2 y = A1*exp(-x/t1) + y0 72.67163 -71.591 11.436   0.9980 13 
3e 1 y = A1*exp(-x/t1) + y0 74.91512 -73.589 47.771   0.9977 52 
45 10.0 22.3 
3e 2 y = A1*exp(-x/t1) + y0 72.46091 -71.959 32.328   0.9973 38 
4e 1 y = A1*exp(-x/t1) + y0 76.05616 -75.432 8.261   0.9985 9 
9 0.4 4.4 
4e 2 y = A1*exp(-x/t1) + y0 76.13371 -76.067 8.752   0.9908 9 
5e 1 y = A1*exp(-x/t1) + y0 72.77079 -72.061 477.722   0.9892 550 
537 18.2 3.4 
5e 2 y = A1*exp(-x/t1) + y0 74.53471 -76.004 463.980   0.9703 525 
1f 1 y = A1*exp(-x/t1) + y0 78.59378 -76.584 24.942   0.9944 25 
19 7.3 37.3 
1f 2 y = A1*exp(-x/t1) + y0 77.05268 -76.456 13.775   0.9996 14 
2f 1 y = A1*exp(-x/t1) + y0 93.94348 -91.725 52.764   0.9967 39 
44 6.8 15.7 
2f 2 y = A1*exp(-x/t1) + y0 80.08334 -77.153 51.499   0.9914 49 
3f 1 y = A1*exp(-x/t1) + y0 86.42536 -84.627 43.064   0.9974 36 
32 5.4 16.6 
3f 2 y = A1*exp(-x/t1) + y0 85.20084 -82.584 33.633   0.9899 29 
4f 1 y = A1*exp(-x/t1) + y0 74.21342 -73.046 28.311   0.9977 31 
30 2.0 6.8 
4f 2 y = A1*exp(-x/t1) + y0 69.60957 -69.438 22.448   0.9970 28 
5f 1 y = A1*exp(-x/t1) + y0 83.76239 -84.362 484.874   0.9887 444 
442 3.3 0.7 
5f 2 y = A1*exp(-x/t1) + y0 93.37255 -94.144 566.935   0.9909 439 
1g 1 y = A1*exp(-x/t1) + y0 76.72075 -78.489 2686.133   0.9958 2894 
3692 1127.5 30.5 
1g 2 y = A1*exp(-x/t1) + y0 66.53598 -68.090 3171.727   0.9966 4489 
2g 1 y = A1*exp(-x/t1) + y0 75.84258 -77.126 188.816   0.9949 206 
196 14.9 7.6 
2g 2 y = A1*exp(-x/t1) + y0 74.77431 -74.129 169.135   0.9861 185 
3g 1 y = A1*exp(-x/t1) + y0 81.07378 -84.168 195.772   0.9936 195 
200 6.3 3.1 
3g 2 y = A1*exp(-x/t1) + y0 76.47531 -78.528 187.572   0.9950 204 
4g 1 y = A1*exp(-x/t1) + y0 61.39411 -61.994 349.177   0.9972 591 
575 23.4 4.1 
4g 2 y = A1*exp(-x/t1) + y0 70.21176 -70.161 448.721   0.9985 558 
1h 1 y = A1*exp(-x/t1) + y0 65.01268 -65.835 2043.954   0.9873 3021 
2839 257.7 9.1 
1h 2 y = A1*exp(-x/t1) + y0 71.82203 -71.654 2234.771   0.9980 2657 
2h 1 y = A1*exp(-x/t1) + y0 63.67911 -63.950 1276.679   0.9935 1969 
2702 1036.1 38.4 
2h 2 y = A1*exp(-x/t1) + y0 59.73834 -61.725 1859.697   0.9890 3434 
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Tabular Summary of Kinetics Data, cont. 
3h 1 y = A1*exp(-x/t1) + y0 49.91274 -51.812 1228.678   0.9897 5912 
4301 2277.6 53.0 
3h 2 y = A1*exp(-x/t1) + y0 64.83985 -66.724 1790.079   0.9919 2691 
4h 1 y = A1*exp(-x/t1) + y0 62.97648 -64.395 1761.994   0.9962 2823 
2813 13.9 0.5 
4h 2 y = A1*exp(-x/t1) + y0 65.23792 -66.919 1894.262   0.9957 2803 
                        
C
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n
 #
 
Logistic Fit Equation A1 A2 x0 p R2 
Half-
Life, t1/2 
(min.) 
Mean 
Half-
Life, t1/2 
(min.) 
Std. Dev. 
Half Life, t1/2 
(min.) 
% Std. 
Dev./Mean 
1a 1 
y = A2 + (A1-
A2)/(1+(x/x0)^p) 
0.3875 71.5254 16.131 3.7217 0.9968 20 
21 1.6 7.5 
1a 2 
y = A2 + (A1-
A2)/(1+(x/x0)^p) 
0.2735 76.7689 18.787 3.4760 0.9966 22 
2a 1 
y = A2 + (A1-
A2)/(1+(x/x0)^p) 
1.1706 76.6484 273.939 2.1601 0.9992 363 
351 15.9 4.5 
2a 2 See Exponential Fit 340 
3a 1 
y = A2 + (A1-
A2)/(1+(x/x0)^p) 
0.3986 88.1119 74.526 2.0139 0.9981 85 
82 4.8 5.9 
3a 2 
y = A2 + (A1-
A2)/(1+(x/x0)^p) 
1.3015 84.9240 66.122 1.9978 0.9982 78 
4a 1 
y = A2 + (A1-
A2)/(1+(x/x0)^p) 
1.2301 91.6541 40.594 1.8218 0.9967 44 
44 0.3 0.7 
4a 2 
y = A2 + (A1-
A2)/(1+(x/x0)^p) 
1.4027 85.6183 37.465 1.9753 0.9955 44 
3b 1 
y = A2 + (A1-
A2)/(1+(x/x0)^p) 
0.3867 76.6582 81.822 2.4361 0.9938 106 
95 14.3 15.0 
3b 2 
y = A2 + (A1-
A2)/(1+(x/x0)^p) 
0.5777 80.0775 71.717 2.8616 0.9941 85 
5g 1 
y = A2 + (A1-
A2)/(1+(x/x0)^p) 
0.4305 70.0148 2226.744 2.5905 0.9988 3160 
3216 79.5 2.5 
5g 2 
y = A2 + (A1-
A2)/(1+(x/x0)^p) 
0.3700 72.7524 2388.631 2.4770 0.9991 3273 
  257 
5.2.3. Variable Stirring Speed Kinetics 
 
 A 2 mL scintillation vial was fitted with a Teflon lined rubber septum and tert-butyl 2-
(diphenylmethyleneamino)acetate (100 mg, 0.34 mmol), and catalyst 2e (4.5 mg, 8.48 μmol, 
0.025 equiv) were added.  The liquid reagents, benzyl bromide (800 μL, 0.51 M in toluene, 1.2 
equiv), internal standard (790 μL, 0.32 M in tolune, 0.75 equiv), and toluene (410 μL) were 
added via syringe.  Then, a 1.5 cm egg-shaped magnetic stir bar was placed in the vial and the 
contents were briefly agitated in an ultrasonic bath (10-20 s). Reaction vials were then 
transferred to a cold room maintained at 2-4 oC and were allowed to equilibrate for at least 1 h.  
 The stirring was conducted with the aid of an adjustable electric motor, which had been 
calibrated for 500, 1000, 1500, 2000, and 2300 rpm. Lastly, 50% aq. (w/w) KOH solution (670 
μL, 11.9 mmol, 17.8 M, 35.0 equiv) was added to the rapidly stirred organic phase.  Aliquots 
were taken at the indicated times and analyzed as follows.  
 The internal standard employed in these reactions was 1,1-diphenyl-1-heptene. 
  258 
500 rpm, run #1: 
Time 
(min) 
Standard 
(μmol) 
Standard 
Area 
Product 
Area 
Product 
(μmol) 
% 
Product 
0 254.4 1.00 0.00 0.0 0.0 
2 254.4 6437.92 132.45 6.2 1.8 
4 254.4 6637.03 281.99 12.9 3.8 
6 254.4 7181.21 433.58 18.3 5.4 
8 254.4 7047.37 587.57 25.2 7.4 
10 254.4 7057.40 758.58 32.6 9.6 
20 254.4 7078.95 1597.66 68.3 20.2 
30 254.4 6943.09 1967.14 85.8 25.3 
45 254.4 7163.60 2650.90 112.1 33.1 
60 254.4 7258.78 3303.17 137.8 40.7 
120 254.4 7982.79 4586.44 174.0 51.3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Half Life = 106.8 min 
  259 
500 rpm, run #2: 
Time 
(min) 
Standard 
(μmol) 
Standard 
Area 
Product 
Area 
Product 
(μmol) 
% 
Product 
0 254.4 1.00 0.00 0.0 0.0 
2 254.4 7631.87 115.88 4.6 1.4 
4 254.4 7120.02 248.01 10.5 3.1 
6 254.4 7015.93 375.41 16.2 4.8 
8 254.4 8023.84 555.25 21.0 6.2 
10 254.4 6709.50 615.91 27.8 8.2 
20 254.4 7292.47 1727.03 71.7 21.2 
30 254.4 7631.40 2453.57 97.4 28.7 
45 254.4 7739.22 3125.34 122.3 36.1 
60 254.4 7620.41 3433.52 136.4 40.3 
120 254.4 7005.24 3274.78 141.6 41.8 
 
 
 
 
 
 
 
 
 
 
 
Half-Life = N/A 
Mean Half-Life = 106.8 min 
Std. Dev. Half-Life = N/A 
  260 
1000 rpm, run #1: 
Time 
(min) 
Standard 
(μmol) 
Standard 
Area 
Product 
Area 
Product 
(μmol) 
% 
Product 
0 254.4 1.00 0.00 0.0 0.0 
2 254.4 6907.60 666.70 29.2 8.6 
4 254.4 7569.94 969.85 38.8 11.4 
6 254.4 7271.96 1284.57 53.5 15.8 
8 254.4 7109.72 1969.87 83.9 24.8 
10 254.4 6975.17 2564.42 111.3 32.8 
20 254.4 7507.12 4052.65 163.5 48.2 
30 254.4 7625.62 5216.00 207.1 61.1 
60 254.4 7040.61 5230.99 225.0 66.4 
90 254.4 7544.90 5847.38 234.7 69.2 
120 254.4 7749.85 6435.76 251.5 74.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
Half-Life = 21.4 min 
  261 
1000 rpm, run #2: 
Time 
(min) 
Standard 
(μmol) 
Standard 
Area 
Product 
Area 
Product 
(μmol) 
% 
Product 
0 254.4 1.00 0.00 0.0 0.0 
2 254.4 7742.97 635.95 24.9 7.3 
4 254.4 7798.82 1196.63 46.5 13.7 
6 254.4 8498.09 1876.61 66.9 19.7 
8 254.4 7154.80 1967.00 83.3 24.6 
10 254.4 7919.97 2668.84 102.0 30.1 
20 254.4 8827.49 4574.43 156.9 46.3 
30 254.4 7102.79 4089.52 174.4 51.4 
60 254.4 8225.70 5931.56 218.4 64.4 
90 254.4 7150.95 6123.30 259.3 76.5 
120 254.4 8223.83 7148.37 263.2 77.7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Half-Life = 25.0 min 
  262 
1000 rpm, run #3: 
Time 
(min) 
Standard 
(μmol) 
Standard 
Area 
Product 
Area 
Product 
(μmol) 
% 
Product 
0 253.0 1.00 0.00 0.0 0.0 
2 253.0 7406.06 317.85 12.9 3.8 
4 253.0 7134.87 808.99 34.1 10.1 
6 253.0 7720.24 1284.24 50.1 14.8 
8 253.0 7612.40 1655.88 65.5 19.3 
10 253.0 7429.29 1966.75 79.7 23.5 
20 253.0 7685.22 3678.26 144.1 42.5 
30 253.0 7854.41 4155.35 159.3 47.0 
60 253.0 7835.35 4663.45 179.3 52.9 
90 253.0 7600.92 5056.73 200.4 59.1 
120 253.0 6996.34 5046.64 217.2 64.1 
 
 
 
 
 
 
 
 
 
 
 
 
Half-Life = 34.0 min 
Mean Half-Life = 26.8 min 
Std. Dev. Half-Life = 6.5 min 
  263 
1500 rpm, run #1: 
Time 
(min) 
Standard 
(μmol) 
Standard 
Area 
Product 
Area 
Product 
(μmol) 
% 
Product 
0 254.4 1.00 0.00 0.0 0.0 
1 254.4 8377.79 483.31 17.5 5.2 
2 254.4 7465.36 892.07 36.2 10.7 
4 254.4 8402.12 1942.10 70.0 20.6 
6 254.4 8015.91 2563.79 96.9 28.6 
10 254.4 8232.21 3887.93 143.0 42.2 
20 254.4 7482.32 5155.25 208.7 61.5 
30 254.4 7483.57 5752.44 232.8 68.7 
60 254.4 8196.79 7093.93 262.1 77.3 
90 254.4 7735.65 6733.55 263.6 77.8 
120 254.4 7617.29 6565.23 261.0 77.0 
 
 
 
 
 
 
 
 
 
 
 
 
Half-Life = 13.4 min 
  264 
1500 rpm, run #2: 
Time 
(min) 
Standard 
(μmol) 
Standard 
Area 
Product 
Area 
Product 
(μmol) 
% 
Product 
0 253.0 1.00 0.00 0.0 0.0 
1 253.0 7286.60 326.66 13.5 4.0 
2 253.0 7145.05 740.24 31.2 9.2 
4 253.0 7855.38 1663.44 63.8 18.8 
6 253.0 7608.65 2315.22 91.6 27.0 
10 253.0 7688.90 3650.55 143.0 42.2 
20 253.0 7114.52 4766.10 201.8 59.5 
30 253.0 7877.26 5626.12 215.1 63.5 
60 253.0 8438.24 6217.95 221.9 65.5 
90 253.0 7514.21 5876.77 235.5 69.5 
120 253.0 8105.07 6396.96 237.7 70.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
Half-Life = 14.3 min 
  265 
1500 rpm, run #3: 
Time 
(min) 
Standard 
(μmol) 
Standard 
Area 
Product 
Area 
Product 
(μmol) 
% 
Product 
0 253.0 1.00 0.00 0.0 0.0 
1 253.0 7446.05 263.12 10.6 3.1 
2 253.0 7699.97 765.31 29.9 8.8 
4 253.0 7544.21 1860.18 74.3 21.9 
6 253.0 7780.83 2657.92 102.9 30.3 
10 253.0 7364.03 3856.57 157.7 46.5 
20 253.0 7656.47 5103.86 200.8 59.2 
30 253.0 7959.16 5425.05 205.3 60.6 
60 253.0 7714.38 5716.63 223.2 65.8 
90 253.0 7695.83 5613.79 219.7 64.8 
120 253.0 7360.48 6018.39 246.3 72.6 
 
 
 
 
 
 
 
 
 
 
 
Half-Life = 13.0 min 
Mean Half-Life = 13.6 min 
Std. Dev. Half-Life = 0.7 min 
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2000 rpm, run #1: 
Time 
(min) 
Standard 
(umol) 
Standard 
Area 
Product 
Area 
Product 
(umol) 
% 
Product 
0 254.4 1.00 0.00 0.0 0.0 
2 254.4 5653.04 1134.85 60.8 17.9 
5 254.4 7351.38 3232.63 133.2 39.3 
10 254.4 6749.59 4171.90 187.2 55.2 
15 254.4 7169.98 4982.19 210.4 62.1 
20 254.4 6653.72 4997.43 227.5 67.1 
30 254.4 7133.76 5366.90 227.8 67.2 
40 254.4 8019.39 6269.67 236.8 69.8 
50 254.4 6773.78 5336.10 238.6 70.4 
60 254.4 7433.37 5996.49 244.3 72.1 
90 254.4 7119.14 5754.32 244.8 72.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
Half-Life = 8.1 min 
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2000 rpm, run #2: 
Time 
(min) 
Standard 
(umol) 
Standard 
Area 
Product 
Area 
Product 
(umol) 
% 
Product 
0 254.4 1.00 0.00 0.0 0.0 
2 254.4 6972.05 1263.41 54.9 16.2 
5 254.4 8026.83 3445.32 130.0 38.3 
10 254.4 7548.45 4507.19 180.8 53.3 
15 254.4 7328.14 4933.91 203.9 60.1 
20 254.4 7583.32 5659.04 226.0 66.7 
30 254.4 7173.76 5472.64 231.0 68.1 
40 254.4 7765.54 6102.93 238.0 70.2 
50 254.4 7295.28 5803.40 240.9 71.1 
60 254.4 7464.10 5882.34 238.7 70.4 
90 254.4 7117.35 5730.68 243.8 71.9 
 
 
 
 
 
 
 
 
 
 
 
 
 
Half-Life = 8.7 min 
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2000 rpm, run #3: 
Time 
(min) 
Standard 
(μmol) 
Standard 
Area 
Product 
Area 
Product 
(μmol) 
% 
Product 
0 253.0 1.00 0.00 0.0 0.0 
1 253.0 8359.90 342.30 12.3 3.6 
2 253.0 7725.21 992.16 38.7 11.4 
3 253.0 7871.34 1843.81 70.5 20.8 
5 253.0 7393.20 2735.44 111.4 32.9 
7 253.0 8030.21 3581.43 134.3 39.6 
10 253.0 7451.54 3717.45 150.2 44.3 
20 253.0 8663.43 4770.92 165.9 48.9 
30 253.0 8727.97 5143.40 177.5 52.4 
60 253.0 7918.46 5055.23 192.3 56.7 
90 253.0 8354.42 5974.50 215.4 63.5 
 
 
 
 
 
 
 
 
 
 
 
Half-Life = 13.7 min 
Mean Half-Life = 10.1 min 
Std. Dev. Half-Life = 3.1 min 
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2300 rpm, run #1: 
Time 
(min) 
Standard 
(μmol) 
Standard 
Area 
Product 
Area 
Product 
(μmol) 
% 
Product 
0 254.4 1.00 0.00 0.0 0.0 
1 254.4 7123.56 691.73 29.4 8.7 
2 254.4 7518.77 1671.71 67.3 19.9 
4 254.4 7708.58 3240.43 127.3 37.6 
6 254.4 7249.74 3911.00 163.4 48.2 
10 254.4 7621.18 4585.20 182.2 53.7 
15 254.4 7236.83 4712.44 197.2 58.2 
20 254.4 7652.51 5565.63 220.3 65.0 
30 254.4 8012.57 5100.21 192.8 56.9 
40 254.4 7004.13 5104.24 220.7 65.1 
60 254.4 7242.69 4969.38 207.8 61.3 
 
 
 
 
 
 
 
 
 
 
 
 
 
Half-Life = 7.4 min 
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2300 rpm, run #2: 
Time 
(min) 
Standard 
(μmol) 
Standard 
Area 
Product 
Area 
Product 
(μmol) 
% 
Product 
0 254.4 1.00 0.00 0.0 0.0 
1 254.4 7443.34 701.80 28.6 8.4 
2 254.4 7405.37 1322.74 54.1 16.0 
3 254.4 7318.67 1891.89 78.3 23.1 
4 254.4 7543.53 2976.50 119.5 35.2 
5 254.4 7593.28 3091.76 123.3 36.4 
10 254.4 7811.98 5341.21 207.1 61.1 
20 254.4 7430.44 4758.20 193.9 57.2 
30 254.4 7198.15 5663.44 238.3 70.3 
40 254.4 6969.31 5006.45 217.5 64.2 
60 254.4 7267.40 5196.27 216.5 63.9 
 
 
 
 
 
 
 
 
 
 
 
 
 
Half-Life = 8.1 min 
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2300 rpm, run #3: 
Time 
(min) 
Standard 
(μmol) 
Standard 
Area 
Product 
Area 
Product 
(μmol) 
% 
Product 
0 253.0 1.00 0.00 0.0 0.0 
1 253.0 8272.83 385.47 14.0 4.1 
2 253.0 8024.14 1128.75 42.4 12.5 
3 253.0 8157.81 1896.86 70.0 20.7 
5 253.0 7896.12 2925.50 111.6 32.9 
7 253.0 8263.07 3861.98 140.8 41.5 
10 253.0 7400.10 4131.48 168.1 49.6 
20 253.0 7708.77 5651.04 220.8 65.1 
30 253.0 7564.32 5843.62 232.7 68.6 
45 253.0 7984.10 6480.25 244.4 72.1 
60 253.0 7823.20 6333.40 243.8 71.9 
 
 
 
 
 
 
 
 
 
 
 
Half-Life = 10 min 
Mean Half-Life = 8.5 min 
Std. Dev. Half-Life = 1.4 min 
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Variable Stirring Speed Tabular Summary 
Catalyst 
Run 
# 
Stirring 
Speed 
Origin Fit Parameters 
Half-Life, 
t1/2 (min) 
Mean 
Half-Life, 
t1/2 (min) 
Std. Dev. 
Half-Life, 
t1/2 (min) 
Equation y0 A1 t1 R
2
 
2e 1 500 y = A1*exp(-x/t1) + y0 56.16555 -56.81888 48.0843 0.99791 106.8 
106.8 N/A 
2e 2 500 y = A1*exp(-x/t1) + y0 44.55275 -47.40353 29.0067 0.98412 N/A 
2e 1 1000 y = A1*exp(-x/t1) + y0 71.52223 -72.78669 17.56488 0.99002 21.4 
26.8 6.5 2e 2 1000 y = A1*exp(-x/t1) + y0 75.83132 -73.44886 23.95971 0.98778 25.0 
2e 3 1000 y = A1*exp(-x/t1) + y0 60.28612 -61.5503 19.02381 0.98677 34.0 
2e 1 1500 y = A1*exp(-x/t1) + y0 77.42871 -77.7437 12.83687 0.9996 13.4 
13.6 0.7 2e 2 1500 y = A1*exp(-x/t1) + y0 68.65205 -70.49529 10.78205 0.99601 14.3 
2e 3 1500 y = A1*exp(-x/t1) + y0 67.04909 -69.51563 9.24747 0.98761 13.0 
2e 1 2000 y = A1*exp(-x/t1) + y0 70.42926 -70.34747 6.53685 0.99648 8.1 
10.1 3.1 2e 2 2000 y = A1*exp(-x/t1) + y0 70.47614 -70.49338 7.02423 0.99672 8.7 
2e 3 2000 y = A1*exp(-x/t1) + y0 56.59145 -58.85067 6.23538 0.96857 13.7 
2e 1 2300 y = A1*exp(-x/t1) + y0 61.84822 -63.83922 4.36509 0.98288 7.4 
8.5 1.4 2e 2 2300 y = A1*exp(-x/t1) + y0 65.34476 -67.79178 5.4631 0.971 8.1 
2e 3 2300 y = A1*exp(-x/t1) + y0 71.67264 -73.80543 8.14754 0.99729 10.0 
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5.3 Chapter 3 
5.3.1. Substrate Synthesis 
Preparation of benzeneacetonitrile, α-(2-propen-1-yloxy)- (12)200 
 
 To a 5.0 mL round-bottom flask fitted with an argon inlet and magnetic stir-bar, was 
added ferric (III) chloride (43 mg, 246 μmol, 0.054 equiv.), benzaldehyde (0.50 mL, 4.92 mmol), 
and then trimethylsilyl allyl ether (2.1 mL, 11.8 mmol, 2.4 equiv.). The reaction mixture was 
then cooled to 0 °C on an ice-bath for 2 h. Trimethylsilyl cyanide (0.98 mL, 7.38 mmol, 1.5 
equiv.) was then added dropwise via syringe under argon.  After addition was complete, the 
reaction mixture was allowed to warm to room temperature over 1 h. 
 The reaction mixture was then diluted with CHCl3 (10 mL) and then poured into a 50 mL 
separatory funnel containing a 50 mM solution of KH2PO4 pH 7 buffer (10 mL).  Phases were 
separated and the aqueous phase was extracted with additional CHCl3 (3 x 10 mL).  The organic 
phases were combined and washed with more pH 7 buffer (10 mL), followed by brine (10 mL). 
The organic phase was dried over Na2SO4 and the solvent was removed on a rotary evaporator.  
The oily residue was then further dried on high-vacuum (<1 mm Hg) overnight. No additional 
purification was found to be necessary. 
 
Data for 12: 
 1H-NMR: (500 MHz, CDCl3)  
7.53-7.47 (m, 2H), 7.47-7.39 (m, 3H), 6.00-5.88 (dddd, J = 17.2, 10.4, 6.4, 5.4 
Hz, 1H), 5.45-5.37 (dd, J = 17.2, 1.5 Hz, 1H), 5.36-5.30 (d, J = 10.4 Hz, 1H), 
5.30 (s, 1H), 4.34-4.27 (dd, J = 12.3, 5.4 Hz, 1H), 4.21-4.13 (dd, J = 12.3, 6.5 Hz, 
2H) 
 13C-NMR: (126 MHz, CDCl3) 
133.44, 132.47, 129.79, 129.02, 127.32, 119.58, 117.22, 70.68, 69.54 
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Preparation of benzeneacetonitrile, α-((E)-2-buten-1-yloxy)- (13) 
 
 To a 5.0 mL one-piece, round-bottom flask/condenser, fitted with an argon inlet, was 
added alpha-tosyl-phenylacetonitrile (1.000 g, 3.13 mmol) followed by (E)-2-buten-4-ol (1.32 
mL, 15.7 mmol, 5 equiv.).  The reaction mixture was heated to 80 °C on an oil bath and heated 
overnight. 
 The reaction mixture was diluted with EtOAc (10 mL) and poured into a 60 mL 
separatory funnel containing a 50 mM KH2HO4 pH 7 buffer (10 mL). The phases were separated 
and the organic phase was dried over Na2SO4.  The solvent was then removed on a rotatory 
evaporator to afford a dark brown oil. 
 This oil was purified by silica gel flash chromatography ( 2, 
10% MTBE /hexane) to afford 123 mg (21%) of 13 as a clear, yellow oil. 
 
Data for 13: 
 1H-NMR: (500 MHz, CDCl3) 
7.52-7.46 (dd, J = 7.4, 2.0 Hz, 2H), 7.46-7.39 (dd, J = 4.9, 2.2 Hz, 3H), 5.92-5.80 
(m, 1H), 5.65-5.56 (m, 1H), 5.27 (s, 1H), 4.29-4.21 (ddt, J = 11.6, 5.9, 1.2 Hz, 
1H), 4.14-4.08 (dd, J = 11.5, 7.3 Hz, 1H), 1.79-1.74 (d, J = 6.5 Hz, 3H) 
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Preparation of silane, trimethyl[(3-methyl-2-buten-1-yl)oxy]- (18) 
 
 To a 50 mL, single-neck, round-bottom flask, fitted with a condenser and an argon inlet, 
was added 3-methyl-2-buten-1-ol (10.0 mL, 98.5 mmol) followed by hexamethyldisilazane (12.5 
mL, 59.1 mmol, 0.6 equiv.). This solution was then placed in a 140 °C oil bath and was allowed 
to stir overnight (> 14 h) under argon. 
 The reaction was then removed from the heating bath and allowed to cool to room 
temperature.  The condenser was removed and a 10 cm fractional distillation column (glass 
helices) was attached.  The reaction was then placed back into the heating bath set to 180 °C and 
the product was collected by distillation under argon at 145-146 °C.  The distillation afforded 
14.51 g (93%) of 18 as a clear, colorless liquid. 
 
Data for 18: 
 1H-NMR: (500 MHz, CDCl3) 
5.36-5.29 (m, 1H), 4.15-4.09 (d, J = 6.8 Hz, 2H), 1.72 (s, 3H), 1.65 (s, 3H), 0.13 
(s, 9H) 
 13C-NMR: (126 MHz, CDCl3) 
134.61, 123.92, 59.36, 25.79, 17.83, -0.36 
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Preparation of benzene, [bis[(3-methyl-2-buten-1-yl)oxy]methyl]- (16) 
 
 To a 25 mL, single-neck, round-bottom flask, fitted with a argon inlet/septum, was added 
18 (1.711 g, 10.8 mmol, 2.2 equiv.), benzaldehyde (0.50 mL, 4.92 mmol), and CH2Cl2 (10 mL, 
0.49 M). The reaction mixture was cooled to -75 °C (external) with a refrigerator unit in a 2-
propanol bath. To this mixture trimethylsilyl-trifluoromethylsulfonate (50 μL, 250 μmol, 0.05 
equiv.) was added dropwise via syringe while cold. The reaction mixture turned homogeneous 
after the addition was complete.  The reaction was stirred overnight at -75 °C. 
 The reaction mixture was quenched with dry pyridine (2.0 mL) at -75 °C and then 
warmed to room temperature. The quenched reaction was then poured into a 60 mL separatory 
funnel containing a 50 mM KH2PO4 pH 7 buffer solution (15 mL) and diluted with CH2Cl2 (30 
mL).  The phases were separated and the organic phase was washed with H2O (2 x 15 mL) and 
then brine (15 mL). The organic phase was dried over Na2SO4 and the solvent removed on a 
rotatory evaporator to afford a crude 16 as a light amber oil. 
 The crude 16 was purified by silica gel flash chromatography (50 g SiO2,  = 30, 5% 
MTBE in hexane) to afford 1.051 g (82%) of 16 as a colorless liquid after drying several hours 
under high-vacuum (<1 mm Hg). 
 
Data for 16: 
 1H-NMR: (500 MHz, CDCl3) 
7.53-7.46 (m, 2H), 7.40-7.32 (m, 2H), 7.34-7.27 (m, 1H), 5.58 (s, 1H), 5.43-5.34 
(dddt, J = 7.0, 5.6, 2.7, 1.3 Hz, 2H), 4.11-3.99 (m, 4H), 1.75 (s, 6H), 1.65 (s, 6H) 
 13C-NMR: (126 MHz, CDCl3) 
139.17, 136.70, 128.20, 128.11, 126.84, 121.10, 100.50, 61.93, 25.71, 17.97 
 
 
  277 
Preparation of benzeneacetonitrile, α-(3-methyl-2-buten-1-yloxy)- (14) 
 
 To a 2.0 mL react-vial, fitted with a septum cap, was charged with stannous (II) chloride 
(40 mg, 173 μmol, 0.18 equiv.) in an argon glove box. The vial was sealed and removed from the 
box and then a solution of 16 (299 mg, 1.15 mmol) in CH2Cl2 (0.5 mL, 2.3 M) was added via 
syringe under argon. The reaction mixture was stirred for several minutes at room temperature 
and then trimethylsilyl cyanide (170 μL, 1.27 mmol, 1.1 equiv.) was added via syringe under 
argon. The reaction mixture became gradually darker over the course of one hour to an 
amber/honey color. 
 After 3.5 h the reaction mixture was diluted with Et2O (~1 mL) and poured into a test 
tube containing a solution of saturated aqueous NaHCO3 (5-6 mL).  The phases were separated 
and the aqueous phase was extracted with additional Et2O (3 x 5 mL). The organic phases were 
combined, dried over Na2SO4, and then the solvent was removed on a rotatory evaportator to 
afford crude 14 as yellow oil. 
 This oil was purified by silica gel flash chromatography (30 g SiO2,  = 20, 10% MTBE 
in hexane) to afford 140 mg (61%) of 14 as a light yellow oil. 
 
Data for 14: 
 1H-NMR: (500 MHz, CDCl3) 
7.53 -7.46 (dd, J = 7.6, 2.0 Hz, 2H), 7.45-7.38 (dq, J = 8.8, 3.1, 2.4 Hz, 3H), 5.41-
5.34 (tdd, J = 8.0, 2.6, 1.3 Hz, 1H), 5.28 (s, 1H), 4.30-4.17 (m, 2H), 1.79 (s, 3H), 
1.73 (s, 3H) 
 13C-NMR: (100 MHz, CDCl3) 
140.43, 133.76, 129.66, 128.96, 127.35, 118.82, 117.50, 69.25, 66.18, 25.87, 
18.17 
  278 
Preparation of 2-butenoic, 3-phenyl-, ethyl ester, (2E)- (20) and 2-butenoic, 3-phenyl-, ethyl 
ester, (2Z)- (21)
201
 
 
 To a 250 mL, three-neck, round-bottom flask, fitted with a condenser, argon inlet, 
septum, and thermometer, was added triethylphosphonoacetate (10.1 mL, 50 mmol), hexane (50 
mL, 1 M). This solution was then cooled to 0 °C (internal) on an ice-bath. To this solution 2.5 M 
n-BuLi in hexane (20.0 mL, 50 mmol, 1.0 equiv.) was added dropwise via gas-tight syringe over 
2 h, keeping the internal temperature between 3-5 °C. The addition of base afforded a white 
suspension. 
 Acetophenone (5.9 mL, 50.0 mmol, 1.0 equiv.) was then added dropwise via syringe, 
keeping the internal temperature between 2-10 °C. The reaction was then removed from the ice 
bath and the septum and thermometer replaced with glass stoppers. The reaction was then placed 
in a 70 C oil bath and heated to reflux overnight (>12 h). 
 The reaction mixture was removed from the oil bath and cooled to room temperature. 
This mixture was then poured into a 500 mL separatory funnel containing a saturated aqueous 
solution of Na2CO3 (100 mL).  The phases were separated and the aqueous phase was extracted 
with Et2O (5 x 100 mL). The organic extracts were combined and washed with H2O (3 x 50 mL) 
and then dried over MgSO4.  The solvent was then removed on a rotatory evaporator to afford 
crude 20/21 as an amber/orange oil. 1H-NMR spectroscopic analysis indicated this crude product 
mixture was a 5:1 ratio of E to Z isomers with a trace amount of acetophenone.202 
 The crude 20/21 oil was purified by successive (>3) silica gel flash columns (300 g,  = 
60, 5% EtOAc in hexane) to afford 6.155 g (65%) of 20 as a light yellow oil and 1.402 g (15%) 
of 21 as a light yellow oil. 
 
Data for 20: 
 1H-NMR: (500 MHz, CDCl3) 
7.51-7.45 (m, 2H), 7.41-7.34 (m, 3H), 6.16-6.11 (q, J = 1.3 Hz, 1H), 4.27-4.15 (q, 
J = 7.1 Hz, 2H), 2.61-2.54 (d, J = 1.3 Hz, 3H), 1.36-1.28 (t, J = 7.1 Hz, 3H) 
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Data for 21: 
 1H-NMR: (500 MHz, CDCl3) 
7.38-7.27 (m, 3H), 7.23-7.17 (m, 2H), 5.93-5.89 (q, J = 1.4 Hz, 1H), 4.04-3.96 (q, 
J = 7.1 Hz, 2H), 2.20-2.16 (d, J = 1.5 Hz, 3H), 1.11-1.05 (t, J = 7.1 Hz, 3H) 
  280 
Preparation of (E)-3-phenyl-2-buten-1-ol (22) 
 
 To a 250 mL, three-neck, round-bottom flask, fitted with a thermometer, 50 mL pressure-
equilibrate addition funnel, and an argon inlet/septum, was added lithium aluminum hydride 
(2.470 g, 61.7 mmol, 1.1 equiv.) and then Et2O (75 mL). This suspension was then cooled to 0 
°C (internal) on an ice-bath. The addition funnel was then charged with a solution of 20 (10.679 
g, 56.1 mmol) in Et2O (50 mL, 1.12 M) and this was added dropwise to the hydride suspension 
over 2-3 h, keeping the temperature under 5 °C (internal). 
 After the addition was complete, the reaction mixture was then stirred for 30 min at 0 °C 
(internal). The septum was removed and under a steady stream of argon the reaction was 
carefully quenched, first H2O (2.5 mL), second 15% (w/w) aq. NaOH (2.5 mL), and third H2O 
(7.5 mL). A small amount of MgSO4 (<1 g) was added the reaction mixture was allowed to 
warm to room temperature over 1-2 h. The off-white precipitate that formed was removed by 
filtration through a Buchner funnel.  The filter cake was washed with boiling Et2O (~100 mL) 
and the resulting filtrate was concentrated on a rotatory evaporator to afford crude 22 as a 
colorless oil. 
 The crude 22 was purified by silica gel flash chromatography (300 g SiO2 , 0 = 60, 40% 
EtOAc in hexane) to afford 7.440 g (89%) of 22 as a clear, colorless oil. 
 
Data for 22: 
 1H-NMR: (500 MHz, CDCl3) 
7.44-7.39 (m, 2H), 7.36-7.30 (m, 2H), 7.30-7.24 (m, 1H), 6.03-5.94 (td, J = 6.7, 
1.3 Hz, 1H), 4.43-4.31 (d, J = 3.9 Hz, 2H), 2.13-2.06 (d, J = 0.6 Hz, 3H), 1.39 (br 
s, 1H) 
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Preparation of silane, trimethyl[(3-phenyl-2-butenyl)oxy] (19) 
 
 To a 25 mL, single-neck, round-bottom flask, fitted with a condenser and an argon inlet, 
was added 22 (2.414 g, 16.29 mmol) followed by freshly distilled hexamethyldisilazane (2.00 
mL, 9.77 mmol, 0.59 equiv.). This solution was then heated to 100 °C on an oil-bath and stirred 
for 1 h.  The reaction mixture became a clear yellow solution while heating.  After 1 h, the 
reaction was cooled to room temperature. 
 The product was isolated by Kugelrohr distillation (160-170 °C, 0.45-0.55 mmHg) to 
afford 3.552 g (99%) of a semi-pure 19. This compound was further purified by short-path 
distillation (75-78 °C, 0.57 mmHg) to afford 3.192 g (89%) of 19 as a clear, colorless oil. 
 
Data for 19: 
 1H-NMR: (500 MHz, CDCl3) 
7.44-7.38 (m, 2H), 7.35-7.29 (m, 2H), 7.26-7.22 (m, 1H), 5.94-5.87 (td, J = 6.3, 
1.4 Hz, 1H), 4.41-4.31 (d, J = 7.1 Hz, 2H), 2.08-2.02 (d, J = 1.1 Hz, 3H), 0.17 (s, 
9H) 
 13C-NMR: (126 MHz, CDCl3) 
143.04, 135.96, 128.18, 127.35, 127.01, 125.73, 60.11, 16.00, -0.29 
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Preparation of benzene, [bis[(3-phenyl-(E)-2-buten-1-yl)oxy]methyl]- (17) 
 
 To a 25 mL, single-neck, round-bottom flask, fitted with a argon inlet/septum, was added 
19 (2.082 g, 9.45 mmol, 2.2 equiv), benzaldehyde (440 μL, 4.33 mmol), and CH2Cl2 (10 mL, 
0.43 M). The reaction mixture was cooled to -77 °C (external) with the aid of refrigerator unit on 
a 2-propanol bath and then stirred for 30 m. Trimethylsilyl-trifluoromethlysulfonate (50 μL, 256 
μmol, 0.06 equiv.) was added via syringe. This mixture was stirred overnight (> 16 h) at -77 °C 
(external). 
 The reaction mixture was quenched with dry pyridine (0.2 mL, 2.48 mmol) at -80 °C 
(external) and was then warmed to room temperature. This mixture was then poured into a 60 
mL separatory funnel containing a saturated aqueous solution of NaHCO3 (20 mL). The phases 
were separated and the aqueous phase was then extracted with Et2O (2 x 10 mL).  The organic 
phases were combined and then washed with a 50 mM KH2PO4 pH 7 buffer solution (10 mL) 
followed by brine (10 mL).  The organic phase was then dried over Na2SO4 and the solvent 
removed on a rotatory evaporator to afford crude 17 as an amber oil. 
 The crude 17 was purified by two consecutive silica gel flash columns (#1: 100 g SiO2,  
= 40, 5% MTBE in hexane, #2: 140 g SiO2,  = 40, 2% Et3N, 5% MTBE in hexane) to afford 
773 mg (46%) of 17 as a colorless/very pale yellow oil. 
 
Data for 17: 
 1H-NMR: (500 MHz, CDCl3) 
7.60-7.53 (dd, J = 8.0, 1.4 Hz, 2H), 7.44-7.38 (m, 6H), 7.38-7.29 (m, 5H), 7.29-
7.22 (m, 2H), 6.04-5.96 (td, J = 6.6, 1.3 Hz, 2H), 5.74 (s, 1H), 4.39-4.25 (qd, J = 
12.5, 6.6 Hz, 4H), 2.06 (s, 6H) 
 13C-NMR: (126 MHz, CDCl3) 
142.86, 138.57, 138.30, 128.45, 128.25, 128.19, 127.17, 126.80, 125.75, 124.01, 
100.63, 62.40, 16.18 
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Preparation of benzeneacetonitrile, α-(3-phenyl-(E)-2-buten-1-yloxy)- (15) 
 
 To a 10.0 mL, single-neck, round-bottom flask, fitted with an argon inlet and a septum, 
was added stannous (II) chloride (40 mg, 197 μmol, 0.11 equiv.) in an argon glove box.  The 
flask was removed from the box and then a solution of 17 (758 mg, 1.97 mmol) in CH2Cl2 (2.5 
mL, 0.79 M) was added via syringe under argon. The reaction mixture was then cooled to 0 °C 
on an ice-bath for 45 m.  Trimethylsilyl cyanide (290 μL, 2.17 mmol, 1.1 equiv) was then added 
via syringe under argon at 0 °C and stirred for 10 m. The reaction mixture was then warmed to 
room temperature. 
 After 4 h, more stannous (II) chloride (38 mg, 0.10 equiv.) was added, and at 5 h 
additional trimethylsilyl cyanide (290 μL, 1.1 equiv.) was added. After 8 h, the reaction mixture 
was diluted with Et2O (25 mL) and then poured in a 60 mL separatory funnel containing a 
saturated aqueous solution of NaHCO3 (25 mL).  The phases were separated and the aqueous 
phase was extracted with Et2O (3 x 25 mL).  The organic phases were combined and dried over 
Na2SO4. The solvent was then removed on a rotatory evaporatory to afford crude 15 as a dark 
amber oil. 
 This crude oil was purified by two consecutive silica gel flash chromatography columns 
(#1: 60 g SiO2,  = 30, 5% to 10% MTBE in hexane, #2: 10 g SiO2,  = 10, 5% EtOAc in 
hexane) to afford 125 mg (24% of 15 as a light amber oil. 
 
Data for 15: 
 1H-NMR: (500 MHz, CDCl3) 
7.56-7.49 (m, 2H), 7.48-7.39 (m, 5H), 7.39-7.31 (t, J = 7.6 Hz, 2H), 7.31-7.27 (d, 
J = 7.3 Hz, 1H), 5.97-5.91 (m, 1H), 5.35 (s, 1H), 4.52-4.39 (m, 2H), 2.13 (s, 3H) 
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5.3.2. PTC [2,3]-Wittig Rearrangements 
PTC [2,3]-rearrangement of benzeneacetonitrile, α-(2-propen-1-yloxy)- (12) 
 
 To a 4.0 mL dram vial was added 12 (101 mg, 583 μmol), toluene (2.0 mL, 0.29 M), and 
tetra(n-butyl)ammonium bromide (9.5 mg, 29.2 μmol, 0.05 equiv.). A solution of 50% (w/w) aq. 
KOH (670 μL) was then added at room temperature and the reaction mixture was vigorously 
stirred for 20 m. 
 The phases were then allowed to separate, the organic phase was saved and the aqueous 
phase was extracted with additional toluene (2 x 1 mL).  The organic phases were combined and 
washed with a saturated aqueous solution of NH4Cl (2-3 mL) followed by brine (1-2 mL).  The 
organic phase was dried over Na2SO4 and the solvent was then removed on a rotatory evaporator 
to afford 73 mg (86%) of crude 23 as a dark orange oil 
 The crude 23 was purified by silica gel flash chromatography (7 g SiO2,  = 10, 5% to 
10% MTBE in hexane) to afford 43 mg (51%) of 23 as a pale yellow oil. 
 
Data for 23: 
 1H-NMR: (500 MHz, CDCl3) 
8.05-7.99 (dd, J = 8.3, 1.1 Hz, 2H), 7.81-7.76 (dd, J = 8.3, 1.2 Hz, 2H), 7.61-7.35 
(m, 16H), 5.95-5.84 (m, 2H), 5.79-5.69 (m, 2H), 5.35-5.28 (dd, J = 17.2, 1.7 Hz, 
2H), 5.22-5.19 (m, 1H), 5.19-5.07 (dddd, J = 44.1, 10.5, 2.9, 1.4 Hz, 3H), 4.12-
3.96 (ddd, J = 38.0, 12.1, 5.3 Hz, 4H), 3.80-3.64 (m, 5H), 3.04-2.86 (m, 6H), 
2.84-2.75 (d, J = 13.9 Hz, 2H), 1.28-1.22 (d, J = 6.1 Hz, 3H), 0.86-0.83 (d, J = 6.6 
Hz, 3H). 
 13C-NMR: (126 MHz, CDCl3) 
198.48, 197.51, 137.04, 136.66, 135.97, 135.65, 133.16, 133.09, 132.88, 129.49, 
129.44, 128.91, 128.87, 128.57, 128.53, 128.15, 127.96, 126.58, 126.41, 117.62, 
117.28, 117.21, 117.10, 85.44, 85.03, 67.83, 67.82, 41.16, 40.96, 40.84, 40.58, 
15.70, 15.45 
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 LRMS: (CI+, 70 VSE(A)) 
105.0 (100), 147.1 (11.0), 175.0 (12.5), 262.1 (97.5), 293.1 (M+H+, 63.7) 
 
PTC [2,3]-Wittig rearrangement of benzeneacetonitrile, α-((E)-2-buten-1-yloxy)- (13) 
 
 To a 4.0 mL dram vial, fitted with a septum cap, was charged 13 (107 mg, 571 μmol), 
toluene (2.0 mL, 0.29 M), and tetra(n-butyl)ammonium bromide (9.5 mg, 29.5 μmol, 0.05 
equiv.). To this reaction mixture was added a solution of 50% (w/w) aq. KOH (670 μL) and the 
mixture was vigorously stirred for 1 h at room temperature (20-25 °C). 
 The stirring was then ceased and the phases were allowed to separate. The organic phase 
was set aside and the aqueous phase extracted with additional toluene (2 x 1 mL). The organic 
phases were then combined and washed with a saturated aqueous solution of NH4Cl (2-3 mL), 
followed by brine (1-2 mL), and then dried over Na2SO4. The solvent was then removed on a 
rotatory evaporator to afford 74 mg (81%) of crude 24. 
 The crude 24 was then purified by silica gel flash chromatography (7-8 g SiO2,  = 10, 
5% to 10% MTBE in hexane) to afford 30 mg (33%) of 24 as a yellow oil. 
 
Data for 24: 
 1H-NMR: (500 MHz, CDCl3) 
7.67-7.57 (dd, J = 8.2, 1.4 Hz, 2H), 7.53-7.44 (m, 1H), 7.43-7.33 (m, 2H), 6.46-
6.34 (dddd, J = 8.3, 6.9, 5.5, 1.4 Hz, 1H), 2.00-1.93 (m, 3H), 1.91-1.85 (dd, J = 
6.9, 1.1 Hz, 3H) 
 13C-NMR: (126 MHz, CDCl3) 
198.85, 141.45, 138.80, 137.62, 131.17, 129.14, 127.95, 14.73, 12.11 
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PTC [2,3]-Wittig rearrangement of benzeneacetonitrile, α-(3-methyl-2-buten-1-yloxy)- (14) 
 
 To a 4.0 mL dram vial was added 14 (59 mg, 293 umol), toluene (1.00 mL, 0.29 M), and 
tetra(n-butyl)ammonium bromide (4.8 mg, 15 umol, 0.05 equiv.). To this a solution of 50% 
(w/w) aq. KOH (330 μL) was added at room temperature.  The reaction mixture was vigorously 
stirred for 60 m at room temperature. 
 The stirring was ceased and the phases allowed to separate. The aqueous phase was 
extracted with EtOAc (2 x 1 mL).  The organic phases were combined and washed with a 
saturated aqueous solution of NH4Cl (3-4 mL).  The organic phase was then dried over Na2SO4 
and the solvent was removed on a rotatory evaporator to afford 44 mg (86%) of crude 25. 
 The crude 25 was purified by silica gel flash chromatography (5 g SiO2,  = 10, 5% 
MTBE in hexane) to afford 32 mg (63%) of 25 as a colorless oil. 
 
Data for 25: 
 1H-NMR: (500 MHz, CDCl3) 
7.92-7.82 (dd, J = 8.5, 1.4 Hz, 2H), 7.50-7.42 (m, 1H), 7.41-7.32 (m, 2H), 6.24-
6.13 (dd, J = 17.6, 10.6 Hz, 1H), 5.29-5.17 (m, 2H), 1.40 (s, 6H) 
 13C-NMR: (126 MHz, CDCl3) 
204.61, 143.86, 137.11, 131.60, 129.24, 127.91, 114.03, 50.15, 26.04 
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PTC [2,3]-Wittig rearrangement of benzeneacetonitrile, α-(3-phenyl-(E)-2-buten-1-yloxy)- 
(15) 
 
 To a 1.0 mL glass conical vial was charged with 15 (30 mg, 114 μmol), toluene (0.50 
mL, 0.23 M), and tetra(n-butyl)ammonium bromide (1.8 mg, 5.7 μmol, 0.05 equiv.). The 
reaction mixture was stirred for several minutes at room temperature and then a solution 50% 
(w/w) aq. KOH (150 μL) was added.  This mixture was vigorously stirred for 60 m and then 
diluted with additional Et2O (~5 mL). 
 The stirring was ceased and the phases were allowed to separate.  The organic phase was 
removed and then washed with a saturated aqueous solution of NH4Cl (~2 mL). The organic 
phase was then concentrated on a rotatory evaporator to afford 29 mg of crude 26 as a yellow oil. 
 The product was purified by preparative thin-layer chromatography on an analytical silica 
gel plate (20 x 20 cm, 5% MTBE in hexane) to afford 6 mg (22%) of 26 as a colorless oil. 
 
Data for 26: 
 1H-NMR: (500 MHz, CDCl3) 
7.57-7.51 (m, 2H), 7.41-7.31 (m, 3H), 7.31-7.20 (m, 5H), 6.67-6.56 (dd, J = 17.4, 
10.8 Hz, 1H), 5.34-5.27 (dd, J = 10.7, 0.8 Hz, 1H), 5.20-5.12 (dd, J = 17.4, 0.8 
Hz, 1H), 1.67 (s, 3H) 
 TLC: Rf 0.31 (5% MTBE in hexane) [Silica gel, UV] 
 CSP-SFC: (Chiralcel OJ, SFC Method 1) 
3.2 m (50%), 4.4 m (50%), α= 1.5 
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APTC [2,3]-Wittig rearrangement of benzeneacetonitrile, α-(3-phenyl-(E)-2-buten-1-
yloxy)- (15) 
 
 To a 2.0 mL conical, glass vial, fitted with a septum cap, was charged 15 (52 mg, 197 
μmol), toluene (1.0 mL, 0.2 M), and catalyst (6.7 mg, 9.85 μmol, 0.05 equiv.). The reaction 
mixture was then cooled to 0 °C (external) on an ice-bath for 1 h. A solution of 50% (w/w) aq. 
KOH (300 μL) was then added and the mixture was vigorously stirred for 2 h. 
 The stirred was ceased and the reaction was poured into a test tube containing a solution 
of saturated aqueous NH4Cl (2-3 mL) and Et2O (2-3 mL). The phases were separated and the 
aqueous phase was extracted with additional Et2O (2 x 1-2 mL). The organic phases were 
combined, passed through a pipette silica gel plug (0.5 x 1.0 cm), and then concentrated on a 
rotatory evaporator to afford crude 26 as a yellow oil. 
 The crude 26 was purified by silica gel flash chromatography (6 g SiO2,  = 10, 5% 
MTBE in hexane) to afford 23 mg (49%) of 26 as a very pale amber oil. 
 
Data for 26: 
 CSP-SFC: (Chiralcel, SFC Method 1) 
3.1 m (major, 55%), 4.3 m (minor, 45%) 
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5.4 Chapter 4 
5.4.1 Preparation of Quaternary Ammonium Hydroxides 
 
An amberlist A-26 hydroxide form resin was utilized to generate the quaternary 
ammonium hydroxide solutions from the bromides or iodides, The protocol of Harlow, Noble 
and Wild was followed closely with the exception that anhydrous methanol was utilized rather 
than isopropanol. In a typical exchange ~10 mmols of quaternary ammonium bromide was 
brought up in minimal amount of methanol (~20 mL) and added to the top of the amberlyst resin, 
which was pre-packed in a standard 30 mm column with anhydrous methanol. The resultant 
suspension was allowed to sit undisturbed for 3-6 h, then eluted slowly (~2 h) total. The resin 
was rinsed with another 100 mL of methanol overnight (~12 h). Between each pass over the 
resin the hydroxide form was regenerated, following the same procedure, eluting with 1 M 
NaOH in methanol (3 times) followed anhydrous methanol (~1 L) until the eluent was neutral. 
Typically this process was repeated six times.  The final solution was concentrated to ~0.5 molar 
and tritrated to a phenolphthalein endpoint in a solution of methanol and water (1:1) as well as 
titrated for bromide (weight %) of the solution. 
compound  
number 
ammonium 
cation OH conc, [M]
a
 st. dev. Br, weight %b 
Br, 
mmol 
%d 
31 methyl4N
+ 0.127 0.0095 0.16 1.56 
32 ethyl4N
+ 0.668 0.0014 0.33 0.61 
33 n-propyl4N
+ 0.229 0.0050 0.34 1.82 
34 n-butyl4N
+ 0.588 0.0054 <0.1c <0.10 
35 n-hexyl4N
+ 0.685 0.0096 0.31 0.56 
36 n-octyl4N
+ 0.426 0.0013 0.41 1.19 
a. Total base titrations are an average of 3-6 determinations to a phenolphthalein endpoint. b. 
Bromide weight percentage is an average of 2-3 determinations by ion selective electrode. c. 
Prepared from the quaternary ammonium iodide and no residual iodide could be detected. d. The 
total mmols of anions is taken as the mmols of hydroxide plus the mmols of bromide. 
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Preparation of  N,N,N-trimethyl-Methanaminium, hydroxide 
 
 
acid, 
mL 
acid, 
[M] 
acid,  
 mmol  
 base,  
 mmol 
base, 
mL 
base, 
[M] 
 1.338 0.100 0.1338 0.1338 0.200 0.6690 
 1.365 0.100 0.1365 0.1365 0.200 0.6825 
  1.306 0.100 0.1306 0.1306 0.200 0.6530 
avg 1.3363 0.100 0.1336 0.1336 0.000 0.668 
dev 0.0295 0.000 0.0030 0.0030 0.000 0.014 
 
Residual Halide: 0.16 weight % 
Preparation of Ethanaminium, N,N,N-triethyl-, hydroxide 
 
 
acid, 
mL 
acid, 
[M] 
acid,  
 mmol  
 base,  
 mmol 
base, 
mL 
base, 
[M] 
 1.1500 0.1000 0.1150 0.1150 0.9000 0.1278 
 1.1400 0.1000 0.1140 0.1140 0.9000 0.1267 
 1.1500 0.1000 0.1150 0.1150 0.9000 0.1278 
 1.1200 0.1000 0.1120 0.1120 0.9000 0.1244 
 1.1520 0.1000 0.1152 0.1152 0.9000 0.1280 
  1.1300 0.1000 0.1130 0.1130 0.9000 0.1256 
avg. 1.1403 0.1000 0.1140 0.1140 0.9000 0.1267 
dev. 0.0130 0.0000 0.0013 0.0013 0.0000 0.0014 
 
Residual Halide: 0.33 weight % 
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Preparation of Propanaminium, N,N,N-tripropyl-, hydroxide 
 
 
acid, 
mL 
acid, 
[M] 
acid,  
 mmol  
 base,  
 mmol 
base, 
mL 
base, 
[M] 
 0.4570 0.1000 0.0457 0.0457 0.2000 0.2285 
 0.4490 0.1000 0.0449 0.0449 0.2000 0.2245 
 0.4690 0.1000 0.0469 0.0469 0.2000 0.2345 
avg 0.4583 0.1000 0.0458 0.0458 0.2000 0.2292 
dev 0.0101 0.0000 0.0010 0.0010 0.0000 0.0050 
 
Residual Halide: 0.34 weight % 
 
Preparation of Butanaminium, N,N,N-tributyl-, hydroxide 
 
 acid, mL acid, [M] acid,  mmol base, mmol base, mL base, [M] 
 1.0400 0.1000 0.1040 0.1040 0.1750 0.5943 
 1.0220 0.1000 0.1022 0.1022 0.1750 0.5840 
 1.0260 0.1000 0.1026 0.1026 0.1750 0.5863 
avg 1.0293 0.1000 0.1029 0.1029 0.1750 0.5882 
dev 0.0095 0.0000 0.0009 0.0009 0.0000 0.0054 
 
Residual Halide: <0.01 weight % 
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Preparation of Hexanaminium, N,N,N-trihexyl-, hydroxide 
 
 acid, mL acid [M] acid,  mmol   base,  mmol base, mL base, [M] 
 1.1800 0.1000 0.1180 0.1180 0.1750 0.6743 
 1.2080 0.1000 0.1208 0.1208 0.1750 0.6903 
 1.2100 0.1000 0.1210 0.1210 0.1750 0.6914 
avg 1.1993 0.1000 0.1199 0.1199 0.1750 0.6853 
dev 0.0168 0.0000 0.0017 0.0017 0.0000 0.0096 
 
Residual Halide: 0.31 weight % 
 
Preparation of Octanaminium, N,N,N-trioctyl-, hydroxide 
 
 acid, mL acid [M] acid, mmol   base,  mmol base, mL base, [M] 
 0.7580 0.1000 0.0758 0.0758 0.1750 0.4331 
 0.7580 0.1000 0.0758 0.0758 0.1750 0.4331 
 0.7200 0.1000 0.0720 0.0720 0.1750 0.4114 
 0.7200 0.1000 0.0720 0.0720 0.1750 0.4114 
avg 0.7390 0.1000 0.0745 0.0745 0.1750 0.4259 
dev 0.0219 0.0000 0.0022 0.0022 0.0000 0.0125 
 
Residual Halide: 0.41 weight % 
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5.4.2 Preparation of Quaternary Ammonium Phenoxides 
 
 To a 250-mL, one-necked, round-bottomed flask fitted a septa, magnetic stir bar, and 
nitrogen inlet adaptor was added phenol (62.7 mg, 0.2 mmol) followed by dioxane (100 mL). To 
the clear solution was added the appropriate quaternary ammonium hydroxide (0.1 mmol).  The 
resulting solution was stirred for 30 min, then concentrated by rotary evaporation. Another 100 
mL of dioxane was added and the solution was again concentrated by rotary evaporation. This 
process was repeated three times, then again three times with hexanes (100 mL portions).  The 
resulting solid quaternary ammonium phenolate complexes were used within 1 hour. 
 The stoichiometry of the ammonium phenoxide complexes prepared in this way was 
checked by quenching a small sample into an acetonitrile solution containing a large excess of 
benzyl bromide and a standard. After being stirred overnight, the relative amounts of phenol and 
benzyl phenyl ether were determined by gas chromatography. The stoichiometry was found to be 
1:1 (+/- 0.04) in all cases. 
 
R 
PhOH/PhOBn, 
mol/mol 
methyl 1.04 
ethyl 0.98  
n-propyl 1.02 
n-butyl 1.00 
n-hexyl 0.94 
n-octyl 0.98 
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Preparation of Tetramethylammonium phenol-phenolate (A) 
 
 Data for A: 
 1H-NMR: (500 MHz, CD3CN) 
6.99 (t, J = 8.7, 4 H, HC(3)), 6.63 (dd, J = 8.6, 1.2, 4 H HC(4)), 6.42 (t, J = 
7.2, HC(5)), 6.13 (s, 1 H, HO), 3.03 (s, 12 H, HC(1)) 
 13C-NMR: (126 MHz, CD3CN) 
165.6 (C(2)), 129.7 (C(4)), 118.0 (C(5)), 114.4 (C(3)), 55.8 (C(1)) 
 
Preparation of Tetraethylammonium phenol-phenolate (B) 
 
 Data for B: 
 1H-NMR: (500 MHz, CD3CN) 
9.09 (s, 1 HO)), 6.96 (t, J = 7.5, 4 H, HC(x)), 6.57 (d, 4 H, J = 7.8), 6.35 (t, 
2H, J = 7.2), 3.12 (q, 8 H, J = 7.4), 1.16 (m, 12 H, HC(x)) 
 13C-NMR: (126 MHz, CD3CN) 
166.7 (C(5)), 129.6 (C(6)), 118.0 (C(4)), 113.4 (C(3)), 52.8 (C(1)), 7.4 (C(2)),  
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Preparation of Tetrapropylammonium phenol-phenolate (C) 
 
 Data for C: 
 1H-NMR: (500 MHz, CD3CN) 
11.5-13 (broad s, 1 H HO), 6.98 (t, J = 8.0, 4 H, HC(x)), 6.61 (d, J = 8.4, 4 H 
HC(x)), 6.39 (t, J = 7.2, 2 H, HC(x)), 3.02 (ddd, J = 8.6, 4.9, 3.7, 8 H, HC(x)) 
1.61 (m, 8 H, HC(x)), 0.92 (t, J = 7.3, 12 H, HC(x)) 
 13C-NMR: (126 MHz, CD3CN) 
165.95 (C(6)), 129.63 (C(7)), 118.00 (C(5)), 114.00 (C(4)), 60.73 (C(1)), 
15.77 (C(2)), 10.55 (C(3)) 
Preparation of Tetrabutylammonium phenol-phenolate (D) 
 
Data for D: 
1H-NMR: (500 MHz, CD3CN) 
 7.05 (t, J = 7.8, 4 H, HC(6)), 6.73 (d, J = 7.5, 4 H, HC(7)) 6.49 (t, J = 7.2 2 H, 
HC(8)) 3.05 (m, 8 H, HC(1)), 1.55 (t, J = 11.6, 8 H, HC(2)) 1.35 (qd, J = 7.2, 
14.3, 8 H, HC(3)) 0.98 (t, J = 7.3, 12 H, HC(4)) 
13C-NMR: (126 MHz, CDCl3) 
165.07 C(7), 129.76 C(6), 117.84 C(5), 114.89 C(8), 59.01 C(1), 24.17 C(2), 
20.12 C(3), 13.73 C(4) 
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Preparation of Tetrahextylammonium phenol-phenolate  (E) 
 
Data for E: 
1H-NMR: (500 MHz, CD3CN) 
7.04 (t, J = 7.7, 4 H, HC(8))  6.72 (d, J = 7.8, 4 H, HC(9))  6.47 (t, J = 7.2, 2 
H, HC(10)) 3.04 (m, 8 H, HC(1)) 0.96 (t, J = 6.6, 8 H, HC(2)) 1.57 (m, 24 H, 
HC(3) HC(4) HC(5)) 1.35 (m, 12 H, HC(6)) 
13C-NMR: (126 MHz, CD3CN) 
265.54 HC(9), 129.86 HC(8), 118.22 HC(7), 114.63 HC(10), 59.35 HC(1), 
31.78 HC(2), 26.48 HC(3), 23.14 HC(4), 22.95 HC(5), 14.24 HC(6) 
 
Preparation of Tetraoctylammonium phenol-phenolate  (F) 
 
Data for F: 
1H-NMR: (500 MHz, CD3CN) 
7.05 (t, J = 7.8, 1H, HC(10)) 6.77 (d, J = 7.6,  4 H, HC(1)) 6.52 (t, J = 7.2, 2H, 
HC(12)) 3.01 (m, 8 H, HC(1)) ppm 1.44 (m, 48 H, HC(2-7)) 0.92 (m, 12H, 
HC(8)) 
13C-NMR: (126 MHz, CD3CN) 
164.68 C(11), 129.91 HC(10), 117.99 HC(9), 115.53 HC(12), 59.25 HC(1), 
35.40 HC(2), 32.49 HC(3), 29.73 HC(4), 26.88 HC(5), 23.41 HC(6), 22.39 
HC(7), 14.49 HC(8),  
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5.4.3 Kinetic Analysis Procedure 
 
In a drybox, a stock solution of biphenyl ( , 21.0 μmol) was made up in the appropriate 
solvent (CH3CN or DIPK, 18.75 mL). The solution was then added to the appropriate 
quaternaryammonium phenol-phenolate complex at room temperature. The resulting solution 
was transferred removed from the drybox and transferred to three one-neck, 10-mL round-
bottom flasks with magnetic stir bars fitted with reflux condensers, and nitrogen inlet adaptors. 
Each of the flasks were placed in a 40 0C oil bath for 20 minutes prior to initiation of a kinetic 
run. Reaction progress was monitored by GC analysis. Sampling of the reaction was performed 
by removing 300 μL aliquots of the mixture by syringe and quenching the aliquots at regular 
intervals. The quench was performed as follows: the withdrawn aliquot of the reaction mixture 
was injected into 200 μL of a biphase of NH4Cl (aq, 50 μL) and MTBE (150 μL). The organic 
solution was filtered through a 0.5 x 1.0 cm plug of silica gel rinsing with ~200 μL of EtOAc. 
The resulting sample was subjected to GC analysis, Method 1. Response factors were obtained 
by Eqn 6.1 and are shown below: 
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Response Factors 
Phenol (2.087 minutes, Ph2, 6.085 minutes, GC Method 1) 
entry 
PhOH, 
mg 
Ph2, 
mg 
PhOH, 
mmol 
Ph2, 
mmol 
PhOH, 
area 
Ph2 
area 
Rf 
1 2.3 5.51 0.024439 0.035731 22.134 77.866 2.406186 
2 2.3 5.51 0.024439 0.035731 22.099 77.901 2.41108 
3 2.3 5.51 0.024439 0.035731 22.021 77.979 2.422043 
4 10.2 4.1 0.108382 0.026588 59.214 39.682 2.73181 
5 10.2 4.1 0.108382 0.026588 59.71 40.015 2.731852 
6 10.2 4.1 0.108382 0.026588 59.829 40.171 2.737047 
7 6.4 5.64 0.068005 0.036574 43.124 56.876 2.452313 
8 6.4 5.64 0.068005 0.036574 42.224 57.776 2.544216 
9 6.4 5.64 0.068005 0.036574 41.732 58.268 2.596132 
10 3.0 6.14 0.031877 0.039816 26.494 73.506 2.221228 
11 3.0 6.14 0.031877 0.039816 25.284 74.716 2.365842 
12 3.0 6.14 0.031877 0.039816 24.721 75.279 2.437955 
      average 2.504809 
      st. dev 0.16493 
 
PhOn-Bu (4.950 minutes, Ph2, 6.085 minutes, GC Method 1) 
entry PhOn-Bu, 
mg 
Ph2, 
mg 
PhOn-Bu, 
mmol 
Ph2, 
mmol 
PhOn-Bu, 
area 
Ph2 
area 
Rf 
1 7.07 2.7 0.047065 0.017509 63.952 36.048 1.515194 
2 7.07 2.7 0.047065 0.017509 64.015 35.958 1.509924 
3 8.68 4.56 0.057783 0.02957 57.285 42.715 1.457068 
4 8.68 4.56 0.057783 0.02957 57.019 42.981 1.472982 
5 6.54 6.06 0.043537 0.039298 44.144 55.856 1.401809 
6 6.54 6.06 0.043537 0.039298 43.439 56.561 1.44254 
7 2.96 7.9 0.019705 0.05123 23.175 76.825 1.275067 
8 2.96 7.9 0.019705 0.05123 21.705 78.295 1.387472 
9 5.65 9.3 0.037612 0.060308 29.339 70.661 1.502054 
10 5.65 9.3 0.037612 0.060308 29.463 70.537 1.493107 
      average 1.445722 
      st. dev 0.074307 
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PhOBn (8.242 minutes, Ph2, 6.085 minutes, GC Method 1) 
entry PhOBn, 
mg 
Ph2, 
mg 
PhOBn, 
mmol 
Ph2, 
mmol 
PhOBn, 
area 
Ph2 
area 
Rf 
1 4.76 7.5 0.025837 0.048636 36.409 63.591 0.927833 
2 4.76 7.5 0.025837 0.048636 36.569 63.431 0.921449 
3 4.76 7.5 0.025837 0.048636 36.723 63.277 0.915357 
4 2.86 10.81 0.015524 0.0701 20.689 79.311 0.848929 
5 2.86 10.81 0.015524 0.0701 19.949 80.051 0.888634 
6 2.86 10.81 0.015524 0.0701 19.649 80.351 0.905583 
7 6.93 9.81 0.037615 0.063615 37.792 62.208 0.973302 
8 6.93 9.81 0.037615 0.063615 38.257 61.743 0.954285 
9 6.93 9.81 0.037615 0.063615 38.562 61.438 0.94206 
      average 0.919715 
      st. dev 0.036794 
  302 
Kinetic Alkylation of Phenol-Phenolates in Acetonitrile 
Na
+
, MeCN, run 1: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 0.000 7.000 0.000 0.000 0.000 0.000 
360 6.673 7.341 0.475 0.625 0.104 0.625 
540 6.673 7.297 0.678 0.896 0.149 0.896 
720 6.673 7.314 0.938 1.237 0.206 1.237 
900 6.673 7.299 1.188 1.570 0.262 1.570 
1080 6.673 7.312 1.474 1.945 0.324 1.945 
1260 6.673 7.276 1.713 2.271 0.378 2.271 
1440 6.673 7.323 1.954 2.574 0.429 2.574 
1620 6.673 7.278 2.226 2.951 0.492 2.951 
1800 6.673 7.324 2.501 3.295 0.549 3.295 
2700 6.673 7.315 3.734 4.924 0.821 4.924 
 
 
  303 
Na
+
, MeCN, run 2: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 0.000 0.000 0.000 0.000 0.000 0.000 
360 6.673 7.339 0.518 0.680 0.113 0.001 
540 6.673 7.320 0.824 1.086 0.181 0.001 
720 6.673 7.305 1.156 1.527 0.254 0.002 
900 6.673 7.290 1.444 1.911 0.318 0.002 
1080 6.673 7.277 1.792 2.376 0.395 0.002 
1260 6.673 7.308 2.047 2.702 0.450 0.003 
1440 6.673 7.283 2.334 3.092 0.515 0.003 
1620 6.673 7.259 2.645 3.515 0.585 0.004 
1800 6.673 7.277 3.004 3.982 0.663 0.004 
2700 6.673 7.262 4.420 5.872 0.978 0.006 
 
 
  304 
Na
+
, MeCN, run 3: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.673 7.000 0.000 0.000 0 0.00 
360 6.673 7.338 0.597 0.785 0.1308 0.78 
540 6.673 7.283 0.886 1.173 0.1955 1.17 
720 6.673 7.364 1.185 1.553 0.2588 1.55 
900 6.673 7.321 1.495 1.970 0.3283 1.97 
1080 6.673 7.423 1.768 2.298 0.3830 2.30 
1260 6.673 7.320 2.033 2.679 0.4466 2.68 
1440 6.673 7.259 2.359 3.135 0.5225 3.13 
1620 6.673 7.358 2.649 3.473 0.5788 3.47 
1800 6.673 7.310 2.965 3.913 0.6521 3.91 
2700 6.673 7.264 4.331 5.751 0.9585 5.75 
 
 
  305 
K
+
, MeCN, run 1: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.67 7.000 0.000 0.000 0.0000 0.00 
60 6.67 7.444 1.079 1.398 0.2331 1.40 
120 6.67 7.497 2.166 2.788 0.4646 2.79 
180 6.67 7.358 3.115 4.084 0.6807 4.08 
240 6.67 7.288 4.026 5.329 0.8882 5.33 
360 6.67 7.622 5.848 7.402 1.2336 7.40 
480 6.67 7.390 7.162 9.357 1.5595 9.36 
600 6.67 7.137 8.497 11.486 1.9143 11.49 
 
 
 
 
 
 
 
 
 
 
 
  306 
K
+
, MeCN, run 2: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.67 7.000 0.000 0.000 0.0000 0.00 
60 6.67 7.421 1.268 1.648 0.2746 1.65 
120 6.67 7.454 2.163 2.800 0.4666 2.80 
180 6.67 7.384 3.160 4.128 0.6880 4.13 
240 6.67 7.528 4.154 5.328 0.8881 5.33 
360 6.67 7.318 5.859 7.724 1.2873 7.72 
480 6.67 7.227 7.557 10.088 1.6813 10.09 
600 6.67 7.273 9.180 12.176 2.0294 12.18 
 
 
 
  307 
K
+
, MeCN, run 3: 
time, 
seconds 
standard, 
µmol 
standard, 
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.67 7.000 0.000 0.000 0.0000 0.00 
60 6.67 7.143 1.054 1.423 0.2372 1.42 
120 6.67 7.080 1.936 2.638 0.4397 2.64 
180 6.67 7.130 2.834 3.834 0.6390 3.83 
240 6.67 7.056 3.694 5.051 0.8418 5.05 
300 6.67 7.074 4.530 6.177 1.0296 6.18 
360 6.67 7.060 5.325 7.277 1.2128 7.28 
480 6.67 7.066 6.595 9.004 1.5007 9.00 
 
 
 
 
 
  308 
Me4N
+
, MeCN, run 1: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.67 7.000 0.000 0.000 0.0000 0.00 
60 6.67 7.027 0.928 1.275 0.2125 1.28 
120 6.67 7.086 1.806 2.461 0.4101 2.46 
180 6.67 6.918 2.647 3.691 0.6152 3.69 
240 6.67 6.912 3.531 4.928 0.8214 4.93 
300 6.67 6.887 4.347 6.090 1.0149 6.09 
360 6.67 6.918 5.007 6.982 1.1636 6.98 
480 6.67 6.939 6.315 8.779 1.4631 8.78 
 
 
 
  309 
Me4N
+
, MeCN, run 2: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.67 7.000 0.000 0.000 0.0000 0.00 
60 6.67 7.269 0.949 1.260 0.2099 1.26 
120 6.67 7.213 1.841 2.462 0.4104 2.46 
180 6.67 7.172 2.737 3.681 0.6136 3.68 
240 6.67 7.245 3.646 4.855 0.8092 4.86 
300 6.67 7.189 4.368 5.861 0.9769 5.86 
360 6.67 7.165 5.116 6.888 1.1481 6.89 
480 6.67 7.092 6.372 8.668 1.4446 8.67 
 
y = 0.00304x + 0.04075
R² = 0.99530
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
0 200 400 600
p
d
t 
c
o
n
c
.,
 [
M
] 
X
 1
0
0
0
time, sec  
 
 
  310 
Me4N
+
, MeCN, run 3: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.67 7.000 0.000 0.000 0.0000 0.00 
60 6.67 7.612 1.958 2.492 0.4153 2.49 
120 6.67 7.298 3.495 4.621 0.7701 4.62 
180 6.67 7.151 5.151 6.950 1.1583 6.95 
240 6.67 7.223 6.439 8.600 1.4333 8.60 
300 6.67 7.119 7.640 10.354 1.7256 10.35 
360 6.67 7.110 8.770 11.899 1.9832 11.90 
 
y = 0.0055x + 0.0801
R² = 0.9928
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  311 
Me4N
+
, MeCN, run 4: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.67 7.000 0.000 0.000 0.0000 0.00 
60 6.67 7.271 0.689 0.914 0.1524 0.91 
90 6.67 7.301 1.062 1.403 0.2338 1.40 
120 6.67 7.229 1.371 1.830 0.3050 1.83 
180 6.67 7.334 2.036 2.678 0.4463 2.68 
240 6.67 7.274 2.687 3.564 0.5940 3.56 
300 6.67 7.231 3.381 4.511 0.7519 4.51 
360 6.67 7.259 3.884 5.162 0.8604 5.16 
420 6.67 7.214 4.328 5.788 0.9646 5.79 
y = 0.00233x + 0.01964
R² = 0.99665
0.0
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  312 
Me4N
+
, MeCN, run 5: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.67 7.000 0.000 0.000 0.0000 0.00 
60 6.67 7.323 0.648 0.854 0.1424 0.85 
90 6.67 7.349 0.928 1.218 0.2030 1.22 
120 6.67 7.405 1.282 1.671 0.2785 1.67 
150 6.67 7.411 1.584 2.062 0.3436 2.06 
180 6.67 7.412 1.917 2.496 0.4159 2.50 
240 6.67 7.357 2.589 3.395 0.5658 3.39 
300 6.67 7.386 3.287 4.294 0.7156 4.29 
360 6.67 7.388 4.016 5.244 0.8739 5.24 
y = 0.00242x - 0.01029
R² = 0.99914
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  313 
Me4N
+
, MeCN, run 6: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.67 7.000 0.000 0.000 0.0000 0.00 
60 6.67 7.465 0.855 1.105 0.1841 1.10 
90 6.67 7.500 1.265 1.627 0.2711 1.63 
120 6.67 7.445 1.657 2.148 0.3579 2.15 
150 6.67 7.499 2.060 2.650 0.4416 2.65 
180 6.67 7.409 2.374 3.091 0.5152 3.09 
240 6.67 7.405 3.052 3.977 0.6628 3.98 
300 6.67 7.395 3.694 4.819 0.8031 4.82 
360 6.67 7.390 4.296 5.609 0.9348 5.61 
 
  314 
Et4N
+
, MeCN, run 1:  
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.67 7.000 0.000 0.000 0.0000 0.000 
30 6.67 7.016 0.675 0.928 0.1547 0.928 
60 6.67 7.044 1.300 1.780 0.2967 1.780 
90 6.67 7.000 1.995 2.743 0.4571 2.743 
120 6.67 7.000 2.629 3.623 0.6038 3.623 
180 6.67 6.955 3.910 5.423 0.9038 5.423 
240 6.67 6.896 5.007 6.974 1.1624 6.974 
300 6.67 6.877 6.180 8.593 1.4322 8.593 
360 6.67 6.877 6.869 9.636 1.6060 9.636 
y = 0.00457x + 0.03481
R² = 0.99562
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  315 
Et4N
+
, MeCN, run 2: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.67 7.000 0.000 0.000 0.0000 0.00 
30 6.67 7.138 0.690 0.933 0.1554 0.93 
60 6.67 7.112 1.335 1.810 0.3017 1.81 
90 6.67 7.110 1.941 2.634 0.4390 2.63 
120 6.67 7.103 2.557 3.473 0.5788 3.47 
180 6.67 7.043 3.614 4.949 0.8249 4.95 
240 6.67 7.030 4.628 6.351 1.0585 6.35 
300 6.67 6.989 5.512 7.609 1.2682 7.61 
360 6.67 6.965 6.319 8.753 1.4588 8.75 
y = 0.00405x + 0.05448
R² = 0.99473
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  316 
Et4N
+
, MeCN, run 3: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.67 7.000 0.000 0.000 0.0000 0.00 
30 6.67 7.231 0.603 0.804 0.1340 0.80 
60 6.67 7.108 1.157 1.570 0.2617 1.57 
90 6.67 7.144 1.814 2.449 0.4082 2.45 
120 6.67 7.102 2.340 3.179 0.5298 3.18 
180 6.67 7.114 3.460 4.692 0.7820 4.69 
240 6.67 7.034 4.541 6.228 1.0380 6.23 
300 6.67 7.048 5.621 7.694 1.2824 7.69 
360 6.67 6.918 7.178 10.017 1.6695 10.02 
 
y = 0.00448x - 0.00786
R² = 0.99663
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  317 
Et4N
+
, MeCN, run 4: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 9.34 7.000 0.000 0.000 0.0000 0.00 
30 9.34 10.122 1.225 1.634 0.2723 1.63 
60 9.34 10.090 2.205 2.950 0.4916 2.95 
90 9.34 9.993 3.115 4.208 0.7013 4.21 
120 9.34 9.843 3.818 5.236 0.8727 5.24 
150 9.34 9.866 4.510 6.171 1.0284 6.17 
180 9.34 9.792 5.114 7.051 1.1751 7.05 
240 9.34 9.779 6.122 8.452 1.4087 8.45 
300 9.34 9.729 7.064 9.803 1.6338 9.80 
 
y = 0.00584x + 0.10829
R² = 0.97832
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  318 
Et4N
+
, MeCN, run 5: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 9.338 7.000 0.000 0.000 0.0000 0.00 
30 9.338 10.078 1.116 1.494 0.2490 1.49 
60 9.338 9.858 2.137 2.926 0.4877 2.93 
90 9.338 9.817 2.972 4.087 0.6811 4.09 
120 9.338 9.807 3.690 5.079 0.8465 5.08 
150 9.338 9.798 4.349 5.993 0.9988 5.99 
180 9.338 10.055 5.077 6.817 1.1361 6.82 
240 9.338 9.707 5.882 8.181 1.3635 8.18 
300 9.338 9.579 6.787 9.565 1.5942 9.57 
 
y = 0.0057x + 0.1038
R² = 0.977
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  319 
Pr4N
+
, MeCN, run 1: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.673 7.000 0.000 0.000 0.0000 0.00 
30 6.673 7.068 0.645 0.881 0.1468 0.88 
60 6.673 7.104 1.355 1.840 0.3067 1.84 
90 6.673 7.113 2.151 2.918 0.4863 2.92 
120 6.673 7.036 3.015 4.135 0.6891 4.13 
180 6.673 6.936 4.655 6.474 1.0790 6.47 
240 6.673 7.005 6.334 8.723 1.4538 8.72 
300 6.673 6.940 7.793 10.833 1.8055 10.83 
360 6.673 6.863 9.154 12.868 2.1447 12.87 
 
y = 0.00610x - 0.03378
R² = 0.99916
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  320 
Pr4N
+
, MeCN, run 2: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.673 7.000 0.000 0.000 0.0000 0.00 
30 6.673 7.168 1.303 1.753 0.2922 1.75 
60 6.673 7.067 2.367 3.231 0.5385 3.23 
90 6.673 7.077 3.169 4.318 0.7197 4.32 
120 6.673 7.011 4.506 6.200 1.0333 6.20 
180 6.673 7.051 6.428 8.795 1.4658 8.80 
240 6.673 6.931 7.980 11.109 1.8514 11.11 
300 6.673 6.953 9.363 12.991 2.1652 12.99 
360 6.673 6.886 10.555 14.789 2.4648 14.79 
 
y = 0.00688x + 0.11494
R² = 0.99010
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  321 
Bu4N
+
, MeCN, run 1: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.466 7.000 0.000 0.000 0.0000 0.00 
30 6.466 7.396 0.941 1.189 0.1982 1.19 
45 6.466 7.400 1.487 1.878 0.3130 1.88 
60 6.466 7.444 1.962 2.464 0.4107 2.46 
90 6.466 7.408 2.799 3.532 0.5887 3.53 
120 6.466 7.347 3.417 4.345 0.7242 4.35 
150 6.466 7.328 4.500 5.741 0.9568 5.74 
180 6.466 7.290 4.890 6.270 1.0450 6.27 
210 6.466 7.272 6.007 7.723 1.2871 7.72 
240 6.466 7.268 6.846 8.806 1.4677 8.81 
300 6.466 7.293 8.099 10.382 1.7303 10.38 
 
y = 0.005172x + 0.045375
R² = 0.994981
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  322 
Bu4N
+
, MeCN, run 2: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.673 7.000 0.000 0.000 0.0000 0.00 
30 0.000 7.910 1.242 1.515 0.2525 1.51 
60 0.000 7.942 2.521 3.062 0.5104 3.06 
90 6.673 7.841 3.773 4.642 0.7737 4.64 
300 0.000 7.656 9.895 12.468 2.0781 12.47 
 
y = 0.00680x + 0.07027
R² = 0.99397
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  323 
Bu4N
+
, MeCN, run 3: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.466 7.000 0.000 0.000 0.0000 0.00 
30 6.466 7.459 1.085 1.359 0.2266 1.36 
45 6.466 7.502 1.660 2.069 0.3448 2.07 
90 6.466 7.475 2.229 2.788 0.4646 2.79 
120 6.466 7.425 3.219 4.053 0.6755 4.05 
150 6.466 7.367 3.817 4.844 0.8073 4.84 
180 6.466 7.299 4.621 5.918 0.9864 5.92 
210 6.466 7.312 5.184 6.628 1.1047 6.63 
240 6.466 7.241 5.888 7.601 1.2669 7.60 
300 6.466 7.193 7.720 10.033 1.6722 10.03 
360 6.466 7.467 8.974 11.235 1.8725 11.23 
 
y = 0.005172x + 0.045375
R² = 0.994981
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  324 
Bu4N
+
, MeCN, run 4: 
time,  
seconds 
standard,  
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 5.910 7.000 0.000 0.000 0.0000 0.00 
30 5.910 7.400 1.158 1.337 0.2228 1.34 
45 5.910 7.396 1.761 2.034 0.3391 2.03 
60 5.910 7.410 2.279 2.628 0.4380 2.63 
90 5.910 7.403 3.328 3.841 0.6402 3.84 
120 5.910 7.341 4.269 4.969 0.8282 4.97 
150 5.910 7.439 5.154 5.921 0.9868 5.92 
180 5.910 7.330 5.980 6.972 1.1619 6.97 
210 5.910 7.403 6.806 7.857 1.3095 7.86 
240 5.910 7.251 7.426 8.751 1.4584 8.75 
300 5.910 7.252 8.728 10.284 1.7140 10.28 
 
 
 
  325 
Hexyl4N
+
, MeCN, run 1: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.673 7.000 0.000 0.000 0.0000 0.00 
30 6.673 7.652 1.022 1.288 0.2147 1.29 
60 6.673 7.719 1.879 2.348 0.3914 2.35 
90 6.673 7.627 2.909 3.679 0.6132 3.68 
300 6.673 7.446 8.290 10.741 1.7901 10.74 
 
y = 0.005896x + 0.035888
R² = 0.998125
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  326 
Hexyl4N
+
, MeCN, run 2: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 5.910 7.000 0.000 0.000 0.0000 0.00 
45 5.910 7.242 0.426 0.503 0.0838 0.50 
75 5.910 7.245 0.692 0.816 0.1360 0.82 
90 5.910 7.445 0.883 1.013 0.1689 1.01 
120 5.910 7.498 1.176 1.340 0.2234 1.34 
180 5.910 7.494 1.836 2.093 0.3489 2.09 
270 5.910 7.291 2.516 2.949 0.4914 2.95 
300 5.910 7.358 2.944 3.419 0.5698 3.42 
 
y = 0.001876x - 0.000462
R² = 0.998483
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  327 
Hexyl4N
+
, MeCN, run 3: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 0.000 7.000 0.000 0.000 0.0000 0.00 
30 0.000 7.369 1.107 1.284 0.2139 1.28 
60 0.000 7.185 1.886 2.243 0.3738 2.24 
90 0.000 7.226 2.847 3.367 0.5611 3.37 
120 0.000 7.201 3.707 4.399 0.7331 4.40 
150 0.000 7.244 4.474 5.277 0.8796 5.28 
180 0.000 7.260 5.329 6.272 1.0453 6.27 
240 0.000 7.266 6.346 7.463 1.2438 7.46 
360 0.000 7.118 8.326 9.995 1.6658 9.99 
y = 0.005272x + 0.057956
R² = 0.988335
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  328 
Hexyl4N
+
, MeCN, run 4: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 5.910 7.000 0.000 0.000 0.0000 0.00 
60 5.910 7.291 1.220 1.430 0.2383 1.43 
90 5.910 7.303 1.929 2.257 0.3762 2.26 
120 5.910 7.266 2.615 3.075 0.5125 3.08 
210 5.910 7.271 4.553 5.351 0.8918 5.35 
240 5.910 7.316 5.104 5.961 0.9935 5.96 
300 5.910 7.077 5.996 7.240 1.2066 7.24 
360 5.910 7.228 7.214 8.528 1.4214 8.53 
 
y = 0.003988x + 0.017082
R² = 0.997880
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  329 
Octyl4N
+
, MeCN, run 1: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.206 7.000 0.000 0.000 0.0000 0.00 
30 6.206 7.192 0.654 0.816 0.1360 0.82 
60 6.206 7.183 1.181 1.475 0.2459 1.48 
90 6.206 7.057 1.910 2.429 0.4048 2.43 
105 6.206 7.211 2.201 2.739 0.4565 2.74 
120 6.206 6.995 2.507 3.216 0.5360 3.22 
150 6.206 7.093 3.075 3.889 0.6482 3.89 
165 6.206 6.829 3.305 4.342 0.7237 4.34 
180 6.206 6.566 3.389 4.630 0.7717 4.63 
210 6.206 6.625 3.861 5.228 0.8714 5.23 
240 6.206 6.857 4.429 5.795 0.9658 5.80 
 
y = 0.004112x + 0.018996
R² = 0.995439
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  330 
Octyl4N
+
, MeCN, run 2: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.906 7.000 0.000 0.000 0.0000 0.00 
30 6.906 7.045 0.591 0.837 0.1395 0.84 
45 6.906 6.935 0.944 1.358 0.2264 1.36 
60 6.906 6.831 1.196 1.748 0.2913 1.75 
75 6.906 5.546 1.174 2.113 0.3521 2.11 
90 6.906 6.296 1.425 2.258 0.3763 2.26 
120 6.906 7.073 2.358 3.328 0.5547 3.33 
 
y = 0.004473x + 0.008780
R² = 0.989907
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  331 
Octyl4N
+
, MeCN, run 3: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.906 7.000 0.000 0.000 0.0000 0.00 
60 6.906 7.312 0.660 0.901 0.1502 0.90 
75 6.906 7.342 0.842 1.144 0.1906 1.14 
90 6.906 7.354 0.977 1.326 0.2210 1.33 
120 6.906 7.322 1.257 1.714 0.2856 1.71 
180 6.906 7.307 1.808 2.469 0.4116 2.47 
240 6.906 6.220 1.993 3.199 0.5332 3.20 
300 6.906 6.827 2.659 3.889 0.6482 3.89 
360 6.906 7.199 3.288 4.560 0.7599 4.56 
y = 0.002108x + 0.019574
R² = 0.997028
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  332 
Kinetic Alkylation of Phenol-Phenolates in Diisopropyl Ketone (DIPK) 
Na
+
, DIPK, run 1: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product,  
µmol 
product, 
[M] x 1000 
product, 
% 
0 19.454 17.000 0.000 0.000 0.0000 0.00 
900 19.454 17.611 0.000 0.000 0.0000 0.00 
1800 19.454 18.795 0.000 0.000 0.0000 0.00 
3600 19.454 17.995 0.000 0.000 0.0000 0.00 
7200 19.454 18.012 0.364 0.568 0.0947 0.57 
10800 19.454 17.754 0.536 0.849 0.1415 0.85 
21600 19.454 18.069 1.150 1.790 0.2983 1.79 
28800 19.454 18.206 1.548 2.391 0.3986 2.39 
68400 19.454 17.763 3.649 5.778 0.9630 5.78 
79200 19.454 17.738 4.165 6.604 1.1007 6.60 
 
y = 0.000014x - 0.016529
R² = 0.998756
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  333 
Na
+
, DIPK, run 2:  
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product,  
µmol 
product, 
[M] x 1000 
product, 
% 
0 49.933 15.000 0.000 0.000 0.0000 0.00 
9000 49.933 15.335 0.528 2.486 0.4143 2.49 
14400 49.933 15.237 0.795 3.766 0.6277 3.77 
16200 49.933 15.545 0.929 4.314 0.7190 4.31 
28800 49.933 15.134 1.722 8.214 1.3690 8.21 
30600 49.933 15.404 1.857 8.703 1.4504 8.70 
 
y = 0.000048x - 0.025208
R² = 0.997854
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  334 
Na
+
, DIPK, run 3: 
time, 
seconds 
standard, 
µmol 
standard, 
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 49.933 15.000 0.000 0.000 0.0000 0.00 
9000 49.933 15.893 0.509 2.312 0.3853 2.31 
14400 49.933 16.021 0.818 3.686 0.6143 3.69 
16200 49.933 16.284 0.915 4.056 0.6760 4.06 
28800 49.933 15.240 1.712 8.109 1.3516 8.11 
30600 49.933 16.144 1.956 8.746 1.4577 8.75 
 
y = 0.000048x - 0.044664
R² = 0.995200
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  335 
Na
+
, DIPK, run 4: 
time, 
seconds 
standard, 
µmol 
standard, 
area 
product, 
area 
product,  
µmol 
product, 
[M]x1000 
product, 
% 
0 49.933 15.000 0.000 0.000 0.0000 0.00 
9000 49.933 15.943 0.554 2.508 0.4181 2.51 
14400 49.933 15.445 0.841 3.931 0.6551 3.93 
16200 49.933 16.104 1.100 4.931 0.8218 4.93 
28800 49.933 15.280 1.866 8.816 1.4693 8.82 
30600 49.933 15.380 1.976 9.275 1.5458 9.27 
 
y = 0.000051x - 0.029715
R² = 0.997306
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  336 
K
+
, DIPK, run 1: 
time, 
seconds 
standard, 
µmol 
standard, 
area 
product, 
area 
product, 
µmol 
product, 
[M] x 1000 
product, 
% 
0 15.563 7.000 0.000 0.000 0.0000 0.00 
900 15.563 20.722 0.933 1.013 0.1688 1.01 
1800 15.563 19.845 1.787 2.026 0.3377 2.03 
3600 15.563 19.518 3.571 4.117 0.6861 4.12 
7200 15.563 19.561 7.169 8.246 1.3744 8.25 
10800 15.563 19.953 10.977 12.378 2.0631 12.38 
20700 15.563 17.775 18.666 23.628 3.9380 23.63 
27900 15.563 18.030 24.128 30.110 5.0184 30.11 
 
y = 0.000183x + 0.032109
R² = 0.998601
0.0
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  337 
K
+
, DIPK, run 2: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product,  
µmol 
product, 
[M]x1000 
product, 
% 
0 6.906 7.000 0.000 0.000 0.0000 0.00 
900 6.906 6.983 0.398 0.570 0.0949 0.57 
1600 6.906 6.947 0.711 1.022 0.1704 1.02 
1900 6.906 7.028 0.886 1.259 0.2099 1.26 
2200 6.906 7.037 1.025 1.455 0.2426 1.46 
2600 6.906 7.025 1.267 1.803 0.3005 1.80 
3200 6.906 6.897 1.552 2.247 0.3745 2.25 
4200 6.906 6.946 2.067 2.958 0.4930 2.96 
6600 6.906 6.967 3.345 4.808 0.8013 4.81 
9000 6.906 6.785 4.580 6.741 1.1235 6.74 
 
y = 0.000126x - 0.024009
R² = 0.998879
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  338 
K
+
, DIPK, run 3: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]  
x 1000 
product, 
% 
0 6.906 7.000 0.000 0.000 0.0000 0.00 
1500 6.906 6.968 0.732 1.049 0.1748 1.05 
1800 6.906 7.014 0.912 1.298 0.2163 1.30 
2100 6.906 6.950 1.052 1.511 0.2518 1.51 
2400 6.906 6.966 1.234 1.769 0.2949 1.77 
3000 6.906 7.069 1.548 2.186 0.3644 2.19 
3600 6.906 6.924 1.925 2.776 0.4626 2.78 
5400 6.906 7.067 2.796 3.950 0.6583 3.95 
9000 6.906 6.805 4.525 6.640 1.1067 6.64 
 
y = 0.000123x - 0.002848
R² = 0.999315
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  339 
K
+
, DIPK, run 4: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.906 7.000 0.000 0.000 0.0000 0.00 
1500 6.906 7.195 0.685 0.950 0.1584 0.95 
1800 6.906 7.118 0.808 1.133 0.1889 1.13 
2100 6.906 7.168 0.941 1.311 0.2185 1.31 
2400 6.906 7.360 1.112 1.511 0.2518 1.51 
3000 6.906 7.097 1.387 1.953 0.3255 1.95 
3600 6.906 7.261 1.583 2.178 0.3631 2.18 
5400 6.906 7.048 2.375 3.365 0.5608 3.36 
9000 6.906 6.938 4.189 6.029 1.0048 6.03 
 
y = 0.000111x - 0.013465
R² = 0.997395
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  340 
Me4N
+
, DIPK, run 1: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.91 7.000 0.000 0.000 0.0000 0.00 
180 6.91 7.164 0.353 0.491 0.0819 0.49 
240 6.91 7.143 0.458 0.640 0.1066 0.64 
300 6.91 7.154 0.692 0.778 0.1296 0.78 
360 6.91 7.154 0.692 0.966 0.1610 0.97 
420 6.91 7.143 0.833 1.169 0.1948 1.16 
 
y = 0.00046x - 0.00145
R² = 0.99724
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  341 
Me4N
+
, DIPK, run 2: 
time, 
seconds 
standard, 
 
standard,  
area 
product, 
area 
product,  
µmol 
product, 
[M]  
x 1000 
product, 
% 
0 6.906 7.000 0.000 0.000 0.0000 0.00 
180 6.906 7.097 0.380 0.534 0.0890 0.53 
240 6.906 7.131 0.507 0.710 0.1183 0.71 
300 6.906 7.180 0.646 0.898 0.1497 0.90 
360 6.906 7.296 0.791 1.082 0.1804 1.08 
420 6.906 7.240 0.922 1.272 0.2119 1.27 
y = 0.00050x - 0.00111
R² = 0.99979
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  342 
Me4N
+
, DIPK, run 3: 
time, 
seconds 
standard, 
 
standard,  
area 
product, 
area 
product,  
µmol 
product, [M]  
x 1000 
product, 
% 
0 6.906 7.000 0.000 0.000 0.0000 0.00 
180 6.906 7.173 0.372 0.518 0.0863 0.52 
240 6.906 7.153 0.518 0.723 0.1205 0.72 
300 6.906 7.035 0.644 0.913 0.1522 0.91 
360 6.906 7.163 0.774 1.079 0.1798 1.08 
420 6.906 7.240 0.922 1.272 0.2119 1.27 
y = 0.00215x + 0.01735
R² = 0.99714
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  343 
Et4N
+
, DIPK, run 1: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.91 7.000 0.000 0.000 0.0000 0.00 
60 6.91 7.284 0.627 0.847 0.1412 0.85 
90 6.91 7.243 0.913 1.258 0.2097 1.24 
120 6.91 7.133 1.235 1.751 0.2919 1.70 
180 6.91 7.117 1.769 2.516 0.4193 2.45 
240 6.91 7.109 2.309 3.287 0.5478 3.20 
300 6.91 7.105 2.794 3.980 0.6633 3.87 
360 6.91 7.083 3.239 4.628 0.7714 4.50 
y = 0.00051x - 0.00138
R² = 0.99936
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  344 
Et4N
+
, DIPK, run 2: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.81 7.000 0.000 0.000 0.0000 0.00 
60 6.81 7.139 0.586 0.808 0.1347 0.81 
90 6.81 7.276 0.877 1.186 0.1976 1.19 
120 6.81 7.171 1.156 1.587 0.2645 1.59 
180 6.81 7.129 1.690 2.334 0.3889 2.33 
240 6.81 7.180 2.195 3.009 0.5014 3.01 
300 6.81 7.091 2.657 3.689 0.6148 3.69 
360 6.81 7.058 3.114 4.159 0.6931 4.34 
y = 0.00195x + 0.02053
R² = 0.99526
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  345 
Et4N
+
, DIPK, run 3: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.91 7.000 0.000 0.000 0.0000 0.00 
60 6.91 7.220 0.669 0.925 0.1542 0.93 
90 0.00 7.150 1.126 1.572 0.2621 1.57 
120 6.91 7.076 1.271 1.794 0.2989 1.79 
180 6.91 7.156 1.818 2.536 0.4227 2.54 
240 0.00 7.096 2.326 3.273 0.5455 3.27 
300 6.91 7.112 2.834 3.979 0.6631 3.98 
360 0.00 6.945 3.315 4.766 0.7943 4.77 
y = 0.00214x + 0.03194
R² = 0.99439
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  346 
Pr4N
+
, DIPK, run 1: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.906 7.000 0.000 0.000 0.0000 0.00 
45 6.906 7.221 0.838 1.159 0.1932 1.16 
60 6.906 7.094 1.082 1.523 0.2538 1.52 
90 6.906 7.050 1.539 2.179 0.3632 2.18 
120 6.906 7.120 1.995 2.798 0.4663 2.80 
180 6.906 7.116 2.865 4.021 0.6701 4.02 
240 6.906 7.096 3.644 5.127 0.8546 5.13 
300 6.906 6.988 4.298 6.141 1.0235 6.14 
360 6.906 6.948 4.944 7.105 1.1842 7.11 
y = 0.00325x + 0.05228
R² = 0.99478
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  347 
Pr4N
+
, DIPK, run 2: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.906 7.000 0.000 0.000 0.0000 0.00 
45 6.906 7.301 0.809 1.106 0.1843 1.11 
60 6.906 7.311 1.042 1.423 0.2372 1.42 
90 6.906 7.161 1.466 2.044 0.3407 2.04 
120 6.906 7.100 1.900 2.672 0.4453 2.67 
180 6.906 7.134 2.739 3.833 0.6388 3.83 
240 6.906 7.082 3.425 4.828 0.8047 4.83 
300 6.906 7.027 4.087 5.806 0.9677 5.81 
360 6.906 6.974 4.812 6.889 1.1482 6.89 
y = 0.00312x + 0.04548
R² = 0.99608
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Pr4N
+
, DIPK, run 3: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.906 7.000 0.000 0.000 0.0000 0.00 
45 6.906 7.270 0.752 1.033 0.1721 1.03 
60 6.906 7.291 1.002 1.372 0.2286 1.37 
90 6.906 7.224 1.405 1.942 0.3236 1.94 
120 6.906 7.136 1.877 2.626 0.4377 2.63 
180 6.906 7.032 2.647 3.759 0.6265 3.76 
240 6.906 7.154 3.392 4.734 0.7890 4.73 
300 6.906 7.036 4.147 5.885 0.9808 5.88 
360 6.906 6.962 4.639 6.652 1.1087 6.65 
y = 0.00309x + 0.03989
R² = 0.99529
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Bu4N
+
, DIPK, run 1: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 9.338 7.000 0.000 0.000 0.0000 0.00 
45 9.338 9.751 0.809 1.120 0.1867 1.12 
60 9.338 9.557 0.982 1.387 0.2311 1.39 
75 9.338 9.594 1.241 1.746 0.2910 1.75 
90 9.338 9.574 1.464 2.065 0.3441 2.06 
120 9.338 9.466 1.856 2.647 0.4412 2.65 
180 9.338 9.621 2.710 3.804 0.6340 3.80 
240 9.338 9.343 3.423 4.946 0.8243 4.95 
300 9.338 9.341 4.064 5.873 0.9789 5.87 
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Bu4N
+
, DIPK, run 2: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 9.338 7.000 0.000 0.000 0.0000 0.00 
30 9.338 9.639 0.648 0.907 0.1512 0.91 
45 0.000 9.539 0.969 1.371 0.2286 1.37 
60 9.338 9.431 1.305 1.868 0.3113 1.87 
75 9.338 9.481 1.666 2.372 0.3953 2.37 
90 0.000 9.384 1.985 2.856 0.4760 2.86 
120 9.338 9.466 2.382 3.397 0.5662 3.40 
180 9.338 9.506 3.331 4.730 0.7883 4.73 
240 0.000 9.365 4.099 5.910 0.9849 5.91 
300 9.338 9.333 4.639 6.710 1.1184 6.71 
y = 0.00372x + 0.07743
R² = 0.98102
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Bu4N
+
, DIPK, run 3: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 9.338 7.000 0.000 0.000 0.0000 0.00 
30 9.338 9.581 0.582 0.819 0.1366 0.82 
45 0.000 9.568 0.854 1.205 0.2008 1.20 
60 9.338 9.592 1.127 1.586 0.2644 1.59 
75 9.338 9.514 1.450 2.058 0.3429 2.06 
90 0.000 9.514 1.630 2.313 0.3855 2.31 
120 9.338 9.527 2.068 2.930 0.4883 2.93 
180 9.338 9.449 2.929 4.184 0.6973 4.18 
240 0.000 9.382 3.848 5.537 0.9228 5.54 
300 9.338 9.317 4.471 6.478 1.0796 6.48 
 
 
  352 
Hexyl4N
+
, DIPK, run 1: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.906 7.000 0.000 0.000 0.0000 0.00 
90 6.906 7.386 0.856 1.159 0.1931 1.16 
120 6.906 7.533 1.122 1.487 0.2478 1.49 
180 6.906 7.276 1.652 2.268 0.3779 2.27 
240 6.906 7.273 2.155 2.958 0.4929 2.96 
300 6.906 7.236 2.739 3.780 0.6299 3.78 
360 6.906 7.360 3.209 4.353 0.7255 4.35 
420 6.906 7.264 3.744 5.146 0.8577 5.15 
y = 0.002031x + 0.006509
R² = 0.999239
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  353 
Hexyl4N
+
, DIPK, run 2: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.906 7.000 0.000 0.000 0.0000 0.00 
60 6.906 7.419 0.682 0.917 0.1529 0.92 
75 6.906 7.426 0.825 1.109 0.1848 1.11 
90 6.906 7.354 1.002 1.360 0.2267 1.36 
120 6.906 7.435 1.284 1.724 0.2874 1.72 
180 6.906 7.354 1.913 2.597 0.4328 2.60 
240 6.906 7.448 2.576 3.453 0.5755 3.45 
300 6.906 7.323 3.180 4.336 0.7227 4.34 
360 6.906 7.179 3.617 5.031 0.8384 5.03 
420 6.906 7.367 4.186 5.674 0.9457 5.67 
y = 0.002279x + 0.016240
R² = 0.998061
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Hexyl4N
+
, DIPK, run 3: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.906 7.000 0.000 0.000 0.0000 0.00 
60 6.906 7.230 0.744 1.029 0.1715 1.03 
75 6.906 7.106 0.965 1.355 0.2259 1.36 
90 6.906 7.239 1.152 1.588 0.2647 1.59 
120 6.906 7.116 1.436 2.015 0.3358 2.01 
180 6.906 7.451 2.164 2.899 0.4831 2.90 
240 6.906 7.295 2.905 3.976 0.6627 3.98 
300 6.906 7.309 3.416 4.668 0.7781 4.67 
360 6.906 7.221 4.020 5.556 0.9260 5.56 
420 6.906 7.102 4.433 6.232 1.0387 6.23 
y = 0.002475x + 0.032061
R² = 0.996511
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Octyl4N
+
, DIPK, run 1: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.906 7.000 0.000 0.000 0.0000 0.00 
60 6.906 7.297 0.595 0.813 0.1356 0.81 
75 6.906 7.157 0.790 1.102 0.1836 1.10 
90 6.906 7.010 0.945 1.346 0.2243 1.35 
120 6.906 7.146 1.175 1.642 0.2736 1.64 
150 6.906 7.053 1.487 2.112 0.3520 2.11 
210 6.906 7.049 1.980 2.802 0.4670 2.80 
270 6.906 7.144 2.706 3.784 0.6306 3.78 
330 6.906 7.173 3.246 4.517 0.7529 4.52 
360 6.906 7.099 3.401 4.783 0.7972 4.78 
 
y = 0.002234x + 0.009723
R² = 0.998153
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Octyl4N
+
, DIPK, run 2: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 7.198 7.000 0.000 0.000 0.0000 0.00 
90 7.198 7.254 0.816 1.172 0.1953 1.17 
120 7.198 7.356 1.050 1.486 0.2476 1.49 
180 7.198 7.269 1.521 2.178 0.3629 2.18 
240 7.198 7.169 2.053 2.982 0.4969 2.98 
300 7.198 7.060 2.481 3.657 0.6095 3.66 
360 7.198 7.284 3.074 4.391 0.7318 4.39 
 
y = 0.002035x + 0.001960
R² = 0.999694
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  357 
Octyl4N
+
, DIPK, run 3: 
time, 
seconds 
standard, 
µmol 
standard,  
area 
product, 
area 
product, 
µmol 
product, 
[M]x1000 
product, 
% 
0 6.906 7.000 0.000 0.000 0.0000 0.00 
60 6.906 7.312 0.660 0.901 0.1502 0.90 
75 6.906 7.342 0.842 1.144 0.1906 1.14 
90 6.906 7.354 0.977 1.326 0.2210 1.33 
120 6.906 7.322 1.257 1.714 0.2856 1.71 
180 6.906 7.307 1.808 2.469 0.4116 2.47 
240 6.906 6.220 1.993 3.199 0.5332 3.20 
300 6.906 6.827 2.659 3.889 0.6482 3.89 
360 6.906 7.199 3.288 4.560 0.7599 4.56 
 
y = 0.002108x + 0.019574
R² = 0.997028
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Summary Table for Ammonium Phenoxide Alkylation Under Homogeneous Conditions 
compound 
number 
cation, Y
+
 R solvent 
ki, s
-1
 
log(ki/kNa-DIPK) log(ki/kNa-CH3CN) log(ki/kNa-DIPK) x 10,000 
43 Na+ - DIPK 0.03±0.001 0  0.00±0.02 
44 K+ - DIPK 0.09±0.021 0.46  0.46±0.02 
37 R4N
+ methyl DIPK 0.24±0.096 0.9  0.90±0.10 
38 R4N
+ ethyl DIPK 1.91±0.10 1.81  1.81±0.02 
39 R4N
+ n-propyl DIPK 1.97±0.05 1.81  1.81±0.01 
40 R4N
+ n-butyl DIPK 2.20±0.10 1.86  1.86±0.03 
41 R4N
+ n-hexyl DIPK 1.41±0.10 1.66  1.66±0.04 
42 R4N
+ n-octyl DIPK 1.36±0.06 1.64  1.64±0.02 
43 Na+ - CH3CN 0.215±0.02  0 0.85±0.04 
44 K+ - CH3CN 1.98±0.1  0.96 1.81±0.03 
37 R4N
+ methyl CH3CN 1.9±0.1  0.91 1.76±0.06 
38 R4N
+ ethyl CH3CN 2.77±0.07  1.11 1.96±0.03 
39 R4N
+ n-propyl CH3CN 3.16±0.06  1.16 2.01±0.08 
40 R4N
+ n-butyl CH3CN 3.37±0.05  1.19 2.04±0.02 
41 R4N
+ n-hexyl CH3CN 3.14±0.09  1.16 2.01±0.09 
42 R4N
+ n-octyl CH3CN 2.23±0.09  0.99 1.84±0.17 
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5.4.4 Catalyst Survey Kinetics 
 To a 4 mL dram vial, the respective quaternary ammonium bromide (4.1 to 29.6 mg, 26.6 
to 53.1 μmol) was added followed by a solution of phenol (50 mg, 531 μmol) and biphenyl (20.4 
to 20.7 mg, 132 to 134 μmol) in 2,4-dimethyl-3-pentanone (2.0 mL).  A 5 M aqueous KOH 
solution (0.70 mL) was then added followed by the addition of a 1.5 cm egg-shaped magnetic 
stir-bar.  A septa screw-cap was then installed on the vial. 
 This vial was placed on a silicone oil bath kept at 40-42 °C on a hotplate/stirrer and was 
allowed to come to temperature with moderate stirring for at least 30 minutes.  To start the 
reaction, n-butyl bromide (68 μL, 637 μmol, 1.2 equiv) was added via syringe and the stirring 
speed was set to maximum (~2000 rpm). 
 Reaction aliquots were withdrawn directly from the organic phase (15-20 μL) 
approximately 2 seconds after the reaction had stopped stirring.  Aliquots were quenched in a 
biphasic mixture of ethyl acetate (1-2 mL) and a saturated aqueous ammonium chloride solution 
(1-2 mL).  After a quick mixing via pipette the organic phase was passed through a silica gel 
plug (1-2 cm x 0.5 cm) into a vial and used directly for GC analysis (GC Method 1). 
  360 
Background Reaction, Run #1: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.00E+00 0.00E+00 0.0 
1380 82800 134 18000.668 532.301 5.7 5.73E-06 2.86E-03 1.1 
2760 165600 134 21154.184 1059.274 9.7 9.70E-06 4.85E-03 1.8 
4260 255600 134 19539.275 1471.788 14.6 1.46E-05 7.30E-03 2.7 
5640 338400 134 20528.344 2147.449 20.3 2.03E-05 1.01E-02 3.8 
7140 428400 134 20009.566 2721.034 26.3 2.63E-05 1.32E-02 5.0 
          0.0036 6.00E-11 3.00E-08   
          Rate 
(μmol/min) Rate (mol/s) 
Rate 
(mol/L*s) 
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Background Reaction, Run #2: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-
Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.00E+00 0.00E+00 0.0 
1380 82800 134 21059.742 563.531 5.2 5.18E-06 2.59E-03 1.0 
2760 165600 134 21483.316 953.002 8.6 8.59E-06 4.30E-03 1.6 
4260 255600 134 23499.623 1855.842 15.3 1.53E-05 7.65E-03 2.9 
5640 338400 134 24459.049 2567.105 20.3 2.03E-05 1.02E-02 3.8 
7140 428400 134 23474.443 3027.089 25.0 2.50E-05 1.25E-02 4.7 
          3.57E-03 5.94E-11 2.97E-08   
          Rate (μmol/min) Rate (mol/s) Rate (mol/L*s)   
 
Mean alkylation rate = 2.99*10-8 (mol*L-1*s-1) 
Std. Dev. alkylation rate = 1.86*10-10 (mol*L-1*s-1) 
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Tetramethylammonium Bromide (0.05 equivalents), Run #1: 
 
Time 
(h) 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
21 1260 75600 134 20060.613 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
44 2640 158400 134 20029.234 1133.176 11.0 1.0960E-05 5.4801E-03 2.1 
53 3180 190800 134 21138.584 1377.045 12.6 1.2620E-05 6.3099E-03 2.4 
75 4500 270000 134 21437.701 1842.787 16.7 1.6653E-05 8.3263E-03 3.1 
92 5520 331200 134 20137.510 2140.704 20.6 2.0594E-05 1.0297E-02 3.9 
116 6960 417600 134 21719.225 2822.385 25.2 2.5174E-05 1.2587E-02 4.7 
140 8400 504000 134 23890.166 3690.465 29.9 2.9926E-05 1.4963E-02 5.6 
164 9850 591000 134 24804.859 4607.494 36.0 3.5984E-05 1.7992E-02 6.8 
            3.4310E-03 5.7183E-11 2.8591E-08   
            Rate 
(μmol/min) 
Rate (mol/s) 
Rate 
(mol*L
-1
*s
-1
) 
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Tetramethylammonium Bromide (0.05 equivalents), Run #2: 
 
Time 
(h) 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-
Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
21 1260 75600 134 19966.896 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
44 2640 158400 134 21664.426 1121.914 10.0 1.0032E-05 5.0161E-03 1.9 
53 3180 190800 134 22068.523 1440.381 12.6 1.2644E-05 6.3220E-03 2.4 
75 4500 270000 134 20048.412 1735.472 16.8 1.6770E-05 8.3848E-03 3.2 
92 5520 331200 134 22057.816 2255.092 19.8 1.9805E-05 9.9027E-03 3.7 
116 6960 417600 134 23611.295 2932.789 24.1 2.4063E-05 1.2031E-02 4.5 
140 8400 504000 134 23097.730 3484.897 29.2 2.9228E-05 1.4614E-02 5.5 
164 9850 591000 134 23780.686 4049.721 33.0 3.2990E-05 1.6495E-02 6.2 
            3.1553E-03 5.2588E-11 2.6294E-08   
            Rate 
(μmol/min) 
Rate (mol/s) Rate (mol*L
-1
*s
-1
)   
 
Mean alkylation rate = 2.74*10-8 (mol*L-1*s-1) 
Std. Dev. alkylation rate = 1.62*10-9 (mol*L-1*s-1) 
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Tetraethylammonium Bromide (0.05 equivalents), Run #1: 
 
Time 
(h) 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 0 132 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
19 1140 68400 132 17414.016 1625.749 17.8 1.7816E-05 8.9079E-03 3.4 
24 1440 86400 132 18371.736 2364.149 24.6 2.4557E-05 1.2279E-02 4.6 
28 1680 100800 132 13959.378 2219.996 30.3 3.0349E-05 1.5174E-02 5.7 
43 2580 154800 132 17251.484 3777.865 41.8 4.1790E-05 2.0895E-02 7.9 
48 2880 172800 132 17583.271 4442.323 48.2 4.8213E-05 2.4106E-02 9.1 
55 3300 198000 132 17524.023 4876.349 53.1 5.3102E-05 2.6551E-02 10.0 
67 4020 241200 132 16557.992 5854.275 67.5 6.7471E-05 3.3736E-02 12.7 
75 4500 270000 132 16183.960 6259.519 73.8 7.3809E-05 3.6904E-02 13.9 
            1.6309E-02 2.7181E-10 1.3591E-07   
            Rate 
(μmol/min) 
Rate (mol/s) Rate (mol*L
-1
*s
-1
)   
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Tetraethylammonium Bromide (0.05 equivalents), Run #2: 
 
Time 
(h) 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 0 132 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
19 1140 68400 132 18497.441 1859.863 19.2 1.9188E-05 9.5938E-03 3.6 
24 1440 86400 132 16267.138 2120.483 24.9 2.4876E-05 1.2438E-02 4.7 
28 1680 100800 132 13267.677 1982.330 28.5 2.8512E-05 1.4256E-02 5.4 
43 2580 154800 132 16960.045 3994.921 45.0 4.4950E-05 2.2475E-02 8.5 
48 2880 172800 132 17910.084 4705.736 50.1 5.0140E-05 2.5070E-02 9.4 
55 3300 198000 132 17149.270 5223.124 58.1 5.8121E-05 2.9061E-02 10.9 
67 4020 241200 132 17440.840 6306.243 69.0 6.9001E-05 3.4501E-02 13.0 
75 4500 270000 132 18916.951 7931.071 80.0 8.0008E-05 4.0004E-02 15.1 
            1.7803E-02 2.9672E-10 1.4836E-07   
            Rate 
(μmol/min) 
Rate (mol/s) Rate (mol*L
-1
*s
-1
)   
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Tetraethylammonium Bromide (0.05 equivalents), Run #3: 
 
Time 
(h) 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 0 133 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
16 960 57600 133 13775.634 1164.866 16.3 1.6259E-05 8.1295E-03 3.1 
27 1620 97200 133 18171.801 2637.678 27.9 2.7910E-05 1.3955E-02 5.2 
45 2700 162000 133 15997.878 3974.793 47.8 4.7773E-05 2.3886E-02 9.0 
68 4080 244800 133 15771.731 5845.070 71.3 7.1259E-05 3.5630E-02 13.4 
88 5280 316800 133 16996.545 7545.832 85.4 8.5364E-05 4.2682E-02 16.0 
            1.6284E-02 2.7141E-10 1.3570E-07   
            Rate 
(μmol/min) 
Rate (mol/s) Rate (mol*L
-1
*s
-1
)   
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Tetraethylammonium Bromide (0.05 equivalents), Run #4: 
 
Time 
(h) 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 0 133 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
16 960 57600 133 15902.801 1292.565 15.6 1.5628E-05 7.8141E-03 2.9 
27 1620 97200 133 16994.441 2350.526 26.6 2.6594E-05 1.3297E-02 5.0 
45 2700 162000 133 16510.598 3820.847 44.5 4.4497E-05 2.2248E-02 8.4 
68 4080 244800 133 18948.859 6179.663 62.7 6.2706E-05 3.1353E-02 11.8 
88 5280 316800 133 17013.270 7131.009 80.6 8.0592E-05 4.0296E-02 15.1 
            1.4894E-02 2.4824E-10 1.2412E-07   
            Rate 
(μmol/min) 
Rate (mol/s) Rate (mol*L
-1
*s
-1
)   
 
Mean alkylation rate = 1.36*10-7 (mol*L-1*s-1) 
Std. Dev. alkylation rate = 9.90*10-9 (mol*L-1*s-1) 
  368 
Tetra(n-propyl)ammonium Bromide (0.05 equivalents), Run #1: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 132 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
15 900 132 18822.996 608.495 6.2 6.1691E-06 3.0845E-03 1.2 
30 1800 132 19753.721 1303.879 12.6 1.2596E-05 6.2981E-03 2.4 
45 2700 132 19617.428 1892.916 18.4 1.8414E-05 9.2069E-03 3.5 
60 3600 132 19687.752 2703.854 26.2 2.6208E-05 1.3104E-02 4.9 
90 5400 132 21077.332 4272.436 38.7 3.8682E-05 1.9341E-02 7.3 
120 7200 132 20215.801 5527.928 52.2 5.2182E-05 2.6091E-02 9.8 
187 11220 132 22014.656 9312.616 80.7 8.0726E-05 4.0363E-02 15.2 
          4.3533E-01 7.2555E-09 3.6278E-06   
          Rate 
(μmol/min) 
Rate (mol/s) Rate (mol*L
-1
*s
-1
)   
 
  369 
Tetra(n-propyl)ammonium Bromide (0.05 equivalents), Run #2: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 132 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
12 720 132 20379.836 737.315 6.9 6.9041E-06 3.4520E-03 1.3 
24 1440 132 18766.324 813.123 8.3 8.2685E-06 4.1343E-03 1.6 
36 2160 132 21809.865 1660.214 14.5 1.4527E-05 7.2633E-03 2.7 
48 2880 132 19263.789 1947.858 19.3 1.9296E-05 9.6480E-03 3.6 
60 3600 132 19488.670 2584.348 25.3 2.5306E-05 1.2653E-02 4.8 
72 4320 132 19766.701 3154.050 30.4 3.0450E-05 1.5225E-02 5.7 
84 5040 132 23830.998 4639.583 37.2 3.7153E-05 1.8576E-02 7.0 
96 5760 132 18739.170 4151.652 42.3 4.2279E-05 2.1139E-02 8.0 
108 6480 132 19802.281 5000.891 48.2 4.8193E-05 2.4097E-02 9.1 
120 7200 132 19638.748 5506.706 53.5 5.3509E-05 2.6755E-02 10.1 
          4.5272E-01 7.5454E-09 3.7727E-06   
          
Rate 
(μmol/min) 
Rate (mol/s) Rate (mol*L
-1
*s
-1
)   
 
  370 
Tetra(n-propyl)ammonium Bromide (0.05 equivalents), Run #3: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-
Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 132 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
12 720 132 22757.387 664.239 5.6 5.5700E-06 2.7850E-03 1.0 
24 1440 132 18992.676 940.222 9.4 9.4471E-06 4.7235E-03 1.8 
36 2160 132 18804.895 1393.647 14.1 1.4143E-05 7.0714E-03 2.7 
48 2880 132 20526.416 2029.130 18.9 1.8865E-05 9.4323E-03 3.6 
60 3600 132 18308.018 2199.208 22.9 2.2923E-05 1.1462E-02 4.3 
72 4320 132 20383.789 2967.208 27.8 2.7779E-05 1.3889E-02 5.2 
84 5040 132 19019.729 3210.219 32.2 3.2209E-05 1.6105E-02 6.1 
96 5760 132 19091.594 3706.319 37.0 3.7047E-05 1.8523E-02 7.0 
108 6480 132 19577.986 4303.996 42.0 4.1952E-05 2.0976E-02 7.9 
120 7200 132 18042.338 4533.514 48.0 4.7951E-05 2.3975E-02 9.0 
          3.8807E-01 6.4678E-09 3.2339E-06   
          
Rate 
(μmol/min) 
Rate (mol/s) Rate (mol*L
-1
*s
-1
)   
 
  371 
Tetra(n-propyl)ammonium Bromide (0.05 equivalents), Run #4: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-
Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
12 720 134 18210.188 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
24 1440 134 18531.648 869.086 9.1 9.0851E-06 4.5426E-03 1.7 
36 2160 134 17067.246 1283.855 14.6 1.4573E-05 7.2863E-03 2.7 
48 2880 134 17912.191 1850.186 20.0 2.0010E-05 1.0005E-02 3.8 
60 3600 134 16681.412 2156.954 25.0 2.5049E-05 1.2525E-02 4.7 
72 4320 134 18994.670 2935.339 29.9 2.9937E-05 1.4969E-02 5.6 
84 5040 134 18774.553 3337.103 34.4 3.4434E-05 1.7217E-02 6.5 
96 5760 134 16841.502 3475.806 40.0 3.9981E-05 1.9991E-02 7.5 
108 6480 134 17945.006 4191.219 45.2 4.5246E-05 2.2623E-02 8.5 
120 7200 134 19587.809 5155.014 51.0 5.0983E-05 2.5492E-02 9.6 
          4.2908E-01 7.1514E-09 3.5757E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
Mean alkylation rate = 3.55*10-6 (mol*L-1*s-1) 
Std. Dev. alkylation rate = 2.28*10-7 (mol*L-1*s-1) 
  372 
Tetra(n-butyl)ammonium Bromide (0.05 equivalents), Run #1: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 132.0 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
2 120 132.0 15621.172 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
4 240 132.0 15957.985 756.020 9.0 9.0408E-06 4.5204E-03 1.7 
6 360 132.0 15363.379 1174.770 14.6 1.4592E-05 7.2961E-03 2.7 
8 480 132.0 16118.517 1609.172 19.1 1.9052E-05 9.5258E-03 3.6 
10 600 132.0 14945.260 1789.216 22.8 2.2846E-05 1.1423E-02 4.3 
12 720 132.0 15437.999 2224.325 27.5 2.7495E-05 1.3748E-02 5.2 
14 840 132.0 14088.265 2438.603 33.0 3.3032E-05 1.6516E-02 6.2 
16 960 132.0 15432.511 3069.000 38.0 3.7950E-05 1.8975E-02 7.1 
18 1080 132.0 14637.714 3319.178 43.3 4.3272E-05 2.1636E-02 8.1 
20 1200 132.0 16727.932 4320.749 49.3 4.9291E-05 2.4646E-02 9.3 
          2.4585E+00 4.0976E-08 2.0488E-05   
          Rate 
(μmol/min) 
Rate (mol/s) Rate (mol*L
-1
*s
-1
)   
 
  373 
Tetra(n-butyl)ammonium Bromide (0.05 equivalents), Run #2: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-
Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 132.0 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
2 120 132.0 16591.078 640.342 7.4 7.3653E-06 3.6826E-03 1.4 
4 240 132.0 20913.287 1319.675 12.0 1.2042E-05 6.0210E-03 2.3 
6 360 132.0 16104.247 1509.696 17.9 1.7890E-05 8.9448E-03 3.4 
8 480 132.0 16265.122 1930.510 22.6 2.2650E-05 1.1325E-02 4.3 
10 600 132.0 16589.773 2433.773 28.0 2.7996E-05 1.3998E-02 5.3 
12 720 132.0 16976.654 3029.749 34.1 3.4057E-05 1.7029E-02 6.4 
14 840 132.0 15814.946 3214.189 38.8 3.8784E-05 1.9392E-02 7.3 
16 960 132.0 17102.354 4040.927 45.1 4.5090E-05 2.2545E-02 8.5 
18 1080 132.0 17426.592 4628.763 50.7 5.0688E-05 2.5344E-02 9.5 
20 1200 132.0 17858.295 5400.289 57.7 5.7707E-05 2.8854E-02 10.9 
          2.7699E+00 4.6165E-08 2.3082E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  374 
Tetra(n-butyl)ammonium Bromide (0.05 equivalents), Run #3: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-
Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 132 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
2 120 132 24062.645 546.988 4.3 4.3380E-06 2.1690E-03 0.8 
4 240 132 19211.037 967.760 9.6 9.6132E-06 4.8066E-03 1.8 
6 360 132 20913.420 1508.631 13.8 1.3766E-05 6.8830E-03 2.6 
8 480 132 20446.957 1890.851 17.6 1.7647E-05 8.8237E-03 3.3 
10 600 132 20848.557 2371.605 21.7 2.1708E-05 1.0854E-02 4.1 
12 720 132 19769.068 2659.623 25.7 2.5674E-05 1.2837E-02 4.8 
14 840 132 19474.953 3013.777 29.5 2.9532E-05 1.4766E-02 5.6 
16 960 132 21764.037 3929.550 34.5 3.4455E-05 1.7228E-02 6.5 
18 1080 132 21847.590 4511.358 39.4 3.9405E-05 1.9703E-02 7.4 
20 1200 132 21726.320 5063.462 44.5 4.4475E-05 2.2237E-02 8.4 
          2.1601E+00 3.6002E-08 1.8001E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
 
  375 
Tetra(n-butyl)ammonium Bromide (0.05 equivalents), Run #4: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 132 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
4 240 132 22249.770 1092.949 9.4 9.3740E-06 4.6870E-03 1.8 
6 360 132 20966.783 1548.639 14.1 1.4095E-05 7.0476E-03 2.7 
8 480 132 20990.369 1910.011 17.4 1.7365E-05 8.6824E-03 3.3 
10 600 132 20985.277 2321.097 21.1 2.1107E-05 1.0554E-02 4.0 
12 720 132 20912.549 2833.490 25.9 2.5856E-05 1.2928E-02 4.9 
14 840 132 20521.619 3257.438 30.3 3.0291E-05 1.5146E-02 5.7 
16 960 132 21514.344 3919.235 34.8 3.4764E-05 1.7382E-02 6.5 
18 1080 132 21670.379 4431.456 39.0 3.9024E-05 1.9512E-02 7.3 
20 1200 132 20554.740 4631.587 43.0 4.3000E-05 2.1500E-02 8.1 
          2.1106E+00 3.5177E-08 1.7588E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
Mean alkylation rate = 1.98 x 10-5 (mol*L-1*s-1) 
Std. Dev. alkylation rate = 2.54 x 10-6 (mol*L-1*s-1) 
  376 
Tetra(n-hexyl)ammonium Bromide (0.05 equivalents), Run #1: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-
Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 132 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
3 180 132 17780.926 562.245 6.0 6.0343E-06 3.0171E-03 1.1 
6 360 132 17775.883 1077.838 11.6 1.1571E-05 5.7855E-03 2.2 
9 540 132 18549.613 1755.370 18.1 1.8059E-05 9.0293E-03 3.4 
12 720 132 17165.291 2136.299 23.7 2.3750E-05 1.1875E-02 4.5 
15 900 132 20682.494 3460.648 31.9 3.1931E-05 1.5965E-02 6.0 
18 1080 132 18365.193 3589.561 37.3 3.7299E-05 1.8650E-02 7.0 
21 1260 132 19137.742 4302.681 42.9 4.2904E-05 2.1452E-02 8.1 
24 1440 132 19944.793 5252.229 50.3 5.0253E-05 2.5127E-02 9.5 
27 1620 132 19583.066 5856.311 57.1 5.7068E-05 2.8534E-02 10.7 
30 1800 132 22480.775 7623.636 64.7 6.4715E-05 3.2357E-02 12.2 
          2.1624E+00 3.6041E-08 1.8020E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  377 
Tetra(n-hexyl)ammonium Bromide (0.05 equivalents), Run #2: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 132 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
3 180 132 18885.441 841.258 8.5 8.5007E-06 4.2503E-03 1.6 
6 360 132 19229.857 1237.680 12.3 1.2282E-05 6.1412E-03 2.3 
9 540 132 19255.857 1893.360 18.8 1.8764E-05 9.3819E-03 3.5 
12 720 132 18878.090 2390.944 24.2 2.4169E-05 1.2085E-02 4.6 
15 900 132 20511.934 3417.555 31.8 3.1795E-05 1.5898E-02 6.0 
18 1080 132 20971.201 4103.237 37.3 3.7338E-05 1.8669E-02 7.0 
21 1260 132 19565.414 4488.589 43.8 4.3780E-05 2.1890E-02 8.2 
24 1440 132 18694.328 4964.882 50.7 5.0682E-05 2.5341E-02 9.5 
27 1620 132 21175.969 6478.634 58.4 5.8384E-05 2.9192E-02 11.0 
30 1800 132 19731.643 6662.090 64.4 6.4432E-05 3.2216E-02 12.1 
          2.1213E+00 3.5355E-08 1.7678E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  378 
Tetra(n-hexyl)ammonium Bromide (0.05 equivalents), Run #3: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 132 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
3 180 132 16910.492 608.387 6.9 6.8656E-06 3.4328E-03 1.3 
6 360 132 18094.947 1212.190 12.8 1.2784E-05 6.3920E-03 2.4 
9 540 132 18019.420 1687.266 17.9 1.7869E-05 8.9344E-03 3.4 
12 720 132 17973.168 2253.632 23.9 2.3928E-05 1.1964E-02 4.5 
15 900 132 18338.520 2856.433 29.7 2.9724E-05 1.4862E-02 5.6 
18 1080 132 17691.598 3336.920 36.0 3.5994E-05 1.7997E-02 6.8 
21 1260 132 17828.934 3974.319 42.5 4.2539E-05 2.1270E-02 8.0 
24 1440 132 18024.189 4570.026 48.4 4.8385E-05 2.4193E-02 9.1 
27 1620 132 17297.961 4915.972 54.2 5.4233E-05 2.7117E-02 10.2 
30 1800 132 17376.840 5425.734 59.6 5.9585E-05 2.9793E-02 11.2 
          1.9784E+00 3.2973E-08 1.6487E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  379 
Tetra(n-hexyl)ammonium Bromide (0.05 equivalents), Run #4: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 132 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
3 180 132 17941.457 613.306 6.5 6.5234E-06 3.2617E-03 1.2 
6 360 132 18011.992 1114.191 11.8 1.1805E-05 5.9023E-03 2.2 
9 540 132 18316.498 1686.764 17.6 1.7574E-05 8.7869E-03 3.3 
12 720 132 18952.941 2208.558 22.2 2.2237E-05 1.1119E-02 4.2 
15 900 132 18859.777 2925.014 29.6 2.9597E-05 1.4798E-02 5.6 
18 1080 132 19396.598 3530.699 34.7 3.4737E-05 1.7368E-02 6.5 
21 1260 132 18153.938 4048.538 42.6 4.2558E-05 2.1279E-02 8.0 
24 1440 132 18385.504 4602.769 47.8 4.7774E-05 2.3887E-02 9.0 
27 1620 132 17753.719 4931.075 53.0 5.3003E-05 2.6502E-02 10.0 
30 1800 132 18245.191 5675.559 59.4 5.9363E-05 2.9681E-02 11.2 
          1.9819E+00 3.3032E-08 1.6516E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
Mean alkylation rate = 1.72*10-5 (mol*L-1*s-1) 
Std. Dev. alkylation rate = 7.91*10-7 (mol*L-1*s-1) 
  380 
Tetra(n-octyl)ammonium Bromide (0.05 equivalents), Run #1: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 132.0 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
3 180 132.0 18326.430 748.054 7.8 7.7895E-06 3.8947E-03 1.5 
6 360 132.0 18523.816 1569.206 16.2 1.6166E-05 8.0830E-03 3.0 
9 540 132.0 18666.947 2384.030 24.4 2.4372E-05 1.2186E-02 4.6 
12 720 132.0 18970.623 3101.016 31.2 3.1194E-05 1.5597E-02 5.9 
15 900 132.0 18743.129 3805.236 38.7 3.8743E-05 1.9371E-02 7.3 
18 1080 132.0 18143.180 4280.708 45.0 4.5025E-05 2.2513E-02 8.5 
21 1260 132.0 17908.512 4984.355 53.1 5.3113E-05 2.6557E-02 10.0 
24 1440 132.0 19779.768 6075.881 58.6 5.8619E-05 2.9310E-02 11.0 
27 1620 132.0 18690.652 6353.627 64.9 6.4871E-05 3.2435E-02 12.2 
30 1800 132.0 18629.602 7069.021 72.4 7.2412E-05 3.6206E-02 13.6 
          2.3552 3.9253E-08 1.9626E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  381 
Tetra(n-octyl)ammonium Bromide (0.05 equivalents), Run #2: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 132.0 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
3 180 132.0 19269.652 700.652 6.9 6.9387E-06 3.4694E-03 1.3 
6 360 132.0 19649.195 1509.247 14.7 1.4658E-05 7.3289E-03 2.8 
9 540 132.0 20258.846 2314.564 21.8 2.1803E-05 1.0901E-02 4.1 
12 720 132.0 19426.961 2904.022 28.5 2.8526E-05 1.4263E-02 5.4 
15 900 132.0 19096.477 3581.094 35.8 3.5786E-05 1.7893E-02 6.7 
18 1080 132.0 20357.695 4519.990 42.4 4.2370E-05 2.1185E-02 8.0 
21 1260 132.0 19987.555 5078.420 48.5 4.8487E-05 2.4243E-02 9.1 
24 1440 132.0 20373.727 5782.203 54.2 5.4160E-05 2.7080E-02 10.2 
27 1620 132.0 20251.730 6632.335 62.5 6.2497E-05 3.1248E-02 11.8 
30 1800 132.0 19183.154 6779.519 67.4 6.7442E-05 3.3721E-02 12.7 
          2.2377E+00 3.7295E-08 1.8647E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  382 
Tetra(n-octyl)ammonium Bromide (0.05 equivalents), Run #3: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 132 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
3 180 132 18317.436 580.605 6.0 6.0488E-06 3.0244E-03 1.1 
6 360 132 18806.389 1206.228 12.2 1.2240E-05 6.1199E-03 2.3 
9 540 132 19164.662 1888.988 18.8 1.8810E-05 9.4048E-03 3.5 
12 720 132 20264.848 2497.524 23.5 2.3519E-05 1.1759E-02 4.4 
15 900 132 19576.225 3047.416 29.7 2.9707E-05 1.4853E-02 5.6 
18 1080 132 19448.631 3739.889 36.7 3.6696E-05 1.8348E-02 6.9 
21 1260 132 18219.752 4160.171 43.6 4.3573E-05 2.1787E-02 8.2 
24 1440 132 17836.674 4643.236 49.7 4.9677E-05 2.4839E-02 9.4 
27 1620 132 19029.469 5586.287 56.0 5.6021E-05 2.8010E-02 10.6 
30 1800 132 18115.148 5880.961 62.0 6.1952E-05 3.0976E-02 11.7 
          2.1 3.4717E-08 1.7358E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  383 
Tetra(n-octyl)ammonium Bromide (0.05 equivalents), Run #4: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
(n-Bu)OPh 
Area 
(n-Bu)OPh 
(μmol) 
(n-Bu)OPh 
(mol) 
(n-Bu)OPh 
(mol/L) 
% 
conversion 
0 0 132 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
3 180 132 19202.187 666.477 6.6 6.6235E-06 3.3117E-03 1.2 
6 360 132 18307.521 1143.449 11.9 1.1919E-05 5.9595E-03 2.2 
9 540 132 19446.437 1785.877 17.5 1.7525E-05 8.7626E-03 3.3 
12 720 132 18387.725 2260.998 23.5 2.3465E-05 1.1733E-02 4.4 
15 900 132 19146.879 2863.752 28.5 2.8542E-05 1.4271E-02 5.4 
18 1080 132 20514.203 3670.185 34.1 3.4142E-05 1.7071E-02 6.4 
21 1260 132 18363.830 3958.304 41.1 4.1134E-05 2.0567E-02 7.7 
24 1440 132 19427.721 4772.564 46.9 4.6879E-05 2.3440E-02 8.8 
27 1620 132 18628.213 5168.787 53.0 5.2950E-05 2.6475E-02 10.0 
30 1800 132 20172.975 6154.693 58.2 5.8222E-05 2.9111E-02 11.0 
          1.9333E+00 3.2222E-08 1.6111E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
Mean alkylation rate = 1.79 x 10-5 (mol*L-1*s-1) 
Std. Dev. alkylation rate = 1.53 x 10-6 (mol*L-1*s-1) 
  384 
Tetra(n-propyl)ammonium Bromide (0.10 equivalents), Run #1: 
 
Time 
(m) 
Time 
(s) 
BuOPh 
Area 
Ph2 Area 
Ph2 
(μmol) 
BuOPh (μmol) BuOPh (mol) BuOPh (mol/L) 
% 
BuOPh 
0 0 0.00000E+00 1.00000E+00 53.1 0.00 0.0000E+00 0.0000E+00 0.0 
8 480 0.00000E+00 7.80588E+03 53.1 0.00 0.0000E+00 0.0000E+00 0.0 
16 960 7.11030E+02 8.11791E+03 53.1 6.72 6.7238E-06 3.3619E-03 1.3 
24 1440 1.48136E+03 8.23338E+03 53.1 13.81 1.3812E-05 6.9060E-03 2.6 
32 1920 2.37177E+03 9.56143E+03 53.1 19.04 1.9042E-05 9.5212E-03 3.6 
40 2400 3.37955E+03 9.01435E+03 53.1 28.78 2.8780E-05 1.4390E-02 5.4 
48 2880 3.35195E+03 8.13227E+03 53.1 31.64 3.1642E-05 1.5821E-02 6.0 
56 3360 4.99929E+03 8.84425E+03 53.1 43.39 4.3393E-05 2.1697E-02 8.2 
64 3840 6.14175E+03 9.66288E+03 53.1 48.79 4.8793E-05 2.4397E-02 9.2 
72 4320 6.65866E+03 9.30460E+03 53.1 54.94 5.4937E-05 2.7468E-02 10.3 
80 4800 7.26408E+03 9.05144E+03 53.1 61.61 6.1608E-05 3.0804E-02 11.6 
          8.6880E-01 1.4480E-08 7.2400E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  385 
Tetra(n-propyl)ammonium Bromide (0.10 equivalents), Run #2: 
 
Time 
(m) 
Time 
(s) 
BuOPh 
Area 
Ph2 Area 
Ph2 
(μmol) 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) % BuOPh 
0 0 0.00000E+00 1.00000E+00 53.1 0.00 0.0000E+00 0.0000E+00 0.0 
8 480 6.99895E+02 9.90766E+03 53.1 5.42 5.4229E-06 2.7115E-03 1.0 
16 960 1.28801E+03 9.88497E+03 53.1 10.00 1.0003E-05 5.0013E-03 1.9 
24 1440 2.05058E+03 1.01701E+04 53.1 15.48 1.5478E-05 7.7392E-03 2.9 
32 1920 2.23957E+03 8.58246E+03 53.1 20.03 2.0032E-05 1.0016E-02 3.8 
40 2400 3.16078E+03 8.93171E+03 53.1 27.17 2.7166E-05 1.3583E-02 5.1 
48 2880 4.16467E+03 9.22703E+03 53.1 34.65 3.4649E-05 1.7325E-02 6.5 
56 3360 4.87753E+03 8.79651E+03 53.1 42.57 4.2566E-05 2.1283E-02 8.0 
64 3840 5.99856E+03 9.44050E+03 53.1 48.78 4.8778E-05 2.4389E-02 9.2 
72 4320 6.37354E+03 8.69722E+03 53.1 56.26 5.6257E-05 2.8128E-02 10.6 
80 4800 7.91624E+03 9.31255E+03 53.1 65.26 6.5256E-05 3.2628E-02 12.3 
          8.3626E-01 1.3938E-08 6.9688E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  386 
Tetra(n-propyl)ammonium Bromide (0.10 equivalents), Run #3: 
 
Time 
(m) 
Time 
(s) 
BuOPh 
Area 
Ph2 Area 
Ph2 
(μmol) 
BuOPh (μmol) BuOPh (mol) BuOPh (mol/L) 
% 
BuOPh 
0 0 0.00000E+00 1.00000E+00 53.1 0.00 0.0000E+00 0.0000E+00 0.0 
8 480 0.00000E+00 9.25049E+03 53.1 0.00 0.0000E+00 0.0000E+00 0.0 
16 960 0.00000E+00 6.42325E+03 53.1 0.00 0.0000E+00 0.0000E+00 0.0 
24 1440 1.53851E+03 8.93887E+03 53.1 13.21 1.3213E-05 6.6063E-03 2.5 
32 1920 2.23293E+03 8.66409E+03 53.1 19.78 1.9784E-05 9.8922E-03 3.7 
40 2400 2.89299E+03 8.69515E+03 53.1 25.54 2.5541E-05 1.2771E-02 4.8 
48 2880 3.83745E+03 8.78137E+03 53.1 33.55 3.3547E-05 1.6773E-02 6.3 
56 3360 4.74619E+03 8.92585E+03 53.1 40.82 4.0820E-05 2.0410E-02 7.7 
64 3840 5.41873E+03 9.03231E+03 53.1 46.05 4.6054E-05 2.3027E-02 8.7 
72 4320 6.49239E+03 9.31183E+03 53.1 53.52 5.3523E-05 2.6762E-02 10.1 
80 4800 7.05517E+03 9.04687E+03 53.1 59.87 5.9866E-05 2.9933E-02 11.3 
          8.3941E-01 1.3990E-08 6.9950E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
Mean alkylation rate = 7.07*10-6 (mol*L-1*s-1) 
Std. Dev. alkylation rate = 1.50 x 10-7 (mol*L-1*s-1) 
  387 
Tetra(n-butyl)ammonium Bromide (0.10 equivalents), Run #1: 
 
Time 
(m) 
Time 
(s) 
BuOPh 
Area 
Ph2 Area 
Ph2 
(μmol) 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
BuOPh 
0 0 0.00000E+00 1.00000E+00 53.1 0.0 0.0000E+00 0.0000E+00 0.0 
2 120 0.00000E+00 8.35043E+03 53.1 0.0 0.0000E+00 0.0000E+00 0.0 
4 240 1.86600E+03 9.13133E+03 53.1 15.7 1.5694E-05 7.8470E-03 3.0 
6 360 3.25994E+03 8.71325E+03 53.1 28.7 2.8733E-05 1.4367E-02 5.4 
8 480 4.88684E+03 9.15984E+03 53.1 41.0 4.0973E-05 2.0486E-02 7.7 
10 600 5.45489E+03 7.62418E+03 53.1 54.9 5.4948E-05 2.7474E-02 10.3 
12 720 7.51201E+03 8.58504E+03 53.1 67.2 6.7200E-05 3.3600E-02 12.7 
14 840 8.92237E+03 8.59003E+03 53.1 79.8 7.9770E-05 3.9885E-02 15.0 
16 960 1.01872E+04 8.42147E+03 53.1 92.9 9.2901E-05 4.6451E-02 17.5 
18 1080 1.22909E+04 9.12937E+03 53.1 103.4 1.0339E-04 5.1697E-02 19.5 
20 1200 1.43553E+04 1.00484E+04 53.1 109.7 1.0972E-04 5.4858E-02 20.7 
          6.0729E+00 1.0122E-07 5.0608E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  388 
Tetra(n-butyl)ammonium Bromide (0.10 equivalents), Run #2: 
 
Time 
(m) 
Time 
(s) 
BuOPh Area Ph2 Area 
Ph2 
(μmol) 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
BuOPh 
0 0 0.00000E+00 1.00000E+00 53.1 0.0 0.0000E+00 0.0000E+00 0.0 
2 120 0.00000E+00 8.44260E+03 53.1 0.0 0.0000E+00 0.0000E+00 0.0 
4 240 2.10866E+03 8.98792E+03 53.1 18.0 1.8018E-05 9.0089E-03 3.4 
6 360 3.85356E+03 8.87515E+03 53.1 33.3 3.3346E-05 1.6673E-02 6.3 
8 480 5.26495E+03 8.69945E+03 53.1 46.5 4.6479E-05 2.3240E-02 8.8 
10 600 6.26426E+03 8.39049E+03 53.1 57.3 5.7337E-05 2.8669E-02 10.8 
12 720 8.29656E+03 8.70735E+03 53.1 73.2 7.3176E-05 3.6588E-02 13.8 
14 840 9.89915E+03 8.91692E+03 53.1 85.3 8.5259E-05 4.2629E-02 16.1 
16 960 1.20210E+04 9.60396E+03 53.1 96.1 9.6127E-05 4.8064E-02 18.1 
18 1080 1.31338E+04 9.37198E+03 53.1 107.6 1.0763E-04 5.3813E-02 20.3 
20 1200 1.40261E+04 8.97624E+03 53.1 120.0 1.2000E-04 6.0002E-02 22.6 
          6.3167E+00 1.0528E-07 5.2639E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
 
  389 
Tetra(n-butyl)ammonium Bromide (0.10 equivalents), Run #3: 
 
Time 
(m) 
Time 
(s) 
BuOPh Area Ph2 Area 
Ph2 
(μmol) 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
BuOPh 
0 0 0.00000E+00 1.00000E+00 53.1 0.0 0.0000E+00 0.0000E+00 0.0 
2 120 0.00000E+00 7.30323E+03 53.1 0.0 0.0000E+00 0.0000E+00 0.0 
4 240 1.57561E+03 7.61365E+03 53.1 15.9 1.5893E-05 7.9466E-03 3.0 
6 360 3.65063E+03 9.12454E+03 53.1 30.7 3.0726E-05 1.5363E-02 5.8 
8 480 4.25427E+03 7.91684E+03 53.1 41.3 4.1269E-05 2.0635E-02 7.8 
10 600 5.76382E+03 8.22108E+03 53.1 53.8 5.3844E-05 2.6922E-02 10.1 
12 720 7.54351E+03 8.62583E+03 53.1 67.2 6.7163E-05 3.3581E-02 12.6 
14 840 8.91804E+03 8.81438E+03 53.1 77.7 7.7702E-05 3.8851E-02 14.6 
16 960 8.69114E+03 7.15663E+03 53.1 93.3 9.3266E-05 4.6633E-02 17.6 
18 1080 1.06282E+04 8.07687E+03 53.1 101.1 1.0106E-04 5.0529E-02 19.0 
20 1200 1.22385E+04 8.39941E+03 53.1 111.9 1.1190E-04 5.5951E-02 21.1 
          6.0240E+00 1.0040E-07 5.0200E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
Mean alkylation rate = 3.68 x 10-4 (mol/s) 
Std. Dev. alkylation rate = 9.41 x 10-6 (mol/s) 
  390 
Tetra(n-hexyl)ammonium Bromide (0.10 equivalents), Run #1: 
 
Time 
(m) 
Time 
(s) 
BuOPh 
Area 
Ph2 Area 
Ph2 
(μmol) 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
BuOPh 
0 0 0.00000E+00 1.00000E+00 53.1 0.0 0.0000E+00 0.0000E+00 0.0 
2 120 5.86876E+02 9.37146E+03 53.1 4.8 4.8094E-06 2.4047E-03 0.9 
4 240 1.88185E+03 8.96706E+03 53.1 16.1 1.6117E-05 8.0586E-03 3.0 
6 360 3.39849E+03 9.18358E+03 53.1 28.4 2.8420E-05 1.4210E-02 5.4 
8 480 5.06127E+03 9.00703E+03 53.1 43.2 4.3155E-05 2.1578E-02 8.1 
10 600 6.41740E+03 9.09738E+03 53.1 54.2 5.4175E-05 2.7087E-02 10.2 
12 720 8.22431E+03 9.42103E+03 53.1 67.0 6.7044E-05 3.3522E-02 12.6 
14 840 9.74993E+03 9.40666E+03 53.1 79.6 7.9602E-05 3.9801E-02 15.0 
16 960 1.17762E+04 1.02273E+04 53.1 88.4 8.8430E-05 4.4215E-02 16.7 
18 1080 1.18292E+04 8.73013E+03 53.1 104.1 1.0406E-04 5.2031E-02 19.6 
20 1200 1.41133E+04 9.45045E+03 53.1 114.7 1.1469E-04 5.7346E-02 21.6 
          6.1418E+00 1.0236E-07 5.1182E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  391 
Tetra(n-hexyl)ammonium Bromide (0.10 equivalents), Run #2: 
 
Time 
(m) 
Time 
(s) 
BuOPh 
Area 
Ph2 Area 
Ph2 
(μmol) 
BuOPh (μmol) BuOPh (mol) BuOPh (mol/L) 
% 
BuOPh 
0 0 0.00000E+00 1.00000E+00 53.1 0.0 0.0000E+00 0.0000E+00 0.0 
2 120 7.57640E+02 9.11261E+03 53.1 6.4 6.3852E-06 3.1926E-03 1.2 
4 240 2.28579E+03 1.00276E+04 53.1 17.5 1.7506E-05 8.7532E-03 3.3 
6 360 3.74642E+03 9.48529E+03 53.1 30.3 3.0333E-05 1.5167E-02 5.7 
8 480 5.37809E+03 9.60173E+03 53.1 43.0 4.3016E-05 2.1508E-02 8.1 
10 600 6.45889E+03 8.85221E+03 53.1 56.0 5.6035E-05 2.8018E-02 10.6 
12 720 8.24945E+03 9.29084E+03 53.1 68.2 6.8191E-05 3.4095E-02 12.8 
14 840 9.84580E+03 9.71317E+03 53.1 77.8 7.7848E-05 3.8924E-02 14.7 
16 960 1.11105E+04 9.22894E+03 53.1 92.5 9.2457E-05 4.6228E-02 17.4 
18 1080 1.21504E+04 8.97840E+03 53.1 103.9 1.0393E-04 5.1966E-02 19.6 
20 1200 1.45671E+04 9.68352E+03 53.1 115.5 1.1553E-04 5.7765E-02 21.8 
          6.1047E+00 1.0174E-07 5.0872E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  392 
Tetra(n-hexyl)ammonium Bromide (0.10 equivalents), Run #3: 
 
Time 
(m) 
Time 
(s) 
BuOPh 
Area 
Ph2 Area 
Ph2 
(μmol) 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
BuOPh 
0 0 0.00000E+00 1.00000E+00 53.1 0.0 0.0000E+00 0.0000E+00 0.0 
2 120 0.00000E+00 8.37093E+03 53.1 0.0 0.0000E+00 0.0000E+00 0.0 
4 240 1.97629E+03 8.95798E+03 53.1 16.9 1.6943E-05 8.4716E-03 3.2 
6 360 3.18103E+03 8.44066E+03 53.1 28.9 2.8943E-05 1.4472E-02 5.5 
8 480 4.88868E+03 8.51110E+03 53.1 44.1 4.4112E-05 2.2056E-02 8.3 
10 600 6.72508E+03 8.95268E+03 53.1 57.7 5.7690E-05 2.8845E-02 10.9 
12 720 8.88840E+03 9.51262E+03 53.1 71.8 7.1759E-05 3.5880E-02 13.5 
14 840 9.47548E+03 8.77373E+03 53.1 82.9 8.2942E-05 4.1471E-02 15.6 
16 960 1.02624E+04 8.32689E+03 53.1 94.7 9.4650E-05 4.7325E-02 17.8 
18 1080 1.12789E+04 8.20420E+03 53.1 105.6 1.0558E-04 5.2791E-02 19.9 
20 1200 1.34170E+04 8.76092E+03 53.1 117.6 1.1761E-04 5.8807E-02 22.1 
          6.3244E+00 1.0541E-07 5.2703E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
Mean alkylation rate = 5.16*10-5 (mol*L-1*s-1) 
Std. Dev. alkylation rate = 9.80 x 10-7 (mol*L-1*s-1) 
  393 
Tetra(n-octyl)ammonium Bromide (0.10 equivalents), Run #1: 
 
Time 
(m) 
Time 
(s) 
BuOPh 
Area 
Ph2 Area 
Ph2 
(μmol) 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
BuOPh 
0 0 0.00000E+00 1.00000E+00 53.1 0.0 0.0000E+00 0.0000E+00 0.0 
2 120 0.00000E+00 8.13202E+03 53.1 0.0 0.0000E+00 0.0000E+00 0.0 
4 240 1.10434E+03 6.17179E+03 53.1 13.7 1.3742E-05 6.8710E-03 2.6 
6 360 2.03499E+03 6.31862E+03 53.1 24.7 2.4734E-05 1.2367E-02 4.7 
8 480 2.93903E+03 6.26227E+03 53.1 36.0 3.6044E-05 1.8022E-02 6.8 
10 600 4.36330E+03 6.49287E+03 53.1 51.6 5.1610E-05 2.5805E-02 9.7 
12 720 5.11628E+03 5.86747E+03 53.1 67.0 6.6967E-05 3.3483E-02 12.6 
14 840 6.01628E+03 5.97181E+03 53.1 77.4 7.7371E-05 3.8685E-02 14.6 
16 960 7.73640E+03 6.54694E+03 53.1 90.8 9.0752E-05 4.5376E-02 17.1 
18 1080 8.78446E+03 6.38022E+03 53.1 105.7 1.0574E-04 5.2869E-02 19.9 
20 1200 9.57817E+03 6.34676E+03 53.1 115.9 1.1590E-04 5.7950E-02 21.8 
          6.5569E+00 1.0928E-07 5.4641E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  394 
Tetra(n-octyl)ammonium Bromide (0.10 equivalents), Run #2: 
 
Time 
(m) 
Time 
(s) 
BuOPh 
Area 
Ph2 Area 
Ph2 
(μmol) 
BuOPh (μmol) BuOPh (mol) BuOPh (mol/L) 
% 
BuOPh 
0 0 0.00000E+00 1.00000E+00 53.1 0.0 0.0000E+00 0.0000E+00 0.0 
2 120 7.94626E+02 8.35715E+03 53.1 7.3 7.3023E-06 3.6512E-03 1.4 
4 240 1.85302E+03 8.17843E+03 53.1 17.4 1.7401E-05 8.7003E-03 3.3 
6 360 2.55294E+03 6.83901E+03 53.1 28.7 2.8668E-05 1.4334E-02 5.4 
8 480 3.88785E+03 6.90990E+03 53.1 43.2 4.3211E-05 2.1605E-02 8.1 
10 600 4.27903E+03 5.70599E+03 53.1 57.6 5.7593E-05 2.8797E-02 10.8 
12 720 5.67330E+03 6.41071E+03 53.1 68.0 6.7965E-05 3.3982E-02 12.8 
14 840 6.76495E+03 6.58292E+03 53.1 78.9 7.8923E-05 3.9461E-02 14.9 
16 960 7.75219E+03 6.28242E+03 53.1 94.8 9.4766E-05 4.7383E-02 17.8 
18 1080 9.38949E+03 6.84639E+03 53.1 105.3 1.0533E-04 5.2663E-02 19.8 
20 1200 1.07227E+04 6.85605E+03 53.1 120.1 1.2011E-04 6.0056E-02 22.6 
          6.2993E+00 1.0499E-07 5.2494E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
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Tetra(n-octyl)ammonium Bromide (0.10 equivalents), Run #3: 
 
Time 
(m) 
Time 
(s) 
BuOPh 
Area 
Ph2 Area 
Ph2 
(μmol) 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
BuOPh 
0 0 0.00000E+00 1.00000E+00 53.1 0.0 0.0000E+00 0.0000E+00 0.0 
2 120 9.85663E+02 9.64401E+03 53.1 7.8 7.8492E-06 3.9246E-03 1.5 
4 240 1.74160E+03 8.58875E+03 53.1 15.6 1.5573E-05 7.7865E-03 2.9 
6 360 2.78230E+03 8.51722E+03 53.1 25.1 2.5088E-05 1.2544E-02 4.7 
8 480 4.51027E+03 9.17197E+03 53.1 37.8 3.7766E-05 1.8883E-02 7.1 
10 600 5.85127E+03 9.27108E+03 53.1 48.5 4.8470E-05 2.4235E-02 9.1 
12 720 6.75354E+03 8.75128E+03 53.1 59.3 5.9267E-05 2.9634E-02 11.2 
14 840 8.94861E+03 9.46380E+03 53.1 72.6 7.2618E-05 3.6309E-02 13.7 
16 960 9.79164E+03 9.14648E+03 53.1 82.2 8.2216E-05 4.1108E-02 15.5 
18 1080 1.09697E+04 8.98938E+03 53.1 93.7 9.3717E-05 4.6859E-02 17.6 
20 1200 1.23028E+04 8.98669E+03 53.1 105.1 1.0514E-04 5.2569E-02 19.8 
          5.5261E+00 9.2101E-08 4.6051E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
Mean alkylation rate = 5.11*10-5 (mol*L-1*s-1) 
Std. Dev. alkylation rate = 4.47*10-6 (mol*L-1*s-1) 
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5.4.5 Variable Stirring Speed Kinetics 
 To a 4 mL dram vial, the respective quaternary ammonium bromide (4.1 to 14.5 mg, 26.6 
μmol) was added followed by a solution of phenol (50 mg, 531 μmol), biphenyl (20.4 to 20.7 
mg, 132 to 134 μmol) in 2,4-dimethyl-3-pentanone (2.0 mL).  A 5 M aqueous KOH solution 
(0.70 mL) was then added followed by the addition of a 1.5 cm egg-shaped magnetic stir-bar.  A 
septa screw-cap was then installed on the vial. 
 This vial was placed over a variable speed motor calibrated form 250, 500, 1000, 1500, 
2000, and 2300 rpm.  To start the reaction, n-butyl bromide (68 μL, 637 μmol, 1.2 equiv) was 
added via syringe and the reaction was stirred at the desired speed. 
 Reaction aliquots were withdrawn directly from the organic phase (15-20 μL) 
approximately 2 seconds after the reaction had stopped stirring.  Aliquots were quenched in a 
biphasic mixture of ethyl acetate (1-2 mL) and a saturated aqueous ammonium chloride solution 
(1-2 mL).  After a quick mixing via pipette the organic phase was passed through a silica gel 
plug (1-2 cm x 0.5 cm) into a vial and used directly for GC analysis (GC Method 1). 
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Variable Stir Speed Kinetics 
2000 rpm, Run #1: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 132 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
3 180 132 16133.876 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
6 360 132 18379.727 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
9 540 132 18042.383 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
12 720 132 18082.299 610.567 6.4 6.4436E-06 3.2218E-03 1.2 
15 900 132 17981.867 761.269 8.1 8.0790E-06 4.0395E-03 1.5 
18 1080 132 19027.209 921.490 9.2 9.2420E-06 4.6210E-03 1.7 
21 1260 132 18363.957 1058.832 11.0 1.1003E-05 5.5015E-03 2.1 
24 1440 132 18793.695 1223.674 12.4 1.2425E-05 6.2126E-03 2.3 
27 1620 132 19442.477 1436.560 14.1 1.4100E-05 7.0501E-03 2.7 
30 1800 132 19674.676 1618.099 15.7 1.5695E-05 7.8473E-03 3.0 
          5.1165E-01 8.5275E-09 4.2637E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
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2000 rpm, Run #2: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 132 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
6 360 132 19154.207 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
12 720 132 20115.064 611.799 5.8 5.8042E-06 2.9021E-03 1.1 
18 1080 132 20737.250 908.483 8.4 8.3602E-06 4.1801E-03 1.6 
24 1440 132 21326.658 1225.625 11.0 1.0967E-05 5.4835E-03 2.1 
30 1800 132 21562.691 1552.476 13.7 1.3740E-05 6.8698E-03 2.6 
36 2160 132 22267.928 1918.987 16.4 1.6445E-05 8.2227E-03 3.1 
42 2520 132 23172.057 2313.074 19.0 1.9049E-05 9.5246E-03 3.6 
48 2880 132 22271.031 2556.484 21.9 2.1906E-05 1.0953E-02 4.1 
54 3240 132 21956.725 2770.256 24.1 2.4077E-05 1.2039E-02 4.5 
60 3600 132 21184.178 3078.125 27.7 2.7729E-05 1.3864E-02 5.2 
          4.5010E-01 7.5016E-09 3.7508E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  399 
1500 rpm, Run #1: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) BuOPh (mol) BuOPh (mol/L) 
% 
conversion 
0 0 132 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
3 180 132 18141.801 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
6 360 132 18094.691 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
9 540 132 18653.461 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
12 720 132 17948.551 623.499 6.6 6.6292E-06 3.3146E-03 1.2 
15 900 132 18288.945 775.832 8.1 8.0953E-06 4.0476E-03 1.5 
18 1080 132 18366.018 937.435 9.7 9.7404E-06 4.8702E-03 1.8 
21 1260 132 18571.088 1092.895 11.2 1.1230E-05 5.6152E-03 2.1 
24 1440 132 19109.533 1291.992 12.9 1.2902E-05 6.4511E-03 2.4 
27 1620 132 18849.270 1403.524 14.2 1.4209E-05 7.1047E-03 2.7 
30 1800 132 17373.400 1484.536 16.3 1.6306E-05 8.1532E-03 3.1 
          5.2883E-01 8.8138E-09 4.4069E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
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1500 rpm, Run #2: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 132 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
6 360 132 20510.309 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
12 720 132 24589.750 780.504 6.1 6.0572E-06 3.0286E-03 1.1 
18 1080 132 20270.752 913.762 8.6 8.6023E-06 4.3012E-03 1.6 
24 1440 132 20044.488 1185.917 11.3 1.1290E-05 5.6452E-03 2.1 
30 1800 132 19895.395 1393.453 13.4 1.3366E-05 6.6829E-03 2.5 
36 2160 132 21041.014 1770.095 16.1 1.6054E-05 8.0270E-03 3.0 
42 2520 132 20747.127 1967.296 18.1 1.8095E-05 9.0476E-03 3.4 
48 2880 132 21329.795 2370.640 21.2 2.1210E-05 1.0605E-02 4.0 
54 3240 132 21446.076 2705.987 24.1 2.4079E-05 1.2039E-02 4.5 
60 3600 132 21130.963 2960.716 26.7 2.6738E-05 1.3369E-02 5.0 
          4.2700E-01 7.1166E-09 3.5583E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
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1000 rpm, Run #1: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 132 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
3 180 132 18436.311 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
6 360 132 17563.691 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
9 540 132 18751.691 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
12 720 132 18435.674 657.182 6.8 6.8027E-06 3.4013E-03 1.3 
15 900 132 17510.895 759.829 8.3 8.2806E-06 4.1403E-03 1.6 
18 1080 132 18984.289 944.427 9.5 9.4935E-06 4.7467E-03 1.8 
21 1260 132 17901.709 1058.577 11.3 1.1284E-05 5.6422E-03 2.1 
24 1440 132 18326.402 1222.537 12.7 1.2730E-05 6.3651E-03 2.4 
27 1620 132 18404.543 1366.709 14.2 1.4171E-05 7.0855E-03 2.7 
30 1800 132 18481.400 1524.619 15.7 1.5743E-05 7.8713E-03 3.0 
          0.498069743 8.3012E-09 4.1506E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
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1000 rpm, Run #2: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
6 360 134 19765.461 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
12 720 134 20100.969 537.562 5.2 5.1808E-06 2.5904E-03 1.0 
18 1080 134 20877.896 870.900 8.1 8.0810E-06 4.0405E-03 1.5 
24 1440 134 19939.379 983.864 9.6 9.5589E-06 4.7794E-03 1.8 
30 1800 134 21153.080 1307.975 12.0 1.1979E-05 5.9893E-03 2.3 
36 2160 134 20980.887 1569.487 14.5 1.4492E-05 7.2458E-03 2.7 
42 2520 134 20770.748 1820.851 17.0 1.6983E-05 8.4913E-03 3.2 
48 2880 134 21611.393 2174.031 19.5 1.9488E-05 9.7440E-03 3.7 
54 3240 134 21919.750 2506.467 22.2 2.2152E-05 1.1076E-02 4.2 
60 3600 134 21745.687 2716.165 24.2 2.4197E-05 1.2099E-02 4.6 
          0.397612512 6.6269E-09 3.3134E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
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500 rpm, Run #1: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 132 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
6 360 132 18678.230 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
12 720 132 18471.770 588.244 6.1 6.0772E-06 3.0386E-03 1.1 
18 1080 132 19371.805 882.908 8.7 8.6976E-06 4.3488E-03 1.6 
24 1440 132 19871.393 1185.361 11.4 1.1383E-05 5.6917E-03 2.1 
30 1800 132 19891.979 1520.518 14.6 1.4587E-05 7.2935E-03 2.7 
36 2160 132 19325.729 1727.349 17.1 1.7057E-05 8.5284E-03 3.2 
42 2520 132 18830.988 1980.134 20.1 2.0067E-05 1.0033E-02 3.8 
48 2880 132 19981.586 2397.123 22.9 2.2894E-05 1.1447E-02 4.3 
54 3240 132 20603.748 2823.536 26.2 2.6152E-05 1.3076E-02 4.9 
60 3600 132 19417.041 2962.257 29.1 2.9113E-05 1.4557E-02 5.5 
          0.480573955 8.0096E-09 4.0048E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
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500 rpm, Run #2: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
6 360 134 21106.480 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
12 720 134 19947.605 578.800 5.6 5.6211E-06 2.8105E-03 1.1 
18 1080 134 20303.650 794.731 7.6 7.5828E-06 3.7914E-03 1.4 
24 1440 134 22016.443 1119.749 9.9 9.8527E-06 4.9264E-03 1.9 
30 1800 134 21540.650 1325.602 11.9 1.1922E-05 5.9608E-03 2.2 
36 2160 134 23338.396 1738.896 14.4 1.4434E-05 7.2170E-03 2.7 
42 2520 134 21169.238 1891.348 17.3 1.7308E-05 8.6540E-03 3.3 
48 2880 134 22386.324 2197.250 19.0 1.9014E-05 9.5071E-03 3.6 
54 3240 134 21616.564 2452.141 22.0 2.1976E-05 1.0988E-02 4.1 
60 3600 134 20902.004 2681.548 24.9 2.4853E-05 1.2427E-02 4.7 
          0.399489245 6.6582E-09 3.3291E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  405 
Summary Table for Variable Stirring Speed Study 
Run 
# 
Stirring 
Speed 
(rpm) 
Rate 
(μmol/min) 
Rate 
(mol/s) 
Rate (mol*L
-1
*s
-1
) Mean Rate (mol*L
-1
*s
-1
) 
Std. Dev. Rate 
(mol*L
-1
*s
-1
) 
1 2000 5.1165E-01 8.5275E-09 4.2637E-06 
4.01E-06 3.63E-07 
2 2000 4.5010E-01 7.5016E-09 3.7508E-06 
1 1500 5.2883E-01 8.8138E-09 4.4069E-06 
3.98E-06 6.00E-07 
2 1500 4.2700E-01 7.1166E-09 3.5583E-06 
1 1000 4.9807E-01 8.3012E-09 4.1506E-06 
3.73E-06 5.92E-07 
2 1000 3.9761E-01 6.6269E-09 3.3134E-06 
1 500 4.8057E-01 8.0096E-09 4.0048E-06 
3.67E-06 4.78E-07 
2 500 3.9949E-01 6.6582E-09 3.3291E-06 
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5.4.6 Order in Bromide Kinetics 
 
 To a 4 mL dram vial, the respective quaternary ammonium bromide (4.1 to 14.5 mg, 26.6 
μmol) was added followed by a solution of phenol (50 mg, 531 μmol), biphenyl (20.4 to 20.7 
mg, 132 to 134 μmol), and n-butyl bromide (28.6 to 286 μL, 0.266 to 2.66 mmol, 0.5 to 5.0 
equiv) in 2,4-dimethyl-3-pentanone (2.00 mL).  A 1.5 cm egg-shaped magnetic stir-bar and a 
septa screw-cap were then installed. 
 This vial was placed on a silicone oil bath kept at 40-42 °C on a hotplate/stirrer and was 
allowed to come to temperature with moderate stirring for at least 30 minutes.  To start the 
reaction, a 5 M aqueous KOH solution pre-warmed to 40 °C (0.70 mL) was added via syringe 
and the stirring speed was set to maximum (~2000 rpm). 
 Reaction aliquots were withdrawn directly from the organic phase (15-20 μL) 
approximately 2 seconds after the reaction had stopped stirring.  Aliquots were quenched in a 
biphasic mixture of ethyl acetate (1-2 mL) and a saturated aqueous ammonium chloride solution 
(1-2 mL).  After a quick mixing via pipette the organic phase was passed through a silica gel 
plug (1-2 cm x 0.5 cm) into a vial and used directly for GC analysis. 
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Tetra(n-octyl)ammonium Bromide, 0.5 equiv n-BuBr, Run #1: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
6 360 134 19116.762 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
12 720 134 18321.969 926.097 9.8 9.7919E-06 4.8960E-03 1.8 
18 1080 134 18412.875 1507.978 15.9 1.5866E-05 7.9328E-03 3.0 
24 1440 134 18616.977 2034.148 21.2 2.1167E-05 1.0583E-02 4.0 
30 1800 134 17726.965 2453.516 26.8 2.6813E-05 1.3406E-02 5.0 
40 2400 134 17644.686 3257.130 35.8 3.5761E-05 1.7880E-02 6.7 
50 3000 134 15560.946 3434.936 42.8 4.2763E-05 2.1381E-02 8.1 
60 3600 134 19312.191 5121.845 51.4 5.1378E-05 2.5689E-02 9.7 
90 5400 134 16342.970 6281.991 74.5 7.4465E-05 3.7232E-02 14.0 
120 7200 134 16636.070 7991.484 93.1 9.3059E-05 4.6530E-02 17.5 
          7.7440E-01 1.2907E-08 6.4534E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
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Tetra(n-octyl)ammonium Bromide, 0.5 equiv n-BuBr, Run #2: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) BuOPh (mol) BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
6 360 134 16912.666 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
12 720 134 16432.424 888.264 10.5 1.0472E-05 5.2359E-03 2.0 
18 1080 134 17465.156 1445.222 16.0 1.6030E-05 8.0152E-03 3.0 
24 1440 134 16455.426 1765.310 20.8 2.0782E-05 1.0391E-02 3.9 
30 1800 134 17138.990 2222.816 25.1 2.5125E-05 1.2562E-02 4.7 
36 2160 134 17290.668 2723.292 30.5 3.0512E-05 1.5256E-02 5.7 
42 2520 134 17395.582 3196.808 35.6 3.5601E-05 1.7800E-02 6.7 
48 2880 134 17364.268 3629.240 40.5 4.0489E-05 2.0245E-02 7.6 
54 3240 134 17443.098 4180.117 46.4 4.6425E-05 2.3212E-02 8.7 
60 3600 134 16589.809 4219.333 49.3 4.9270E-05 2.4635E-02 9.3 
          8.2296E-01 1.3716E-08 6.8580E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
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Tetra(n-octyl)ammonium Bromide, 0.5 equiv n-BuBr, Run #3: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) BuOPh (mol) BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
6 360 134 16137.416 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
12 720 134 16135.539 945.592 11.4 1.1353E-05 5.6764E-03 2.1 
18 1080 134 15899.742 1411.670 17.2 1.7200E-05 8.6000E-03 3.2 
24 1440 134 15294.965 1743.929 22.1 2.2088E-05 1.1044E-02 4.2 
30 1800 134 17308.473 2395.275 26.8 2.6809E-05 1.3404E-02 5.0 
36 2160 134 16147.675 2689.765 32.3 3.2269E-05 1.6135E-02 6.1 
42 2520 134 16624.107 3348.275 39.0 3.9018E-05 1.9509E-02 7.3 
48 2880 134 16942.193 3833.954 43.8 4.3839E-05 2.1919E-02 8.3 
54 3240 134 16540.957 4251.446 49.8 4.9792E-05 2.4896E-02 9.4 
60 3600 134 16308.465 4515.718 53.6 5.3641E-05 2.6820E-02 10.1 
          8.9622E-01 1.4937E-08 7.4685E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
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Tetra(n-octyl)ammonium Bromide, 0.5 equiv n-BuBr, Run #4: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
6 360 134 17722.225 593.963 6.5 6.4927E-06 3.2463E-03 1.2 
12 720 134 16926.090 1067.862 12.2 1.2222E-05 6.1110E-03 2.3 
18 1080 134 17359.869 1624.514 18.1 1.8128E-05 9.0642E-03 3.4 
24 1440 134 17543.205 2094.230 23.1 2.3126E-05 1.1563E-02 4.4 
30 1800 134 16970.471 2464.934 28.1 2.8138E-05 1.4069E-02 5.3 
36 2160 134 17549.732 3079.212 34.0 3.3990E-05 1.6995E-02 6.4 
42 2520 134 17323.734 3539.281 39.6 3.9578E-05 1.9789E-02 7.5 
48 2880 134 17451.707 4076.067 45.2 4.5247E-05 2.2623E-02 8.5 
54 3240 134 17459.871 4586.097 50.9 5.0884E-05 2.5442E-02 9.6 
60 3600 134 17268.553 4933.491 55.3 5.5345E-05 2.7673E-02 10.4 
          9.1021E-01 1.5170E-08 7.5851E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
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Tetra(n-octyl)ammonium Bromide, 1.0 equiv n-BuBr, Run #1: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
6 360 134 19205.057 1135.245 11.5 1.1451E-05 5.7257E-03 2.2 
12 720 134 17851.764 2137.557 23.2 2.3196E-05 1.1598E-02 4.4 
18 1080 134 16514.771 2886.055 33.9 3.3854E-05 1.6927E-02 6.4 
24 1440 134 18360.842 4453.386 47.0 4.6987E-05 2.3494E-02 8.8 
30 1800 134 17567.707 5276.201 58.2 5.8182E-05 2.9091E-02 11.0 
40 2400 134 17083.123 6972.653 79.1 7.9070E-05 3.9535E-02 14.9 
50 3000 134 19231.742 9664.669 97.4 9.7353E-05 4.8677E-02 18.3 
60 3600 134 19222.820 11592.633 116.8 1.1683E-04 5.8414E-02 22.0 
90 5400 134 17911.350 15341.968 165.9 1.6593E-04 8.2967E-02 31.2 
120 7200 134 18763.369 20401.500 210.6 2.1064E-04 1.0532E-01 39.7 
          1.7706E+00 2.9510E-08 1.4755E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  412 
Tetra(n-octyl)ammonium Bromide, 1.0 equiv n-BuBr, Run #2: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
3 180 134 16876.641 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
6 360 134 17648.549 953.507 10.5 1.0466E-05 5.2332E-03 2.0 
9 540 134 16947.404 1362.769 15.6 1.5578E-05 7.7888E-03 2.9 
12 720 134 16672.645 1803.020 20.9 2.0950E-05 1.0475E-02 3.9 
15 900 134 15052.370 2025.872 26.1 2.6073E-05 1.3036E-02 4.9 
18 1080 134 16311.850 2616.154 31.1 3.1070E-05 1.5535E-02 5.9 
21 1260 134 15602.738 2989.149 37.1 3.7113E-05 1.8557E-02 7.0 
24 1440 134 15173.535 3466.544 44.3 4.4258E-05 2.2129E-02 8.3 
27 1620 134 15059.137 3984.425 51.3 5.1256E-05 2.5628E-02 9.7 
30 1800 134 14841.888 4380.361 57.2 5.7175E-05 2.8587E-02 10.8 
          1.9529E+00 3.2549E-08 1.6274E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  413 
Tetra(n-octyl)ammonium Bromide, 1.0 equiv n-BuBr, Run #3: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
3 180 134 16771.848 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
6 360 134 15642.542 854.225 10.6 1.0579E-05 5.2895E-03 2.0 
9 540 134 15784.934 1315.799 16.1 1.6148E-05 8.0742E-03 3.0 
12 720 134 16208.047 1768.376 21.1 2.1136E-05 1.0568E-02 4.0 
15 900 134 17197.801 2378.881 26.8 2.6797E-05 1.3398E-02 5.0 
18 1080 134 17167.852 2925.375 33.0 3.3010E-05 1.6505E-02 6.2 
21 1260 134 16638.600 3281.548 38.2 3.8207E-05 1.9104E-02 7.2 
24 1440 134 17004.162 3975.561 45.3 4.5292E-05 2.2646E-02 8.5 
27 1620 134 17108.459 4611.082 52.2 5.2213E-05 2.6106E-02 9.8 
30 1800 134 17148.447 5292.197 59.8 5.9785E-05 2.9893E-02 11.3 
          2.0263E+00 3.3772E-08 1.6886E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  414 
Tetra(n-octyl)ammonium Bromide, 1.0 equiv n-BuBr, Run #4: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
3 180 134 17686.773 552.787 6.1 6.0547E-06 3.0273E-03 1.1 
6 360 134 16997.621 953.017 10.9 1.0862E-05 5.4308E-03 2.0 
9 540 134 17993.166 1539.975 16.6 1.6580E-05 8.2901E-03 3.1 
12 720 134 18225.240 2035.200 21.6 2.1633E-05 1.0817E-02 4.1 
15 900 134 18637.783 2617.011 27.2 2.7202E-05 1.3601E-02 5.1 
18 1080 134 17680.865 2998.062 32.8 3.2849E-05 1.6424E-02 6.2 
21 1260 134 17118.139 3396.530 38.4 3.8438E-05 1.9219E-02 7.2 
24 1440 134 17789.273 4248.781 46.3 4.6269E-05 2.3134E-02 8.7 
27 1620 134 17952.836 4882.893 52.7 5.2690E-05 2.6345E-02 9.9 
30 1800 134 17763.801 5389.050 58.8 5.8770E-05 2.9385E-02 11.1 
          1.9631E+00 3.2719E-08 1.6359E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  415 
Tetra(n-octyl)ammonium Bromide, 2.0 equiv n-BuBr, Run #1: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
6 360 134 17952.529 1995.944 21.5 2.1538E-05 1.0769E-02 4.1 
12 720 134 19525.402 4627.030 45.9 4.5908E-05 2.2954E-02 8.6 
18 1080 134 20353.260 7092.437 67.5 6.7506E-05 3.3753E-02 12.7 
24 1440 134 20588.752 9416.557 88.6 8.8602E-05 4.4301E-02 16.7 
30 1800 134 21019.037 12131.252 111.8 1.1181E-04 5.5904E-02 21.1 
40 2400 134 18749.113 14681.182 151.7 1.5169E-04 7.5846E-02 28.6 
50 3000 134 18488.639 17471.203 183.1 1.8306E-04 9.1532E-02 34.5 
60 3600 134 18905.066 22014.412 225.6 2.2559E-04 1.1279E-01 42.5 
90 5400 134 18245.902 30423.691 323.0 3.2302E-04 1.6151E-01 60.8 
120 7200 134 18071.594 38418.195 411.8 4.1184E-04 2.0592E-01 77.6 
          3.4576E+00 5.7626E-08 2.8813E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  416 
Tetra(n-octyl)ammonium Bromide, 2.0 equiv n-BuBr, Run #2: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
2 120 134 16018.368 538.017 6.5 6.5067E-06 3.2533E-03 1.2 
4 240 134 16025.078 1273.523 15.4 1.5395E-05 7.6977E-03 2.9 
6 360 134 16056.689 1960.411 23.7 2.3652E-05 1.1826E-02 4.5 
8 480 134 16423.863 2791.170 32.9 3.2923E-05 1.6461E-02 6.2 
10 600 134 16839.432 3599.622 41.4 4.1411E-05 2.0705E-02 7.8 
12 720 134 16633.984 4190.549 48.8 4.8804E-05 2.4402E-02 9.2 
14 840 134 17036.426 5080.082 57.8 5.7766E-05 2.8883E-02 10.9 
16 960 134 16065.076 5533.494 66.7 6.6727E-05 3.3363E-02 12.6 
18 1080 134 15491.553 6214.993 77.7 7.7719E-05 3.8860E-02 14.6 
20 1200 134 15408.543 6899.683 86.7 8.6746E-05 4.3373E-02 16.3 
          4.4113E+00 7.3521E-08 3.6761E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  417 
Tetraoctylammonium Bromide, 2.0 equiv n-BuBr, Run #3: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
2 120 134 17130.557 545.437 6.2 6.1682E-06 3.0841E-03 1.2 
4 240 134 16898.799 1216.992 14.0 1.3951E-05 6.9757E-03 2.6 
6 360 134 17377.707 2013.708 22.4 2.2448E-05 1.1224E-02 4.2 
8 480 134 16894.469 2732.762 31.3 3.1336E-05 1.5668E-02 5.9 
10 600 134 16916.439 3484.008 39.9 3.9898E-05 1.9949E-02 7.5 
12 720 134 16232.164 4009.166 47.8 4.7848E-05 2.3924E-02 9.0 
14 840 134 15767.396 4521.569 55.6 5.5554E-05 2.7777E-02 10.5 
16 960 134 16357.605 5478.212 64.9 6.4879E-05 3.2439E-02 12.2 
18 1080 134 16983.475 6559.248 74.8 7.4819E-05 3.7409E-02 14.1 
20 1200 134 16729.783 7262.986 84.1 8.4102E-05 4.2051E-02 15.8 
          4.3037E+00 7.1729E-08 3.5864E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  418 
Tetraoctylammonium Bromide, 2.0 equiv n-BuBr, Run #4: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
2 120 134 16640.148 686.642 8.0 7.9939E-06 3.9969E-03 1.5 
4 240 134 17836.547 1464.321 15.9 1.5904E-05 7.9520E-03 3.0 
6 360 134 17108.541 2122.625 24.0 2.4035E-05 1.2017E-02 4.5 
8 480 134 18009.631 3004.262 32.3 3.2316E-05 1.6158E-02 6.1 
10 600 134 17066.000 3575.138 40.6 4.0583E-05 2.0291E-02 7.6 
12 720 134 17069.410 4199.752 47.7 4.7664E-05 2.3832E-02 9.0 
14 840 134 17854.418 5014.968 54.4 5.4413E-05 2.7207E-02 10.2 
16 960 134 17694.578 5787.599 63.4 6.3364E-05 3.1682E-02 11.9 
18 1080 134 17885.973 6664.022 72.2 7.2178E-05 3.6089E-02 13.6 
20 1200 134 17215.961 7236.403 81.4 8.1428E-05 4.0714E-02 15.3 
          4.0147E+00 6.6911E-08 3.3456E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  419 
Tetra(n-octyl)ammonium Bromide, 5.0 equiv n-BuBr, Run #1: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
3 180 134 16069.572 1761.991 21.2 2.1241E-05 1.0621E-02 4.0 
6 360 134 16861.133 4032.769 46.3 4.6334E-05 2.3167E-02 8.7 
9 540 134 17174.434 6524.311 73.6 7.3593E-05 3.6796E-02 13.9 
12 720 134 18290.518 9677.358 102.5 1.0250E-04 5.1249E-02 19.3 
15 900 134 16849.092 11526.954 132.5 1.3253E-04 6.6266E-02 25.0 
18 1080 134 18223.445 14855.421 157.9 1.5792E-04 7.8960E-02 29.7 
24 1440 134 17355.617 18942.686 211.4 2.1144E-04 1.0572E-01 39.8 
30 1800 134 17294.885 23261.174 260.6 2.6055E-04 1.3028E-01 49.1 
45 2700 134 17778.490 35737.348 389.4 3.8941E-04 1.9471E-01 73.3 
60 3600 134 18941.723 48688.082 498.0 4.9795E-04 2.4898E-01 93.8 
          8.4641E+00 1.4107E-07 7.0534E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  420 
Tetra(n-octyl)ammonium Bromide, 5.0 equiv n-BuBr, Run #2: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) BuOPh (mol) BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
1 60 134 19052.391 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
2 120 134 16425.687 1048.422 12.4 1.2365E-05 6.1825E-03 2.3 
3 180 134 15873.785 1734.909 21.2 2.1173E-05 1.0586E-02 4.0 
4 240 134 15657.118 2694.641 33.3 3.3340E-05 1.6670E-02 6.3 
5 300 134 16773.846 3769.521 43.5 4.3535E-05 2.1767E-02 8.2 
6 360 134 16375.703 4705.607 55.7 5.5667E-05 2.7834E-02 10.5 
7 420 134 17221.859 5972.263 67.2 6.7180E-05 3.3590E-02 12.7 
8 480 134 16932.920 6899.025 78.9 7.8929E-05 3.9465E-02 14.9 
9 540 134 17127.088 8095.677 91.6 9.1570E-05 4.5785E-02 17.2 
10 600 134 16380.119 8568.793 101.3 1.0134E-04 5.0671E-02 19.1 
          1.1365E+01 1.8942E-07 9.4711E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  421 
Tetra(n-octyl)ammonium Bromide, 5.0 equiv n-BuBr, Run #3: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
1 60 134 16907.453 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
2 120 134 18816.670 1285.343 13.2 1.3233E-05 6.6165E-03 2.5 
3 180 134 18771.627 2202.591 22.7 2.2731E-05 1.1365E-02 4.3 
4 240 134 19254.100 3303.848 33.2 3.3241E-05 1.6621E-02 6.3 
5 300 134 19078.936 4476.478 45.5 4.5453E-05 2.2727E-02 8.6 
6 360 134 19456.859 5816.218 57.9 5.7910E-05 2.8955E-02 10.9 
7 420 134 19061.941 6968.767 70.8 7.0823E-05 3.5411E-02 13.3 
8 480 134 18873.918 8127.806 83.4 8.3425E-05 4.1712E-02 15.7 
9 540 134 18926.285 9414.243 96.4 9.6361E-05 4.8181E-02 18.1 
10 600 134 19671.955 11117.216 109.5 1.0948E-04 5.4740E-02 20.6 
          1.2194E+01 2.0323E-07 1.0161E-04   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  422 
Tetra(n-octyl)ammonium Bromide, 5.0 equiv n-BuBr, Run #4: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
1 60 134 19973.082 833.979 8.1 8.0890E-06 4.0445E-03 1.5 
2 120 134 19988.510 1781.591 17.3 1.7267E-05 8.6334E-03 3.3 
3 180 134 20049.318 2962.491 28.6 2.8625E-05 1.4312E-02 5.4 
4 240 134 20218.346 4252.919 40.7 4.0750E-05 2.0375E-02 7.7 
5 300 134 18562.455 5153.062 53.8 5.3779E-05 2.6890E-02 10.1 
6 360 134 19844.527 6806.364 66.4 6.6444E-05 3.3222E-02 12.5 
7 420 134 19725.836 8177.560 80.3 8.0310E-05 4.0155E-02 15.1 
8 480 134 20691.977 9982.395 93.5 9.3458E-05 4.6729E-02 17.6 
9 540 134 19931.193 10729.437 104.3 1.0429E-04 5.2143E-02 19.6 
10 600 134 19367.439 11566.911 115.7 1.1570E-04 5.7849E-02 21.8 
          1.2322E+01 2.0537E-07 1.0268E-04   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  423 
Tetra(n-propyl)ammonium Bromide, 0.5 equiv n-BuBr, Run #1: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
15 900 134 16798.062 733.198 8.5 8.4556E-06 4.2278E-03 1.6 
30 1800 134 15475.824 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
45 2700 134 14746.916 571.090 7.5 7.5022E-06 3.7511E-03 1.4 
60 3600 134 15361.423 830.817 10.5 1.0477E-05 5.2387E-03 2.0 
80 4800 134 15842.782 1151.492 14.1 1.4080E-05 7.0402E-03 2.7 
100 6000 134 17175.203 1668.922 18.8 1.8824E-05 9.4121E-03 3.5 
120 7200 134 16127.535 1857.101 22.3 2.2307E-05 1.1154E-02 4.2 
150 9000 134 19236.480 2819.733 28.4 2.8397E-05 1.4198E-02 5.3 
180 10800 134 16839.283 3048.878 35.1 3.5075E-05 1.7538E-02 6.6 
240 14400 134 18071.572 4520.152 48.5 4.8455E-05 2.4228E-02 9.1 
          2.0075E-01 3.3458E-09 1.6729E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  424 
Tetra(n-propyl)ammonium Bromide, 0.5 equiv n-BuBr, Run #2: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
20 1200 134 16500.160 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
40 2400 134 17109.801 600.768 6.8 6.8021E-06 3.4011E-03 1.3 
60 3600 134 17899.414 1084.273 11.7 1.1735E-05 5.8675E-03 2.2 
80 4800 134 19115.289 1655.289 16.8 1.6776E-05 8.3878E-03 3.2 
100 6000 134 17257.186 1863.764 20.9 2.0922E-05 1.0461E-02 3.9 
120 7200 134 17825.979 2395.327 26.0 2.6031E-05 1.3016E-02 4.9 
150 9000 134 18186.732 3019.833 32.2 3.2167E-05 1.6084E-02 6.1 
180 10800 134 18705.395 3842.461 39.8 3.9795E-05 1.9897E-02 7.5 
210 12600 134 18405.398 4394.477 46.3 4.6254E-05 2.3127E-02 8.7 
240 14400 134 18014.529 5034.563 54.1 5.4140E-05 2.7070E-02 10.2 
          2.3346E-01 3.8910E-09 1.9455E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  425 
Tetra(n-propyl)ammonium Bromide, 0.5 equiv n-BuBr, Run #3: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
20 1200 134 15754.905 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
40 2400 134 16010.921 622.560 7.5 7.5327E-06 3.7663E-03 1.4 
60 3600 134 16364.426 956.651 11.3 1.1325E-05 5.6625E-03 2.1 
80 4800 134 16565.021 1337.715 15.6 1.5644E-05 7.8221E-03 2.9 
100 6000 134 16896.285 1821.663 20.9 2.0886E-05 1.0443E-02 3.9 
120 7200 134 19252.555 2384.033 24.0 2.3989E-05 1.1994E-02 4.5 
150 9000 134 17808.480 2859.216 31.1 3.1103E-05 1.5552E-02 5.9 
180 10800 134 16040.091 3130.693 37.8 3.7811E-05 1.8905E-02 7.1 
210 12600 134 17574.354 3971.035 43.8 4.3773E-05 2.1887E-02 8.2 
240 14400 134 16406.410 4199.645 49.6 4.9589E-05 2.4794E-02 9.3 
          2.1329E-01 3.5548E-09 1.7774E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  426 
Tetra(n-propyl)ammonium Bromide, 0.5 equiv n-BuBr, Run #4: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
20 1200 134 16950.113 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
40 2400 134 16919.953 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
60 3600 134 17873.277 835.702 9.1 9.0580E-06 4.5290E-03 1.7 
80 4800 134 17961.813 1205.444 13.0 1.3001E-05 6.5005E-03 2.4 
100 6000 134 18069.744 1549.028 16.6 1.6607E-05 8.3035E-03 3.1 
120 7200 134 18016.549 1865.214 20.1 2.0056E-05 1.0028E-02 3.8 
150 9000 134 18083.006 2351.272 25.2 2.5189E-05 1.2595E-02 4.7 
180 10800 134 18436.986 3015.612 31.7 3.1686E-05 1.5843E-02 6.0 
210 12600 134 18805.910 3601.679 37.1 3.7102E-05 1.8551E-02 7.0 
240 14400 134 17250.613 3798.996 42.7 4.2663E-05 2.1331E-02 8.0 
          1.8649E-01 3.1081E-09 1.5541E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  427 
Tetra(n-propyl)ammonium Bromide, 1.0 equiv n-BuBr, Run #1: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
15 900 134 16513.433 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
30 1800 134 15948.785 756.941 9.2 9.1943E-06 4.5971E-03 1.7 
45 2700 134 16978.656 1275.086 14.5 1.4549E-05 7.2743E-03 2.7 
60 3600 134 16223.399 1722.630 20.6 2.0570E-05 1.0285E-02 3.9 
80 4800 134 16886.346 2601.729 29.8 2.9848E-05 1.4924E-02 5.6 
100 6000 134 18930.512 3570.906 36.5 3.6543E-05 1.8271E-02 6.9 
120 7200 134 17302.539 3960.227 44.3 4.4340E-05 2.2170E-02 8.4 
150 9000 134 18681.889 5450.530 56.5 5.6520E-05 2.8260E-02 10.6 
180 10800 134 16800.131 5850.432 67.5 6.7462E-05 3.3731E-02 12.7 
240 14400 134 19824.598 9144.060 89.4 8.9355E-05 4.4677E-02 16.8 
          3.8452E-01 6.4087E-09 3.2044E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  428 
Tetra(n-propyl)ammonium Bromide, 1.0 equiv n-BuBr, Run #2: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
15 900 134 16623.082 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
30 1800 134 18253.627 892.452 9.5 9.4715E-06 4.7357E-03 1.8 
45 2700 134 17135.385 1291.727 14.6 1.4604E-05 7.3018E-03 2.8 
60 3600 134 18144.668 1961.250 20.9 2.0940E-05 1.0470E-02 3.9 
75 4500 134 17790.262 2412.805 26.3 2.6274E-05 1.3137E-02 4.9 
90 5400 134 18218.141 3094.333 32.9 3.2904E-05 1.6452E-02 6.2 
105 6300 134 17159.150 3416.685 38.6 3.8574E-05 1.9287E-02 7.3 
120 7200 134 17497.926 4140.083 45.8 4.5836E-05 2.2918E-02 8.6 
135 8100 134 17707.867 4727.399 51.7 5.1718E-05 2.5859E-02 9.7 
150 9000 134 18706.414 5647.995 58.5 5.8491E-05 2.9245E-02 11.0 
          4.1057E-01 6.8428E-09 3.4214E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  429 
Tetra(n-propyl)ammonium Bromide, 1.0 equiv n-BuBr, Run #3: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
15 900 134 15683.202 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
30 1800 134 15954.385 832.368 10.1 1.0107E-05 5.0535E-03 1.9 
45 2700 134 16756.893 1385.260 16.0 1.6015E-05 8.0074E-03 3.0 
60 3600 134 17117.105 1954.844 22.1 2.2124E-05 1.1062E-02 4.2 
75 4500 134 17143.844 2488.902 28.1 2.8124E-05 1.4062E-02 5.3 
90 5400 134 18846.715 3328.922 34.2 3.4218E-05 1.7109E-02 6.4 
105 6300 134 16086.047 3374.490 40.6 4.0639E-05 2.0319E-02 7.7 
120 7200 134 16908.387 4090.666 46.9 4.6868E-05 2.3434E-02 8.8 
135 8100 134 16775.576 4558.702 52.6 5.2644E-05 2.6322E-02 9.9 
150 9000 134 17872.703 5641.509 61.1 6.1149E-05 3.0574E-02 11.5 
          4.1784E-01 6.9640E-09 3.4820E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  430 
Tetrapropylammonium Bromide, 1.0 equiv n-BuBr, Run #4: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
15 900 134 17511.617 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
30 1800 134 18703.592 908.722 9.4 9.4122E-06 4.7061E-03 1.8 
45 2700 134 18157.174 1447.560 15.4 1.5444E-05 7.7222E-03 2.9 
60 3600 134 18538.637 2049.878 21.4 2.1421E-05 1.0710E-02 4.0 
75 4500 134 17972.441 2450.591 26.4 2.6415E-05 1.3207E-02 5.0 
90 5400 134 17487.186 2989.438 33.1 3.3117E-05 1.6559E-02 6.2 
105 6300 134 18711.449 3713.657 38.4 3.8448E-05 1.9224E-02 7.2 
120 7200 134 17586.398 4077.940 44.9 4.4921E-05 2.2460E-02 8.5 
135 8100 134 18702.449 4917.552 50.9 5.0937E-05 2.5469E-02 9.6 
150 9000 134 18473.937 5468.652 57.3 5.7346E-05 2.8673E-02 10.8 
          3.9694E-01 6.6157E-09 3.3078E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  431 
Tetra(n-propyl)ammonium Bromide, 2.0 equiv n-BuBr, Run #1: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
15 900 134 14724.687 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
30 1800 134 17326.078 1467.968 16.4 1.6413E-05 8.2067E-03 3.1 
45 2700 134 17504.305 2511.926 27.8 2.7800E-05 1.3900E-02 5.2 
60 3600 134 17234.621 3286.974 36.9 3.6947E-05 1.8473E-02 7.0 
80 4800 134 17708.986 4715.360 51.6 5.1583E-05 2.5791E-02 9.7 
100 6000 134 18697.771 6266.645 64.9 6.4927E-05 3.2464E-02 12.2 
120 7200 134 17746.354 7270.846 79.4 7.9370E-05 3.9685E-02 14.9 
150 9000 134 18229.225 9466.163 100.6 1.0060E-04 5.0299E-02 18.9 
180 10800 134 18697.238 11818.046 122.4 1.2245E-04 6.1224E-02 23.1 
240 14400 134 18291.600 15789.863 167.2 1.6723E-04 8.3614E-02 31.5 
          7.1416E-01 1.1903E-08 5.9663E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  432 
Tetra(n-propyl)ammonium Bromide, 2.0 equiv n-BuBr, Run #2: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
9 540 134 17424.557 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
18 1080 134 16655.459 911.100 10.6 1.0597E-05 5.2986E-03 2.0 
27 1620 134 17071.463 1507.068 17.1 1.7102E-05 8.5510E-03 3.2 
36 2160 134 16165.388 2020.450 24.2 2.4213E-05 1.2106E-02 4.6 
45 2700 134 15827.579 2689.815 32.9 3.2922E-05 1.6461E-02 6.2 
54 3240 134 16247.039 3246.892 38.7 3.8715E-05 1.9357E-02 7.3 
63 3780 134 16360.738 3970.433 47.0 4.7013E-05 2.3506E-02 8.9 
72 4320 134 15542.499 4375.651 54.5 5.4539E-05 2.7269E-02 10.3 
81 4860 134 16077.034 5135.301 61.9 6.1879E-05 3.0939E-02 11.7 
90 5400 134 15409.287 5526.438 69.5 6.9478E-05 3.4739E-02 13.1 
          8.2333E-01 1.3722E-08 6.8610E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  433 
Tetra(n-propyl)ammonium Bromide, 2.0 equiv n-BuBr, Run #3: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
9 540 134 16058.112 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
18 1080 134 15504.197 799.676 10.0 9.9919E-06 4.9959E-03 1.9 
27 1620 134 16147.185 1427.604 17.1 1.7127E-05 8.5637E-03 3.2 
36 2160 134 18026.119 2143.969 23.0 2.3041E-05 1.1520E-02 4.3 
45 2700 134 17074.877 2630.333 29.8 2.9843E-05 1.4921E-02 5.6 
54 3240 134 17072.818 3088.026 35.0 3.5040E-05 1.7520E-02 6.6 
63 3780 134 17386.803 3763.942 41.9 4.1938E-05 2.0969E-02 7.9 
72 4320 134 17572.904 4562.116 50.3 5.0293E-05 2.5146E-02 9.5 
81 4860 134 18258.828 5299.599 56.2 5.6228E-05 2.8114E-02 10.6 
90 5400 134 17120.400 5635.513 63.8 6.3768E-05 3.1884E-02 12.0 
          7.3890E-01 1.2315E-08 6.1575E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  434 
Tetra(n-propyl)ammonium Bromide, 2.0 equiv n-BuBr, Run #4: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
9 540 134 17073.229 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
18 1080 134 17758.145 867.811 9.5 9.4670E-06 4.7335E-03 1.8 
27 1620 134 16981.619 1372.736 15.7 1.5660E-05 7.8300E-03 2.9 
36 2160 134 16950.623 1960.971 22.4 2.2411E-05 1.1206E-02 4.2 
45 2700 134 16756.910 2502.348 28.9 2.8929E-05 1.4465E-02 5.4 
54 3240 134 17075.320 2994.901 34.0 3.3978E-05 1.6989E-02 6.4 
63 3780 134 17581.895 3796.974 41.8 4.1836E-05 2.0918E-02 7.9 
72 4320 134 16955.578 4255.677 48.6 4.8623E-05 2.4311E-02 9.2 
81 4860 134 16682.818 4654.520 54.0 5.4049E-05 2.7025E-02 10.2 
90 5400 134 17084.748 5395.973 61.2 6.1185E-05 3.0592E-02 11.5 
          7.1735E-01 1.1956E-08 5.9779E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
 
  435 
Tetra(n-propyl)ammonium Bromide, 5.0 equiv n-BuBr, Run #1: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
5 300 134 17492.379 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
10 600 134 17697.727 549.971 6.0 6.0201E-06 3.0101E-04 1.1 
15 900 134 17728.146 1498.214 16.4 1.6372E-05 8.1858E-04 3.1 
20 1200 134 17359.793 2333.140 26.0 2.6036E-05 1.3018E-03 4.9 
25 1500 134 16907.316 2889.614 33.1 3.3109E-05 1.6555E-03 6.2 
30 1800 134 17782.063 4014.719 43.7 4.3738E-05 2.1869E-03 8.2 
35 2100 134 17057.668 4780.375 54.3 5.4291E-05 2.7145E-03 10.2 
40 2400 134 17839.533 5806.629 63.1 6.3056E-05 3.1528E-03 11.9 
45 2700 134 18201.725 6796.105 72.3 7.2332E-05 3.6166E-03 13.6 
50 3000 134 19295.496 8118.160 81.5 8.1505E-05 4.0753E-03 15.3 
          1.8835E+00 3.1391E-08 1.5696E-06   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  436 
Tetra(n-propyl)ammonium Bromide, 5.0 equiv n-BuBr, Run #2: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
4 240 134 23158.492 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
8 480 134 16364.111 803.072 9.5 9.5070E-06 4.7535E-03 1.8 
12 720 134 18213.346 1387.367 14.8 1.4757E-05 7.3783E-03 2.8 
16 960 134 16715.508 1820.842 21.1 2.1103E-05 1.0551E-02 4.0 
20 1200 134 17144.531 2500.375 28.3 2.8253E-05 1.4126E-02 5.3 
24 1440 134 16484.236 2941.171 34.6 3.4565E-05 1.7282E-02 6.5 
28 1680 134 16734.025 3602.194 41.7 4.1701E-05 2.0851E-02 7.9 
32 1920 134 16341.649 4035.906 47.8 4.7844E-05 2.3922E-02 9.0 
36 2160 134 15974.229 4508.410 54.7 5.4675E-05 2.7337E-02 10.3 
40 2400 134 16409.068 5228.971 61.7 6.1733E-05 3.0866E-02 11.6 
          1.6483E+00 2.7471E-08 1.3736E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  437 
Tetra(n-propyl)ammonium Bromide, 5.0 equiv n-BuBr, Run #3: 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
4 240 134 20343.529 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
8 480 134 17135.459 704.603 8.0 7.9658E-06 3.9829E-03 1.5 
12 720 134 16555.670 1094.000 12.8 1.2801E-05 6.4006E-03 2.4 
16 960 134 16503.512 1634.514 19.2 1.9186E-05 9.5932E-03 3.6 
20 1200 134 19291.602 2494.398 25.0 2.5048E-05 1.2524E-02 4.7 
24 1440 134 18476.527 3121.994 32.7 3.2734E-05 1.6367E-02 6.2 
28 1680 134 19005.387 3795.853 38.7 3.8692E-05 1.9346E-02 7.3 
32 1920 134 18464.424 4249.274 44.6 4.4582E-05 2.2291E-02 8.4 
36 2160 134 18505.396 4935.740 51.7 5.1670E-05 2.5835E-02 9.7 
40 2400 134 17094.543 5072.116 57.5 5.7480E-05 2.8740E-02 10.8 
          1.5796E+00 2.6326E-08 1.3163E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  438 
Tetra(n-propyl)ammonium Bromide, 5.0 equiv n-BuBr, Run #4: 
 
 
Time 
(m) 
Time 
(s) 
Ph2 
(μmol) 
Ph2 Area 
BuOPh 
Area 
BuOPh (μmol) 
BuOPh 
(mol) 
BuOPh (mol/L) 
% 
conversion 
0 0 134 1.000 0.000 0.0 0.0000E+00 0.0000E+00 0.0 
4 240 134 23128.420 541.739 4.5 4.5376E-06 2.2688E-03 0.9 
8 480 134 19329.223 957.956 9.6 9.6009E-06 4.8005E-03 1.8 
12 720 134 18065.643 1417.589 15.2 1.5201E-05 7.6006E-03 2.9 
16 960 134 18757.865 2107.038 21.8 2.1761E-05 1.0880E-02 4.1 
20 1200 134 19849.057 2853.130 27.8 2.7846E-05 1.3923E-02 5.2 
24 1440 134 19563.494 3585.350 35.5 3.5503E-05 1.7752E-02 6.7 
28 1680 134 18421.484 4065.151 42.7 4.2750E-05 2.1375E-02 8.1 
32 1920 134 18571.840 4629.634 48.3 4.8292E-05 2.4146E-02 9.1 
36 2160 134 18080.941 5139.104 55.1 5.5062E-05 2.7531E-02 10.4 
40 2400 134 19159.219 6219.349 62.9 6.2885E-05 3.1443E-02 11.8 
          1.6355E+00 2.7258E-08 1.3629E-05   
          Rate (μmol/min) Rate (mol/s) Rate (mol*L-1*s-1)   
 
  439 
Variable n-butyl bromide equivalents summary table 
Run 
# 
Catalyst 
n-BuBr 
(mol/L) 
Rate 
(μmol/min) 
Rate (mol/s) Rate (mol*L
-1
*s
-1
) 
Mean Rate 
(mol*L
-1
*s
-1
) 
Std. Dev. Rate 
(mol*L
-1
*s
-1
) 
1 TPAB 0.13 0.2091 3.4848E-09 1.7424E-06 
1.75E-06 1.61E-07 
2 TPAB 0.13 0.2335 3.8910E-09 1.9455E-06 
3 TPAB 0.13 0.2133 3.5548E-09 1.7774E-06 
4 TPAB 0.13 0.1865 3.1081E-09 1.5541E-06 
1 TPAB 0.27 0.3845 6.4087E-09 3.2044E-06 
3.35E-06 1.23E-07 
2 TPAB 0.27 0.4106 6.8428E-09 3.4214E-06 
3 TPAB 0.27 0.4178 6.9640E-09 3.4820E-06 
4 TPAB 0.27 0.3969 6.6157E-09 3.3078E-06 
1 TPAB 0.53 0.7142 1.1903E-08 5.9513E-06 
6.24E-06 4.26E-07 
2 TPAB 0.53 0.8233 1.3722E-08 6.8610E-06 
3 TPAB 0.53 0.7389 1.2315E-08 6.1575E-06 
4 TPAB 0.53 0.7173 1.1956E-08 5.9779E-06 
1 TPAB 1.33 1.8835 3.1391E-08 1.5696E-05 
1.41E-05 1.12E-06 
2 TPAB 1.33 1.6483 2.7471E-08 1.3736E-05 
3 TPAB 1.33 1.5796 2.6326E-08 1.3163E-05 
4 TPAB 1.33 1.6355 2.7258E-08 1.3629E-05 
                
1 TOAB 0.13 0.7744 1.2907E-08 6.4534E-06 
7.08E-06 5.23E-07 
2 TOAB 0.13 0.8230 1.3716E-08 6.8580E-06 
3 TOAB 0.13 0.8962 1.4937E-08 7.4685E-06 
4 TOAB 0.13 0.9068 1.5113E-08 7.5566E-06 
1 TOAB 0.27 1.7706 2.9510E-08 1.4755E-05 
1.61E-05 9.17E-07 
2 TOAB 0.27 1.9529 3.2549E-08 1.6274E-05 
3 TOAB 0.27 2.0263 3.3772E-08 1.6886E-05 
4 TOAB 0.27 1.9631 3.2719E-08 1.6359E-05 
1 TOAB 0.53 3.4576 5.7626E-08 2.8813E-05 
3.54E-05 1.71E-06 
2 TOAB 0.53 4.4113 7.3521E-08 3.6761E-05 
3 TOAB 0.53 4.3037 7.1729E-08 3.5864E-05 
4 TOAB 0.53 4.0147 6.6911E-08 3.3456E-05 
1 TOAB 1.33 8.4641 1.4107E-07 7.0534E-05 
9.97E-05 4.33E-06 
2 TOAB 1.33 11.3653 1.8942E-07 9.4711E-05 
3 TOAB 1.33 12.1935 2.0323E-07 1.0161E-04 
4 TOAB 1.33 12.3220 2.0537E-07 1.0268E-04 
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5.4.7 Determination of the Phenoxide Extinction Coefficient 
 To determine the phenoxide extinction coefficient standard phenol solutions were 
prepared. First, a stock solutions of phenol (714.3 mg, 7.59 mmol) in 5 M aq. KOH (10 mL, 759 
mM) was prepared.  An aliquot of this solution (250 μL, 190 μmol) was then diluted with 5 M 
aq. KOH (10.0 mL final volume, 19.0 mM).  Seven different aliquots of the diluted stock 
solution (400, 350, 300, 250, 200, 150, 100 μL) were then further diluted with 0.1 M aq. KOH 
(10.0 mL final volume).  This second dilution was analyzed by UV-vis spectroscopy and the 
absorbance readings were plotted against the solution concentration.  The extinction coefficient 
was calculated as ε=2526. 
Summary Table to Determine Phenol Extinction Coefficient in Aqueous KOH 
[PhO-]aq. (mol/L) 
Wavelength 
(nm) 
Absorbance 
Mean 
Absorbance 
Std. Dev. 
Absorbance 
7.600E-04 287.5 1.914 
1.923 0.014 7.600E-04 287.5 1.939 
7.600E-04 287.5 1.917 
6.650E-04 287.5 1.677 
1.681 0.004 6.650E-04 287.5 1.685 
6.650E-04 287.5 1.681 
5.700E-04 287.5 1.445 
1.440 0.007 5.700E-04 287.5 1.432 
5.700E-04 287.5 1.444 
4.750E-04 287.5 1.203 
1.200 0.004 4.750E-04 287.5 1.202 
4.750E-04 287.5 1.195 
3.800E-04 287.5 0.952 
0.956 0.004 3.800E-04 287.5 0.955 
3.800E-04 287.5 0.960 
2.850E-04 287.5 0.715 
0.713 0.003 2.850E-04 287.5 0.710 
2.850E-04 287.5 0.714 
1.900E-04 287.5 0.478 
0.478 0.002 1.900E-04 287.5 0.480 
1.900E-04 287.5 0.476 
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5.4.8 UV-vis Spectroscopy Measurements 
 For the survey conducted with 0.20 equivalents of the quaternary ammonium bromide, a 
4 mL dram vial was charged with the respective quaternary ammonium bromide (22.3 to 58.0 
mg, 106 μmol) followed by a solution of phenol (50.0 mg, 531 μmol) in 5.0 M aq. KOH (700 
μL) and then 2,4-dimethyl-3-pentanone (2.00 mL). A 1.5 cm egg-shaped magnetic stir-bar and a 
septa screw-cap were then installed. To begin mixing the vial was placed in a 40 °C water bath 
and the stirring speed was set to maximum (~2000 rpm). 
 To determine the phenoxide concentration of the aqueous, stirring was ceased and the 
biphase was allowed to settle over several seconds. After one hour of stirring, a reaction aliquot 
(25 μL) was taken from the aqueous phase and diluted with additional 5 M aq. KOH (975 uL).  
From this new solution, another aliquot (200 μL) was taken and diluted with 0.1 M aq. KOH 
(10.0 mL final volume) in a volumetric flask.  This final solution was then transferred to a 
suitable cuvette for UV-vis spectroscopy.  A UV-vis spectrum was collected from 350 to 200 nm 
and the absorption of interest was observed at 288 to 287 nm. 
 For the survey conducted with 1.00 equivalents of the quaternary ammonium bromide a 
similar procedure was employed. Some differences include larger quantities of the quaternary 
ammonium bromide (81.8 to 290.4 mg, 531 μmol) and a smaller quantity of 2,4-dimethyl-3-
pentanone (700 μL). 
 Based on the initial concentration of the aqueous phenol solution (759 mM), the double 
dilution procedure as described above would afford a solution with a concentration of 0.380 mM.  
This leads to a conversion factor of 1997, which was then applied to the concentration 
determined via UV-vis to afford the effective aqueous concentration in the reaction vial. 
(759 mM)*(25.0 μL) = 19.0 μmol 
(19 μmol)/(1.00 mL) = 19 mM 
(19.0 mM)*(200 μL) = 3.8 μmol 
(3.8 μmol)/(10.0 mL) = 0.380 mM 
(759 mM)/(0.380 m) = 1997 
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UV-vis Summary Table with 0.2 equivalents of R4N
+
Br
-
 
Catalyst 
Run 
# 
Wavelength 
(nm) 
A
b
so
r
b
a
n
c
e
 
M
e
a
n
 
A
b
so
r
b
a
n
c
e
 
S
td
. 
D
e
v
. 
A
b
so
r
b
a
n
c
e
 
Target 
[PhO-]aq. 
(mM) 
[PhO-]aq. 
(mM) 
Mean 
[PhO-]aq. 
(mM) 
Std. Dev. 
[PhO-]aq 
(mM) 
C
o
n
v
er
si
o
n
 
F
a
c
to
r
 
Effective 
[PhO-]aq. 
(mM) 
Mean 
Effective 
[PhO-]aq. 
(mM) 
Std. Dev. 
Effective 
[PhO-]aq. 
(mM) 
% [PhO-] 
in 
organic 
phase 
Mean 
% 
Std. 
Dev. % 
none 1 287.5 0.955 
0.906 0.015 
0.380 0.378 
0.383 0.006 
1997 755.1 
765.2 11.6 
0.5 
-0.82 1.19 
none 2 287.5 0.980 0.380 0.388 1997 774.9 -2.1 
none 3 287.5 0.981 0.380 0.388 1997 775.7 -2.2 
none 4 287.5 0.955 0.380 0.378 1997 755.1 0.5 
TEAB 1 287.5 0.957 
0.952 0.006 
0.380 0.379 
0.377 0.003 
1997 756.7 
752.4 5.0 
0.3 
0.87 0.57 
TEAB 2 287.5 0.957 0.380 0.379 1997 756.7 0.3 
TEAB 3 287.5 0.946 0.380 0.375 1997 748.0 1.4 
TEAB 4 287.5 0.946 0.380 0.375 1997 748.0 1.4 
TPAB 1 287.5 0.152 
0.151 0.001 
0.380 0.060 
0.060 0.001 
1997 120.2 
119.0 1.0 
84.2 
84.32 0.13 
TPAB 2 287.5 0.150 0.380 0.059 1997 118.6 84.4 
TPAB 3 287.5 0.151 0.380 0.060 1997 119.4 84.3 
TPAB 4 287.5 0.149 0.380 0.059 1997 117.8 84.5 
TBAB 1 287.5 0.180 
0.180 0.001 
0.380 0.071 
0.071 0.000 
1997 142.3 
142.1 1.0 
81.2 
81.27 0.13 
TBAB 2 287.5 0.180 0.380 0.071 1997 142.3 81.2 
TBAB 3 287.5 0.178 0.380 0.070 1997 140.7 81.5 
TBAB 4 287.5 0.181 0.380 0.072 1997 143.1 81.1 
THAB 1 287.5 0.183 
0.181 0.002 
0.380 0.072 
0.071 0.001 
1997 144.7 
142.7 1.9 
80.9 
81.20 0.25 
THAB 2 287.5 0.179 0.380 0.071 1997 141.5 81.4 
THAB 3 287.5 0.178 0.380 0.070 1997 140.7 81.5 
THAB 4 287.5 0.182 0.380 0.072 1997 143.9 81.0 
TOAB 1 287.5 0.168 
0.167 0.002 
0.380 0.067 
0.066 0.001 
1997 132.8 
132.1 1.4 
82.5 
82.60 0.19 
TOAB 2 287.5 0.165 0.380 0.065 1997 130.5 82.8 
TOAB 3 287.5 0.166 0.380 0.066 1997 131.3 82.7 
TOAB 4 287.5 0.169 0.380 0.067 1997 133.6 82.4 
 
 In the control study (no catalyst) a minor increase in aqueous phenol concentration was observed.  This was assumed to be the 
result of some water from the initial aqueous solution partitioning into the organic phase after mixing.  The remained UV-vis values 
collected were not normalized to account for this small change in concentration. 
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UV-vis Summary Table with 1.0 equivalents of R4N
+
Br
-
 
C
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R= 
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(n
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) 
A
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M
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n
 
A
b
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S
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. 
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. 
A
b
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Target 
[PhO-]aq. 
(mM) 
[PhO-]aq. 
(mM) 
Mean 
[PhO-
]aq. 
(mM) 
Std. 
Dev. 
[PhO-
]aq. 
(mM) C
o
n
v
er
si
o
n
 
F
a
ct
o
r Effective 
[PhO-
]aq. 
(mM) 
Mean 
Effective 
[PhO-
]aq. 
(mM) 
% 
[PhO-] 
in 
organic 
phase 
Mean 
% 
Std. 
Dev. 
% 
TMAB 1 287.5 0.918 
0.906 0.011 
0.380 0.363 
0.359 0.005 
1997 725.9 
716.6 
4.4 
5.59 1.19 
TMAB 1 287.5 0.898 0.380 0.356 1997 710.1 6.4 
TMAB 1 287.5 0.914 0.380 0.362 1997 722.7 4.8 
TMAB 1 287.5 0.895 0.380 0.354 1997 707.7 6.8 
TEAB 2 287.5 0.876 
0.869 0.005 
0.380 0.347 
0.344 0.002 
1997 692.7 
687.1 
8.7 
9.47 0.57 
TEAB 2 287.5 0.867 0.380 0.343 1997 685.6 9.7 
TEAB 2 287.5 0.870 0.380 0.344 1997 687.9 9.4 
TEAB 2 287.5 0.863 0.380 0.342 1997 682.4 10.1 
TPAB 3 287.5 0.152 
0.151 0.001 
0.380 0.060 
0.060 0.001 
1997 120.2 
119.4 
84.2 
84.27 0.13 
TPAB 3 287.5 0.150 0.380 0.059 1997 118.6 84.4 
TPAB 3 287.5 0.151 0.380 0.060 1997 119.4 84.3 
TPAB 3 287.5 0.149 0.380 0.059 1997 117.8 84.5 
TBAB 4 287.5 0.180 
0.180 0.001 
0.380 0.071 
0.071 0.000 
1997 142.3 
142.1 
81.2 
81.27 0.13 
TBAB 4 287.5 0.180 0.380 0.071 1997 142.3 81.2 
TBAB 4 287.5 0.178 0.380 0.070 1997 140.7 81.5 
TBAB 4 287.5 0.181 0.380 0.072 1997 143.1 81.1 
THAB 6 287.5 0.183 
0.181 0.002 
0.380 0.072 
0.071 0.001 
1997 144.7 
142.7 
80.9 
81.20 0.25 
THAB 6 287.5 0.179 0.380 0.071 1997 141.5 81.4 
THAB 6 287.5 0.178 0.380 0.070 1997 140.7 81.5 
THAB 6 287.5 0.182 0.380 0.072 1997 143.9 81.0 
TOAB 8 287.5 0.168 
0.167 0.002 
0.380 0.067 
0.066 0.001 
1997 132.8 
132.1 
82.5 
82.60 0.19 
TOAB 8 287.5 0.165 0.380 0.065 1997 130.5 82.8 
TOAB 8 287.5 0.166 0.380 0.066 1997 131.3 82.7 
TOAB 8 287.5 0.169 0.380 0.067 1997 133.6 82.4 
              Third   Liquid Phase              
TPAB 3 287.5 2.060 
2.049 0.022 
0.380 0.816 
0.811 0.009 
1997 1628.9 
1620.5 
114.6 
113.50 6.05 
TPAB 3 287.5 2.064 0.380 0.817 1997 1632.1 115.0 
TPAB 3 287.5 1.939 0.380 0.768 1997 1533.2 102.0 
TPAB 3 287.5 2.024 0.380 0.801 1997 1600.4 110.9 
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5.4.9 Determination of Response Factors for Benzyl Phenyl Ether and Phenol 
 Response factors for benzyl phenyl ether and phenol were determined for GC method 2.  
Five different stoichiometric ratios of phenol, benzyl phenyl ether, and biphenyl (1:1:1, 2:2:1, 
3:3:1, 1:1:2, 1:1:3 by mass, respectively) were examined.  All standard solutions were prepared 
in acetonitrile with a final volume of 1.0 mL.  Each unique ratio of components was prepared in 
triplicate.  Each vial was also tested individually in triplicate to ensure that the any error 
associated with the instrument detector was minimal. 
 The response factor for phenol was calculated as 2.4676, and the response factor for 
benzyl phenyl ether was 0.9428 with respect to the biphenyl internal standard. The summary 
table and plot are shown below. 
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Summary Data Table for Benzyl Phenyl Ether and Phenol Response Factors 
Vial 
# 
Inj 
# 
PhOH 
(mg) 
BnOPh 
(mg) 
Ph2 
(mg) 
PhOH 
(μmol) 
BnOPh 
(μmol) 
Ph2 
(μmol) 
PhOH 
(Area) 
BnOPh 
(Area) 
Ph2 
(Area) 
BnOPh 
Response 
Factor 
Instrument 
Std. Dev. 
PhOH 
Response 
Factor 
Instrument 
Std. Dev. 
1 1 0.5 0.5 0.5 5.31 2.71 3.24 39157.4 55448.2 63425.3 0.9574 
0.0037 
2.6541 
0.0444 1 2 0.5 0.5 0.5 5.31 2.71 3.24 41130.0 56732.5 64595.4 0.9530 2.5734 
1 3 0.5 0.5 0.5 5.31 2.71 3.24 41350.0 57396.3 65153.0 0.9501 2.5818 
2 1 0.5 0.5 0.5 5.31 2.71 3.24 41951.2 56917.4 64738.9 0.9520 
0.0035 
2.5286 
0.0049 2 2 0.5 0.5 0.5 5.31 2.71 3.24 42292.8 57942.6 65496.3 0.9461 2.5376 
2 3 0.5 0.5 0.5 5.31 2.71 3.24 42141.1 57580.7 65058.5 0.9457 2.5297 
3 1 0.5 0.5 0.5 5.31 2.71 3.24 42417.1 58049.1 65184.8 0.9399 
0.0019 
2.5181 
0.0212 3 2 0.5 0.5 0.5 5.31 2.71 3.24 44012.1 59197.3 66688.4 0.9429 2.4828 
3 3 0.5 0.5 0.5 5.31 2.71 3.24 44469.7 59724.2 67305.6 0.9433 2.4800 
1 1 1.0 1.0 0.5 10.63 5.43 3.24 91358.5 117621.0 67438.4 0.9598 
0.0008 
2.4191 
0.0120 1 2 1.0 1.0 0.5 10.63 5.43 3.24 90349.4 117209.0 67090.3 0.9582 2.4335 
1 3 1.0 1.0 0.5 10.63 5.43 3.24 89138.2 115981.0 66447.7 0.9591 2.4429 
2 1 1.0 1.0 0.5 10.63 5.43 3.24 91632.5 122364.0 68343.9 0.9350 
0.0027 
2.4442 
0.0073 2 2 1.0 1.0 0.5 10.63 5.43 3.24 90289.4 121350.0 67427.4 0.9302 2.4473 
2 3 1.0 1.0 0.5 10.63 5.43 3.24 92116.8 123061.0 68402.0 0.9305 2.4335 
3 1 1.0 1.0 0.5 10.63 5.43 3.24 90225.2 120531.0 67203.6 0.9334 
0.0012 
2.4410 
0.0067 3 2 1.0 1.0 0.5 10.63 5.43 3.24 89787.6 120848.0 67223.3 0.9312 2.4536 
3 3 1.0 1.0 0.5 10.63 5.43 3.24 92646.1 124132.0 69073.8 0.9315 2.4433 
1 1 1.5 1.5 0.5 15.94 8.14 3.24 140660.0 184708.0 68769.8 0.9349 
0.0007 
2.4033 
0.0017 1 2 1.5 1.5 0.5 15.94 8.14 3.24 141323.0 185709.0 69051.2 0.9337 2.4018 
1 3 1.5 1.5 0.5 15.94 8.14 3.24 135892.0 178630.0 66493.6 0.9347 2.4053 
2 1 1.5 1.5 0.5 15.94 8.14 3.24 138861.0 182372.0 68005.9 0.9364 
0.0026 
2.4074 
0.0072 2 2 1.5 1.5 0.5 15.94 8.14 3.24 137956.0 181427.0 67924.8 0.9401 2.4203 
2 3 1.5 1.5 0.5 15.94 8.14 3.24 137335.0 180295.0 67595.7 0.9414 2.4195 
3 1 1.5 1.5 0.5 15.94 8.14 3.24 160551.0 213260.0 79919.1 0.9410 
0.0015 
2.4469 
0.0050 3 2 1.5 1.5 0.5 15.94 8.14 3.24 155416.0 205936.0 77230.5 0.9417 2.4428 
3 3 1.5 1.5 0.5 15.94 8.14 3.24 159526.0 211751.0 79598.5 0.9439 2.4528 
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Summary Data Table for Benzyl Phenyl Ether and Phenol Response Factors, cont. 
1 1 0.5 0.5 1.0 5.31 2.71 6.48 44782.8 60006.2 134812.0 0.9402 
0.0023 
2.4663 
0.0043 1 2 0.5 0.5 1.0 5.31 2.71 6.48 44292.2 59530.7 133689.0 0.9399 2.4729 
1 3 0.5 0.5 1.0 5.31 2.71 6.48 42729.1 57208.1 129046.0 0.9440 2.4743 
2 1 0.5 0.5 1.0 5.31 2.71 6.48 52927.9 72000.3 160498.0 0.9329 
0.0009 
2.4844 
0.0094 2 2 0.5 0.5 1.0 5.31 2.71 6.48 52492.3 71497.9 159526.0 0.9338 2.4898 
2 3 0.5 0.5 1.0 5.31 2.71 6.48 52902.8 71463.1 159593.0 0.9346 2.4716 
3 1 0.5 0.5 1.0 5.31 2.71 6.48 44690.9 60664.5 136390.0 0.9409 
0.0011 
2.5003 
0.0052 3 2 0.5 0.5 1.0 5.31 2.71 6.48 45148.4 61050.4 137221.0 0.9407 2.4901 
3 3 0.5 0.5 1.0 5.31 2.71 6.48 45043.3 60922.3 137229.0 0.9427 2.4960 
1 1 0.5 0.5 1.5 5.31 2.71 9.73 45772.3 60772.7 210734.0 0.9675 
0.0022 
2.5146 
0.0092 1 2 0.5 0.5 1.5 5.31 2.71 9.73 44355.9 59247.9 204912.0 0.9650 2.5232 
1 3 0.5 0.5 1.5 5.31 2.71 9.73 44404.8 58993.9 203642.0 0.9631 2.5048 
2 1 0.5 0.5 1.5 5.31 2.71 9.73 43887.3 59437.2 201101.0 0.9440 
0.0041 
2.5028 
0.0032 2 2 0.5 0.5 1.5 5.31 2.71 9.73 45881.5 62011.0 210747.0 0.9482 2.5088 
2 3 0.5 0.5 1.5 5.31 2.71 9.73 44909.5 61106.6 205866.0 0.9400 2.5037 
3 1 0.5 0.5 1.5 5.31 2.71 9.73 42523.2 58717.0 198147.0 0.9415 
0.0048 
2.5451 
0.0125 3 2 0.5 0.5 1.5 5.31 2.71 9.73 44316.5 60388.7 204469.0 0.9447 2.5200 
3 3 0.5 0.5 1.5 5.31 2.71 9.73 44342.7 61325.1 205574.0 0.9353 2.5322 
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Benzyl Phenyl Ether and Phenol Response Factor Plot 
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5.4.10 Benzyl Bromide Titration of the Organic Phase 
 To a 4 mL dram vial was charged the appropriate quaternary ammonium bromide (8.2 to 
29.6 mg, 53.1 umol).  To this vial, a solution of biphenyl (8.2 mg, 53.1 umol) in 2,4-dimethyl-3-
pentanone (2.00 mL, 26.6 mM) was added followed by a solution of phenol (50.0 mg, 531 umol) 
in 5 M aq. KOH (700 uL). A 1.5 cm egg-shaped magnetic stir-bar and a septa screw-cap were 
then installed. To begin mixing the vial was placed in a 40 °C water bath and the stirring speed 
was set to maximum (~2000 rpm). The vial was stirred vigorously for one hour. 
 To analyze the organic phase, stirring was ceased and the biphase was allowed to settle 
over several seconds.  A reaction aliquot (100 μL) was taken from the organic phase and quickly 
injected into a small vial containing a solution of benzyl bromide (10.0 mg, 5.85 μmol) in 
acetonitrile (1.00 mL).  The quenched solution was allowed to sit overnight (>12 hours).  This 
solution was analyzed directly via gas chromatography (GC Method 2). 
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Summary Table for Benzyl Bromide Titration Data 
C
a
ta
ly
st
 
R
u
n
 #
 
PhOH 
(Area) 
Ph2 (Area) 
BnOPh 
(Area) 
PhOH 
(μmol) 
Ph2 
(μmol) 
BnOPh 
(μmol) 
% 
PhOH 
Mean 
% 
PhOH 
Std. 
Dev. 
% 
PhOH 
% 
BnOPh 
Mean 
% 
BnOPh 
Std. 
Dev. % 
BnOPh 
% 
PhOH 
+ % 
BnOPH 
Mean 
(% 
PhOH 
+ % 
BnOPh) 
Std. 
Dev. (% 
PhOH 
+ % 
BnOPh) 
TMAB 1 0.00000E+00 4.51207E+04 0.00000E+00 0.00 53.10 0.00 0.00 
0.10 0.17 
0.00 
0.00 0.00 
0.00 
0.10 0.17 TMAB 2 0.00000E+00 4.44911E+04 0.00000E+00 0.00 53.10 0.00 0.00 0.00 0.00 
TMAB 3 5.41190E+02 4.58240E+04 0.00000E+00 1.55 53.10 0.00 0.29 0.00 0.29 
TEAB 1 0.00000E+00 4.49796E+04 0.00000E+00 0.00 53.10 0.00 0.00 
0.26 0.23 
0.00 
0.00 0.00 
0.00 
0.26 0.23 TEAB 2 7.47601E+02 4.53088E+04 0.00000E+00 2.16 53.10 0.00 0.41 0.00 0.41 
TEAB 3 6.96186E+02 4.50351E+04 0.00000E+00 2.03 53.10 0.00 0.38 0.00 0.38 
TPAB 1 1.98958E+03 4.64946E+04 1.44779E+03 5.61 53.10 1.56 1.06 
1.03 0.02 
0.29 
0.28 0.01 
1.35 
1.32 0.03 TPAB 2 1.92605E+03 4.64721E+04 1.37126E+03 5.43 53.10 1.48 1.02 0.28 1.30 
TPAB 3 1.89130E+03 4.55121E+04 1.34741E+03 5.45 53.10 1.48 1.03 0.28 1.30 
TBAB 1 1.21391E+04 4.46383E+04 4.42429E+04 35.63 53.10 49.62 6.71 
6.78 0.11 
9.34 
9.35 0.15 
16.05 
16.13 0.15 
TBAB 2 1.33858E+04 4.72479E+04 4.64583E+04 37.12 53.10 49.23 6.99 9.27 16.26 
TBAB 3 1.27760E+04 4.65350E+04 4.48905E+04 35.97 53.10 48.29 6.77 9.09 15.87 
TBAB 4 1.33845E+04 4.87735E+04 4.88785E+04 35.96 53.10 50.17 6.77 9.45 16.22 
TBAB 5 1.26740E+04 4.65496E+04 4.70446E+04 35.68 53.10 50.60 6.72 9.53 16.25 
TBAB 6 1.30583E+04 4.80559E+04 4.79518E+04 35.60 53.10 49.95 6.71 9.41 16.11 
THAB 1 8.24774E+03 4.61568E+04 7.34046E+04 23.41 53.10 79.62 4.41 
4.92 0.67 
14.99 
14.13 0.53 
19.40 
19.04 0.53 
THAB 2 9.17470E+03 4.49123E+04 6.81226E+04 26.77 53.10 75.93 5.04 14.30 19.34 
THAB 3 1.07727E+04 4.62675E+04 6.83286E+04 30.51 53.10 73.93 5.75 13.92 19.67 
THAB 4 8.28168E+03 4.79174E+04 7.18287E+04 22.65 53.10 75.04 4.26 14.13 18.40 
THAB 5 8.56936E+03 4.83448E+04 7.19967E+04 23.23 53.10 74.56 4.37 14.04 18.41 
THAB 6 1.12643E+04 4.90706E+04 6.96011E+04 30.08 53.10 71.01 5.66 13.37 19.04 
TOAB 1 4.35283E+03 4.54573E+04 7.96443E+04 12.55 53.10 87.71 2.36 
2.30 0.15 
16.52 
16.77 0.23 
18.88 
19.07 0.15 
TOAB 2 4.72829E+03 4.69690E+04 8.24716E+04 13.19 53.10 87.90 2.48 16.55 19.04 
TOAB 3 4.12302E+03 4.66054E+04 8.42662E+04 11.59 53.10 90.52 2.18 17.05 19.23 
TOAB 4 4.10766E+03 4.79866E+04 8.57615E+04 11.22 53.10 89.47 2.11 16.85 18.96 
TOAB 5 4.57867E+03 4.81476E+04 8.61550E+04 12.46 53.10 89.58 2.35 16.87 19.22 
  451 
5.4.11 Potassium Titration 
 As described previously in general procedure H, 1.0 mL of the organic phase was 
transferred to a PTFE digestion test tube containing benzyl bromide (200 uL).  The resulting 
mixture was mixed briefly by swirling, capped with a rubber stopper, and the contents were 
allowed to sit overnight. To this solution, H2O (1.0 mL) and then concentrated nitric acid (6.0 
mL) were added and the entire mixture was digested in a microwave oven (ramp to 1200 watts 
over 40 m, hold for 20 m, cool down over 30 m, max pressure 60 bar). 
 The resulting solution was then diluted to a final volume of 25.0 mL with H2O and then 
analyzed directly by ICP-OES. 
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